Show UniProt / TrEMBL protein name		View in Fasta format (DNA)		View as list

# Buchnera aphidicola str. Sg (Schizaphis graminum), Sg

>BUsg091 Y098, hypothetical protein
MNKNRQLAVNSNILFRKWLNGTREMVQDTIFHSRLHKVNQKIRSKRMFFE
QDVHSNYFSFYKKKDFFKENPVSYVRNKDFTNVLKKLKKGKYYPDIFLDL
HGLNQYQARKKLGQLIAICQKEKMFCAHIMHGYGKNILKKQIPFWLSQHP
DIVAFHQAPKMFGNDAAIMVIIEIHS
>BUsg270 Y281, hypothetical 34.4 kDa protein
MHKIIIIMLFFLVSITWGTTWIAMKIAVETIPPFFATGIRFLAASPLLII
LSYLTKKPLLFPYGQRRFQIFISIFYFSIPFTLMLYGGSYVNSSISSIIF
ANMPVLVLIISHFYLKKKINFIQKVGMVIALITLFFVLLIDLKSECFFQW
KGILALLLALLSHAVIYVECQKKSCNVSVITFNALPSLISGIFLSIISWF
IESPNINFFSTRSILAVFYLGNFCGICGILSYFYLQKRVSSFYASIVFLI
FPLIAGFLEIYIYKKTILLYELWFIIPSGLGILLTLIPINFFKNIIRFSK
>BUsg199 aceE, pyruvate dehydrogenase E1 component
MSEKLYNYDVDPVETNDWVQSIESVIREEGLERAKFLIEKILKKSKITRA
NFFKCFFTSDYINTISSEEEVEYPGDLILEKRIRSAIRWNAIMMVLRASK
KDLELGGHLSSFQSSATIYEVCFNHFFRSKNDEDGGDLVYFQGHIAPGIY
ARSFLEGRLSKKQIDNFRQEVDGKGLSSYPHPKLMPNFWQFPTVSMGLGP
LCAIYQAKFLKYLQNRELKNTSKQTVYAFLGDGEMDEPESKGAISIAVRE
KLDNLIFVINCNLQRLDGPVVGNGKIVNELESFFYGAGWKVIKVIWGGKW
DSLLKKDKTGKLIQLMNETIDGEYQTLKSKDGAYVRKYFFGKYQETLELV
KNMTDEEIWNLNRGGHDPKKMFNALKKAKEIKDKPTVILAHTVKGYGMGV
IAEGKNIAHQIKKININGIIYIRDRFNIPISNEDIKELPYVVFEKNSKEY
CYMHQQRKKLGGYIPFRLSKFTNALNIPDLIDFKSLLKEQNKKMSTTIAF
VRVLNLILKNHSIKNLIVPIIADEARTFGMEGLFRMIGIYSSIGQKYVPQ
DREQLAYYKEEKKGQILQEGINELGAASSWLAAATSYSTNDFPMIPFYIY
YSIFGFQRIGDLFWAAGDQQARGFLIGGTSGRTTLNGEGLQHEDGHSHIQ
SLTIPNCVSYDPAFAYEVAVIIQDGLRRMYGPLQENIYYYITTINENYYM
PAMPQGVEKGICKGIYKLKTFYATELKVQLMGSGAILRCICKAGEILSND
YCITTDIYSVTSFTELARNGEDCERWNMLHPYEKKRIAYIKTVMNSSPAV
AATDYMKLFAEQIRHYIPSNEYHVLGTDGFGRSDSRDKLRDHFEVSAYYI
VVAALNLLAKLNNINKKVVEEAIIKFNINADKINPRLA
>BUsg200 aceF, dihydrolipoamide acetyltransferase component
MKKVHIEVKMPDIGLEEVEVTEILVKIGEEIKLDQGLITVEGDKASMEIP
SPISGIVKDITIKIGEKVKTSSIIMIFKVNNLNSIKNEKDLNYIKTEKKL
NENFLEEKKDIKKIVLVHATPVVRRLARHLNVDLKNITPSGPKNRILKED
IELYIRNNTSNKSSFNIEKNNTTNFHKDLFNEIPITNIQQIIGKNLHQNW
VNIPHVTQFDEVNITLLEEFRHKYNTEKKQKNNMCSKITILPFIIKSVAY
GLLEFPIFNSSLSVNKKTIFLKKYVNVGIAVDVQNALFVPVLKNVDKKNI
ANLSSELIFLSKKAHENKLDASDMKDGCFTISNLGGIGGSWFSPIINSPE
VAILGVSKALIKPLWNGKEFIPSLMLPLSLSYDHRVINGADAARFLTFIG
KMLSDIRFLIM
>BUsg169 ackA, acetate kinase
MVKILNNLIFVLNCGSSSVKFAILNPDNKKKYLSGLVECLFLSKTYMKWK
DLTTEHKKCIGSNLSHKDALNFIFNKFFLEKKDIYKNIVGIGHRVVHGGN
KIKSSTLIDDNIIQLIQKAISFAPLHNPANLIGIKTAIEKFPIFAKKNVA
VFDTSFYQNMPETSFLYAIPYFFYKEHHIRRYGAHGTSHHYVASEVALIL
NKNFNSLNVITCHLGNGASVSAVCNGICVDTSMGLTPLEGLVMGTRSGDI
DPSIIFFMYQKLGMSIDEIHTILTKESGLLGLSGISSDFRYFEKKYYFEK
KARLAVDIFCHRLSKYIASYMSLMENNLDAIVFTGGIGENVPLIREITLS
KLLLIGFKIDTQRNLGIKNGKHGLITTDKSRPAFVIPTDEELAIAQETIK
IIK
>BUsg340 acpP, acyl-carrier protein
MNNVEKKIKKIISKILNIKVEKILNNASFLDDLSADSLDIVELIMAIEEE
FDIEISDEDAEKLNTVQKSIDYINNKNKK
>BUsg247 acpS, holo-[acyl-carrier protein] synthase
MSIIGIGTDIIEIFRIKNIVYNFKDKLAERILSVQELEKYKVNKNPIKFL
AKRFAVKEAASKALGTGISYGIKFNQIELYNNNLGKPKLRFLKYALQKSE
EMKCKSIFVSISDEKLYACALVILEK
>BUsg469 adk, adenylate kinase
MRIILLGAPGTGKGTQAKLITENYNIPKISTGDILRENIQKKNTIGKKIH
NILKNGELVSNRIVCNLIGERIQKKDCIHGFLLDGFPRTQKQAEYISNLK
IKIDYVLELIVPYELILKRICGRRVHTPSGRIYNINYNPPREEGKDDLTQ
EKLTIREDDTIEIVKKRLENYEKNSFLLNKYYLREKKLKKLQYFKIDGKQ
SIYKIQREIKMMLK
>BUsg176 ahpC, alkyl hydroperoxide reductase subunit C
MTLVTQKAPNFIAPAILKNGKIMNNFDLKKYSNGQITVLFFWPMDFTFVC
PSEIIEFNKTFEAFEKRNVKIVGVSIDSVFVHQAWQNTFPENGGIGKIKF
PMVSDIKHEIQKSYHIEHPELNIALRASFLIDENWIIRHQVVNDLPFGRN
IDEMIRMIDALNFHNKYGEVCPVNWKHGQEGMKASQEGVSSYLKKYFS
>BUsg390 alaS, alanyl-tRNA synthetase
MKKTTNEIRQSFLNFFKEKEHVIVPSSSLIPENDSTLLFTNAGMNQFKEY
FLGQKKKFYPRVTTVQNCLRTGGKHNDLENVGYTKRHHTFFEMLGNFSFN
DYFKKEAITYAWELLTSRKWFNIDKNKLWISVYEDDEETYKIWRDIIRIP
CHHIVKIGSKNNSQYDSENFWQMGETGPCGPCTEIFYNYDDSNKSNDFLK
DKNESFIEIWNIVFIEFNRISKTKIVPLINKSIDTGMGLERISAVLQNVH
SNYKIDIFQKLIQKISNFTEIKDLNNISLKIIADHIRSCAFLIAENILPS
NEHRGYVLRRIIRRALRHGHKIGIKNNFFYKLVPSLIEIMGDSAKILRKK
EKIIEETLKIEEIQFSQTLDKGLKILNAEIKKSTNKTISGKTAFYLYDTF
GFPIDLTSDICSEKNIKIDFKGFNIAKEEQKKRSSIKNKFYKDYNKDIII
NDTCIFEGYKKNKTKSLVKYIFIKNESVFLIYKGQTATIFLDKTSFYPES
GGQIGDIGELYHKKSRFIVENTKKYGDTIGHYGKLISGKIIVNDSIYSKI
NHVYRNAIQLNHSATHLLHAALQKVLGKNAIQKGSLVSNTHLRFDFSYSG
NINLSQIQNIENIINKKIRSNDLIKIKNLSLEEAKKKKAIALFDYKYQSS
VRVVFIKDFSIELCGGTHTKRTGNIGLFKIIEQSSVSSGIKRIEAVTGQQ
AIDYLHIKDNDMQNISFLLKCQNSKITEKIKKIIIQVEKLEKKTDQLQKR
ENIYQIKKLSKKINNIKGINLLINTFTNYDQKSMKMIIDQLKKELKISII
IFINKNKNDFTVIIRVTKNLINYITALKIINIFIKKANGKGGGKKEIAEG
GGMNIKKLPMILNYIKSWITIQLENIKTKNFNN
>BUsg555 amiB, N-acetylmuramoyl-L-alanine amidase II precursor
MIDPGHGGQDPGAINSLGLQEKKITLKIGIKLKNLLQNSDLFYPVLTRND
DSYVSLKKRRDFLKNNHVSFLISIHADSSKKRYVSGASIWITTNDRMHRE
INNFIKNREENIYFPKNIQNLIQKNKHDFFLKKTVLDLQFNNFQKMEINL
SRYIFQQLKKIIKLDKINLNYASLGILSSINTPSMLIETGFITNFLEEKK
LRTNKYQNKIANAIYIALKNYFQDRLLSNLRNT
>BUsg135 apaH, bis(5'-nucleosyl)-tetraphosphatase
MSIYFISDIHGCYKEFKLLLKKSFFNDKKDFLWIAGDLVSRGPDSLKVIR
YLYSLRKRIKIILGNHDLNLIAVYSGVKENKKENYFDEFLSAKDNLQLIN
WLRCQSILKIDEERKIIMSHAGISPKWDIDTAKKYALEIEKCLSGKNYSS
FLRSVFNNKINYWNLNLNKLDRLRYSINVFTRMRYCYPDSRLNLICKKSP
NLVKYPLIPWFKIPNKIPKEYSVFFGHWSSLIGTKVPQPFFPLDSGCCWG
GKLTMFRWEDKKYFFQSFQKNNS
>BUsg441 argA, N-acetylglutamate synthase
MRERTTELVQGFRHSVPYINAHRGKKFVIMLSGEAIKYGNFSGIINDIGL
LHSLGIRLIVVYGSCPQINANLKEKNIKITYHKYIRVTDLLSLEQVKQAA
GRLQLDITARLSMSLSNTPLQGANINVVSGNFIIAQPLGVDDGIDYCHSG
RIRRIDKKAINCQLENGAIVLIGPVAVSVTGESFNLTSEEIATQVSIKLK
AEKMIGFCSKQGVIDSQGKTISELLPNNIQNEIKKLEGKGDYISSTIRFL
RGSIKACKSGVNRSHLISYHKNGALLQELFSRDGIGTQMVMESAEKIRQA
NINDIGGILELIRPLEKKGILVRRSREQLEMEVDKFTIIERDNLTIACAA
LYPFFKEKIGEMACVAVHPDYRNSSRGDLLLQTMKLNAKKLNLKKIFVLT
TQSIHWFQERGFILVDVEILPESKKKMYNYQRCSKILMIDLF
>BUsg046 argB, acetylglutamate kinase
MMSPLVIKLGGVLLESDNAMMRLFKALLDYQKSNKRHILIIHGGGRLIDD
LMNKLSLPIEKKNGLRITQSEHINVITGALAGTANKILLSWALKYKINAV
GLCLADGKSVNVEKLDQDLGHVGKAKPGSPLFLTKLCEQGILPIISSIGI
TDDGLLMNVNADLAATALATTLKANLILLSDISSILDGKGQRISEINYLQ
AKKLISQGIITNGMIVKVNAALEAARVLQRSIDIASWQNTDQLKLLFNGI
NIGTRVLV
>BUsg045 argC, N-acetyl-gamma-glutamyl-phosphate reductase
MLNVLIVGASGYSGAELVNYINRHMFSKIKKIFVSENSSHIGKLFSELHQ
EFKNIIDLPFEAINYDTLIEKDIDAVFLATDHHVSYSLVPFFLSLNCVVF
DLSGAYRVKNTDTYLKYYGFSHQHQDILKRSVYGLAEWNKQEIKKAELIA
VPGCYATCIQLALKPLIKENFLNDEFIPIINAISGVSGAGRKANITNSFC
EVSLHPYNVFTHRHTPEIIEHLGIPVIFIPHLGSFSRGILASITCKLKCN
FTFQDIYNLYNTVYKEKPLIRVYEKNFPSIKAVVKLPFCDIGFIIQDKYI
VIIAAEDNLLKGAAAQAIQCFNIRFGFSEIESII
>BUsg515 argD, bifunctional N-succinyldiaminopimelate-aminotransferase/acetylornithine transaminase protein
MIGKIKLITRDSFNKLILPVYNPAFFIPVKGKGSRLWDQKGKEYIDFSGG
IAVTSLGHCHPVLNKVLRQQSKKLWHISNIFTNEPALRLADKLISSSFAS
RVFFANSGAEANEAAFKLARYYSSKIYNLKKNKIISFYNSFHGRTFFTVS
VGGQAKYSDFFGPKPPAIMHAKFNEINSVKSIIDDNTCAVVMELIQGEGG
IVPADVAFVREIRDLCYKYNALLIFDEIQTGIGRTSKLYAYEHYEVQPDI
LTIAKSLGSGFPISATLTTNGIASVIKPGIHGTTYGGNPLACSIAESVVN
IVNTKKFLLGVEKKSKKIISELNIINKRFGLFTEIRGKGLLIGIVLRPEL
SEEIHNILNALFLEGVIVLTAGKNVIRLAPSLIISKRDIVEGMKRFYCAL
EKCL
>BUsg044 argE, acetylornithine deacetylase
MIRKIPSFIKIYESLIKIPTISSLNNKLDQSNKVLIDLLSNYFSELNFLI
NIKNIPNTNKFNMLASFGDGKGGILFSGHTDTVDFDEHLWTKDPFKLTEK
NNKLYGLGTVDMKGFFAFILDALCSINIKSIKKPIYILATANEETDMSGA
RYFIQSSSIKPDFIIIGEPTSLKLVKAHKGHVSYSIDVVGNTGHSSNPAN
GINSIEIMHLVIKKLLKLKIYLREKYFHKDFSIGYPTMNFSSINGGNAIN
RICALCNLKFEIRPTPGLTLTQIEILIQEMLQAIFKKWPNRIFLKNLFFS
VPPYEFPKEKKIIKKIENSCQLKPTTANYCTEAPFLGKIGPTLILGPGSI
QQAHNADEYLDCSFIKPTKKIIRKLIKNFCY
>BUsg356 argF, ornithine carbamoyltransferase chain F
MNCLYQRDCLRLLDFTTAELKHIITLSEKLKKTKQNRQEIKLLKQKNIAL
IFEKESTRTRCSFEVAAFDQGANVTYLGPGSTHLGTKESIEDTARVLSRL
YDGIQYRGHNHKTIEILAQYSTVPVWNGLTEKFHPTQLIADLLTIKEIFP
NRNFSDIKCAYVGDSRNNIGNSLLEAASIVGLNLYLVSPKQYWPEKNLFI
ECKKIIKKNQGNIICTENISEGVKNADFIYTDVWVSMGEHHKIWKERIEL
LKNYQVNDSMIKMTNNSKVKILHCLPALHDQKTSIGKSILKKYGLKDGME
ITDNIFQKHQKTIFEQAENRLHTIKALLVSSLIKEMNF
>BUsg047 argG, argininosuccinate synthase
MNNFKKVVLAYSGGLDTSAIIPWLKENYHVDVVAFVADIGQSKKDLNGIE
KKALQSGAIDCRVFDLKEEFIKDYVYPVLKTGSLYEGNYLLGTAIARPII
AKKQVEFASSIGAKFLCHGATGKGNDQVRFEIAYAALAPYMKVIAPWREW
NLNSRESLLEYLREKNIPTSATLEKIYSRDENSLHISTEGGLLEDLWNKP
NADCWNWTVELEDAPEQPEYISLIVKNGSVVSVNNEFLTPLKCIEKLNKI
GSKHAIGRIDIVENRLVGIKSRGCYETPGGTIMHIALRAIEQLVFDRESF
KWREKIGLEMSSVVYDGRWFTPIRKSLQASADSLSSEVNGEVVLKLYKGS
VIPVQKKSSNSLYSKEYATFGEDEVYKHSDAEGFIRLFSLSSRIRAQNKL
K
>BUsg048 argH, argininosuccinate lyase
MSLWGGRFLDESNETFKKFNASLPFDYILVKEDIFASIAWSKSLVEVGVL
TQEEQKKIESALISLKEEIYNNSKKILESDYEDIHSWIEANLIKKIGELG
KKLHTGRSRNDQITTDLKLWCKRKIFVLLDSIINLQKNFIFVAELNDDVI
MPGYTHLQRAQPITFSYWCLAYVQMFKRDVSRLKDILKRLDISPLGSGAL
SGTAWNINRKKLAISMGFSSETNNALDSVSDRDYLIELLSASSISMTHLS
RFSEDLIFFNSSEANFIELSDSITSGSSLMPQKKNPDALELIRAKCGRVH
GALVSILVVLKSLPLSYNKDLQEDKEGLFDSLKTWNDSLLIASLVLKNIK
LNRLSCRKAAEKGYSNATEIADYLVKKGMTFREAHHVSGKLVLRAIKENK
SLNDLDLSIFQSYSALITDDIYKNITLEACLEKRSSKGGVAPNEIRKEIF
KEKERLNIL
>BUsg237 argS, arginyl-tRNA synthetase
MNIKYLIKKDIEQALIKINSNYTYEVFIISSKKIELGHYQVDNLMKISSR
LKIKPYKLFQKILILIEKKKIYKKIIFSHPGFINIFIKNEWLSEKLEIPF
ISSRLGVKYIYPKKNIVIDYSSPNIAKEMHVGHLRSTIIGDVTVRILEFL
GQKVIRANHIGDWGTQFGILIAYLEDKKLLKKLKKNLLSLQDLDNIYCQS
KKQYNSNELFSKKSREFVVKLQNGDQYCCAIWKKLVSITMLENYKIYKKL
NVTLEEKHTMGESFYNPMLPKIVEDLKKQKIAIEKNGAVIVFLDEFKNRM
GDSMGVIIRKKDKGFLYSTTDIACLKYRYQNLHADRIIYYTDSRQYQHLL
QSWTIAEKANYISKNLLLEHHMFGMMLSKNRRPFKTRDGNTIKLSNLLNE
SINRATNLIQKKQPNLCKKKLIKLGEIIGISAVKYSDLSKNRNTNYIFDW
DKMLSFEGNTAPYIQYAYTRIISILKKSNIPLHKIKMKIILNEESEINLA
IKILEFEEIILLIAKNGTPHIMCKYLYQLSTYFSHFYENCSILFSEKIKI
RKSRIKLSFLTAKTIKKGLNLLGIKTIKKM
>BUsg301 aroA, 3-phosphoshikimate 1-carboxyvinyltransferase
MQKFLELKPVSYINGTIYLPGSKSISNRVLLLSAMANGITCLTNLLDSQD
TQYMLNALRKIGIKFFLSNNNTTCHVHGIGKAFHLSHPISLFLGNAGTAM
RPLLAALSLYENNVVLSGDDRMHERPIAHLVDALKQGGATLEYKKGIGYP
PVLTKGGFKGGSIMLDGSISSQFLTSLLMVAPLALQNTNIFIKGNLVSKP
YIDITLNLMKSFGVNIVNDCYKSFYIKGNQKYESPGNYLVEGDASSASYF
LAAAAIKGGSVKVVGVGKKSVQGDIKFADVLEKMGAIIDWGDSFIVCRHN
KLEKIDLDMNHIPDAAMTIAIVALFAKGTSIIKNIYNWRVKETDRLSAMS
KELKKVGAIIKEGRDCLSITPPNFFKFAEIDTYNDHRMAMCFSLICLSGI
SVRILNPNCISKTFPSYFENFLKISRFD
>BUsg519 aroB, 3-dehydroquinate synthase
MEQLKVVLGKRSYPINIGSSIIQEDNIFWPLNPGNQAMLITNKTLANLFK
DKVFFHLRKSGIKIDQVILSDGEQFKTLNEMEVIISALLEKKHSRDTTLI
ALGGGVIGDLTGFSASIYQRGVRFIQIPTTLLSQVDASVGGKTGVNHLLG
KNMVGSFWQPSSVIIDINFLKTLPYNELVSGMAEVIKYAVIFDANFFEWL
EENIENLLLLNDELMSYCIKKCCELKAQIIALDERENNFRALLNFGHTYG
HAIEAHAGYGSWLHGEAISVGMVMASRTSELIGCLKKTDYKRILSLLKKA
GLPVKGPKNMSAASYLPYMMRDKKVISGEMRLVLPISIGKAKIYSGIDKN
IILSAIKDSQ
>BUsg090 aroC, chorismate synthase
MAGNTIGKVFRVTTFGESHGTALGCVIDGMPPGLELSSDDLQYDLNRRRP
GTSRYTTQRSELDEVQILSGVFKGTTTGTSIGLVIQNKDQRSQDYSEIKD
LFRPGHADYTYEKKYGIRDYRGGGRSSARETAMRVAAGSIAKKYLKIQTG
IVIRAYLSAMGDIKCPFESWEEVEQNPFFCSNKNKVFQLEELIKKLKKTG
DSIGAEITIIAQNVPVGFGEPVFDRLDADLAHALMSINAAKGVEIGDGFS
VVNQKGSENRDEMTPNGFKSNHCGGILGGISNGENIFLKVAFKPTSSIRQ
SGNTINKNNEKVKIVIKGRHDPCVGIRAVPIAEAMVAIVLMDHLLRFRAQ
CAK
>BUsg386 aroD, 3-dehydroquinate dehydratase
MIMKKNINVLLINGPNLNLLGDREKNIYGDKTLSCLINDLKKRSEILNIS
LNDIQSNAEHVIIEKIHSAKKEKIDYIIINPAAFTHTSIAIRDALIAVTI
PFIEVHISNIYARENFRSHSWLSDISKGVITGLGLDGYFWALETISKRCC
V
>BUsg474 aroE, shikimate 5-dehydrogenase
MCKLEKFNYALFGNPIDHSQSPKIHNFFATQTGILHIYKAINIPLDQFSS
VVSDFFKKNIKGANVTAPFKKEAYFFSDKLTERAKIAQSVNTLKKISDKC
ILGDNTDGIGLLSDLVRLNFIKKNFSILILGAGGAVKGVLLPLLSLGCSV
YILNRTILNAKILVKQFNKYGKIFVFDRQNFKQQNFDLVINAMSRNTEKK
NFLPLSLITSKTFFYDMNYSTRNTPFINWCSKAGGSFISNGIGMLVFQAA
YSFLEWHNVLPEINYIINILNIK
>BUsg116 aroH, 3-deoxy-7-phosphoheptulonate synthase
MKKTDELRTIRIDPLITPSELAKKYAITSEIMDNVIITRQNIARIMTGED
LRLLVVIGPCSVHDPIAAVEYAHRLYELRKKYQDRLEIIMRTYFEKPRTV
VGWKGLISDPDLNGSFRVNHGLAVARKLLLDINELGMPAATEFLDMVIGQ
FIADLISWGAIGARTTESQIHREMASALSCPVGFKNGTDGNIRIAIDAIR
AAQARHLFFAPNKDGQMTINHTSGNPYGHIIMRGGRTPNYHAHDINSAIE
HLREFNLLEHLMIDFSHGNCLKEHIRQKDVAKSVSKQISQGSKTIFGVMI
ESFLEEGFQTVKENQPLIYGKSITDACLNWKDSVLIIKQLADAVDTRF
>BUsg520 aroK, shikimate kinase I
MAEKRNIFLIGPMGAGKSTIGRQLSQQLNMEFFDSDQEIEKRTGANISWV
FDVEGEHGFRQREVKVIDELTKKQGIVLATGGGSVKFKENRNILSARGIV
IYLETTIEKQLSRTKRDKKRPLLQSNISNRTVLENLAYERNPLYEEIADF
KIQTDNQSAKSVAYSIIHLLEKM
>BUsg433 asd, aspartate-semialdehyde dehydrogenase
MTKSVGIIGWRGMVGSVLLKRMQEENDFSKIIPYFFSTSQSGQDGPIINN
ILSKNLKDAYNINLLQEMDIIITCQGSSYTEKIYPKLRNNNWQGYWIDAA
STLRMEKDATIILDPVNLNVINNALDKGIKTFVGGNCTVSLMLMALGGLF
VNNLIDWVFVSTYQAASGAGSRYVIELLKQMGSLYNVVSKDLLDKSYSVL
DIEKKVTQESRSKNFPLENFSVPLATSLIPWIDVEMKNGQSREEWKGQAE
TNKILNLKKKVLIDGTCVRISSIRCHSQSFLIKLNKDISLENIKKIIVNH
NQWVDVIPNNMQKTLCNLTPSAVTDTLNIPIGRLRKLNIDDRYLSAFTVG
DQLLWGAAEPLRRMLNLLVNI
>BUsg348 asnS, asparaginyl-tRNA synthetase
MSRISISEIYKDDIIVNTPITIFGWVRSRRSSKSGFSFITVYDGSCLNSV
QVVADKTLSNYYKDILHLTIGCSVTITGILILSIGDKQKYEIKATKFQVL
GWIKNPDTYPISAKKHSLEYLREVAHLRSRTNLIGVIVRIRHHIFQSLHK
FLNKQGYYWIPTPIITGLNTEGTGEMFRVSTMDMRNIPKKINGSVDFKKD
FFGKESFLTVSGQLNLEAYACSLSKVYTFGPTFRAENSNTSRHLAEFWML
EIESSFCNLDEILIFSEDMLKYICKSLLKYCINDIKFLKNYIDNDIINRL
KKFLSVNFIRINYKDAIDILLNSKKKFDNVVSFGVDLNAEHERFLVEKHF
KAPVVIINYPKELKAFYMRLNDDKKTVAAMDLLVPGIGELIGGSQREERI
SVLDLRLSELGLRKEDYWWYRDLRRYGTVHHSGFGMGFERLISYITGISN
IRDIIPFPRTVKNADF
>BUsg306 aspS, aspartyl-tRNA synthetase
MRTKYCGNIRIIDLHKSVILCGWVHKIRNFSQFIFIDMRDWTGIVQLVFE
KKNNKVFTKAVNLKNESCIQVIGIVKKRNANNNNLDTGEIEILVNKIKVF
NISKNLPLDYSNNSNDDIRLKYRYLDLRRSELLENLKIRNKITHLIRIFM
ENKNFLDIETPFLTKSTPEGARDYLVPSRNYPGNFYALPQSPQLFKQILM
ISGIDKYYQIVKCFRDEDLRSDRQPEFTQIDIEASFVSSTKIRNLVETLI
KKIWLKVINYNLNKFPKISFYDSMKRYGSDKPDLRNPMEIVDISDIVIEE
KVASFFQINLKKKNRIALLCFGQGNKISQKKIDEYSNYVKKFGAKKLFYI
KINKIENRFQDIQSSIKNILDKNTLENILRKTNAKNGNILFLLADEEKIV
NKSLGMLRIKLGNDFIFFKKNTWKPVWIVDFPMFKQNSDGKFSSNHHPFT
ALKKNNQNKLEKNPNLAISDSYDLVINGYEIGGGSVRIHDAKIQKKVFNI
IGIEKQFQREKFGFLIEALKYGPPPHAGIALGLDRIVMLLTNTNNIRDVI
AFPKTTSANCLMTDSPSKLKKSILNELGINILKK
>BUsg006 atpA, ATP synthase subunit A
MQLNSTEISQLIKERIAQFEVFNQSYNEGTIISVNDGIIKIYGLSDVMLG
EMILLPDNEYAIALNIERDTIGAVVMGPYIHITEGTKVRCTGKILEVPVG
VALLGRIVNALGFPIDGKGSIEHDIYLPVEADAPGVIERESINEPIQTGY
KAIDAMVPIGRGQRELIIGDRQTGKTALAIDTIINQKKINLPCVYVAIGQ
KLSTIINVVKKLDEHDALLNTIVVVASASEAASLQYLAPYSGCAMGEYFR
DRGKDALIVYDDLSKHAVAYRQISLLLRRPPGREAFPGDVFYLHSRLLER
ASRVSKEHVKNVTKGKITGKTGSLTALPIIETQSGDVSAFVPTNVISITD
GQIFLESNLFNSGIRPAVNAGISVSRVGSAAQTKIIKKLSSGIRTALAQY
HELAAFSQFASDLDQTTRKQLIYGQKITELLKQKQYRPMSISEQGLMFFI
AENNFLDDISVENIIQFEKEILTYAYNYHLDLMEEINKDGNFNDIIKKKF
IELINNFKNS
>BUsg002 atpB, ATP synthase subunit A
MSLEKISNPQKYISHHLNHLQIDLCNFKFVEPGKIVSHFWVLNIDSIIFS
LVLGCFFLSIFYTVAKKITTGVPNGLQASIELIFDFIRSNVKSMYQGKNP
LIAPLSLTVFVWVFLMNLMDLIPIDFFPFISERFFHFPAMRIVPSADINI
TLSMSLGVFILILFYSVKMKGLIGFCKELTLQPFNHPVFFIFNFLLELVS
LLSKPISLGLRLFGNMYSGEMIFILIAGLLPWWSQFFLNVPWAIFHILII
SLQAFIFMVLTIVYLSMASQSH
>BUsg009 atpC, ATP synthase epsilon chain
MDFYLDIVSVEKRIFSGLVDRIQVSGSEGEMGIYPGHTQLLSIIKPGVIY
IFHKNKTEECLYISGGILEVQPSVVSILADVAIRGIDLDRKRVVKAKKQA
EEYFKKETTNVKKDDVLLEISKAIAKLRVLEIMDKFKK
>BUsg008 atpD, ATP synthase subunit B
MIATGKIIQIIGAVVDVEFDQNSVPKIYNALEVKNKKIQLILEVQQQLGA
GIVRTIAMGSTNGLKRGLIVIDLGHYIKVPVGQATLGRIINVLGKTIDNK
GPLKNLDNSKLEYWEIHRSAPSYQEQASSQEILETGIKVIDLICPFSKGG
KVGLFGGAGVGKTVNMMELIRNIAIEHSGYSVFTGVGERTREGNDFYHEM
KDSKVLDKVSLVYGQMNEPPGNRLRVAFTGLTIAEKFRDEGRDVLLFIDN
IYRYTLAGTEVSALLGRMPSAVGYQPTLAEEMGLLQERITSTKEGSITSV
QAVYVPADDLTDPSPATTFAHLDSTVTLSRQIAALGIYPAIDPLNSTSRQ
LDPYIVGDEHYDTARGVQSILQRYQELKDIIAILGMDELSQEDKILVSRA
RKIQRFLSQPFFVAEVFTGFPGKYVSLKDNIRAFKGIIGGEFDNLPEQAF
YMVGTIEEVIKKAKLL
>BUsg003 atpE, ATP synthase subunit C
MESLNVDMLYIAVAIMIGLAAIGAAIGIGILGSKFLEGAARQPDLVPLLR
TQFFVVMGLVDAIPMIAVGLGLYMLFAIS
>BUsg004 atpF, ATP synthase B chain
MNLNATILGQALSFILFVWFCMKYIWPPIIFAIETRQKNIEESLISLKKA
EEELIIIQKKMNQIIQDSKEKASFIINEANKKKSIILEDAKSIALEESKK
IFLRNQLEIDLKVMQVRKNLHKEIVDLSILIAEKIIKDNIQKDQYKYSIK
KLIVSLSKDKKLI
>BUsg007 atpG, ATP synthase gamma chain
MASKKEIKDQIISVTNTKKITKAMEMVAVSKMRKTEERMRLGRPYSEIIK
KVIHHVLQGSLEYKHSYLEKRNDKRIGIIIVSTDRGLCGSLNTNLFKQVL
FKIQNFAKINIPCDLILFGLKSLSVFKLYGSSIISSVTNLGETPDLSKLI
GSIKIILEKYQNNQIDRLFIAYNKFHNKLSQYPKISQLLPLYNEKNIFSN
KKIKWDYLYEPESKLILDTLFDRYIESQIYQSLLENIASEQAARMVAMKT
ATDNSGNRIKELQLIYNKVRQANITQELTEIVAGASAVSVD
>BUsg005 atpH, ATP synthase delta chain
MSVLDTIARPYAKAIFELAIENQSIEKWKKTLIFINEIIRSKKIEKFLSG
SLSPSYLSSFFIFVAGDHIDKDARNLIKLLAENQRFKIFNNILRQFLKLE
TSYQGNTIIELISAYSLQEHEIIDIRCILQKIFLSKIKFIYKIDHQILDG
IIIKKADTVFDFSVRSYLKQLSDVLNF
>BUsg059 bacA, bacitracin resistance protein
MFFFHKIVIPIIIGIIQGITEFFPVSSTGHMIIFIDWLDIKNKDTKILEI
FVQLGSTISVFLFFYKKIIQILQLPMQKESNEKKNIHVLISILPTMFLGL
IFYNKIKSLFNPTNVMYALILGGFFLIIAEKFKPKKPKTNSIKEINLVQS
LIIGCFQTLCLYPGFSRSGASIAIATLLGFKRSVAVNFSFIISIPLIAGA
SVLDLIKNIQNVNMLNIPYLFSGFTISFIISFLLIKKFITILNKVSLTFF
GIYRFLIAGIIYFI
>BUsg089 bcp, bacterioferritin comigratory protein
MTTLKPGDIAPKFILPNCIDKSIKLSDFLGKKVLVYFYPKAMTPGCTVQA
CNIRDNLELFKSKKVEVLGISPDNTNKLLTFVEKKMLNFTLLSDKQNIVS
KKFGVWGEKIFMGKKYFGIYRTSFLINSSGFIDKIFFKFKCKDHHKIILT
YLNSKKSD
>BUsg281 bioA, adenosylmethionine-8-amino-7-oxononanoate aminotransferase
MSQSDIFFDHKHIWHPYSSMVNPLPCYSVISAKGVYLKLKNGKNIIDGMS
SWWSTIHGYNHPILNKSLKKQIRKMSHVMFGGITHPSAILLCRKLLKLTP
KKLDCVFLSDSGSIAIEVAIKMLIQYWEALGQKRTQILTIKNGYHGDTFS
AMSISDPNNSMHKIYNKFLPKNLFAETPTSSFHKEWNSIDIQSFKKIIEK
KSKKIAGVILEPIVQGVGGMNFYHPTYLKEIKKLCKAYSIPLVFDEIATG
FGRTGKFFAFQHANVIPDILCLGKAMTGGTITLAATLTSRNIAHTISSSK
VSCFMHGPTYMGNPLACAVANANIKILEKNEWKKQVINIEKQLCQSLLPL
IHHPRVVDVRVLGAIGVVECFHFVNMALIQKFFVKNGVWIRPFKKIIYIV
PPYIISMNCLKKLINVIEKSLDNDTLFNVENI
>BUsg280 bioB, biotin synthase
MKRKWNLEDTKKLFSKPFFDLIFEAQKKHREYFNPNRIQISTLLSIKTGA
CPEDCKYCPQSSRYKTGLKKEPLLEIEQILKAAKKAKSSGSTRFCMGAAW
KNPKEKDMPYLEKIVKEVKKMGMETCMTLGTLNNSQAKKLAKAGLDFYNH
NLDTSSNFYSSIITTRTYEERLSTLKKVRNSGMKICSGGIIGLGEKKQDR
MELLMELSNLSIQPESVPINMLVKIPGTPMEKNENVDPFEFIRVIAATRI
MMPKSYIRLSAGRENMSDETQAMCFMAGANSIFYGCKLLTSSNPKEEKDQ
KLFEKLDLFPDYKIQSITEENKNNENLKISDVNKAQYYNAAI
>BUsg457 bolA, BolA protein
MLLEKIKKYLEFKINIAFIKIYDESKLHNYSTNTNTISHLKVIIVSDDFI
NKNLIIRHRIIFKALKEIEKESIYSITLYTYTLNEWKDKKYKEFNSIKCI
QKKIKNFVLKN
>BUsg138 carA, carbamoyl-phosphate synthase small subunit
MEDALGQLAVLVLEDGTRFHGRSIGAKGTTVGEVVFNTSITGYQEIITDP
SYSHQIVTLTHPHIGNIGTNCNDEESSKIHIRGLIIRDMSPISSNYRSEK
SFSSYLKENNIVAISDIDTRKLTRILRTKGSQNGCIIEDKKENYSVAYQK
AKKFLSLQGLDLAKKVSTKFIYNWDKGSFFINKSKSKLEKKKKFLFHIVV
YDFGVKRNILRMLVDRGCYLTVVPAKTDPKIALNLNPDGIFLSNGPGDPR
PCDYAIHAIQCFLKKNIPIFGICLGHQLLALASGANIIKMKFGHHGGNHP
VKEIKTNRVIITSQNHSFTVDAKNMPNNIAITHSSLFDGTLQGLCLTDKL
AFSFQGHPEASPGPHDASSLFDHFIKLLNQVKFSN
>BUsg137 carB, carbamoyl-phosphate synthase large chain
MPKSTDIKSILILGAGPIVIGQACEFDYSGAQACKALKEEGYKIILVNSN
PATIMTDPCMADATYIEPIHWKIVKKIIQKEQPDALLPTMGGQTALNCAL
ELNRRGILKKFNVKIIGATIDAINKAEDRKLFEDSMKKLNLKTAKCGIAH
NIQEALLVLKNVGFPCIIRPSFTMGGHGGGIAYNQEEFEDICERGLKLSP
TTELLIDESLIGWKEYEMEVVRDKNNNCIIVCSIENLDPMGIHTGDSITI
APAQTLSDKEYQIMRNASMSILREIGVETGGSNVQFAINPKNGRMIVIEM
NPRVSRSSALASKATGFPIAKIAAKLAVGYTLDELANDITGINTTASFEP
SIDYIVTKIPRFNFEKFLGCNDRLTTQMKSVGEVMAIGRTFQESIQKAIC
GLEIGSSGFDSKVSFADNKQDIIKIRHELKDAGAERIWYIGDAFRCGMSV
NDVFELTSIDPWFLVQIQEIIQLEKKIIQKGFIGLDYNFFYFIKRKGFSD
LRIAILTNKKEEEIRQLRYELNLHPVYKRIDTCSAEFSTETAYMYSTWED
ECESHPTKNTKKIIVIGGGPNRIGQGIEFDYCCVHAAQALREDGFEAIMI
NCNPETVSTDYDISDRLYFEPITLENVLEIVRIENPKGVIIQYGGQTPLK
LARQFEKEGIPIIGTNPDAIDKAEDRNRFQKIVTKLKLKQPLNATVLTLE
EAHKKAIEIGYPIMVRPSYVLGGRAMEIVYEPCDLDNYFKKFLKNNHITP
ILLDQYLNYAIEVDVDAICDGEKVLIGGIMEHIEQAGVHSGDSACSLPAY
TLTNKIQNKIREQVKKLAFALSVKGLMNVQFAIKNNEIYIIEVNPRAART
VPFVSKATGLALAKISVRVMYGKTLSEQGFCKEVIPSYFSVKEAVLPFDK
FQGVDPILGPEMRSTGEVMGIGKNFSEAFSKAMLGSHTNMKKSGRVLLSV
RDDDKNSIVNLAVKLQKFGFKIDATKGTSIALKKSGIMARLVNKVHEGRP
HIQDRLKNGEYSYIVNTTSCHQGMKDSQLICRSALQYKVHYDTTVNGAFA
TVMALNEEPTENIISLQEIHKKINLIN
>BUsg058 cca, tRNA nucleotidyltransferase
MKVYLVGGAVRDSLLNLPIKDRDWVIVGGTKEILLKKNFQQVGKDFPVFL
HPETHEEYSLARKERKSGRGYTGFHTEFSSDVTLEEDLIRRDLTINAIAQ
DENGNYIDPFQGRKDLNLRLLRHVSESFTEDPLRILRTARFAANLMHLGF
HIDKDTMILMCKMVKKNELLYLTKNRIWNETEKAFKTLNPHVYFQILHAC
KALNFIFPEIFFLYERRTFFSILFTNFYSISFLSIGLSKISTLTKDVSIR
FSYLCQFLSEKIDFSSTKENYDDDSAKLVKKLCKRCNIPSHIEELAVLNT
GFCVFLSSIHYQSSSNIIKMFSKIDAWRKPDRIYKLSFLCDFNLFYHQNK
IDNSKLKTGFLKKCFFIIKDISVKKILNQGFKGYQIKNELNKLRVNKLKF
WRMKKKCFFFKE
>BUsg459 clpP, ATP-dependent Clp protease proteolytic subunit
MKSNSVLIPMVVEQHSRGERSYDIYSRLLKERIIFITGTIEDNMASSIVA
QMLFLEAESLDKDIFLYINSPGGIITSGMSIYDTMQFIKPDVNTICIGQA
CSMAAFLLSSGTKGKRSCLPNARIMIHQPLGGYQGQASDIAIHAEEINKM
KKKLNKLMSLNTGQSIKKINKDTERDCFLSAHESIKYGLIDLILTQR
>BUsg460 clpX, ATP-dependent protease ATP-binding subunit
MTDKSKDNSKKLLQCSFCGKNQKEVKKLIAGPAVYICDECIRLCNNIIQE
TKTTKKIEDDELSYLPTPHEIKKHLDNYVIGQNHTKKVLSVAVYNHYQRI
RNVSKNKDNVELGKSNILLIGPTGSGKTLLAETLAKLLNVPFSIADATTL
TEAGYVGEDVENVIQKLLQKCEYNVKKAELGIVYIDEIDKISRKSDNPSI
TRDVSGEGVQQALLKLIEGTLASIPPQGGRKHPQQEFLQVNTANILFICA
GAFSELSKIISKRIDTGNTIGFNCNLKKQKKKKSEQYFLQQVQSKDLIKF
GLIPEFIGRLPIITILKELNETALVQILCKPKNALIKQYQTLFNLEKVKL
EFTKEAVTSIAKKALSKKTGARGLRSIIENILLDIMYELPSMKNVEKILI
DESVVNSHSLPKIIYEEKNKSKKASGE
>BUsg262 cls, cardiolipin synthetase
MDIFYDLIKWLVVLIYWLLIANITYRILIKRRSIPSSMSWLLTIYIIPFI
GIAIWFFFGELYLGKRQKKIAKKIWSISNTYLNKLKSYKYIFQIKNSEVA
TSLFQLCKHRQGIYGIKNNKITLLTNTQNTIEVLIRDIYSARNNIEMVFY
IWKPGGIADDVAMALIDSAKRGVHCRLMLDSAGSVEFFRSPWFDIMKKSG
IEIVEALKVSLIRIFLRRLDVRQHRKIILIDNYISYSGSMNLVDPYLFKQ
SSGVGQWIDLMTRIEGPVATAIGIIYSCDWEIETGFKILPKLPNKEMLKK
KCNQNSSIQVIASGPGFPKNVIHQALLTAIYSARNELIMTTPYLVPSDDL
LHAICTAAQRGVKVSIIIPLYHDSILVKWASRVFFSELLEAGVKIYQFKK
GLLHSKSILIDQQLSLIGTVNLDMRSLWLNFEITLVIDDRKFSHHLSAIQ
KEYIDNSRLLDKNTWSMRAYWTRILEKIFYFLSPLL
>BUsg060 crr, glucose-specific PTS system enzyme IIA component
MSFFSGFFNKKKSKYSKKIDILAPLSGDIINIEDVPDVVFSKKIVGDGIA
INPTGNKILAPINGTIGKILNSMHAFSIISEEGVELFVHFGIDTVKLRGE
GFKQIAQDNQKVKIGDTIILFDLNLLKEKARSILTPVVISNIEKFKNIEK
SSGTIIAGKTIIMSLYN
>BUsg473 cspE, cold shock protein E
MSKIKGNVKWFNESKGFGFITPEDGSKDVFVHFSAIQSNGFKTLAEGQSV
EFEITEGAKGPSAANVISL
>BUsg391 csrA, carbon storage regulator
MLILTRRVGETLIIGDEITVTVLGVKGNQVRIGVNAPKEVSVHREEIYQR
IQAEKKQKKS
>BUsg569 cyaY, CyaY protein
MKKNTNFTQINNNFYRLVDDLFLKIEDNLNFYDDKIDIDYEVQDYVMTIT
FLNKSIIVVNKQESLRQIWLATKFNAYHFNYKIDKWICNRSNKDFWEIFE
KSCSIQSNENLIFTAFKRIKK
>BUsg456 cyoA, cytochrome O ubiquinol oxidase A
MISINFNNFFKTLLLILIAFTLHGCDSILFNPHGIIAIQECSILLISFLI
MLFVIIPVIFMTIYFSVKYRASNINAKYKPDWCDSKKIEIIVWTIPISII
LFLAFVTWNYSHILDPKKSIISKYKPIKIDVVSLDWRWLFIYPEYHIATI
NEIMFPINRSIIFHITSNSVMNSFFIPSLGSQIYAMPGMMTTLNLMSNSP
GKYKGISSNYSGKGFSNMKFTAISVLNIKDFENWIKKAQQSPKKLNKMSI
FNIISLPNENHFIEYFSDVKKNLFYEIINQTYSKNKVFKH
>BUsg455 cyoB, cytochrome O ubiquinol oxidase B
MFGKLTLKAIPVDEPIIMVTYISIILIALFISFSITYFKKWKYLWYEWFT
TVDHKKISIMYGILAFIMLFRGFVDAILMRTQQVIASSGNTGFLPPHHYD
QIFTAHGVIMIFFVAMPLVIGLMNLVVPLQIGARDVAFPFLNNLSFWLNV
SGAILLTLSLGIGEFAQTGWLAYPPLSEVKYSPGVGVDYWIWSLQISGVG
TTLTGINFLITILKMRAPGMCFFKMPVFTWAALCTNILIVISFPVLTTTL
LLLTLDRCFDFHFFTNNFGGNPMMYVNLIWIWGHPEVYILVLPVFGVFSE
VVATFSKKRLFGYVSLVWATLAITILSFIVWLHHFFTMGAGSNVNAFFGI
TTMIIAIPTGVKIFNWLFTMYQGRVHMHSSMLWTIGFLITFSIGGMTGVL
LSIPPADFILHNSLFLVAHFHNVIIGGVVFGCFAGINYWFPKLFGFILNE
LWGKRAFWFWIIGFFTAFMPLYFLGFMGMTRRLSQNIDIEFHFLLSIAAI
GAILIGIGILCQIIQFWVSVRDRHINLDVTGDPWDGRTLEWSTSSPAPLY
NFAIIPHIKNKDDFWELKKQKNQVQKKQYSAIHMPKNTGLGIFISFFSLL
FGFSAVWNIIWLSFLSFLVVIISLIFKSIDENTEYTVSVKEIESIENRHL
ENVQKAGLK
>BUsg454 cyoC, cytochrome O ubiquinol oxidase C
MIKETMRNNKLFGLWIYLMSDCIIFAVLFAVYAIISSNFSTNLINHKIFN
LSYVFLETLILLLSSLSSGMLTIQKNKNNIKIIYFYLLLTFFLGLSFLLM
EVNEFYKLILENCSPSQHAFFSIFFTIVGVHGIHVFFGLIFILSILYQLF
YLGITNTIRIRILCFSLFWHFLDIIWICVFTFVYLNGVI
>BUsg453 cyoD, cytochrome O ubiquinol oxidase D
MNKYKKIKNNFDKEKKSYIVGFLFSLFLTIIPFFCTLNHLFSRKINFFVI
LLCALSQIIIHFIYFLHLDFSKKNSWNIISLLFILIIVFIIVFGSIWIMY
NLNHHVIL
>BUsg452 cyoE, protoheme IX farnesyltransferase
MLKDYLEITKPRIIIGNIILIIGSFLFSSFPFFNVFLFFFTILGTSLVIA
SSCIFNNLIDIDIDTKMNRTKNRVLVKNLISPTSASIFASFIGIVGFFIL
GLFVNILSMFLSFIGFVIYVFFYTFFLKRKSMYSTFIGSFSGSIPSVIGH
TAISNSIDLFCFLLFIIFIFWQMSHFYAIAILYINDYRKANLPFFPVVKG
ILKTKKHIFYYITCFIIASSMLTFLGYLSYIFLLFFSFFSFYWLYISYLS
IREKDDRKFSSKLFYYSIAVVILFNFLISIDFIF
>BUsg407 cysC, adenylylsulfate kinase
MHNNSKKNIIWQKHSVTRIKREQKNGHKSIVIWFTGLSGSGKSSIANSLE
EILFQNNFNTYLLDGDNIRSSLCSDLSFSILDRNENIRRIGEVSKLMIDA
GIIVLVSVISPYRNQRKKIRLMLGKINFLEVFVDTPLNICEERDPKKLYQ
KSRLGKISDLTGIQSLYEIPEKPDLHLDETISLKNNTKKLIHILCDKNII
SFPNIDETFLF
>BUsg051 cysE, serine acetyltransferase
MIKHKAQKILKKEPILSNFYQKSILNHKKLSHSLSCILSDKLSTSMISEK
DIYNIFNKIYANNISIINSVVKDIKAASQRDPVVKHYLTPLLYLKGFHAL
EAYRLSHYLWNIKRYELSAYLQSRISTVFSVDIHPAASIGSGIMLDHATG
IVIGEGVIIENDVSIFHSVTLGGTGSNTGKNRHPIIRKNVTIGAGAKILG
NIEVGQGVKVGAGSIVLKNIPPFVTVVGVPAKIIKKIKNSNKNLFQKEKK
>BUsg413 cysJ, sulfite reductase (NADPH) flavoprotein alpha-component
MKNKNPFNIFFPLSLDKIENLEKIKKNCSSIQYAWLSGYFWNLANQTPSR
LICEKNEFFRKDNEEKIITIISASQTGNARQLAKRFNKYLKNENKKTNLI
DAADYNFKKIKNERFLILIISTQGEGEPPEEALSFYKFIMSKKAPRLENL
HYSVFGLGDVSYNLFCQAGKDFDKRFSELGGKSLLHRLDSDIEYESNYIQ
WSEELLLAINKIDVSTCSVFKKNDKKNFIDKLNYTKYKPAVATVLLNQKI
TGRNSTKDVHHIELDITNSNIVYTPGDALGVWYQNSSQLIKQILKLLSIR
ISDKVKVKDKIITIFEALKKNFELTTNTKHIIQKYTDVTQNKFLKKIISD
NKKLNNYVKKTPLLKMIYDHPKKLSSQQLISILRPLKPRLYSISSSQSEM
NDEVHITVGVVKKQISGTIHLGGSSSYLSQFLKIDDSVKIFVEEKSNFRL
PENKDVPIIMIGSGTGIAPFRAFIQQRDNDKATGKNWIFFGNPNFTEDFL
YQLEWQKYLKKKLLTKMSLAWSRDQKEKIYVQDKIRENGKELWEWVNQGA
QIYVCGNASKMAKDVEKELLDVFSKNGSMDIEESSEFLNNLRITRRYQRD
VY
>BUsg063 cysK, cysteine synthase A
MNKIYEDNSFTIGNTPLVRLNNIGNGNILAKIESRNPSFSVKCRIGANMI
WDAEKKGRLNKNIEIIEATSGNTGIALAYVAAARNYSLTLIMPDSMSIER
RKLLKSLGAHLILTNGKHGMKGAISKANEIVSLNTKRYLLLKQFENPANP
EIHQKTTGPEIWKDTKGNIDILISGVGTGGTITGITKYIKIKEGKKDLIS
VAVEPLESPVITQFLSGKKIKPGLHKIQGIGAGFIPKNLDLSLIDRIITV
SSEEAIFNAKKIMKKEGILSGISSGAAIAAALKIQKENDFKNKNIVVILP
SSGERYLSTELFSRSFKNENNY
>BUsg471 cysS, cysteinyl-tRNA synthetase
MLKIFNTATSKKEIFKPIKNKKINLYVCGVTVYDFCHIGHARTFVVFDMI
VRYLRLIGFQVKYIRNITDIDDKIILKSLKEKIDISAFTNIMIKEMNKDF
SLLGISPPDEEPRVTNYIIDIIKVIEKLIKNKNAYVNDHGDVIFSINSDK
FYGTLSRQSLDKLISGTRISIDKEKKNSSDFILWKKSKKEEKFSWNSPWG
KGRPGWHIECTAITNVFFKDYIDIHGGGSDLLFPHHENEISQSRCLNKNF
RVKFWMHSGLVIIKNQKMSKSLGNSFFLKDVLEKYEAEVLRFFFLSTHYR
HPIYYTEENLKKSEMSLEYLYVTLYGTKPIFDPIEGVNFEIDFFEALNDD
FNTPQAFSILFKLARKINYLKKIDLSKSNFFAFRLQKLAGYLGFLLNTSQ
YFLQKKLPFDEEIIKKIESLIEKRNFARKSKLWKEADKLRDKLIKLNVIL
EDLPEKTLWRFKR
>BUsg088 dapA, dihydrodipicolinate synthase
MFKGSIVALITPMNEEGEICHSSLKKLIDYHVLNKTKAIVSIGTTGESAT
LSQEEHIEVVMLTLKLANKRIPIIAGTGANATTEAISLTKRFEKSGIEAC
LTVTPYYNKPTQEGLYQHFKAISENTKLPQILYNVPSRTGCDLLPSTVAR
LSEFKNIIGIKEATGDLSRIHKIKKLVKDDFLLISGDDPTALDFIQLGGQ
GVISVTANIAAKEMTQMCSYALEGNFKSARSINERLMLLHESLFIEPNPI
PIKWLAKKIGLIKSDTLRLPMTPILNSTRTQIEKALQYANLQKI
>BUsg139 dapB, dihydrodipicolinate reductase
MKKKITRIAITGAMGRMGQVLIKEIQKNKNTVLTAALVKNNHPLIGQNIG
EKIGIGKTSVSISSDINIEKNDFDVLIDFTKPSGTFYFLEQCYEFKKNMI
IGTTGFSEKEIKTINSYAKKIALIKASNFSIGINLLYQLIQKTTKILGNT
SDIDIIEYHHRNKIDIPSGTALSIGENISKVMNWELNKHSLYYTKGITKK
IRETKKIGFSSIRSGNIIGKHTVLFSSSDEEIKITHSAFNRESFAKGAIE
AAVWIHEKKHGLFNMNDILKDKF
>BUsg223 dapD, 2,3,4,5-tetrahydropyridine-2-carboxylate N-succinyltransferase
MKKYYDIIENAYLKKNEVNTKNIDIETKQTIHHVIELLNSGKIRVAEKKD
NIWITNQWIKKSILLYMYLNQNNVFQGSFSNYYDKIPLKYENYNEKKFKE
ERIRVVPPATIRYGSFINSNTIIMPSYVNIGAYVDQGTMIDTWTTVGSCA
QIGKNVHLSGGVGIGGVLEPLQNNPTIIEDNCFIGARSEIVEGVIIEEGS
VISMGVFIGQSTKIYNRETGEILYGRVPANSVVVSGSLPSKDRKYNLYAA
VIVKRVDSKTLNKVEINQLLRDK
>BUsg087 dapE, succinyl-diaminopimelate desuccinylase
MKEDIHEEKMVCSITKLAQKLISIPSISPKDLGCQDIMIDFLDNLGFEIK
KININDTKNFWATRGFGKTLTFAGHTDVVPPGDYKYWNDDPFNPVIKNGL
LFGRGSSDMKGALASMLIASERFIKKNPNYEGRLSFLITSDEESSAIDGT
KKVIDYLISRKDTIDYCVIGEPCSSSKIGDVIKNGRRGSITANLTIHGIQ
GHIAYPHLADNPIHKGLPIILKILSIKLDDGNAFFAPTSVNISNIHAGDG
INNIIPGSLFVQFNFRFSTETSEKEIKSKFTQILDNNNINYSLNWFFSGN
PFITKKGLLIDNITKSIINLNKVKPVLSTDGGTSDGRFIASMNAEIVELG
LMNNTIHKSNEYVRISDLEKLAIIYEDIMYRLLT
>BUsg568 dapF, diaminopimelate epimerase
MHGLGNDFMVIESIKQDFILTKSIIENLSNRNTGVGFDQLLLIEKSNNFK
FDFHYRIFNANGNEVEQCGNGARCVGLFLFLKGLINKRKIMLSTNKKNIS
IKFMSDNNIQVNMNEPSFKLEEISISKKIVLNNFSVKLINKNLKCSLVSI
GNPHCVIKVESINNAPVKKIGELLEKNSIFPQGINVGFMKVINKNHIQLR
VYERDVGETQSCGSGACAAVAVGIAKNLLCDNVKVDLLGGNLIIKWKGFN
YPLYMIGTACHIYDGYIYI
>BUsg101 dcd, deoxycytidine triphosphate deaminase
MRLSDTDIEEWLSKKKLVIQPYPKKQLINGITVDIHLGNKFRFFYDHTTS
CIDLSGSKEKIALDLNKIVSCETIFSKKEPFFLKPGALALFSTLENITLP
NNLVGWLDGRSSLARLGLMVHVTSHRIDPGWHGNIVLEFFNAGKLTLVLT
PGIKIAALSFELLSKPVLRPYNSRNESKYKRQNGVVPSRIYEE
>BUsg208 ddlB, D-alanine--D-alanine ligase
MKKKIAVLLGGNSSERKISIKSGYAILQSLLRSGFNAYAIDTRDFPIMQL
KKQGFDSAYIALHGTGGEDGSIQGILEYLNIPYTGSGIMSSAISLDKWRT
KLLWKSLSLRVLPDIYLQKKDISKYTYSYILKKILKLKFPVVIKPNNAGS
SIGITIVNHPDLLIDSINLAFNYSNNIIIEKFLKGTEYTVSILNKKVLPP
IKIITKNNFYDYSSKYIESSTEYICPSGLNYQKEEELKKIVEIAWNSLGC
KGCGRIDAILDNKDKFWLLEINTIPGMTHRSLVPMAAKSIGISFDELILK
ILKINK
>BUsg360 deaD, ATP-dependent RNA helicase DeaD
MTHTESTFSFLGLNPFIIKSLSKMGYVKPSPIQAACIPLLLEGRDVLGMA
QTGSGKTAAFSLPLLHNLNINLKAPQILVLAPTRELAVQVAEAFSDFSKY
IMGIHVLPLYGGQRYEVQLRALRQGPQIVVGTPGRLLDHLKRGTLNLSNL
YALVLDEADEMLRMGFIEDVETIMSQIPKEHQTALFSATMPEAIRRISKR
FMKNPQEIKIQSNITTRPDIKQSYWMVYGRKTDALIRFLEVEDFSATIIF
VKTKNATLEVSEALERNGYNSAALNGDMNQALREQTLERLKSGRLDILIA
TDVAARGLDVDRISFVINYDIPMDSESYVHRIGRTGRAGRAGRALLFVEN
RERRLLRNIERTINQTIPEVQLPKIEVLCKRRLERFAKKVQEQLESRDLD
EYSALLDKLYSPDDLDIKTLASALLKMAQGGRPLIIKKDLLQRPSREFSF
KDDRRREDNHRNNNRNRRERRELKDIDLYRIEAGRNDGVEVRHIVGAIAN
EGNINSRNIGNIKLFSSYAIVELPKGLSKDLLQRLIKTKILNKKINIKLL
RDIKNYETRTHNRSIFNKDKNNKRRFSDNRLNKSSSIKNETKSSFFRRKS
V
>BUsg477 def, polypeptide deformylase
MSVLKILHYPDQRLRLIAKPVEKITKEIYKITNNMIDTMYQEEGIGLAAT
QVNIQLQIIVIHKIHAIEKNLILINPKIIEKKGSISIEEGCLSIPEYRAF
VPRFNYIKIQAINLNGNTVEIEADSILSICIQHEIDHLNGKLFIDYLSEL
KRERILKKLIKLKKRIK
>BUsg522 deoB, phosphopentomutase
MKRVFLMILDSLGIGSSVDACKFNDSGADTLGHIAEKCFFNEANVQRRGS
LYIPNLIKLGIVKSYQSSTGKYLLGFNQKEDANIIASYGYASELSSGKDT
TSGHWEIAGAPFLKDWYYFKEKDNSFPSSLINKIITKLKLPGILGNCHAS
GTEIIKILGEEHIKTGKPIFYTSCDSVFQIACHEIKFGLSNLYKICENIR
EILDQNKYQVARVIARPFIGTNKSNFNRTGNRRDISMKPLSITFMEKLIQ
EKQGKVIAIGKISDIYAGVGISKNIKSTGLYELCHTTIHQMKSAKNNTVI
FTNFVDFDSVWGHRRDVSGYAKGLEFFDSKLSEMIDLVKEGDLFILTADH
GCDPTWKGTDHTRENVPILIYSPGEEIKFLGHRDTFSDIGQTIAKYFSLS
DMKYGKSMF
>BUsg521 deoD, purine nucleoside phosphorylase
MPTLHIKSEKNAFSNIVLMPGDPVRAKYIAENYLANPVQINDTRLMLAYT
GYYKNKKISVMSHGMGIPSASLYVRELILEYNVKKIIRVGTCGTIQNNIK
LRDIVISMGASTDSKINRIRFNNHDYAAIADFEMIFHAFSTAKKMNFKVH
IGNFFTTDSFYTESEDMLKILKKYNIIGIDMETAGIYAVAAELKAQALSI
CTVSDHIIKKDAVSSKDRESSFHNMITLSLETTLLL
>BUsg192 dksA, DnaK suppressor protein
MEKEQNKKTSSLNVLAIAGLQPYQKKTDEEYMNEKQMLHFKKILETWKNQ
LTIEINHTLLYIQDKSTNFPDPIDRAAQEEEFSLELRNRDRSRKLIKKIQ
ETLKKIKDKDFGYCNSCAVEIGIRRLEARPTANLCIDCKTLAEIREKQMA
G
>BUsg012 dnaA, chromosomal replication initiator protein
MSLCLWKQCLDRLQSELPSTEFSMWIRSLKAKLNNNILEIYAPNQFILDW
VKDKYLIHFKKILQDFCGSNSPFIKFKVYQTSKEKKFKKNILQKIQNLNA
KPIWDKIPIFKKSSHRSNINKKHSFENFIEGKSNQLARAAASQVAKNPGN
SYNPLFLYGGTGLGKTHLLHAIGNGILAYKYNVKIIYMHSERFVQDMVKA
LQNNAIEKFKLYYRSVDALLIDDIQFFAHKERSQEEFFHTFNALLEGNQQ
IILTSDRYPKEINGVEDRLKSRFGWGLTVAIDPPELETRVAILIKKADEN
NIVLSDEVAFFIAKHLRSNVRELEGALNRVIVNANFTHRSITVEFVREAL
RDILALQEKLVTIANIQKTVAEYYKIKVADLLSRRRSRSVARPRQMAMAM
AKELTNHSLPEIGDAFSGRDHTTVLHACRKIEQLRKENHDIKEDFSNLIR
TLSV
>BUsg528 dnaB, replicative DNA helicase
MVYPIYMAKNKSYLHQINRLKIPPHSLEAEQSVLGGLMLDNEQWDSVSEH
VVADDFFSKPHRLIFQEMQQLLDLGHPIDLITLSESLEQKGKLESVGRFS
YLAELSKNTPSTANIIAYADIIRERAIVREMILVANKIANAGYDTQGRKS
EELLDYAESSVFKIAEKRFKKDSGPKNIEQILDETVTSIEKLFLSPNDGV
TGINTGYQDLNKKTSGLQPSELIIIAARPSMGKTTFAMNLCENAAMLYDK
PVLIFSLEMPGEQIMMRMLASLSRVNQARIRTGQLNDEDWSRMSGTINVL
LKKKNIYIDDSSALTPSEVRSRARRIYRENKGLTLIMVDYLQLMRVPSLS
DNRTLEIAEISRTLKALAKELQVPVIALSQLNRSLEQRSDKRPVNSDLRE
SGSLEQDADLIMFIYRDEIYHENSDFKGVAEIIIGKQRNGPIGTICLTFN
GHWSRFDNYCGPKYD
>BUsg022 dnaC, DNA replication protein DnaC
MTFYNEFFKRLQRLMPSNVKPKFESDQDLLAWNQEQGRLSSESILRENKA
MKMQRVLGRSGIRELYMNCSFENYKIEHDGQRKVLKAAKRYAEEFNENIA
SFIFSGRPGTGKNHLASAIGNYLILHGKSILIVTVADLMSNMKGTFSGTS
NITEENLLHNLSSVDLLMIDEIGMQTESRYEKVIINQIVDRRSSSKRSTG
MLSNLDHRGMKNLLGERVIDRMRLGNSLWLTFEWDSYRQYVRGDEY
>BUsg233 dnaE, DNA polymerase III alpha chain
MNLEEFVHLHVHSDYSIVDGLSKPEDLIKKSVNLGMKALSITDFNNLYGA
IKFYNAAHKWGLKPIIGVTVKFFSELIKNELTELTLLATNQDGYKNLILL
ISRAYKKGYFCEKYVTIEKKWLSELNNGLILLSGGCQGEIGKTLLRGQTS
LISDCLHFYEKYFSGFYYLELIRTYRENEEKYLSLAVDLSYSQNIPVVAT
NDVCFLNKEDFKIHKIRIAINEGVRLKESKIQNNYSKHQFLKTEKEMCFL
FSDIPEAIINSVEISKRCNVFIKSGQYFLPQFNTRKISIENYLIQKSNKG
LKKRLESNFKKVDKEIFLKYKNRLDTELGIINKMGFPSYFLIVMEFIQWA
KDNNIPVGPGRGSGAGSLVAYVLNITEVDPLFFDLLFERFLNPERISLPD
FDIDFCMEKRDRVIEHVVHTYGRESVAQIITFGTMTAKAVIRDVGRVLGY
PYGFINNLSKLVPLDPGITLKDAFSKNSELYTLYKSDEDIQNLIDVSKKL
EGVNRNVGKHAGGVVISPSKITDFCPVYCDEKGNNPVTQFDKNDIEYVGL
LKFDFLGLRTLTIINCAVNMINKNLLLSNKKTININSIPLNESKCFLLLK
KCETTGIFQLESYGMKDLVKRLQPDCFEDIIALIALFRPGPLQSGMVDNF
INRKHGYEEISYPDHKWQHILLKPVLESTYGIILYQEQVMQIAQILAGYT
LGKADILRRAMSKKNIKDMAEQRSIFIEGAQKNGINRKLAIKIFDLLEKF
AGYGFNKSHSVAYALVSYQTLWLKAHYPSEFMASAMTSDIDNTDKIVMLV
NESIQMGIKIIPPNINLSKYEFYVDHTKNIVYGLGAVKGIGRNPILNLVQ
EREKNGLFSDLFDLCMRTDPNKITRKVLEKLIMSGSCDCFNKNRNYLLSL
IEDAIKASKEHFKIKKFQQESLFGSFKEELNILKKNNNLLNSFSDEEKKL
ENEHKVLGLYLTGHPIDRYAEELKYYLNNSTFSKLKLFNHTKKKIMVAGI
VVSIKTKVTKNKNRIVILILDDSTGLLEVVIFKRLLNISEKLIQLNKILI
VSGFLNTNFISKNLKMTAYDIMNLNLAREKYLDKLTIVLTEKQRDKCFLK
KIYQFFQNQTTGIVPVYIFCKKKDLDSEYKLIKKWLITISNKLLVELDIF
SKENKMQIKYF
>BUsg053 dnaG, DNA primase
MSGKIPKYFINELLFRTNIVELIETRIKLKKNGKNYQTHCPFHNDKTPSF
TVSYEKQFYYCFGCSAHGNAIDFLINYDNLNFVESIEELATIHSIEIPFD
KKGTIEKKIYLKKQKLYFLMDKMSKLYQKNIIFTNSANKYLTERGINKNM
IDFFCIGFSSNKWDLFSKQFNIKKDFEKDLLHYKIISTNKNGYIYDTFQG
RIVFPIHDQHGRIISFGGRSITNNILPKYLNSHENDIFHKGKQIYGLYQV
KKKHSKPKYLLVVEGYIDVIMLTQYNIEYVVSSLGTSITKEHIQILFRHT
NTVIYCYDGDDAGRNASWRTLKIALPYISDKKNIKFIILPNNEDPDTIIK
KEGQKKFQLRIDNALTMSKFFFKNILKNVDLSSDDDKFHLSVRALPLINC
ISSDTIRIYLRQILARTIGIVDDYQFEKFLYEKERKKKSLQFQIKHTPMR
TLIGLLIQNPNLARLVPSTKKFENEKIQGLPIFLEILKTCSDNPNFNTGQ
LLEFYRYSKIINILKILSKWDHMIIKEKIQNMFLDLLKNTYSKILEKRQE
KLIAKERIQGLTIDEKKEIWSINKKLSKK
>BUsg145 dnaJ, DnaJ protein
MAKKDYYQILGIPKSAEEREIKKAYKRLAMKYHPDRNQGDKNAENKFKEI
KEAYEILINEEKRTAYDQYGHAAFENGYNQNNTYSTFTSSTDFGDIFGDV
FGDIFGGSRNQRVKKGADLCYNMEISLEEAVKGTTKEIRIPTFQKCKTCY
GMGTSTGTKPNGCSTCHGKGQIHIRKGFFTVQQSCPTCNGIGTVIKNPCR
MCRGQGRIKTNKTLSVKIPPGIDTNDKIRLSKEGEAGTNGAQPGDLYVQM
KVNKHPIFEREENNLYCEVPINFTMAALGGEIEVPTLDGRVNLKIPSETQ
SGKLFRIRGKGVKSVQSRSRGDLLCRVVVETPVNLNEKQKYLLSELGNSF
NGFRGDKNSPRSKRFFDGVKRFFDDLTK
>BUsg146 dnaK, DnaK protein
MGKIIGIDLGTTNSCVAIMDGNKPRVLENSEGDRTTPSIIAYTEKGEVLV
GQPAKRQAITNPKNTLFAIKRLIGRKFRDDEVQRDIKIMPYSIINSENGD
AWIDVKKQKMAPPQISAEVLKKMKKTAEDYLGESIKEAVITVPAYFNDAQ
RQATKDAGRIAGLEVKRIINEPTAAALAYGLDKGEGNRTIAVYDLGGGTF
DISIIEIDDVDKEKTFEVLATNGDTHLGGEDFDSRLINYLVQEFKKEQGI
DLRNDSLAMQRLKEAAEKAKIELSSAQQTDVNLPYITADSNGPKHLNIKV
TRSKLESLVEDLVMRSIEPLKVALKDAGLSVGDINDVILVGGQTRMPMVQ
SKVADFFGKEPRKDVNPDEAVAVGAAVQGGVLSGDVKDVLLLDVTPLSLG
IETMGGIMTSLINKNTTIPTKHSQVFSTAEDNQSAVTIHILQGERKRALD
NKSLGQFNLDGIEPAPRGTAQIEVTFDIDSDGILHVSAKDKKTGKEQKIT
IKASSGLNEEEIKKMINDAEANSEADRKFEELIQVRNQGDQLIHSIRKQL
DENKNQIEKKELEKIKSALDELERSLKGENKSEIEKNIQNLLNISSKLTE
INQKKSEENLKKEDTSSESKKDENVVDAEFEEIKDPKK
>BUsg011 dnaN, DNA polymerase III beta chain
MKFTIQNDILTKNLKKITRVLVKNISFPILENILIQVEDGTLSLTTTNLE
IELISKIEIITKYIPGKTTISGRKILNICRTLSEKSKIKMQLKNKKMYIS
SENSNYILSTLSADTFPNHQNFDYISKFDISSNILKEMIEKTEFSMGKQD
VRYYLNGMLLEKKDKFLRSVATDGYRLAISYTQLKKDINFFSIIIPNKAV
MELLKLLNTQPQLLNILIGSNSIRIYTKNLIFTTQLIEGEYPDYKSVLFK
EKKNPIITNSILLKKSLLRVAILAHEKFCGIEIKIENGKFKVLSDNQEEE
TAEDLFEIDYFGEKIEISINVYYLLDVINNIKSENIALFLNKSKSSIQIE
AENNSSNAYVVMLLKR
>BUsg240 dnaQ, DNA polymerase III epsilon chain
MMNNTQRIIVLDTETTGMNSVGPPYLNHRIIEIGAIEIINRRFTGKKFHT
YIKPNRLIESDASKIHGITDDFLSDKPSFKDIAKDFFNYIKNSELIIHNA
SFDVGFINQEFSMLTKKIQDISNFCNIIDTLKIARKLFPGKKNTLDALCM
RYKIKNSHRVLHGAILDAFLLGKLYLLMTSGQESIIFNKNIQNERNFRYI
KKSITKKHRFLKIIKANKTELKLHNEYLKFLKEK
>BUsg023 dnaT, primosomal protein I
MKILVSKKITLDLFCKNPIQIIEKEKNEIISISKNKKTVFYVIQPKALKK
LFDIKEYFVKSKITKKEKKIIEKFPMHTNWIPDKDFIQKAALWGISLNEE
VSKYELASFISYWEAEGLFFHHIQWQQKLARSLERSRSMNNAIQQKKDIT
YIPVPDQKTPDGFRGK
>BUsg466 dnaX, DNA polymerase III subunits gamma and tau
MNYQILARKWRPQSFKKIIGQKYIVKAISNGFSLGKIHHAWLLSGTRGVG
KTTIARLIAKSLNCEIGITSLPCRKCTICQEIEKGICLDFIEIDAASRTK
VEEIREILDNIYYTPSKSRFKVYLIDEVHMLSRHSFNALLKTLEEPPQHI
KFILATTDVEKIPKTIRSRCLHFKLNILSEEDIFNFLKHILKKGGNNFDE
EALKIISDYANGSMRDALNLLEHAMHLSKNNINLKNTTEMLGIPNKKHAF
LLTKFLLEQDSKKMMCLLNKISKIGLEWQNILIEMMRFLHHIAMLKSYPK
IWNQIFIKNNENEIKKIAENNSKYNIQLCYKILLKGRKELFFSPNHKMGV
EMILLQAITEIKR
>BUsg415 dsbA, thiol:disulfide interchange protein DsbA precursor
MKKILIVLYSIFLSFTASSYEFNNKKEYEIEKRNISNVPKVMHFFSFFCP
YCYELEKIYNIQSLIKNKIDKKIKIQTYHVNFLGGEFSKILTKIWIIAQK
MKVEEKIMMPIFKEIQENNTISHTSNIKNIFLQKTGINKDQYNKFWNSFT
IKMLIKKNDNDINKIKLNHVPTMIVNGKYVIDYYKLEKIFKTNFSKKYIK
LIKFLLSKK
>BUsg540 dut, deoxyuridine 5'-triphosphate nucleotidohydrolase
MQKHLINNNIKIRILDSNIKKNSSFFLPQYATPGSSGLDLRASIKKKISL
PSKEVILVPTGIAIHIDNPYITALVLPRSGLGHKNGIILGNLIGLIDSDY
QGELMISLWNRSKNIFFINPYDRIAQMIFVPIIRPTFSIVDDFEETVRFG
KGFGHSGVQ
>BUsg229 dxr, 1-deoxy-D-xylulose 5-phosphate reductoisomerase
MKKITVLGSTGSIGISTLSIVKNNPSLFKVIVLVANKNSSMMLEQCEYFS
PDWAIMKNKKSAHILKKRLKDKKIKTQVLSGNKAICQLAALKESDLVISA
IVGMAGLLPTLSAINAGKTILLANKESLIVCGIIFMKALSSNKAKIFPID
SEHNAIFQVLPKFVQKNLGKVNLKKNGVKSIILTASGGPFYNFKRENLSF
VTPLEACSHPNWSMGRKISIDSATMINKGFEYAEARLLFNASSSEIDILI
HPQSIIHSMVEYIDGTILAQLSVPDMKVAISYAMSWPNRISSGAKFLNFN
KLSNLSFFKPDFIQFPCLKLAIDAFSQGQAAMTVLNAVNEVTVSAFLDSK
ISFNKISEINTDILMSSSFSEPVSVEEVLEIDKKTRIKSQKKISSLIF
>BUsg448 dxs, 1-deoxy-D-xylulose-5-phosphate synthase
MNFDITRYPILSFAHSVRRLRLLSIEQLPQLCTELRKYLLDVVSITQGHF
ASGLGVIEITVALHYVYDTPFDNLLWDVGHQSYPHKILTGRAEKIGSIRK
KNGLHPFPFREESKYDILSVGHSSTSISAGLGLSIAAGKEGKNRKTICVV
GDGSMTAGMAFEAMNHAGIIQSDLLVVLNDNQMSISKNIGALNKHLKFLR
DIKKSSKIFNFSIFESLNFKYLGPFDGHNIFKLIEIFKKTKDYRKTCLLH
LITKKGKGYLPAELDPIKWHTISQSFSSSSKILTYSDVFGSWLCEIAEFD
KKIMAITPAMCEGSGMLKFSRLFPNQYFDVAIAEQHAVTFAAGLAIAGYK
PVVSIYSTFLQRAYDQIIHDVALQKLPVLFAIDRGGIVGHDGPTHQGIFD
LSYLRCIPGIVIMTPSNENECRQMLYTGYMYKEGPSVVRYPKGKGIGMSL
SPMKLIPLGKSLIKRVGEKIAILNFGALLQNAYLAAEKLNATLIDMRFVK
PLDTNMILKLSLKYNFLVTIEEGVIAGGAGSAVNEFIMMRKILLPVLNIG
LPDMFIAHGSQEEIKHDYQLDPEGIQNKILAWLSY
>BUsg021 efp, elongation factor P
MRVYHSNNFRSGRKIIFEKEPCLIESSEFVKPGKGQSFVRVKLRKLLTKQ
LIEKTFKSTDSLEIADVSEYTLSYLYNDGHFWYFINNNFEELSVDKKIVG
VNKKWLSEQDTCVITFWNNQAISITPNIFVELKVIDTEIALKSDTINTTT
KLATLSTGAILKVPLFIQIGSLIKVDTRSGEYVSRIK
>BUsg582 engA, putative GPT-binding protein EngA
MLPIIVLIGRTNVGKSTLFNILSKTRNALVADYPGLTRDRNYGYCYLKEN
KKITIVDTAGINFKSQKIEKQSHEQTLKAIKECDGILFLVNARDGVMPEE
YEISRKIRKYEKKTILVINKIDGIKEISKINEFYSLGFKENIKISASHNQ
GINNLISKYLTPWINSKFKEKKLEKISQEHSKKEKNSVKIACIGKPNVGK
STLINSLLMKKRMITSNKAGTTLDTVLVPIKYNYKNYIFIDTAGMSKKKS
KTNKIEKFCKIKTLQTIEKSHLTLLIIDAKDQISKQDLLLSSFIEKSGKP
LIIVINKCDLLSLKEKKNLENLIKKQLKCNFFSKIHFISALNNEGTVELF
KSIDTSYHTSQKKIKTSQVMKIMHKAVKKHQPPIINGRRIKLKYAHLGNS
NPIEIMIHGNQVKNLSLCYKKYLKNFFYKTLKMNGTPIKIQFKETMNPYI
SKK
>BUsg400 eno, enolase
MSKILKIIGREIIDSRGNPTIECEVLLEGGFVGLASVPSGASTGSFETWE
LRDQDKNRFMGKGVQKAVEIINNKIFYSLKNKNAIDQFDIDQTMINLDGT
ENKSNLGSNSILSVSLATAKAAASSKGMPLYQHIAEINNTPGVFSMPLPM
INIINGGKHANNNIDIQEFMIQPISAKSITEAIRIGAEIFHSLGNLLKDK
GMSTTVGDEGGYAPNFKSNEEALNVIQDAVHKTKYKLGKDITLAIDCAAS
ELYNKTRKKYQFIGEGTEFSSQELTHYLKKLSNKYPIISIEDGQDESDWE
GFLYQTKELGNSLQLVGDDLFVTNKNILKKGIKKGVANAILIKLNQIGTL
TETIETIKIAKKFNYGVIISHRSGETEDTSIADLSVGTASGQIKTGSMSR
SDRTSKYNQLIRIEEILNKKRAPFYGLKEVKSSF
>BUsg248 era, GTP-binding protein Era
MKKRKQYCGYIAIVGKPNVGKSTLINEIIENEISITSKKKNTTQKNILGI
KTKQLHQFIYVDTPGIYLNNEKDDSFKIIKSSILILFIVDRTVWKTDDEI
VLNKIKKNKIPIICVINKIDKILDKSIILPHINFLLKKINPIEIIPISAK
KRENIVLLENLIYPYLPNNNHIFPKKYITTHSLSFSISEIIRQKLIFFLR
DELPSIITVKIESIEEKFKKKLYIRAAIYVKHERQKKIIIGKKAEGIKKI
SIASRLDIEKKINMKIYLIIWVKVKIKK
>BUsg084 fabB, 3-oxoacyl-[acyl-carrier-protein] synthase I
MKRVVITGFGIISSIGNNKKEVLNSLYNGISGITFSEEMKESGMRSQVWG
NIKLENKKFFKKNKISRFMNNGSIYAFLSMEQAIKDANLQTKQYQKNPRI
GIIAGSGGGFPKYHIQGIDAIRSNRGLNSVSPYIAIKAMNSGISACLSTL
FKIYGVNYSISSACATSGHCIGNAFELIKFGKQDLIFAGGGEEVSWELAY
EFDAMKALSSNFNKNPTKSSRVYDVNRDGFVISGGGGIIVIEELNCALSR
SAHIYAEIIGYAATSDGKDMVVPSGDGAVRCMNLAKKQNKMLFIDYLNVH
GTSTKIGDLIELEAIKKSFFHEKKPMISATKSMTGHALGVSGVHEIIYTL
LMMKYNFIAPSINIETIEPSADNMNIVQKTFHKKIKTALSNSFGFGGTNV
SLILKKY
>BUsg338 fabD, malonyl CoA-acyl carrier protein transacylase
MNSFAMLFPGQGSQYKNMLSSFFQKKNNLFKKIFDEASEYVNYNLLNLIK
NGAKKKRDDYKYIQSAILTSSIAIYQLWKEKNGRRPALMSGHSLGEYSAL
VCANAIKFSDALKIVKLRSKLMQKIIINKPSLVQAIIGLDKVIIKNICLQ
YLPKIVSIASINSDDQIIISGEKLAVREVGLKCKKKGAKYVIKLNINTPI
HSQLMKPVSEQIKYLLKSIKIKSPQIPVINNVDVICEKNEKKIKKALVRQ
FYSTVRWKEIIDLIKSKKIFTMLEIGPNKILSNLIKKNDNITVLNTNNLK
NFLIAFKTIH
>BUsg339 fabG, 3-oxoacyl-[acyl-carrier protein] reductase
MKIEKKTALVTGANQGLGKEIAIKLSQKGIQVIGTSTTVDGVKTINKYLK
KNGFGFILDLKDTDSILEKMKEICQKKYSIDILINNAGITSDNLLVYMSN
KEWENVIKINLTSVFYMSKSVIRSMIKKRYGRIVTIGSVIGYLGNRGQIN
YSASKSGLIGFHKSLALEVAQKGITVNIVSPGFIKTNLTKNLNVFQYKKH
LSKIPMKRIGTAEEIANAVIFLSSEKASYITGQTIHVNGGMYMT
>BUsg255 fabI, enoyl-[acyl-carrier-protein] reductase
MGILKGKKILITGILNEKSIAFGIAKSMYKQEAELIFVCQNKKIINKIKY
LIKSINYNTIFFCDVSHDENIKELFFNIKKVWNNFDGLVHSIAYCPKKQM
HEDFVESSSRKSFNICHEISSYSFLSMARECKNMLNKFSSLVTLSYLGSQ
KIVSNYNMMGLAKSSLEANVRYMANSLGKNNIRVNAISSGPIKTTSSYQI
KNFNKIQKIHKLFSLTKNHVSSEEIGNVAAFLCSDLSIGITGSIINVDHG
FNLNGINSII
>BUsg232 fabZ, (3R)-hydroxymyristoyl-[acyl carrier protein] dehydratase
MNSDEYIFNIKDILNILPHRYPFLLIDRILDFKAFQYLKALKNCTVNEPF
FQGHFIKEPVFPGVLMIEAMSQAAAVLIFKSIGKLNINQLYYFVGIENTR
FKKIVVPGDQIFIEVIYLKSKKNFIKFKIFAIVNKKNVCKSTIIFYKKNI
FN
>BUsg436 fba, fructose-bisphosphate aldolase
MKILNLIQPGVVTGNECQIIFELAKKKKFAIPAVNCIGTDSINAVLETAS
RVKSPVIIQFSYGGASFIAGYKRTSSKNPEDQAIQGSISGAQHVHLMSQY
YQIPVILHTDHCSKEMLPWIDGLLEEGKKHYKNFGKPLFTSHMIDLSKEH
LKENIAICSNYLKKIKKINMILEIELGCTGGEEDGIDNSNIDKKLLYTQP
KDVNYAYKKLSKISTNFTIAASFGNVHGVYQPGNVNLKPNILKESQEYVS
TKHNLKKLPLNLVFHGGSGSDLKEIHESIEYGIVKMNIDTDIQWASWKGV
FNFYKKNKDFLQKQIGNKNGKNIPNKKYYDPRSWIRESQESMSKRLEKTF
KDLNAFNIL
>BUsg581 fdx, ferredoxin, 2Fe-2S
MPKIFFLPHKLLLPKGGCFECKEGETILNVALKNNIKLEHACEKSCACST
CHCIIRKGFLSLSGWSEKEEDVLDKAWGLESTSRLSCQAIIGNIDIEVQI
PLYNTNYIIEN
>BUsg380 ffh, signal recognition particle protein
MFNNLTERLSQSLRKIINKGRLTEENIKDTIREVRKALLEADVTLSVIKK
FIQNVSKKAIGHEINKSLTPGQEFIKIVKNELILSMGEKNHDLNLSIQPP
AIILVVGLQGVGKTTTLVKLAKWIKEKYKKKILTVSTDIYRAAAIKQLQI
LSDQVKIDFYLSDTTQTPINITKEAIEHAKLKLYDLLLIDTAGRLHINTE
MMNEINTIQNISKPIETLLIVDSMMGQDAINIAKKFSASLSISGIVITKT
DSDARSGVALSIRHITGKPIKFIGTGEKLHQLEPFHPERIADRILGMNQV
ISLIKDIEEKVNQSQVKNLTKKFRKGDDFNLNDFLIQLKEMKNMGNLNYF
IEKFSKNKILSNNPLLGENKNTLNRIEAIIYSMTHKERMHPIIIKGSRKR
RIALGSGTKIQDVNKLLKNFDNIKKIMKKIKKGGIGKMIRNISNILPKNF
>BUsg387 fis, factor-for-inversion stimulation protein
MSEESMDTGFLVINTKDKQDKTVKKPLRILIKKSLENYFLHLDKSQCVSN
LYQLVLSELEQPLLDIIMQHTRGNQTRAASIMGINRSTLRKKLKRYGMN
>BUsg514 fkpA, FKBP-type peptidyl-prolyl cis-trans isomerase FkpA precursor
MIVFLLKRILLLYLIFFVPKSFSENLPFFKIKSYSEKKEFFQNDNEKVGY
SLGVSLGNYVNESFERQKKMGINLDKYNILLGVQDAISGNLKLSNEEIST
ILQKLEKNLKNAAKIEFEKSEKENLIQGKLYMKKFSEMKGVSKTSSGLLY
IIDKLGEGEEIKTKNAEITVHYKGSLINGTEFDSSYKRGKPITLMLKDVI
LGWQEGLKYIKKGGKIKLIIPPNLGYGSNRINEIPANSILIFDIELLDIK
NI
>BUsg289 fldA, flavodoxin
MKKIGIFFGSDTGNTEKAAELIHKKIGSNISMLYDISNVSKKDFESFDHL
ILGVPTWYYGEIQCDWDDFLPILKKINFLHKTVALFGCGDQEDYAEYFCD
ALGLIYQVLKKNNAKIVGKWPTIEYNFESYKALLNKDYFVGLVLDEARQP
EKTE
>BUsg324 flgA, flagella basal body P-ring formation protein
MKLIKIFFCLFIFFLFFKSFKATAYNLSDQLNNFFKKEYSLKTKNIKTII
HTPLKKNFFCKKPVFSLVNNLHNFGIIDIILICGSQHKYLQVELQAEGEY
VIAKKKILRGTKIRGDDLIKVVGRLDTLPRGAYLNEKDLINRVNLRDIFP
FQPITSFMTRPYWLVKMNQLVTVKMKGVDFEVIFVGKSLSNGAERQKIRV
QLKNGKVLTGVINNNSEVIVFL
>BUsg325 flgB, flagellar basal-body rod protein FlgB
MFDKINKTLDFNQNLLNLYAKRQEILSSNIANADTPNYKAMDINFKDEMD
KITKKSNLDITLTKTSSHHLNPRKKNFFIFEVKPITSKEIQSNGNTVDMN
RERIEFIKNTLKYEENLVFIKNEIKNIMNVLKG
>BUsg326 flgC, flagellar basal-body rod protein FlgC
MSLLNILNIAGSAMSAQSEKINVIASNLANAESIVCKDGKFYPYIAKKVI
FKLDPLKNSLIGGVKVFSIINDLNPMKLIYDPSNPLSNKNGYVLQTNVNP
VSETINHISASRSYQANVEVLKTAKSMIMKTLSIGE
>BUsg327 flgD, basal-body rod modification protein FlgD
MGTVNINSSINNNIIENNTNNVKNNSNALDLQKNFLSLLMAQMKNQDPTD
PIKNSELTSQLAQINTATGIERLNSTVGIFSNKINQSQNIQVSSLIGHHV
MIPSSQIVHTKGIETKYGIELISDATAVNIQITDKNGKIIHIQKIKNLKS
GIHSLTWDGQNLDKEDMKTEKYNVTVIAKNQNREIPVQVLSEALVNSIIT
SSSIDPIIDLGTVGTVTLSKIRKILK
>BUsg328 flgE, flagellar hook protein FlgE
MSIIETINGLMINNDYIDIVSNNIANASTIGFKSSTPSFFDIVSHSFYSN
QIIKSGVGISNLVQNFSDGVLVQTNRDLDLGIVQDGFFRVLDSKGYVYYT
RNGHFLLDKNKNIVNGQGMYLTGQNQFDLKNNLNSISNLEPINLRKSDLL
SAKATSQIKLKADLINDFSSTNSITGKNDDISNSEIHDITIYDKNENPHK
LNISFNQIDDHQWKLNIQLNDEKIPDNEIINDNFILKFDSEGNLISNSSL
QIKSKNSKNIILDPITLNLECFLEKSETNMPSIELSQNGYTKGFLKHFEI
LNNGEIIGQYTNEEEQKIGQIFLAKFINPEKLKPESGSIWSATHESGQEK
IGAAGDQGFGSLYTKFLESSNVDLNKELINMIIAQRNYQSSAQAFKTEDR
IINTLVNLK
>BUsg329 flgF, flagellar basal-body rod protein FlgF
MDHLMNKAIYESMNAAIKLLDKQAVIANNLANISTVGFKESFNLFIKDRN
LQNLKKTYNQNVKEYYNFYPGTLIHTQRNLDLVIKNNGWLAIKDINGQEA
YTKNGHIKINKEGKMTVQNYELIGNNGNIKIPNNVNLKISSNGIIKEIKK
NKDSIIESTIGSLKLVRLQNDNLIQKENGLFYLKKDNLNKYKNILHDSSV
RIQSEMLEASNVNPTKNMIDMISNARQFEMNMKIISMCDQNTEYANQLFN
VNN
>BUsg330 flgG, flagellar basal-body rod protein FlgG
MIPSLWISKTGLDAQQINMNVISNNLANVSTNGFKRSRAVFEDLMYQTMR
QAGTNSSIDTTLPSGLQLGTGVRPVSTEKIYSQGNLSKTDSSKDVAINGP
GFFQVQLPDGNIAYTRDGSFQLDQNGQLVTNSGYPIIPEINIPPNSINMN
IGRDGIVSVTIQGQTQPISIGQLNLINFVNHSGLESLGENLYQETQASGN
PIDTTPGLNGTGLLYQGYVETSNVNVAEELVNMIQTQRAYEINSKSINTS
DQMLQKLSQL
>BUsg331 flgH, flagellar L-ring protein precursor
MVKLFSYKIKYYLTAFFIIIIQSCASVEHKPLVDGITTAIAPNIIPKIKN
GSLFQEKTPINYGYQPLFEDHRSHNIGDTITVVLQENISASNSSSSNLTR
DGKANVGVTVTPGTLNPILGLNVNDNKTGIDSIGKNDFSGKGSNSAKNTF
TGLITVTVKNVLPNGNLKVIGEKQVAINQGTEFIRFSGVINPNNINKNNL
VASTQIADTRIEYVSNNRINDIQKMGWLQRFLLKISPI
>BUsg332 flgI, flagellar P-ring protein precursor
MNIRYVMSKTISLLKFIICILISLCSFTYAEKIRDLTSIEGIRDNQLIGY
GLIVGLDGTGDQSTQTPFTNQSLHNMLSQLGVTIPPDTNMHLKNVAAVIV
TANLPPFSHTGEAIDVVVSSMGDAKSLKGGTLLMTPLRGADNQIYAIAQG
NILVSEKNNLKKNNSIFSNQVNSGRINHGATIEREINTDFGKKKIINLQL
NKEDFGIAQKISDMINVQYPDTATALNSKTVQLNTYANNTIQVHMLSNIQ
NIDISMPSQEAKVIINPRTGSIVINQEVKLGTCIVSHGDLSILIEKKEEE
KINSFLFETLRKNQKESFLKNIINRNYINNNSVKNTSLNNIVRVLNSLGT
KPNELISILQLMKNAGCLHAKLEIV
>BUsg333 flgJ, flagellar protein flgJ
MKNDLSLFNIINYRTKFINDLKYQVKNNPKKYQLETAKEVESLFIQMLLK
SMRNSLTQDNLLDSNQSRFYTEIYDQKISKEIAKRGIGLTHIILQQIQKI
NNNFYL
>BUsg334 flgK, flagellar hook-associated protein 1
MSSILTSTVTGIDAIKILINNTADKIINSKYKDEIKHNVFVENTVDESNF
NAGVKIKKIYDDYNDFLKEEKRKISERVQDEQTKIEEYLKLEDLFGEKSN
IFTLLINQLYSSIENDIVNNHGNVFNENIENNLNTIIHELKNFDEKLSFL
ERDVKESIKEKIKQANILINKIYDTNIDIRFFPTAQLPNRIDSFIDKRDK
LIDELNDIIGVKVIKENSTFKVCLNNGMCIIDDYNKKNLMTLTSDTDDKY
ISVGYFDDNEQRLKKIEHMIPSASLGALLTFRREDLQNAKNKIGQLTINF
ADSINSVHTLGYDILGNIGKQVFKISNPEIISSSQNQSYLPTSIKWVDTA
DAQDTNYIVFLKNNHWTVTRLRDHSVVEPDIYQQDNNTYITFDGIEFKIE
GNDAEGNMYMIKPYSKTLNELELLIIKNDLFSISSSDDLNQKNRNNAIKI
QHLHQEKIVNKKETLYESYLRFLKSISYKCNDLEEKVPFKRNMIEILNNK
KLSESDDMYENYQNLNYEQKCYLANVKVLKMAETIFDEIVDCYS
>BUsg323 flgN, flagella synthesis protein FlgN
MKKLINIIKDIKENLMSLQNLMHQEYDNLLKSKINIKKIKLIIEEKEFFL
RKIASLKKEKSFLEKRYNIFPPYLQFNELNLHWDEIISICFLLKKKNIKN
KIILNEKFYLNQRFLNTFQKYRLNQNNTTYGVDGHLEN
>BUsg236 flhA, flagellar protein FlhA
MLQEKVMINFSSFFRIIQNLKKTQWQTLIGPVLILIILSMMVLPLAPFVL
DVFFTFNIALSIIILLVSMFTRHTLDFAAFPTILLFSTLLRLALNVASTR
VIFLNGHNGTHSAGRVIESFGHFLVGGNFAIGIVVFVILVIINFMVITKG
SGRIAEVGARFILDAMPGKQMAIDADLNAGLIGEEEAKKRRLKITKEADF
YGSMDGASKFVRGDAIAGILIMVLNIFGGLIIGFFQHNMLLGKAAEVYTL
LTIGDGLVAQIPALVISTAAGVIVTRVSTNQNVGEQMISQLFCNSQVILL
SAIVLGILGLVPGMPNIIFLVFTVSLLSLSWWLSRKKNNIKKNVLISDSK
YKSRENSISEASWNDVELEDPIRIEIGYNLIPMVDIQKKGDLLDKIRIIR
KKFAQEIGFLPPLVHIKNNINLKRTSYQIFIKGVEVGQGTCFYGKYMAIR
SGRETEPLPFKEVYEPTFGLSGYWIDLNFKNKAEKKGYSVVEASAIIATH
LNFLISKHIDELFGRQEAQQLLDHVNLEMPKLTEDLIPNIINLTILHKIL
KNLLLEEVPIRDMRTILETLSEFSIDQKDPNELTSLVRIALSKIITQKLF
YKKDIIEIIGLEKNLEQLLLDNLKGQNNTIEPSLFELLMIKTQEAIEKQK
LINAPIVLLVTHPLRFFLSKILRKKFPELTVLSQFEVTDIKKVKMTSIIG
S
>BUsg235 flhB, flagellar biosynthetic protein FlhB
MNHDINEEKTEQPTEHHIKKFRKKGETRYSRELNSLLILIFGLSNLWWSR
YSIIFELKTIMFNSFNFNQNILTNQQNISLNFFFFIKKILIVFFPFFSFL
ICIIIIPPILFGGIKFNFTSLKLNFARLNLLHGLKKFFSFQIFIELFKTT
LKLFIISCISIFYLWIYFYKILFLSTKNISSSLLDGFNVIFYCCILIILG
LIPIVILDVFWRQWSYYKKLKMTHQEIKDEFKEREGSPQIKARIRQQMKI
NLRRRMISDVPKADVIITNPIHYAIALKYDIHKMNAPKVIAKGIGATAMK
IQKIALKNGIAIIASPSLARALYRYSEIGQYIPGPLYKAVAEILAWVWKV
KKWKREGGIFPEKPKNISVPSELNVTGESND
>BUsg066 fliE, flagellar hook-basal body complex protein FliE
MFIDNIYDQNIYTNIDFLDTNKQKNKKSNNFINHFQKALGEISNIQNNSK
KNIEKFQSNHSDISLNDIMINLQKSSISIELAIQVRNRIISAYKEIMNQQ
I
>BUsg067 fliF, flagellar M-ring protein
MNFSTIEESVSEEKKKFNNFLSYFFKNSRVLIILFVLAVITTVSISMWRK
SPDYQVLYNNLSNEDGEMIIDQLNQMQIPYKLSEDSGQLLVPKDKVYELR
LHFSENNSPHRDIGYEILDKERFGVSQFGEQINYQRALEGELARTIEKIN
VVKNAKIHIAFPKNSLFLEDKKKPSVSVILNLKSNQGLDHSQVNAILHLI
SSSICDLSIENITIIDQFGKLLNNSSLGLNQIDDLKLRYSEEVESRYRNR
IKNILEPLLGFNNVYAQVTAQINFNSHEKTQEKYTPNTNYKNQAIRSRQS
TVNDKINNRKEENKPDELFPQTSFSSNKDLNSTTYSNKKIKKSIIQNNQD
NNILHSNSAISHDDTINYELNHSLSHTKMNIGEIKRLSAAVIVNFVKDKN
GKSVPINVEQIKKIKNLVREAIGYSKVRGDSVYVVNESFFQKNKNSPIKL
LKDSNQSNFYSTFLTFTPWFISLFFLFFLVKKCFFSSSKNNINNQSYKNK
TEEDLLEKDTKAENISELKFSKTSNTDKLIHQICNISNQNPRIIASIIRQ
WMSDKK
>BUsg068 fliG, flagellar motor switch protein FliG
MTLNGTEKSAILLMSIGADQASEVLKHLTPFEVQELVASMVNINQFSNTI
LNTVLSECYDLFSKKNNLICNNDENYISDVLTKTLGEKQGRILLNEVLET
RNVKMCIETFNHMDPEKFISLLDQEHPQILTTILMYLDKRQSSKVLSRLS
EKKCTEIVLRMAEFNCIKESNLIDLKKIIENLLKRKKLIFSEKNGIKTVA
EILNSMKIEDEQNILKKINVLNKNLTRKIIKEMFLFDNIVNIEDKYIQCL
ISNLEKEKLCIALQGTSEVIRNKFFKNMNEEEANKLSIYLEEKSYISDIA
IKNEQKLILIMLKNILDNGIFSLKKLGKYYV
>BUsg069 fliH, flagellar assembly protein FliH
MSNIDVKQNWKRWYPEEIFLKNSKNKKKYFWNLYKLTQQDFFTNNENKKN
SNKLKKTDELKDYPSKEEAYNLAFKSGIEKKEEKKILFNDNLNKLLSNFE
AAISLFDQMLFTRLLKTILIISSYIVGKNIKMDELILLKNVKKIINNDSF
FLKKKQLIIHPNNKKFLEKIIKNSVYSDKWELCYDVNIDINGCKIRSENG
DIDNTIEARWKELCRLVSEEC
>BUsg070 fliI, flagellum-specific ATP synthase
MLMKLRFSELLNNISSFEKKVNNLSDIFSYGCLISVNGLLLEVIGLTAPI
GSRCYVERIIDGKILNISAEVVGFKKEKTLLFSLEETYGVFPGTRVFLKC
FKNTYSITGKIPLSTELLGRVLDSKGRPLDGRSQLNPKFFTFLKSNVVNP
LNRKPITEVLDTGIRAINALITVGRGQRIGIFSSSGLGKSILLGMMAKYT
KADVVIIGLIGERGREVKDFIENILGSNGLSRSVVIAAPADVSPLLQIEA
ASYATSIAEYFRKKNKHVLLIMDSLTRYAMAQRAVSLSLGELPVSKGYPS
SVFSKIPILVERTGNTDNYGSITSFYTVLTESEEDPQDPIAHICRSILDG
HIVLSRHYAELGHYPAIDIENSISRVMPNIISKKQYSQACYFKKLIASYQ
RNRDLINIGAYLKGTDSTLDHAIKIWPILERFLQQKQSEKSSYLSSCEEL
NQIFI
>BUsg071 fliJ, flagellar FliJ protein
MKYKKKIFSILENLEKKNIEKDIINIKNLYLQKEKYVTQLSLLKDYQNEY
LIKLKSKIELGICLYQWRNYNNFIFILYFLIKDNEQKIKKNQKILEKSLK
QYSKNQIKLKTWNYLYKKYKKKEIKKILLVEEMISDEFSQLKNLAEGSCY
NV
>BUsg072 fliK, flagellar hook-length control protein
MFKYSDNIALEGKLSDNQNNNLTSLNFFSKSNINAFKKLFINKGIEFDNV
STKKKKEEDKNIPSINFVITNLINILNKKDTMLKETMLNHIAKKNYKCRN
IQRKNKDKNFKLKKYIKLDIETKNETKKNQKYKKFIVHPIFKKSIEIKNQ
SNEFKQINIFHNFNDKFFFRKDRYSNIKSNKSIFSDNKILRCFRNFRKNT
PDLFFLKNINKISNVTTYETNTFKDNNNKKHLKCVNSSLELLNSKKNDKW
KQVINHQILLSISNKENKAEISFTPEYLGSIHIKIKMRNDQATLNFISNH
DEVKVFLKNCIPFLKNSLMKNGIQLEKINIYNSSFSKNHISQKNKRIVKN
YFFHGNEFKKTFNFQENYMKLIQYKSIDMYI
>BUsg073 fliM, flagellar motor switch protein FliM
MLHTMGKSTNLDNEYKIIYKREKNLDRFLDQNEMKKLEKINKKFIQKIIM
IFSSFIKSNIELNFYTVKINSYTNDDKNFKHLYANSLKIETLEKKSFIFF
SPNFLSVFIDFLFGGKGNSIIRMDIKKEITYTEHVINKKIVGFIIDAYCE
SCKDFFYIDIKFLDFNIIKLNKHFFYTNDLFITNYFSFNLNGIKIFLSIL
IPVSIIKEKNKKIINFLDKNIFSKKTILKENFFIENLSNIELDVTVELIP
SYISKHTFDNLREGDVITIEDPGKVTVCIEKKPIFLGKHKIFDEKSIIFL
EKFLHQNLEKK
>BUsg074 fliN, flagellar motor switch protein FliN
MKKVEKKDNFKKFKNDNIYKKDDKNINQELINEEKKIKNFNSSNNESSNE
KKILFDIEMNITVELGKSKVKIKDLLNFSKGSMLFLQRKKEDPLKVFANN
KLIALGEIVFSNNKYGIRIISINNSLNGINTSV
>BUsg075 fliP, flagellar biosynthetic protein FliP
MENNVYSQIAPSIFKRIFDDTNIFHVMSSLFGMLLLVLILIWILKKISLL
KINKNNYFIKTIDRMSLGPNESIVIIKIEEIKLVLGITKNHITHLYTLSS
DVKDDVVDKKKEVILPTKNFNDSLKNFAKIFWKKTMFYRIIPLFFLFLFC
PLVYADIPGPTSHILRDGSQTWSLPVQTLIFLTSLTFLPAFLLMMTSFTR
IIIVFGLLRNALGTPYAPPNQILLGLALFLTFFIMSPTFDQVYKEAYLPF
SQEKINMDEAIIKGAVPLKKFMLNQTRNSDLELFSKLAHISSYKNKDEIP
MRILLPSFITSELKTAFQIGFTIFIPFLIIDLVVASVLMALGMMMVPPST
ISLPFKLMLFVLVDGWQLLVTSLSQSFKI
>BUsg076 fliQ, flagellar biosynthetic protein FliQ
MTPEYVMGLFHSAMKVTLMLASPLLLSALVSGLIISILQAATQVNEQTLS
FIPKIISILVVITLLGPWMLGVMLDYMHNLFYNIPSIIIR
>BUsg077 fliR, flagellar biosynthetic protein FliR
MLTFNSFNLAILISNFFWPLVRILAFFSTAPIFNDQNVNKKVKIILSFLI
AFLIKPFLPKVNVELFSIIGLFLLFQQILIGIALGLTCQFLFAAFTLSGE
IIALQIGLSFANFFNSNRYIGTSLISRWLNILNLLFFLTLNVHLYLVFML
IDSFYKIPVDVNFLSANIFFIFLKFSSNIFLNGVMFALPIMIFFLISTLI
MSILNRLSPQISIFSIGFPLNLLIGILILYYLMSMSFPFFKSLVNQLISF
IFYTFLKI
>BUsg478 fmt, methionyl-tRNA formyltransferase
MKKLTIIFAGTAYFSMRYLDALTKSEHKVIAVITQPDRPSGRGQKIIFSP
VKILSIKRNIPIFQPSELKNEKIQREIFNLNADMMIVVSYGKLIPKEILT
MFPKGCINVHTSLLPRWRGATPIQSAILFGDKETGISIIKMNEKMDAGTI
INSVKCNILPNDTTETLTFKLIEIGIQVLLKTLYYINKNIVVEKEQNEKH
ATFSKKISKKDALLNWNTEAYLLERLIRAFNPWPVCYFIVNQIAIRVWQA
KIIPTVMKSACVGEIVAFNKNGIQINTAHQILNLQKIQFPGKKIINVEKI
ISSKKHWFHIGKII
>BUsg136 folA, dihydrofolate reductase
MKISLISAISNNLVIGHNNKIPWYLPEDLKWFKKNTIHKDIIMGRLTWES
ILNHPLPMRKNIVISHKEIIHKDVIWANSISKALLSTTYDKEIMVIGGSK
IYKQMLFYATKLYLTHVDFNGIGDTYFPQYKSCKFWKTIFRKQHFKDKNN
PYNFCFEILSR
>BUsg161 folC, dihydrofolate synthase
MHKKKYTFSMWMKYLEKFDKKDRKNLFELKLIAKKLGLLNLKSFFFTVGG
TNGKGTTCAMLEKLLLDSGYQVGLYTSPHLINYSERIKVNGLYLSEKDHI
FSFLIIDAEKGNVSLTYFEFITLSALFLFSQYSLDIIILEVGLGGRLDAT
NIIDSDLSVITNIGIDHTSCLGTDRISIGREKSGIFRKGKIAVIGEKNIP
ISVDEIAKEKKTILKKIDVDWFWTRTKIDSWNFIHSNIELYNLPVSRIPL
SNTAIALASLFYSGLEVNLKKLKSSISKVQLSGRFQTVFNSPRIILDVAH
NVHAALYLSEKIDEIDTEGQIYAVFGILKDKDVAGVVQVLQKKINYWYVV
NLKTNRSASINYLKKKLSLNNALFFNNINESWQAIKKVITKKDIILVFGS
FFTVSEFMSIKDRRLTLY
>BUsg470 folD, methenyltetrahydrofolate cyclohydrolase
MSAIIIDGIKIAKKIELNLLKKIEEREKNKKRIPGLAVILIGKNPASEIY
VKRKISVCKKVGFISKYWSFPINVDEKDILNLIEKLNNNINIDGILVQLP
IPKQINYYKIFSSIRPDKDVDGFHPYNTGSLCQRNPTLRACTPKGIITML
NYTKIKTHGLNAVMVGASNIVGRPMSMELLLAGCTTTVTHRFTKNLRHHI
KNADLLVVAIGKPNFLHGDWIKEGAIVIDVGINKLKDGSIVGDVDFKSAS
LKAAYITPVPGGVGPITVITLLENTLEACEKYHEF
>BUsg129 folE, GTP cyclohydrolase I
MIKITKEANIARNVLLLKGLENPILKEYNDIKEKERELLIAEYLYKIMSL
LNLDLKNESLKDTPIRISKMYVNEIFSGLDYKNFPKIMLMDNKIKFHEMI
IVRDILLISTCEHHFITINGQATIAYIPENKIIGLSKINRIAQFFAKRPQ
IQERLTKQILLVLQVLLQTKNVAIIIHMDHFCVKARGVCDTSSSTVTSCL
DGLFKSDKNIREEFFFKK
>BUsg560 fpr, ferridoxin NADP reductase
MNPWINANVLKVHKWTQNLFSLILNAEIAPFQAGQFTKLALNEENINFSN
NVKKKKIQRAYSFVNAPSNKNLEIYIVRILNGKLSNLLYNLKSGDNLFIK
EKSFGFFTLDEIPNCKTLWMFATGTGIGPYCSILQEYKNINRFKNIILIH
AVRYQNELTYLPLMKQLYKSYNGKLKIETIVSREKNHNSLYGRIPLLLQN
QILEKKIGLKINRNDSHVMLCGNPAMVKDTYLFLQKDRCMQKNLRRKHGH
ITMENYW
>BUsg228 frr, ribosome recycling factor
MINDIYIKSNEKMKVCINNFQIQVNNVRTGRASPELLNSIYVEYFGSKVP
LRQISNVVVENYHTLKINIFDDSSTSLIKKAILNSNLDLNPILYGKDIIV
PIPGLTEERRTHLIKVIRNNAENARIYIRNIRRDANDKIKNYLKSKIISE
DNEHAAQNKIQTMTDDYIKKIDKILSEKEKDLMKF
>BUsg207 ftsA, cell division protein FtsA
MIISKNRKLVVGLEIGTTKVVTLVGEVLTNGKIKIIGIGICQSNGIDKGR
INNLDAVISCIRESIHQAEIMANCQITSVYLSLSSKYINCQNEIGIVPIS
EDEVTKEDIENVIHTAKSVKILNEHHILHVIPQEYSIDQQSGIKNPIGLS
GTRMQVRVHLITCHQNMAKNIIKAVEKCDIKVDQVIFSGLASSKAVLTED
ECKLGVCMIDIGGGTIDLITYIDGSIQDSQVIPYAGNIVTKDISYAFSTS
YSDSEKIKIKYGSAIKLSPGTSKNIDLSSKYGNFQKNLQQDTVIEVIESR
YNELLHLINNRILYVQKKLYKEGRKYQLTGGIVLTGGASTISFLTECAEK
IFQKKIRIAKPLNISGLTDNVTEPHYSTVVGLLHYGKEFYFDDTNQKREI
SFIEKWFQKISNWFKKEF
>BUsg369 ftsH, cell division protein FtsH
MVKNLIFWLVITVVLMSVFQNFNSSDTSNHRVDYSTFLSEVNQDQVREAY
INGRIISVTKKDSSKYITYIPINDPKLLDNLLTKNVKIVGEIPEEPSLLI
SIFISWFPMLLLIGVWIFFMRQMQMGGGKGAMSFGKSKARMLSEDQIQTT
FADVAGCDEAKEEVSELVEYLKEPSRFQKLGGKIPKGILMVGPPGTGKTL
LAKAIAGEAKVPFFTISGSDFVEMFVGVGASRVRDMFEHARKSAPCIIFI
DEIDAVGRQRGAGLGGGHDEREQTLNQMLVEMDGFDGNEGVILIAATNRP
DVLDPALLRPGRFDRQVIVALPDVRGRKQILKVHMRKVPLSEDVDPMIIA
RGTPGFSGADLANLVNEAALFAARFNNRVVSMIHFEKAKDKIMMGSERRS
MVMSDFQKESTAYHEAGHVIIGRLVPDHDPAHKVTIIPRGQALGITFFLP
ESDILSISRQKLESQISTLYGGRLAEEIIYGSQNVSTGAFNDIKVATNLA
RNMVTQWGFSDKLGPLLYAEEEGEVFLGRSVAKAKHMSDETARIIDEEVK
LLIEVNYNRARKILNENLDILHAMKDALIKYETIDSLQIDDLMERREVRK
PKGWLEVDQKKDI
>BUsg216 ftsI, penicillin binding protein 3 precursor
MNLFKEKKIKKIIYINWRFVTLCSIVFLFLVILTLRIIFLQIINSKKLAY
EGDRRTLRIQSVINRRGIINDRLGYPLAVAVPVNAVFIDPTMITNKNDIK
NNIRWKALSEILSIPLNKLIFFINSDKNIKFIYLARQINPEIGDYIKALK
LPGVFLIEESKRYYPTGAIAAQLIGINNIDGEGIEGIEKSFNSYLTGTPG
KRKIRKDNQGQIIENESLINKSNSNNLILSIDKKLQTIVYQKLNNAVNEN
QADFGIAILINIETGEILAMANSPSYNPNNMQYMINKNLRNKAITDIFEP
GSTVKPIVIMEALKRGIIKKNSIINTKPYFIKKHKITDVAYHEKLNITGI
LKKSSNVGVSKIALSMNTSELINSYIKFGLGQPTNLGLIGEQKGFLPKKK
KLSDLEKATFSFGYGLMITPLQLARLYTIIGSYGIYRPLSIIKIDHPLYE
KRIFPKRYVKNVIHMMETVAHPGEGGSQAAIKGYRVAIKTGTAKKVGIHG
YYIKKYIAYTAGIAPASNPKFSLTIIIDNPKGEKYYGGAVSAPVFSKIMK
LVLKEMKIKPDNLKNKLS
>BUsg370 ftsJ, cell division protein FtsJ
MISKKKSNSSNRWLSEHFQDQYVKEAKKQKIRSRSWFKLEEIDKNNRLFK
PGMNVLDLGSSPGGWSQYAAKKIGKKGYILACDILPMKKIKGVDFFQGDF
CNKKTLNLILTNLSNVNLNLIMSDMAPNITGCSSIDMPRIIEICKTVFTI
SDHVLSRNGVVLVKSFQGEGFNEFFAQMKNLFSKIKICKPKTSRSRSREI
FMLATR
>BUsg217 ftsL, cell division protein FtsL
MKIKRYDLPKIIKKDFFIYGKIHLILLLAIILSANSVVIVVYNTRLLIAE
EENLNLKTKKKDDEWRNLIIEKNAISMPSIH
>BUsg211 ftsW, cell division protein FtsW
MMVTSSSIPIGQILYHDPFFFVKREIFYFFLIFLLSFILLRIPMSFWEKN
SNLILIISIFLLTIVLLIGKSVHGSYRWINIGILHIQPAEICKISSFFYI
SNYLSRKTNEVRNNFWGFLKPITIIIIQSVLLLAEPDLGTVIVLFLTTLS
VLFLSGVKIKQFFIIIFFVTLIITALVLFEPYRIKRILSFWNPWKDPFGN
GYQLTQSLIALGRGHFFGQGLGNSIQKLNYLPEAHSDFIFSIIGEELGYI
GCFLILLMIFFISFRAMYIGQQSFEKKQVFSGFLACSIGLWFSFQTLINI
GAVTGILPTKGLTLPLISYGGSSLIVNLMAICILLRIDFEIRLSEHQAFP
KGI
>BUsg025 ftsY, cell division protein FtsY
MNFDKKNSFFSWINSKIKKNNKKEKKENILLKKEKEGIHTIQNIDNKKID
FLFKLKNSLNKTKQFFGDSISRIFLSKKIDDAFFEELEDTMLLSDIGVHT
TDQIISKLINDATHKELKNPEKVYFLLKEHMYSILNRVEKPLKISNHTPF
VILVVGINGTGKTTTVSKLAKKYKLAGKSVMLAAADTFRAAGIEQLQILG
KRNNIPVISQSSGSDPASVAFDAVKSAISKKIDVLIIDTAGRLHNKLHLL
EELKKMVRVIKKLNLSAPHEIMLIIDACNGQNTIKQTEMFHKAINLTGLV
ITKLDGTAKGGVIFSLANQFLIPIRYIGIGEKTTDLVVFNSNDFIKSIFV
K
>BUsg206 ftsZ, cell division protein FtsZ
MFEPVELSNNAVIKVVGVGGGGGNAVEHMVRERIEGVEFFAINTDAQALR
KVEVGQTIQIGNNITKGLGAGANPEIGRTSAEEDKELLKSALDGSDMVFI
AAGMGGGTGTGAAPVVAEIAKELGILTVAVVTKPFNFEGKKRMMVADQGV
LELSKHVDSLITIPNDKLLKVLSRGISLLDAFGAANNVLKGAVQGIAELI
TRPGLMNVDFADVRTVMVEMGYAMMGTGISSGENRAEEAAEIAISSPLLE
DIDLSGARGVLVNITAGFDLKLDEFETVGNTIRSFASDNATVVIGTSLDP
DMNDTLRVTVVATGIGMEKYSDVNQTKNKSSKEILMDYRYQYLNISPTAI
DKKNVKNEIKETDNKKRKEPEYLDIPAFLRKRSD
>BUsg508 fusA, elongation factor G
MSRTTPICQYRNIGISAHIDAGKTTTTERILFYTGINHKIGEVHDGAATM
DWMEQEQERGITITSAATTAFWSGMAKQFKPHRINIIDTPGHVDFTIEVE
RSMRVLDGAVMVYCAVGGVQPQSETVWRQANKYNVPRIAFINKMDRMGAN
FLRSVKQIKTRLGGNPVPLQLPIGSEENFKGVIDLIKMKAIKWKDIDQGI
TFTYDEIPSDMIELSEKWHQNLIESAVESNEELMEKYLSGFVLSEKEIKS
ELRKRSLNNEITLITCGSAFKNKGVQALLDAIIEYLPAPNDIQDIKGITN
DKASTVAFRSSNDKAPFSALAFKIASDPFVGNLTFFRVYSGIVKSGDSVL
NSVKSQRERFGRIVQMHANKREEIKEVYAGDIAAAIGLKDVTTGDTLCDL
NQPIILERMEFPEPVISISVEPKTKADQEKMGLALARLAKEDPSFRVRTD
QESNQTIISGMGELHLEIIVDRMKREFSVDANVGKPQVAYRETILNKVTD
IEGKHIKQSGGRGQYGHVVIELFPLESGGKGYLFVNDIKGGVIPNEYISA
IDKGIQEQLKYGPLAGYPVVDIGVRLYFGSYHDVDSSELAFKLAASLAFK
NGFKKAKPILLEPIMKVEVETPDDYMGDVIGDLNRRRGIIEGMKDLEIGK
IINACVPLSEMFGYATDLRSQTQGRASYSMEFLKYVEAPSVISDLIIQKR
ER
>BUsg287 gapA, glyceraldehyde 3-phosphate dehydrogenase
MTIKIGINGFGRIGRVLFRLAQERENIEVVAINDLLDPKYIAYMLKYDST
HGNFKKDIEVKNNNLIINGKKIRITSIKDPEKLMWDKLLIDVVIESTGLF
LTKDTAYKHILSGAKKVVITGPSKDDIPMFVRGANFDKYKGEKIVSNASC
TTNCLAPLSKVIDDHFGIIEGLMTTVHASTATQKIVDSASKKDWRGGRGA
LQNIIPSSTGAAVAVGKVLPNLNGKLTGIAFRVPTANVSVVDLTVRYKKT
ATYNEICEVVKNASEQKMKGILGYTEDEVVSTDFNGKELTSIFDAKAGLS
LNKNFAKLISWYDNETGYSSKVLDLVELVALK
>BUsg055 gcp, probable O-sialoglycoprotein endopeptidase
MKVLGIETSCDDTGIAIYDVSKGLLINELHSQKKIHANYGGIIPELASRE
HTRKIIFLLDKIFKEKNIMKEIDLIAYTAGPGLAGSLLVGATFACSLGFS
LNIPVLPVNHMEAHLLSPMLEYKSMQFPFIALLVSGKHTQIIAAYELGKY
EILGNSLDDAAGEAFDKVSKMLGLKYPSGRELSSLAAQGIKNYFYFPRPM
IHHSSLNFSFSGLKTFTSKVISNNTLNIQQKANIARAFEDAVIDVLLIKT
KKALYKKGWKRLVIAGGVSANTVLRKRSKDMMENVFHGKVFYSSLKFCTD
NGAMIAYLGSLRYKEASVSQLEIIVKPKWSIDKLSYI
>BUsg276 gcpE, GcpE
MNKYKNIKRRKSNRIYVGNVPIGDGAPISVQSMTNTQTTNIEETIKQIIK
LKKVGVDIVRISVPTLEAAESFKIIKLNVDVPLIADIHFDYRLAIKSIKY
GADCLRINPGNIGNKRRILDIVNCAKDKNIPIRIGVNAGSLENDLLKKYK
SPIPEALVESAIRHIEYLDSLNFNQFKVSVKTSDVFSAIEANEILAKKTV
QPIHIGITESGALRNGIVKSSIGITSLLLSGIGDTLRISLAADPVEEVKV
GYDILKTLGIRFRGVNFIACPTCSRQEFNVIDVVNQLEKNLEDLSTPMNV
SIIGCIVNGIGEAKVSTLGIVGGSKTSALYKDGIRQKNKLKNQEIIKELE
IKIRKKAKSLDKLKKII
>BUsg001 gidA, glucose-inhibited division protein A
MSKSYLKNFDVIVIGGGHAGTEAAAASARVGCKTLLLTQKITDIGVLSCN
PAIGGIGKSHLVKEIDALGGLMARAIDYSGIQFRVLNSKKGPAVRSTRAQ
ADRILYCQNIKKLLKKELNLLILETEVKDLIVKNYQVIGVLTQSNMSFYS
RSVVLSTGTFLGGKIHIGLESYSAGRKGEKASIDLALRLRDLPFRVDRLK
TGTPPRIDINTINFENLFVQHGDVPTPVFSFMGDISNHPLQIPCFLTHTN
EKTHEIIRKNLHKSPLYTGIIKGVGPRYCPSIEDKIVRFPDRKSHQIFLE
PEGLTSIEIYPNGISTSLPLDVQKEIVSSVKGLEKSKIITPGYAVEYDFF
DPKDLNLTLESKWIKGLFLAGQINGTTGYEEAASQGLLAGLNAALSAKDC
KQWFPRRDQAYLGVLIDDLTTQGANEPYRMFTSRSEYRLTLREDNADLRL
TEIAYKLGLVDNPRWIRYNEKVLNISNEKNRLKKIKIYPKSSDSTILNQL
FNIVLTKEINILNLLKRPEITYENLKYLKNFKVGISDLEAAGQIENEIKY
EGYIKRQLEEINRHLKNENTPLLPTYDYNKIKGLSHEAVLKLNDYKPVSV
GQASRISGITPATISILLIHLKKEYYKNHLS
>BUsg027 glmS, glucosamine--fructose-6-phosphate aminotransferase
MCGIVAAVTQRNIIDFLLEGIKKLEYRGYDSSGLAIINKNQNIVRIRCVG
RVNKLLKKVKKKKLFSNIGLAHTRWATHGQVSEKNTHPHISSHIAVVHNG
VIENNTKLRHFLEKKGYIFYSDTDTEVIAHLLHWEQTKTGESLVEVIQRS
KMKLNGNYSMVVMDAYNSSRLIAVRSGSPLVIGLGIKENFIASDQIALLN
ITKRFIYLEEGDTAIVETKKINIFNKNNLIIKRKEITSNVKYKSINKGKY
KHYMEKEIYEQPISIQNTLNNRIKKDTINFSELGDREKKFFLNAEHIQIV
ACGTSYHAAMVSRYWFESLANIPCDVEIASEFSSRKLAVRKKSVFITLSQ
SGETADTLAALRISKKLGYLGSLTICNMKGSSLVQESDCYLLTKAGIEIG
VASTKSFTTQLTVLLMLIAKITKLKKQKNNIEKKIAQILSLLPSKVEAIL
KKNTLIKTLANQLCNKKNILFLGRGDQYPIAMEGALKLKEISYIHAEAYP
SGELKHGPLALIDKNIPVIITAPKNSLLEKTKKNIKEICARGGIIYVFSD
QEIDLEKNMTIIKIPYVEEIIAPILYIIPLQLLAYYIALSKGKNIDQPRH
LAKSVTVE
>BUsg028 glmU, UDP-N-acetylglucosamine pyrophosphorylase
MLKKEINVVILAAGKGTRMQSSYPKVLHKLGGKTILEHVINIAKSVKPKK
IILVYNNKEKEIKSKISDTSIDWVIQKEQKGTGDAILKASKKFSDKDDIV
VLYGDMPYISIESIKKLFTSKKQSDISLLTAYVKNPDGYGRVFKKNGKVI
KIIEEQDANFHEKKIKEVYSGTFIANGKDLKRWLNQINNKNIKKEFYATD
IVHFANLENSTIKTVQVLNCKEILGVNNKLQLSILEKIFRKKQVNDLLLS
GVTLKDPNHFILRGILKHGKNIEIDTGVILEGNIILGNNIKIGVGSVIKN
SFIDDQTEIKEYTIIENVKIGKKCIIGPFAHLRPKTVLDDQIHVGNFVEI
KDSIIKKESKIKHLSYFGNSEIGSQVNIGAGSITCNYDGVNKFKTIIGDN
VLIGANTKLIAPIKITKNATIAAGTTLTQDVNTPCLIYNNKEQKQKKNWK
RPQKIIKKTDQ
>BUsg398 glnS, glutaminyl-tRNA synthetase
MRFKKMNNKIEKNDNNFIYKIINEDFKKNKNLLLHTRFPPEPNGYLHIGH
AKSICLNFELANVYNGYCNLRFDDTNPVKENIKYINSIKNDIKWLGYQWH
KKVRYSSEYFPILYEYAKELIQKGLAYVDELTKEEIREYRGTLSTVGKNS
PYRNRSITENLKLFEKMKKGEFKEGEACLRAKINMSSSFIVMRDPVLYRI
IFSTHHQTKKKWCIYPTYDFAHCLSDSIEGITHSFCTLEFQDNKNLYNWI
LKNTSIKHYSKQYEFSRLNLEYSILSKRKISILIEKKIVNGWDDPRILTI
SGLRKKGYTASSIRDFCHRIGITKQNNLIEFSMLEYCIRKELNKKAIRTM
AVLEPIKIFLYNIDNDHEEKLIVPNHPKHLHLGTHEIIFTNTIYIEREDF
KEKYDKKYKRLKIGEEVRLRYAYIIKAEKIEKDESGNIIKIICFCDINSL
GKKPINRKNPAVIHWIAVKNSFPAKFKLYNQLFKIKNPDQEKNFLSYLNS
NSLIVKNGFVEKKIAQKIIKKMSNNFIKLFFQFERTGYFCVDEVDSKENK
LVFNRTVSLKDSWNLKK
>BUsg238 gloB, probable hydroxyacylglutathione hydrolase
MILTSISVLKDNYVWILYNDNCSCIIIDPGVSEDIIKKIEKKNWKLIAIL
LTHNHIDHVGGVEEIIRRYPNVTVFGPEETKTRNVNKIVKQGDVIKLLKS
EIHVFLTPGHTLGHVSYYLKPYIFCGDTLFSGGCGRVFKNKFFDMYQSIN
FIKSLPKKTILCCSHEYTLSNLNFAMSILPFDKKIKKYYKKIKKHISQNK
TSLPVSLETEKKINIFLRTNEKTIKKAMGLKKDTSSFEVFILLRKEKDDF
>BUsg296 glpF, glycerol uptake facilitator protein
MNFCSKKKILKQCFFEFLGTGLIIFLGISSLVVSKLTNFHFNHCEISCIW
GLGVFISICFCSSVSGAHLNPAITIFLFLSSQFNKKKVIPYILSQISGTF
FFTFLIYLIFNNLLNSFESKYNIVRGTKKSLELASLFCVFPKENYNFIHD
FILEILIGIIFIIILMKLSEKNNLFKFYKFINPFLIGTLVIIINLFLTSY
SNITLNPARDLGPRIFLSLIGWGKLAFTGDDNIIFPYFLIPTIAPIIGIN
LGGWIYILYIKK
>BUsg065 gltX, glutamyl-tRNA synthetase
MNQIKFLVKELMKVKTRFAPSPTGNLHIGSIRTALYSWLFARHYHGKFIL
RIEDTDFERFDSKSVESILYGLKWLGLNWDEGPYFQSKRLERYKEVIKMM
LESGNAYKCFCSVKELEDERIRQVSKGKKPRYSGICRNLHYRNYIANENY
VVRFKNPISGQVTFEDKIRGKITFQNEELDDLVIQRSNGIPTYNFCVVID
DLDMNITHVIRGEDHINNTPRQINILKSLNAKIPIYAHVSMIFNEDGHKF
SKRQDALNILEYCKDGFLPEALLNYVIRLGWSCGNQEIFSISEMKELFDL
RKISKSSSAVSMKKLFWLNKYYINNLPLSYISNLLKDHMNHEKINLKNGP
DLESVLTLLKNRHHTLKEIAQSSRYFYEEFANFDKSAADEYLIPENHFIL
KNLYKNIKKISIWSNETLSSLIKNDCIKLKITLRKISMLLRVVLTGNIFS
PSISSVIFLIGKEKTLLRLKKAILFIDNKIKNINN
>BUsg278 glyA, serine hydroxymethyltransferase
MFNTKIEFSKYDPELWKAIDQEKNRQENHIELIASENYTSNYVMHVQGSQ
LTNKYAEGYPEKRYYGGCKYVDIIEKLAINRAKKLFNADYANVQPHSGSQ
ANFAVYTALLNPGDTILGMKLSHGGHLTHGSSVNFSGKTYNVIGYGVDKK
GNIDYQEILTLAKKYKPKMIIGGFSAYSGICNWSKMRDIADEINAYFVVD
IAHVAGLIAANLYPNPIDYAHVVTSTTHKTLAGPRGGLILAKNGTNTFYK
KINLSVFPGAQGGPLMHVIAAKAIAFKEALEPAFKIYQKQVIKNAQVMVQ
SFLKKDYQIVSGNTFNHLFLLDLTSKNITGQEADIALGKCNITVNKNTIP
NDLRSPFITSGIRIGTPAVTKRGFKENEMLQISDWIVHILNNIKDKNSLL
GIKNEVLKLCSKYPVYI
>BUsg128 glyQ, glycyl-tRNA synthetase alpha subunit
MENNHNNFSNLITILQEYWTEQECAIFQPLDLPIGAGTFHNTTFFGTIGP
EPIRAAYIQSCRRPTDGRYGKNPNRLQHYYQFQVIIKPPLKNIQNIYLKS
LNLLKISEKRNDIRFVEDNWENPTLGAWGIGWEVWLNGMEITQFTYFQQV
GGLECNPVTVEITYGLERIAMHMQNQSNVYDLIWSENKFKKITYGDIFQQ
NEIEQSKYNFEYSDINLLFEYFQKYIFEAKKLIELKKPLLLVSYEKILQA
SHVFNLLDARKAISSSERQNYILKIRKLAKKIAQEYLYSRKK
>BUsg127 glyS, glyS: glycyl-tRNA synthetase beta chain
MHKNIYIQEKNKIFIIINEKKMIKKTFLVEIGTEELPSNILKKIILVFYK
NFVDELSFNKILYKNINYFSTPRRLALQIIELDTSEKINEKIKKGPAIKH
AFDENGNPTKAAYYWAKSCKINLNQAERLKTKTGEWIIHRIQEKKEKIEL
LFPKIIEKILKQINLKNTMRWETTNLRFIRPIRNIVMLLDEKIIKSEVFN
VPSNNFLYHHISCKEEKIYIKNAIEYPAVLFKKNKIIANYETRKEKIKYE
AKKIAKKVDGIIKTNPFLLEEVTSLVESPQALLARFKKDYINYIPKKILI
HTIEKQQRCFSIYSNNSKKEILPYFIFISNIKSKKNKEIILGNEKVMHAR
LSDAMFFLKQDRKRKLENYLPFLKKVSFYNNLGTLYEKTLRLKLLIESIS
CYTNTINKNDLIRSAVLSKCDLITQMVDEFPELQGTIGMYYALENKENKE
VAIAIKEQYLPSFSGDELPSTPIGCLLSISDKIDTLSGMFAIGETPTPEK
DPFGLRRAALGILRIIITKKIPIDLKKIIEISLKIYTFKKVNYSIISKKI
IKFFISRLSFFYEKKGYSTKVIKSVLSCKLTEPLDIDKRINAISDLKKIE
SIILIAKRIDNIVKNNHQIISSEIHVELMKKTEEKNLLKEIKIFNSKTKE
LFIQKKYKEILVEIKKLEKPIDNFFDKVQINHSNFEIRQNRLLLLIKIQK
FFLKIANFSYLY
>BUsg419 gmk, guanylate kinase
MSQGILFIISAPSGTGKSSLIEGLLKTKFLYNIQVSISHTTRVMRPGESH
GKHYYFISKKEFRIMIKQESFLEYAKVFNNYYGTSRQSIEKMLLSGIDVF
LDIDWQGANQIRYKMPNSKSIFLLPPSKDELYKRLRERGQDSDTVISKRM
EKAVDEMNHYSEYDYLIINDDFQKAINDLRTIIIAEHLCLFHQKNKHNVL
ISQLLKS
>BUsg100 gnd, 6-phosphogluconate dehydrogenase
MLKQQVGVIGMAVMGRNLALNIESKKYTVSIFNRTQSVTEEVINNNKEKK
IFPYFSIKDFVNSLRKPRCILLMVKSGQPTDETIQFILPYLNKGDILIDG
GNTFYKDSIRRSNDLMKCGINFIGMGVSGGELGALNGPSIMPGGSREAYD
LVSSMLKKISAKFKNEPCVSYIGPNGAGHYVKMIHNGIEYGDMQLISESY
FILKNVLNMKNEELSNTFSQWNKGELNSYLIEITKNIFLKKEKDGIHYLI
DSILDHAEDKGTGKWISQDALELHEPLSLITESVFARYLSSLKDQRLIAS
KILKGPILKCISSQNKELFVEEVRRALYLGKIISYAQGFSQLKKASEKYS
WNLQYGKIAKIFRAGCIIRADFLERITDAFKSNNVTNLLLTPYFSEISNK
YEKSLRYITSYAIKYGIPVPTFASAISYYDNYRTMSSSANLIQAQRDYFG
AHTYRRTDKKGYFHTNWLTKKEL
>BUsg294 gpmA, phosphoglycerate mutase
MKTNKLVLIRHGQSKWNKLNKFTGWHDIELSDNGINEALKAGSLLKKEKF
FFDYAHTSMLKRAIHTLRYILDTLDQSWLPVQKSWRLNERHYGALEGLNK
DEMISKYGEEQVNLWRRSFEIIPPQIRLNDKRFPGNDIRYSNIDNNELPL
GESLELTAKRVIPYWNKFILPQIKKRNRVLIVAHGNSLRALIQFLNKIDN
KKILELNIPTATPIILEFNEEYNSIKWYYL
>BUsg242 gpt, xanthine phosphoribosyltransferase
MSEKYIVTWDMLQIHTRILAHRLLKTKNAWNGIIAVSRGGLVPSAILARE
LGIRCVDTVCIASYNYDCLQKNRKIIKKARGDGEKIIVVDDLVDTGGTAK
IIRNLYPKAYFVTIFAKPLGRLLVDDYIIDIDQNIWIEQPWDMSISYISP
LIKK
>BUsg371 greA, transcription elongation factor GreA
MINLIPMTVRGAEKLREELEQLKNVKRPRITVQIAEARKHGDLKENAEYH
SAREEQSFCEGRIQEIESKLSNSQIIDITKISNDGRVVFGSTVTILNIKN
NAVFTYQIVGDDESDFKKNLISINSPMSRGLIGKTVNTIAIIHTPSGNVK
YKILKIDYI
>BUsg018 groES, co-chaperonin GroES
MKIRPLHDRVLVKRNEAELKSAGGIVLTGSAAAKSTRGTITAVGNGRVLD
NGQIKPLDVKVGDVVIFNEGYGAKTEKIDNEELLILNESDILAIVE
>BUsg178 grpE, GrpE
MDNQEKKTNYQNTDKENDLEKNKEKKNDESIFQNKKMNEIREKIFKNKKE
INNLKLRHLANIENIKKNTEKKIKKIKNAEIENFFKQIIPIINNLEDILT
ISTKLNLNDEPSIQGIELTLKSLLSILIKFGVKIEGKKNEIFNPKIHDVI
LTESSNTIEPNYIISVKKKGFIFKKTILRKAAVVISKT
>BUsg243 grpE1, GrpE
MKNKKEEKINNLKKEEKINNLKKEEKINNLKKEEKEKNDDVQNKIIDLLE
IKLKKSQEKIINMQLKNHEEILKLNYRLNSDIEKSRKFSLEKVIIEFLPI
IDNIERALSVIKDKKEAFYLEIINKMNFIFSLLEEILSEFNVSKINEKNI
SFDPEIHQAMSINYNDEIEDNHVVDVMQSGYMLHKARLLRPAMVIVSKRK
NN
>BUsg392 gshA, glutamate--cysteine ligase
MIEDISKKISWLEKNPEIIKNIFRGIERETLRIKKNGKFSNTKHPYLLGS
PLTHRWITTDFSENLLEFITPTSSNIDYLIKFLKNLHSFVSYKIKHERMW
PFSIPYLYNKSTAIKIAEYGTSHLGKIKNIYRKGLKNRYGDLVNTISGIH
YNFSLPKIFWKNWKKSEINLKNEDYISSGYLNLIRNYYRFGWVITYLFGA
SPAISKYFLKDKKYKFKKNIENILYLPWSTSLRLSDIGYTKTPTIKLNIM
FNDLKSYIKSLRKAINTPSKKFSKIGIKDKQGEFLQLNTNILQMESELYT
PIRPKRQTNPGESLLEALGKRGIEYIEIRSLDINPFSSIGINKKQILILD
LFLIWCALIHAPQMNKENFLVNNKNWNKIIFEGRKPHQKIYINSQYETKT
LIEIGQIIFQDLKKIAKILDYQSKNFEYQKACQETILFFKNPELTYSAKF
LQLLIKHGIKKTGLNLANKYHKEFINRYNYNSEKNILERETILSHKKQKQ
IENNEISFKKNNFSHANN
>BUsg529 gshB, glutathione synthetase
MRKKKNLKIGIVMDSITLINIKKDSSFAILLEAQKRQHEIYYMEMNDLYL
RKGQSYATTKSIEIQKNQNNYFKFIQKKDISLNELDAILMRKDPPFNTEF
IYATYILERAEEKGVLVINKPKSLRDCNEKIFISWFSRFTTDTLVTRKLS
KIHNFWKEKNDIILKPLDAMGGKGVFRIKKDDPNFSVIVETLTNYEKKYC
MIQTYLPEVQFGDKRILIVNGKPIPWSLTRIPKHGETRANLAVGGEGRVQ
KLNDKDWEIANYLAPILKKRGLILVGLDVIGDKLTEINVTSPTCICEIEE
KKNISITGILIDYIEDKIYK
>BUsg198 guaC, guanosine 5'-monophosphate oxidoreductase
MRIEEDIKLGFKDVLIRPKRSTLKSRSEVNLIRCFSFKYSTMKWFGIPLI
AANMDTIGTFRMAEALSKFNILTAVHKYYSFDEWKNFISVSSKEILEHVI
VSIGTSNLDFFKIKKIFSLSSELKYICIDVANGYSEHFVSFLKKIRSFFP
DKIICAGNVVTGEMVEELILSGADIVKVGIGPGSVCTTRLKTGIGYPQLS
AIIECADAAHGLNGQIISDGGCTVSGDIAKAFGGGADFVMLGGMFAGHTE
CLGEIIQEKSKKFMLFYGMSSTSAMKRYTGKIPGYRASEGKIVKIPFRGN
VDVTVRDILGGLRSSCTYVGAQKLKELTKRTTFIRVSEQENCIFNNFKN
>BUsg174 gyrA, DNA gyrase subunit A
MKHLAREIVQVDIEKELKSSYLDYAMSVIVGRALPDVRDGLKPVHRRILF
AMHVLSNYWNKAYKKSARVVGDVIGKYHPHGDSAVYDSIVRMAQNFSLRY
MLIDGQGNFGSIDGDAAAAMRYTEVRMSKISQELLADLEKNTVEFIPNYD
GTEHIPEILPSKIPNLLINGSSGIAVGMATNIPPHNLNEVIDGCLAYIKD
DNITLRELIQHIPGPDFPTAGIINGKKGIEEAYRTGKGKIYIRARNKIEK
NKKNKKESIIFYEIPYQVNKSRLIEKIAELVKEKRIDGITALRDESDKDG
MRIVVEIKKEAMSEIILNQLYSLTQLQISFGINMVALCQGQPKTLSLKEI
LKHFLSHREEIVTRRSIFELDKTCKRSHILEGLSIALININCIIDLIKKA
KSSLEAKELIIKKTWIYKNSEKINQKDHDYHFTEEQVQAILDLRLHKLTS
LEKNKLVLEYDCLTKKIKELKKILKSRDRMREVIRDELVSIKNNFGDQRR
TEITENNPDISIEDLINQEDVVVTLSHSGYVKYQPLSDYNAQKRGGKGKS
AAKIKEEDFIESLVVTNTHDTILCFSSRGILYWMKVYQLPESSRHAKGRP
IVNLLPLSNKERITAILPIHEFKDNLNIFMATAQGIVKKSSLKEFKKPRI
AGIIAINLRANDELIGVSLTNGKNNIMLFTQNGKVVQFLENSVRTMGRTA
SGVRGIKISKNDKVVSLIVPYKKESILIATNNGYGKRTKITDFPIKSRAT
QGVISIKITKKNGKIIGAIQVVEKDQIMMITNAGTLVRIRASEIGVLKRN
TQGVILIRTSKNEKVVALQRIVEPI
>BUsg010 gyrB, DNA gyrase subunit B
MIDTYDSSKIKILRGLDAVRKRPGMYIGDTDDGSGLHHMVFEIVDNSIDE
ALAGFCKEIKVVIHSDNSVSIKDDGRGIPTDIHPEEKISAAEVIMTVLHS
GGKFDNASYKISGGLHGVGISVVNALSEKLELIIYKNKKKYRQQYKNGNP
ESPLCIIGATEITGTYIRFWPSYKIFTNKTQFQYEILSKRLRELSFLNSN
ILIHLKDNRTNLEEKYHYKGGIKAFIKFLNKNKFPINLNIFYFRCIKNQI
ELEIAIQWNNSHQENILCFTNNIPQKDGGTHLSGFRAGITRTLNLHIERE
GYNKKNKTIITGEDTREGLTAIISIKIPDPKFSSQTKDKLVSSEVKSVIE
SLINENLIEYLLENPIDAKFIIQKIINSAKIREAARRAREINKKKGTLDL
GTLPGKLSDCQENDPKLSEIYLVEGDSAGGSAKQGRNRKNQAILPLKGKI
LNVQKTKFDKIILSQELTSLITALGCSITKSEYSLDKLRYNHIIIMTDAD
VDGAHIRTLLLTFFYRQLPELIKKGYVYIAQPPLYKVKKGKQEKYIKNDE
EMNKYQIKIALKEIVIKNKKNENCNKIIKEFQKIVSDFNHIQIKMKKNKN
YFPELILNELIYHPRLYNLKNENVVQNWIEKLVEKLNKKDKNNTIYTSKI
KRNENDSIFEPSIKLSRYANHTQYDLKNDFLESKEYFLITNLGEKFKKFQ
ENENFIEKGEKIYKINDIKNTLEWLIKETKRGFFVQRYKGLGEMNPDQLW
NTTMNPETRNMLQVTIKDAISANNLFNTLMGDLVEPRRKFIQKNALKAEN
IDI
>BUsg166 hemK, HemK
MNINYWLKKAIKKLSHCENPRYEAEILLSHVLKCTRIAIIINQEIDLSKE
QYQKLNNFIYRRSIGEPIAYIIGKKEFWSLSLCVSYKTLIPRPDTEILVE
KILSKVNKNFRSILDLGTGSGAIALALASVCSHWNIIGVDNSYSALKIAK
INGLKLNLKNVEFFYSNWFSHINEKFHIIVSNPPYIGIKEIQSLKKDIFY
EPFNALISKKDGLLDIELIIQKASQYLFDKGWLFIEHGWKQKLKVQYFFK
KYNFFCIQSFKDYGGNDRITFGQKK
>BUsg547 hflC, HflC protein
MNKIVICILSFFLLIFSSSFFIVKEGERGIILQFGKVLRNNKQKTLVYTP
GLHFKIPFFENVKILDSRIHTMDNQADRFVTKEKKDLIVDSYIKWRISDF
SRYYLATGGGDFFQAEVLLKRKFSDRLRSEIGRLNVKEIVTDSRGRLTTD
VLYSLNKGTINLDSTSLINVNSMNALGIEVVDVRIKQINLPLEVSDAIYN
RMRAERESVARSQRSQGQEKAEKLRATADYRVSLILAEAQKKALMIKGQG
EAEVAKLFLENFGQESSFYFFIRSLHAYENSFKNSNNIMLINSDNEFFKY
MNTEIKN
>BUsg548 hflK, HflK protein
MAWNKFNNSEPELDPWGKKNSQEKNGSKNKDDRKNHEKIITLDFKKFLYN
INNIFNKTNNSQNLSKNKINPFLIIAFVSFFVWCFSGFYTIKEAERGVVT
TFGKFSHLVAPGLNWRPVFINEVKAVNVETVRELATSGVMLTSDENVVRV
EMNVQYKITDPADYLFSVAYPDDSLRQATDSALRGVIGHSNMDRVLTEGR
TLIRSDTQKEIEETIKPYKLGITILDVNFQTARPPEEVKEAFDDAIAARE
NREQYIREAEAYSNEVQPKAHGKAQRILEEAKAYSSRRILEAQGEVVRFL
KILPEYRKNKEMTLKRLYIESMEKLLSKTKKIFIDKKNHSKLFLSLNNFF
HQDKFNKQDLFNNPINLSKNHSCSFQKNKEINDVSSLPPSDFFKKRRIES
IRTNIKNIERE
>BUsg123 himA, integration host factor alpha-subunit
MVVTKAAISENLFEKLKLTKRDSKEFVEFFFEEVRKSLEKGEDVKLSGFG
NFQLKNKKERPGRNPRTGENILITQRRVVIFKAGQKLKNRVEHYLMKVKY
>BUsg298 himD, integration host factor beta subunit
MTKSELFERIAERKAHISNKIIECAVKEMLEYISISLSKGKRIEIRGFGT
FSLHYRSSRIGRNPKTGKKIKLNERYIPYFKPGKQLRDRANYK
>BUsg097 hisA, phosphoribosylformimino-5-aminoimidazole carboxamide ribotide isomerase
MIIPAFDLINGEIVRLYKGNFFNRTKYDINLYKRLKDYEIKGVKKIHLVD
LDGAKNIKDRQIKVFRDIISYTNIPIQIGGGIRNEEDINMFLNLGVKKVV
IGSSAIKNKTKVKKWLKIYGPNVIILALDIIIKNNNKEIAIHGWQETTNI
TLEEIIEYFSPIGLKHVLCTDISKDGTLSGPNNILYKDIVKKFKHISFQA
SGGVSRLKDLLSLKKTGVKSVIIGRSLLENKFTIEEALKCWQSE
>BUsg095 hisB, imidazole glycerol-phosphate dehydratase/histidinol phosphatase
MKQKILFIDRDGTLIHEPSNDCQVDAINKLEFKKYIISSLCQLMNFGYKF
VMVTNQDGLGSKSFPRENFNIPHFFMLNIFRSEGIIFEDVLICPHFLDDN
CDCRKPQTKLLKPWLKKNKIDKQRSYVIGDRETDMELAKNINLTGIQYKE
KEFNWIDITKEIIKRNRYREVIRETKETYIHIKLWLDLEHHSCIQTGINF
FDHMLEQLSIHSGISMYILAKGDLQIDDHHTIEDTGIVLGEALSQALNNK
NGLSRYGFVLPMDESQAKCIIDLSNRPYLSFNAHFKHKMVGDMNTDMVEH
FFYSLCCSMKITLHIDVKGKNDHHCIESLFKAFGRALRKAVKIEGNTLPT
SKGIL
>BUsg094 hisC, histidinolphosphate aminotransferase
MTANINKLARKNIQKLNPYQSARRIGGKGDTWLNANESPISVPFKGKVKV
FNRYPECQPNNLLSSYANYVGLLNNQILVTRGADEGIELLIKAFCEPGKD
AIIYCPPTYDMYAINAKIANVEIKEIPTFKNTWKIDLLNIRSNLNKVKLI
YICNPNNPTGNIVSQEDLKSLLKVTLGQSLVIIDEAYIEFSPKNSMVNYL
KTFPNLIILRTLSKAFALAGIRCGFTLAQKEVIDILHKVISPYPISTLIA
DIAVQSLEKKAIDDMKNRVLKLNMNRIWLIDELKKISCVKKVFDSHANYI
LVEFYMFKKIFQSLWQKGIILRNQNHKNNLKNCLRISIGSKSECMRLVQE
LKNFI
>BUsg093 hisD, histidinol dehydrogenase
MKYFNTIVNWNMLNSNEQKNILLRPVIKNNNSIKKKVKKIIENIQVLGEK
ALREYTILFEKCHINKFEVSKEKMLSSSLYVNQSLKDAISTAKKNITSFH
TAQILSPIDIETQVGVRCQQIYLPLNSVGIYIPSGIAPLFSTVLMLAIPA
KIAGCKQIILCSPPPIDNTILYAANICGVDKIFQMGGAQAIAALAFGTKN
IPKVDKIFGPGNAYVTEAKLQVSSIFNGPQIDMLAGPSELLIIADEASNA
DFIAADLLSQAEHSISSQVILLTPSLQLAKKVIISINNQLKNLSKSDDIS
TALDNSVIILTKDLFECIKISNIYAPEHLIIQTKEPRLILKEILNASSIF
LGPWSPESAGDYASGTNHVLPTYGKSVSSSALGLCDFKKRVLIQELTSQG
FINLSNTLKILSEAEKLEAHKNAVKIRVDFLKEKI
>BUsg098 hisF, imidazole glycerol phosphate synthase subunit HisF
MLAKRIIACLDVNNGVVVKGIQFKNHEIVGDIISLSKRYTKEGIDELVFY
DITASTNNKLVDRSWIKKVAEIINIPFCVAGGIKSVEDAQNILSFGADKI
SINSSALIDPDLITKIANRFGVQCTVVGIDSWFDSDKKKYMVQQYTGDAN
RTYQTDWETIDWVEKVQKKGAGEIVLNMMNQDGLQNGYDLSQLNEIRKKC
KVPLIASGGAGCADHFYQAFDHANVDGVLAASVFHKKIVNIKDLKYFLIQ
KGLEIRIC
>BUsg092 hisG, ATP phosphoribosyltransferase
MFNTNRVRIAMQKTGRLSSESIKLLTCCGIKINLKQQKLIAFAENMPIDV
MLVRDDDIPGLVMDGVVDLGIVGENVLQEELLHRISQNLENSYITLRRLD
FGICRLSLAIPINTPYVDITSLKNFRIATSYPHLLKKYLDSKNIVFKSCM
LNGSVEVAPRAGLADAICDLVSTGATLEANGLREVQVVFRSHACLICKTG
NINFAKKEVINKLMTRIKGVIKARESKYIMLHAPVNKLEEVISLLHGAEK
PTILKLAGDDHRVAMHMVSSETLFWETMEKLKSLGASSILVLPIEKMME
>BUsg096 hisH, amidotransferase
MDIAILNTGCANLTSIQVAIKKLGYDSIVTSDPSIVLKSKKIFLPGVGTA
LAAMEQLHKKNLINTLKKLTQPILGICLGMQIFSQFSEECKGVKTIGIFD
NCFTHLLKSSNLPLPHMGWNHIVFNNLHPLFKNIDKKERFYFVHSYIIPL
NKYTLAKTKYGVSFSSVMQKNNFFGVQFHPEKSGDAGAQLLKNFLEI
>BUsg099 hisI, histidine biosynthesis bifunctional protein
MLSKKENLLKLDWIKTNGLIPAIIQDFASNLVLMHGYMNKEAFLKTQKEG
FVTFYSRTKKRLWTKGEESGNLLKVIDIVTDCDYDTILIIVEPLGKTCHL
NRKSCFFLKENTLNFLSKLEDLIEDRKNFNTDNSYTARLYKSGTKRIAQK
VGEEAIETILAAMKNDGDELINESSDLIYHLIVLLHDQNLNFNLIIENLK
KRKTEKL
>BUsg277 hisS, histidyl-tRNA synthetase
MNKKINSVRGMHDYLPEELKIWKKIENIIQKILTSYCYEEIRLPILEKTK
IFQRAIGNITDVVEKEMYSFKDKKGNSLTLRPEGTVGCVRAIIENNLLFQ
KKQRFWYLGPMFRYERPQKGRYRQFYQLGVEVFGLNTPDIDLEIILLISR
LWKCLGINLHIKLEINSIGSKLDRIKYQKELVFFLEKYKNILDEDSKKRL
YTNPFRILDSKNDMMQKILKKAPLLKNYINTSAINHFNSLCNMMDSYGIK
YIHNQNLVRGLDYYNSTVFEWKIDQIGSQNTICAGGRYDSLVQELGGNKT
SAIGFAIGIERLVLLIKSLNIISCKEEDINIYIIFIGELNKIYAISLSEE
IRNIYPKLKIFVDFMTCSLSKKIKNAVDSLAHIAILIGANEIKKNCFLLK
DLKRGREYFFSKSELILKIKKIFYKQGN
>BUsg430 holA, DNA polymerase III delta subunit
MKIIYPEELKQKLIKKLNYFYILLGEDSILLSKAEQLIFYFAKDKKFIEK
NTINIEKSTDWNKVINFHKSKNLFFKKTILIINFTIKKLNLSLVKNINKI
PLFKNKDILTVIKLNALSSLIKKSTILKILILESEIIYCSTPYEWAFKKW
LQYEIKTRNLKITQESFLLLHKYYEGNTLCLNQILDILSITWPNENIKIE
KIKKIINQFSIFSPVNWINAIFNKNKKKAIYILDSFFKQKYNPLILIRTL
QKDLLILLNMKREKKLNINFFLKKNNISLNRSKFFANALYYIDFNNFLKI
IRILLQIEIKIKKEYNNSVWIQLKTLTLLLSSPMKYTP
>BUsg342 holB, DNA polymerase III delta' subunit
MKWYPWLIKPYKKIIRLHERKKAHHAILIKTQKGMGVFKLVWFISKWLLC
LKPKGTNFCDNCHGCKLMSANNHPDWHTIINEKNDVFDVDSIRVINEKIF
KRAQQGNNKIIFLPNVHKLTESAVNALLKILEEPPEKNWFFLIDYNYLKL
HSTLKSRCFLYRLPLPLEKESLNWLKNNNKKDNISNLTSLRINQDSPISA
KNFIESDLWDERKNLYKSLSHSIKDKNLLKILPVLCKKNTIMKIDWICLL
LFDAVKTNFNERKKLINCDQIKLINFFSKKYNNILLNKSIRKWTKCRYIL
SSVSSINSELLLLEQLLLWEKILCFITP
>BUsg189 hpt, hypoxanthine phosphoribosyltransferase
MKHTIKVIISEKELDIRVRELGEEITKKYKNSKNKIILIALLRGSFVFIA
DLCRRIKIEHEIDFMTTSSYGRGMISTGDVKIIKDLDEDIYNKNVLIVED
IIDSGKTLSKVLGILKLRNPKSLSICTLLDKPECREVNINIDFVGFSIPD
EFMVGYGIDYAQSYRYLPYIGKVIFKK
>BUsg580 hscA, chaperone protein HscA
MVFLKNKVKKKLILGIDFGTTYSLLASVQNERVVLLTDDKKRYLLPSIVN
FNKKKPLIGWEAEKKIIKDPINTITSVKRLIGRSIDFIKKEFPILPYVIE
DNKDGGILFHTNSGLVTPIDVTSEILKFLKEKSCEFFNKKIDATVITVPA
YFDNLQRDSIKKAAISAKINLIRLLNEPTSAAVAYGLQLNTEGLVVVYDL
GGGTFDISVLKLNKGIFEVLGTAGHANLGGDDFDTLLSKYIYKKLNLSNQ
CDNFFQSLLLKKAKEIKIKLTKYEKVEVNFFNWKGIIFRDEFNLIIKDLI
QKTLFICSNLLKEIDLKIESIKEVIMVGGSTRVPLVYQEVKKFFRKSPLI
SINPDQVVAIGAAIQSDMLMKNTIQKRTILLDVTPLSLGIEVMGGFVEKI
IFRNTPIPISKTKEFTTAKDNQTIIVIHILQGERELVKDCISLSRFILKD
IPSKKAGVVRILVTFEIDTDGLISVKILEKFSHKEKKIQIENVTFLQNKN
IHKIIKESTINAKEDYYLRVRKEKKIESKYILDLLNNALQEDRNLITSEE
LKKIKSHQIKLQKSIDEDDFFSMKLNLKKLEEVSKNFLSLRLKKNMDSFS
IKNLSDEIT
>BUsg579 hscB, chaperone protein HscB
MDYFALFNLPKKYIIDKFLLSKNFYKLQLKFHPDLFIHHSESKKRIVLQK
SIEINKGYKILQDSLNRAIHLLFLNGFKISKEKVLSEDNSFLKKYFFLYE
ELDFLLKNNCDEVQIDIFFKKIRNKIDNYEKIIEIKFNEKKWDDIIKLIT
KLLFFKKIQTRLKQS
>BUsg558 hslU, ATP-dependent protease ATP-binding subunit
MSEMTPPQIVSELNKFIIGQEQAKKAVAIALRNRWRRMQLNNELRHEITP
KNILMIGPTGVGKTEIARRLAKLANSPFIKVEATKFTEVGYVGKEVDSII
RDLTDAAIKMIRVKNIEKNKLRVEEIVEERILDVLVPRPKNNWTENEKNE
SLLNTLQVFRKKLREGILDEKEIEINVLASTMGVEIMAPPGMEELTSQLQ
SLFQNLGGHKKNTRRLKIKDAVLLLKEEEAAKLINQEEIKKEAINAVEQN
GIVFVDEIDKICKRRDSSGPDVSREGVQRDLLPLVEGCTVSTKYGMVKTD
HILFIASGAFQTSTPSDLIPELQGRLPIKVELQPLTINDFEKILTEPTAS
ITAQYKALMKTEGVCINFTKEGIRNIAEAAWKVNESMENIGARRLHTILE
KLMEDISFNACDNVGKTIEINSEYVGKHLDQLISNEDLGRFIL
>BUsg557 hslV, ATP-dependent protease peptidase subunit
MTTILSVRLKNKVVIGGDGQATLGNTIMKSNVKKIRTLYHEKVIAGFAGG
TADAFTLFEMFEKKLAMYQGQLPRAAIELAKDWRSDRMLRKLEALLAVAD
KDTSLIITGNGDVIQPEDDLIAIGSGGSYAQSAARALINNTTLNADEIVE
KSLNIAANICIYTNHSFTIKELFSEK
>BUsg468 htpG, heat shock protein 90
MNIQKKEVYSFQSEVKQLLHLMIHSLYSNKEIFLRELISNASDAIDKLRF
QSISNPELYENDSDFKIQISINKSQGTLIISDNGIGMTRQDVVENLGTIA
KSGTKSFIKSLEKKEKNVKNELIGEFGVGFYSSFIVSKKVSVRTRFAGSK
SNLGVLWESSGEGEYNITDIKKKTRGTEITLFLKKEEEEFLELWRIEGIV
SKYSDHITVPVKIQKYDEKNKIYFWEKINKAKALWTQNKATISEKEYQEF
YKHLTNDQNNPLFWSHNHVEGINEYISLLFIPEKAAWDIWNRDNKSGLKL
YVKRVYIMDNSQAFLPNYLRFIRGLIDSNNLPLNVSREILQDNSITQNLK
KALIKRSLKMLQTLSKKDNEKYQIFWNQFGSVLKEGPAEDSNNLNLIASL
LRFTSIQNNSSEQNISLEKYISNMHEKQEKIYYITADSYTSAKNSPHLEL
FNKKNIDVLLLSDRIDEWMMNYLTEFEGKKFQSISKEDLSLNKLTKENEN
KKETSTEMIEFLKKVKKTLGDKVKSVRLTYRLTETPCIVLSDSNEMSTQM
AKLFSAAGQSVPELKYIFEINPEHKLIQKICKIKENEKFDEWIKLLLDQA
LFAEKGNLENPHEFIARTNKLILEQ
>BUsg313 htpX, heat shock protein HtpX
MIRIILFLLTNLAVMLTFSLILAVTGIQSESIYGLLIMSSLFGFSGSILS
LIMSKWIALRSVNGRIINHPSNETESWLIDTIRQQSIKKNIIMPQIAIYE
AADINAFATGARRNAALIAISTGLLENMTRSEAEAVIAHEISHVSNGDMI
TMTLVQGVVNTFVIFISRIISQALSSLLSSNRNENSEDEKDSFLFFLIST
FLEIIFGVLASIITMWFSRHREFYADASSAKLVGKEKMISALNRLKSSHE
PQESDSIIAFCINGKSNSFIELFASHPSLEKRIQALKNKKYM
>BUsg222 htrA, periplasmic serine protease
MKRINIVLSGIMLFLTLLLSFGMSWGNKNFTSSQNVSSVQLAPSLAPMLE
KVMPSVISINIEGSTVVHTSRLPHQFQPFFGHNSPFCQGNSPFRNSPFCR
SNPNSNSMHEKFHALGSGVIINADKAYAVTNNHVVENANKIQVQLSDGRR
YEASIIGKDSRSDIALIQLKNAKNLSAIKIADSDTLRVGDYTVAIGNPYG
LGETVTSGIISALGRSGLNIEHYENFIQTDAAINRGNSGGALVNLKGELI
GINTAILAPDGGNIGIGFAIPGNMVKNLTEQMVKFGQVKRGELGIIGMEL
NSDLAHVMKINAQKGAFVSQVLPNSSAFHAGIKAGDIIVSLNKKTISSFA
ALRAEVGSLPVSTKMELGIFRNGITKNVIVELKPSLKNSVSLGDIYTGIE
GADLSDCSLNGQKGVKIENIKLNTQASKIGFKKDDIIVEVNQKVINNLND
LKNILDSKPNILVFSVKRGNNSIYLVSE
>BUsg033 hupA, DNA-binding protein hu-alpha
MNKTQLIKIISKQSNLSKIQIKSTLEKILSAIIESLKKGESVQIVGFGTF
KVNSRASRTGRNPQTGKEIIIPATKVPSFISGKTLKNAIK
>BUsg559 ibp, heat inducible protein Ibp
MKGGFMSYRSFSFLPNIDQNSVFSNRFNQIDKIFSTLTGEKPLSDTPAYN
LFQIDEHKYELILSIPGYEEKELDISVHNSQLTVQGKKQNQENDDKKIKK
YLHKGIIFNDFSLNFNFDHKIQVKKAELFSGLLKINFECRVPDEEKPKKI
FINIPNKVKEIEKNKI
>BUsg142 ileS, isoleucyl-tRNA synthetase
MNDYKNTLNLPKTQFSMRANLSQKEPKILKNWYDNNLYKLIRQKKEGKKI
FFLHDGPPYANGNIHIGHAVNKILKDIIIKSKNMSGFDAPYIPSWDCHGL
PIEQKVEEQMGLKSNNIITTIFQKKCRKYAEKQIKKQKKDFIRLGVIGDW
ENAHLTMDFKNEANIIKTLSKIIEKKYLYKESKPIHWCLKCYSSLSDAEI
EHFDKESDSIFVAIKSKNNKILKEVLNLNISSEKDIYLPIWTTTPWTLPS
SQAITVNPIFEYQIIETKKYNLILAKELVKNVMKILEINHWNILSSFKGK
ILEGKKFLHPFLENISLPVILGDHVNLDSGTGAVHTAPDHGPDDYIVSQK
YKIKTMNLVDFKGNYINNIHPKLNGVNIFQANEIIINLLIKKDCLLHHNI
LKHSYPHCWRHKTPVIFRATEQWFINIDQKKLRYKTLEEIKKVSWIPKWG
GSRIEEMIKKRPDWCVSRQRKWGVPMCLFLHKKTGKIHPENTLLIKKIIK
KVELEGIEAWWKINLKEMLGETYNMYNQTFDILDVWFESGNTHTVIKYKN
KKYSKNHADMFLEGSDQHRGWFMSSLIISMLVKNQSPYSEVLTHGFVVDK
NGQKMSKSIGNTISPNEVVKTLGGDILRLWVASSNYSNDISISNEILKRS
SDIYRRIRNTARFMLANINDFNPQKNTVLKENMVLLDRWAISQAKIVQEE
IIEFYKKYNFHAIIKRLMYFCSIEMGSFYLDIIKDRQYTLKTNSQERRSC
QTAIYYIINALVRWIAPILSFTADEIWNHLPGKHAQYVFTEEWFNKLFDL
DKNDLFNREFWKNLIEMKNEINKFLETEIKNKNINNSLEACLILYVTPEV
KKTLNILGEELKFIFLTSKVKIELYNTAPINSTKSKKISNFKIFLKKIKE
KKCPRCWHYNIFIENNNDKICTRCILNTKGNGEKRFFI
>BUsg575 ilvC, ketol-acid reductoisomerase
MNYFNKLCFRKRINEIKKCRFMKENEFKNENKILKNKKIVIVGCGSQGLN
QALNMRDSGLNISFALKKNSILRKNSSWLNATKNNFEVNDYESLIPNADL
VINLTPDKQHENVVKELQKLMKKNSCLGYSHGFNIVECGEIIRKDITVVM
VAPKCPGTEVREEFKRGFGVPTLIAVHTENDPKKIGLEIAKAWAFSTGGH
RAGVLESSFIAEVKSDLMGEQTILCGLLQTASLICYEKLIKDKHNPSYAA
KLIQYGWETITESLKHGGITLMMDRLSNPSKIKAFKISKKIKKILSPLFK
KHMDDIISGSFSKEMMIDWHNNDKKLLNWREDTKKTPFEKNILSYSEKIS
EQEYYDHGTLMVSILKSGIELAFETMINTGIINESAYYESLHELPLIANT
IARKKLYEMNIVISDTAEYGSYLFSEAAYPILKDFIMSLEKNVLGLSLPN
TKIDNIELYKINEEIRNHPIEIVGKKLRKHMKEMKSICVAK
>BUsg576 ilvD, dihydroxy-acid dehydratase
MPKYRSFTTTHGRNMSGARSLWRATGMTDEDFKKPIIAIVNSFSQFVPGH
IHLQEVGKIISKEIKKYGGVPKEFNTIAIDDGIAMGHSGMLYSLPSRELI
ADSIEYVINAHCVDSMICVSNCDKITPAMFMASLRLNIPSVFVSGGPMEA
GKIKTKDKTKKIDLVDAIIHGGDSNKSDDFIREIELSACPTCGSCSGMFT
ANSMNCLIEAIGLSLPGNGTLLATHIDRKKLFKKSARNIVKITKDYYLNN
NKNVLPRNIANKESFENAMALDIAMGGSTNTILHLLAAAYEGKVDFKMSD
INNLSKKIPHICKVAPSTNLYHVEDVHRAGGVMRILGELNRSNLLNKKTE
NILGLNLEKTLKKYDILSTKNKNVIKMFHAGPGGNRTIKPFSQNYRWNKL
DKDRVNGCIRSHENAYSKNGGLSVLYGNLAKNGCIIKTASIDKKHYIFSG
PAKVYESQEEAVSAILSGKIIAGDVIVIRYEGPKGGPGMQEMLYPTTYLK
SINLDKQCALITDGRFSGGTSGLSIGHISPEAANKGIIALVENGDDIQIN
IVNKTIHLNITEKELNLRIIKENAKGLKAYKPLNRKRNISFALRAYAHFA
LSADKGAIRNKKKLFNF
>BUsg219 ilvH, acetolactate synthase small subunit
MRRILSVLLENESGALSRVIGLFSQRGYNIETITVAPTEDPSLSKMTIQT
IGNEKSIEQIEKQLHKLIDVLRVIKVGQNSHIEREIMLLKVQTNNCKKDD
VKHITEVFRGQIVDITSTTYVLQITGTAKKLDSFLKIIRNTTEIIEMTRS
GIVGIARG
>BUsg220 ilvI, acetolactate synthase large subunit
MEILSGAEMVIRSLINQGIQHIFGYPGGAVLDIYDALKTVGGVEHILVRH
EQAATHMADGYARSTGKIGVVLVTSGPGATNAITGIATAYMDSIPMVVIS
GQVASSLIGYDAFQECDMIGISRPIVKHSFLVKRTEDIPIIFKKAFWLAS
TGRPGPVVIDLPKDILKKTNKYNFIWPKNIHIRSYNPTTKGHQGQIKKAL
RILLKAKKPIIYAGGGIISSNSSEELRIFAEKINCPVTTSLMGLGAFPGN
HIQSISMLGMHGTYEANMAMHYSDVIFAIGVRFDDRTTNNLKKYCPNATI
LHVDIDPTSISKTVSADIPIVGDAKQVLKEMIELIKKEKQIHSLKEWWSS
IGKWKKIKSLEYNKKSNKIKPQKIIQTLFKLTKGTSYITSDVGQHQMFTA
LYYQFNKPRRWINSGGLGTMGFGLPAALGVKLALPKATVICVTGDGSIQM
NIQELSTARQYNLAVLILNLNNSSLGMVKQWQDMIYSGRHSHSYMDSLPD
FVKLVESYGHIGLKVKTNEELEEKLILALKKLSEGNLVFLDIQIDDSEHV
YPMQIQGGGMNEMWLRKKEVS
>BUsg305 infA, translation initiation factor IF-1
MTKEDNIEMQGIVIDTLPNTMFRVELENKHVITAHISGKMRKNYIRILTG
DKVTIELTPYDLTKGRIIFRSR
>BUsg365 infB, translation initiation factor IF-2
MVDISLKILSNEMKISIKELIKTLSEISISKTENDCISITEKKNLLKYLE
SKKKPFLNTFILQRKTRSTLNVFTPGGKNKSVQIEIRKKRMYLKNNKSEL
EPLLKNKNLLQNKEKNNLKSLKNTISKAKESQKNIDILEESKANINFKNL
NKLTKSNVFNKNEKNKSLKKNINFNNHSFYSKKTIKNNTENQKLYKEEKK
DYHLTTFIHNRNTEDNRDREIEKNKRNFHRNIKNYRQKKNNKQNNQIKSK
KDEVRISKNRKNVKQKNKSILLQQVFKKPESVINRDVVINGAITVCDLAN
KMAIKSSEVIKNMMNMGIIGTINHVLDQDTAQLIAEEMGHKVILRRENEL
EELIMKDRDTGNNISLTRAPVVTIMGHVDHGKTSLLDYIRSTKVASSEAG
GITQNIGAYHVTTDFGSVTFLDTPGHSAFTGMRSRGVKITDIVVLVVAAD
DGVKPQTIEAIQHAKEANVPIIVAINKIDKVDSNIDQIKNDLTKYNILSE
EWGGENIFVLISAKTGKGIDNLLNAILLQSEILELKAISTGMAEGVVIES
FLDKGRGPIATVLVQKGNLKKGDIILCGFEYGRIKVLRNENGKTLKHAGP
SMPVEVLGLSKVPFSGEKVTVVRDEKKAKEVASYRKNKSREIKLANQNRS
SLENMFKNIKKNDFSELKIIIKSDVQGSLEAISSALFKLSTNEVKVNIIG
SGIGGITETDASLALASNAIILGFNVRADASAKKIIDLENLDLRYYSVIY
DLLNEVKAAMTGLLSPQYKQNIIGLAEVRNIFKSPKFGLIAGCMVTEGII
KRNNPIRILRNNVVVYEGELESLRRFKEDINEIRNGMECGIGIKNYHDLN
IGDVIEVFEVKEIKRIL
>BUsg118 infC, translation initiation factor IF-3
MKGGKRIQFTRPNRINNEIRAIKVRLTGVEGDQIGIVNLREALEKAEELG
LDLVEISPNAEPPVCRIMDYGKFLYEKSKSSKEQKKKQKVIQVKEIKFRP
STDEGDYQVKLRNLIRFLEDGDKVKITLRFRGREMAHQKIGIDVLNRVKN
DLIELAIIESFPSKIEGRQMIMVLAPKKK
>BUsg164 ipk, isopentenyl monophosphate kinase
MINTWPSPAKINLFLYVTGIRSDGYHYIQSLFQFLNYGDTLTIIPNTKGT
IELFTESNSLVNIKNSIITAAELLKEKALHSLGKKTSHFGAKIFLNKKIP
IGSGLGGGSSNAATTLVVLNNLWKTKFTLQELAELSLKIGSDIPAFIMGK
TTIVEGIGEILYPIHRKEKWYLIVYPNISISTKNIFSIYSIKKNTIKKPI
DFLLRSRFHNDFENVIKKKFKKIKQLISMLSLYAPSRITGTGSCIFAEFN
DKKSAQKIHSLLPHNVQGTIVKSVNVSPLHHAFYKKNINLFN
>BUsg449 ispA, geranyltranstransferase
MNFSHLYDIYYNRINKKLFEIIQELPFQDSVLFRAMKYSTLSGGKRLRAC
LIYATGETFQVNIAALDVISAAVELVHSYSLIHDDLPCIDNDYFRRGKIS
CHIKYGENFALLAGDALQGLAFNILSNSNMPGVHDSIRLKMIAEFSNAIG
YSGMCIGQMLDLEKERKKINISELEKINLYKTAFLIRCSIRLAYFASNNF
SKEVLFILDKFSVSIGLAFQIQDDILDLKNDIKKLESKRNKTKNTYPLLI
GLKKSKIKIKELYKEAFFTLEILKKNFNVNILKLLTQFIMKRFK
>BUsg264 ispZ, probable intracellular septation protein
MKKILNLLPIFTFFIFYRFYDIFIASKSLIFISGLTCLLYWIIYKEIDKI
NLFSFITIAIFGSLTIIFHNSQFIKWKITIIYMIFSVILFISQFFMKKPI
IQRFLEKDIKISDLYWKKINFFWALFFLFCSILNIYVALCLPEKIWVNFK
VFGLSFLMFLSILITSIYINFKMLKEK
>BUsg562 kdtB, phosphopantetheine adenylyltransferase
MKKIAIYPGTFDPITYGHLDVITRATKIFDNIIIAISNNVHKKTIFNLKE
RIKLTKLATFHLKNIKKVIGFNGLLANLAKREKSNILIRGVRTIFDFDYE
IKLAAINKQIYPDLDSIFFLSSKEVSFISSSFVKEIAKYQGNIKPYLPKE
IHFALIKKFKDIPQK
>BUsg134 ksgA, dimethyladenosine transferase
MKKKIKKHLPLKRFSQNFLINQNLIKKIVKFINPQLKQTLVEIGPGLGAL
TKPICNIVDELIVIEIDLNLLNFLKKYSFYSKLIVFCQDALIFDYLNLFY
KKNKLIRIFGNLPYHISTSLLFCFFEKNKIIQDMNFMLQKEVAERLIAFP
GTKSYGRLSIIAQYYCNIKIIFNVASENFRPIPKIDSTFVNLVPHKKSPY
FTHDIKVLSYITNLAFQKRRKILRHSLGKIFSEKIFLKLNVDPKLRAENL
SILQYCQLSNYIIENDILKNKNFN
>BUsg251 lepA, GTP-binding protein LepA
MVKKMKNIRNFSIIAHIDHGKSTLSDRLIQKCGGLSEREMSDQVLDSMDL
EKERGITIKAQSVMIDYKDKNGNVFHLNFIDTPGHVNFSYEVSRSLAACE
GALLVVDSSQGVEAQTLANCATALEMKLSIVPVLNKIDLPNSNPEKVARE
IKEIIGISALDAIRCSAKTGQGIEELIEQIIKKIPAPDGDEKKPLQALII
DSWFDNYLGVVSLIRIKNGIISKKDKIKVMSTGKTYFVDHLGIFTPKKIN
KNYLKCGEVGWIVCGIKNISAAPVGDTLTNAKNPAMNMLTGFKKIKPQIY
AGLFPVTSDQYEIFRDALGKLSLNDSSLFYEPINSTALGFGFRCGFLGLL
HMEIVQARLEREYSLNLISTAPNVIYQIEFNNGEKIYLDTPSNFPVDNKI
RKIKEPIVECNILLPPKFLGPVMKLCIKKRGTEINMIYHEQQVSLKYHIP
MNEVVLNFFDELKSVSSGYASLEYDFKYFKTVKMVRIDILINSERVDALT
VISYYKNAQNRAREIVNKMKELIPRHQFDINIQATINNSIVARSTIKQLR
KNVLAKCYGGDISRKKKLLKKQKDGKKRMKKIGNVNMPKTAFLDILNIHK
D
>BUsg250 lepB, signal peptidase I
MRNILTIFLLTSTFFTGILWIIDHILLIKNYFYNKKKTKNNNTILINKVI
LENKKCFFRSLSSLFPTFFIVFIIRSFIYEPFQIPSGSMMPTLLIGDFIL
VKKFSYGIKEPITNKTIIKMNLPQRGDIVVFKHPKNNIDYIKRVVGLPGD
KIQYDINRKKIKICINYTNQKNCENKLFITYSKPKLSNFFQKIYLLKSRT
NEEEKVYNSIYFKKVEEKINNLKHNILILDGINSKINDYYQQKGMPKLIW
IVPKNKYFMMGDNRDNSLDSRYWGFVPEENLLGKATKIWMSFEKKENEWP
TGIRIKRIGNIY
>BUsg429 leuS, leucyl-tRNA synthetase
MEKEYCPKNIEPYVQQYWKDNKVFHVYEDDKKEKYYCLPMLPYPSGKLHM
GHVRNYTISDVISRYQRMLGKNVLQPIGWDAFGLPAEEAAIKNKTKPSDW
TQKNIKYMKKQLQSLGFSYDWSREITTCKPDYYCWEQWFFIQLYKKKLVY
KKNSFVNWCPYDKTVLANEQVIKGCCWRCQNKIKVKKIPQWFIKIRNYAE
SLHNDLNDLENWPEKVKNMQRNWIGRSKGFEIVFNVLNSNKKIKAFTNRL
DLIMGATYISISPCHEFSVHVSKEKKEIQKFIDQKINNSASQEDIEKIKF
EGINSNMFVIHPITNKKIPVWISNFIQKEYGTNAIISVPGHNQNDWNFSI
KHNLKIKYVIKNKKYKNTQLHNLFTTEKGILYNSGEFNNLNYHNATEKIK
KTLLKKKIIKEKINYKLQDWCISRQRYWGTPIPMATKKNGEIIAIPEKNL
PVLLPEIKNYSDSLQKPMDSSSKWANIKIENQDVIRETDTFDTFMESSWY
YARYTCPNFNTGMIDPTASKYWLPVDQYIGGIEHATMHLIYFRFYHKLLR
DFKLVELNEPVKNLICQGMVLSEAFYQFDKNNQRNWIHPSCVQVEKNLKG
ETIKVDIKNKKKVIYAGMIKMSKSKNNGIEPELMINRYGADTLRLFIMFA
APIESSLEWRESGVKGIYRFLKKIWKLVFNHIEVKKINKKVNFDILNKKQ
KKMYCLLHKTIIKVSDDIGRRKSFNTAISSIMELVNELSIFKIENEEDKS
IIKESLMSIIKMLYPFTPHFCFRLWQYLNKNCCIDYETWPTFEKKILSSD
KNTLIIQINGKKQCAIEVKNHLNKEEILSYIENQSIIQKKIKNLKIIKII
YIPQKVINFVV
>BUsg259 lipA, lipoyl synthase
MNKKKDSLFKTIKKNNIINVITTESFSKKIIKLNKPDWIKIKIPVDTFRI
REIKSALRKNNLHSVCEEANCPNLPECFNRGTATFMILGSRCTRNCPFCA
VSHGKPNSLNVEEPNNLAKTIFDMGIDYVVITSVVRDDLYDGGAQHFVNC
IKSIRKKNKVKIEILVPDFRGRVELILKIFNSGLPDVFNHNVENVPRLYK
KVRPGADYKKSLFLLESFKKKYSNIPTKSGLMLGLGEKDTEIIQVMKDLY
SNGVTLLTVGQYLQPSINHIPVQRYIPLSEFKNIKKEALSIGFTNAFCGP
FVRSSYHASFQANKLIKKI
>BUsg258 lipB, lipoate-protein ligase B
MNNRIILFQNFGLKHWIDMFNKMHAFTEVRNINTYDEIWFLEHYPIFTQG
LLQKINTITYNNDILHDIPIVSTDRGGQITYHGPGQQILYFLIDLKRRKI
TIRDLINIMQNLIIETLNYFSIKSHIKKNSPGVYVNNKKISSLGLRVKKG
FTLHGLSLNVDMDLTPFNYIYPCGDINIKMTQVKEFNSFLTLNDIRVILI
KKLSQLLNVSIIEKFSIK
>BUsg461 lon, ATP-dependent protease LA
MNSERSERIKIPVLPLRDVVVYPHMVIPLFVGRKKSIHCIETSMNNDKKI
MLIAQKEASKDEPSTNDLFNIGTISSILQMLKLPDGTVKVLVEGLQRACI
KNIESNGEHLVAEVELIISPTVIDKEQEVLIRTTVNQFESYIKLNKKIPS
EILNTLSQTKNAEKLADTIAAHMPLKLADKQSVLEIYNVNERLEFLMAIM
ETEIDLLKVEKRIRNRVKKQMEKSQREYYLNEQIKAIQKELGDMDEIPDE
NKILKRKIKSLKMPKEAKEKTESELQKLKMMSPMSAEATVVRSYIDWMIQ
VPWNIKTKIKKDIQEAKKILDIDHFGLEKVKERILEYLAVQSRTNKVKGP
ILCLIGPPGVGKTSLGKSIAKSTGRKYVRMALGGIRDEAEIRGHRRTYIG
SMPGKLMQKMVKAKVKNPLFLLDEIDKMSCDIRVDPASALLEVLDPEQNI
NFNDHYLEVDYDLSDVMFVATSNSMNIPAPLLDRMEIIRLSGYTENEKLN
IAKCYLYPKQMERNALKRNELIITDCAIISIIQYYTREAGVRSLEREISK
ICRKVVKLLILNKSLKKIEINSKNLKKFLGIKRFDYGKTNNLNQIGQVVG
LAWTEVGGELLTIETACVSGKGKLTYTGSLGEVMQESIQAALTVVRSQAK
KLGIKKDFHEKHDIHVHVPEGATPKDGPSAGIAMCTAIVSSLTKNPVKSN
IAMTGEITLQGRVLTIGGLKEKLLAAHRGGVKTVLIPYENKRNLEEIPKN
IIEGLTIYPVKNIEEVLKIALENTPYV
>BUsg241 lpcA, phosphoheptose isomerase
MYKKIISSELDAALKILKNFLKNEEQIENIEKAAILIAKSFKNKNKVISC
GNGGSHCDAVHFSEELTGLYREKRPGYAAIPISDVGHISAIGNDFGYDQI
FSRYIESIGLPNDVLLAISTSGNSINIINAIQTAHRKKMKVIVLTGNDGG
QVKHLSDVEICIPYHGYSDRIQEMHIKIIHILILIIEKEMKKIN
>BUsg201 lpdA, dihydrolipoamide dehydrogenase
MHQEIQSEVVIIGSGPAGYSAAFRCADLGLETVLIEHQERLGGVCLNVGC
IPSKSLLHIAKIIKDASELSESGVFFNKPIIDIKKINNWKEKIIKKLTTG
LSNMGEKRKVRIVQGKALFNTDHSVLVKNKKNDFTIFFKHAIIATGSKPI
KIPSLPNEDNRIWNSTDALSLKSIPNRFLIIGGGIIGLEMATIYSALGSK
VDIVDRFNAFLPSVDKDITDIYIKSIKKRFKLLLNTHVKSVEKSKDNDLI
VKIAEENSDENVCCYDNILVAIGRSPNVDFLGLEKIGLKLNESGFIEINQ
QLKTNISHIYAIGDVTGFPMLAHKAVQQAHIAAEVISGKKHYFEPKVIPS
VAYTDPEIAWVGLSEKEAENNDIDYEVSLFPWSASGRAHASNCTLGMTKL
IFNKNTNKIIGGSIIGTNASELISEIGLAIEMGSDAEDISLTIHPHPTLS
ESISLASEVFQGTITDLLNLKKSLLN
>BUsg141 lspA, lipoprotein signal peptidase
MKRKYYWIYINIIFFIITVDFYSKKWILNHLNIYEKQKVFFILNLFHVHN
FGAAFSILSDQNGWQKYFLLIFSIIIILAIIKIMIKFKKKDKNKILSYSL
ILAGAIGNLIDRINYGFVIDFIDLHFKSWHFATFNIADFSIFIGMIMIIK
KNYYNS
>BUsg423 lysA, diaminopimelate decarboxylase
MPELLNKTKTNLNFENIKILIKKFQSPFWVYDSNIIHKKINLLKEFDIVR
FAQKACSNIHILRLMKQKNIKVDAVSLGEIERALVAGFKPNSNEIIFTAD
LFDEETLSKVIDFKIPVNAGSIDMLEQLGKLSPGHHVWLRINPGFGHGHS
KKTNTGGENSKHGIWNPRLAIPIIKKYKLKLIGLHMHIGSGVNYKHLKKV
GQAMIEKAMEINEKILFISAGGGLPIPYTFNEKPIDTKKYFIIWDEARKK
ISRFLNTPIQLEIEPGRFLVAESGILISQVRAIKKMGDKNFVLIDAGFND
LMRPTMYGSYHHVSVVTKDDRNIHETETIDTIIGGPLCESGDIFTQKEGG
NITTRKLPILKIGDYLIFHDVGAYGASMSSNYNTRPLIQEILLENNTFRT
IRRRQKINELLNLEK
>BUsg422 lysS, lysyl-tRNA synthetase
MIKKTDLNNNIFQKEKQIRKEKLINMKKNGFSFPNSFKKNTNSIKIHQEY
ENKTINELKVLNVEVTIAGRMIQRRIMGKASFFTLQDMEGKIQIYTREKE
ITSDFYNNHFKKWDIGDILGIEGILFKTKTGELSIFSKKLKILTKSLRPL
PDKFHGLSNQEKRYRKRYLDLISNNQLFNIFKNRSKIIRFIRNFMIENNF
LEVETPMLHNIPGGANARPFITYHNEINEEMYLRIAPELYLKQLIVGGFE
RIFELNRNFRNEGVSARHNPEFTMMEAYIAYSNYEDMMNFTENLLKNIIK
SICGKSEIKYNKYYLNFNIPFKKLTMKESILQFNSNICLSDLKNLQKIKK
IANNIGIEIKDNWNIGYIENEIFEKTVEKNLIQPTFITEYPVEVSPLARR
NDFNSNVTDRFELFIAGYEIGNGFSELNDSEDQKNRFLNQMKIAEKEKNK
DMLYDENYIEALKYGLPPTSGLGIGIDRLIMILTNQISIRDVILFPTLRS
FKK
>BUsg140 lytB, LytB
MNIILAKPRGFCAGVKRALLIVENALKIYKKTIYVQHELVHNQYVIETLR
QKGVVFVEDISDIPNNSIVVFSAHGVSKKIKKKAIKKNLTILNATCPLVT
KVHLEVSKSSKNGIETILIGHRGHPEVIGTIGQYDNKKGKIHLIEDIEDV
NQLTIKIDKKLNFFTQTTLSIKNTQSIILALKKKFLNISGPKKEDICYAT
TNRQNAIIKLSKITDIILVIGSKNSSNSSRLSELGKETGVFTKQIESFSD
IKEEWLKNKKNIGITAGASAPDILVEEVIKHLKKLGFKNPPKEMLGDEEK
TIFKIPKNLNVQN
>BUsg224 map, methionine aminopeptidase
MNCIIKTESEIKKMKVSGKIAAEVLEMIENYIKPNISTEEINNICHNFII
KKKAVSACLGYHGFPKSICISVNDVVCHGIPNKNQILKSGDIVNIDVTII
KKNYHADTSKMFLVGQTNILSQRLCKIAQESLYKSLNILKPGIPLYKIGE
VIQNYVENNNFSVVKEYCGHGIGRAFHEEPYVLHYKNKSHVILEKGMIFT
IEPMINAGSHEVKCMKDGWTVKTKDHSLSAQYEHTVLITENGCDILTWQK
NEKIPSKFINK
>BUsg464 mdlA, multidrug resistance-like ATP-binding protein Mdl
MRLFNQLKWYFIKEWKRYLGSIILLIIIAFLQLLPPKIIGILIDLIIKEK
MSGFEILPWISIILLIAIIVYILRYLWRILLFGASYQLATELRVKFYSYL
SKQSEIFFLKNRTGDLIARATNDVDRVVFAAGEGVLTLVDSSVMGISVLI
VMITQISWLLTIISLIPMPIMAILIKKYGKKLHDTFRNAQSAFSLLNNQT
QEILTSIRMIRAFGLEKNQLKKFNNIVNDTGKKNMEVAEIDARFDPVIYL
SVAFSNLLAITAGGWLVWNNTITIGKLTSFIMYLGLMIWPMLALAWMFNI
VERGSAAWDRIHSIINQNLYIEDGKKTIINMNGKLNINIDMFFYPKNKKP
SLKNIYLSLNPGKTLGICGPTGAGKSTLLKLIQRQFKIHKGEILYNSSSL
LELKIDYWRSKIGVVNQTSFLFSDSISNNISLGKPKASQKEIEKAAKLAD
IHKDIVCLPQGYNTQVGERGVMLSGGQKQRIAIARALLLNTEILILDDAL
SAVDGKTENNILKNLKKWKDKGYSLIIVAHRLSALIHADEIIVIKEGTII
QRGNHEKLIKEKNWYKSMYDHQKIQTEIENF
>BUsg465 mdlB, multidrug resistance-like ATP-binding protein MdlB
MDHLIQFWPILKRLIIYAIPWKKKIILAFFLLLSGATSEVLGPILISYFI
NNILSQHQLNFQLILIIIVIFIMLQILAVFFNYFQSILFNKIAVGIVNKL
RNDVMKAALNQPISEFDSQPIGQMISKVTNDTEVIKELYDTVGPTFFRSI
TLIIIILFAMFTLEWHMAIITIFIIPLVIIVMSIYQYYSTPLLRNVRYYV
ANINNKFNETINGMNVIQQFRQQTRFENNIKESSELHYLARMKILKLDGF
LLRPLLSLLSALVLCSFMFLFSYFSIGVYEVGVLYAFITYLGRLNEPLIS
ITIQQSILQQAIVAGERIFSLIDSPKQKYGNNEEEIKSGKINIKNLSFKY
KESGENILNNINIYIPSKSFVAFVGQTGSGKSTLANLLMGYYPIKHGKIY
LDDKSINCISHDVLRKNILMVQQDPIVLADTFSSNITLGKKISEEKIWNV
LKTVHLSSLVQSMPKGIYSILGEEGNNLSLGQKQLLAIARILVRNPKILI
LDEATANIDSGTEKLIQTTLSSIRAKTTLVVIAHRLSTVIEADMIVVLKK
GKIVELGTHKQLLEKKGFYWKMYNFQLFNC
>BUsg103 mesJ, putative cell cycle protein MesJ
MIEKIINQYQKKLFLIAYSGGIDSTVLLYKMLKIKEKNPQIKIRAIHINH
NLHPSSKKWEEHCIKICHKYKIPIITKEIKILLKKNIEETLRIKRYNTIY
NYLLNDEILLTGHHLNDQCETLFLSLKRGSGPTGLSGMSIENFLGKKRIV
RPFLTKTKKELQKWACENNLESIEDFSNFNIDYDRNFIRHKLIPILEQRW
PFFLKNCFRTTVICREETKLKNIFLKEKIQNLINFDESLNIQNFKNINKE
VCKALIRYWISLKNIKMPSYKTIECIYNEIICSKKDSNPKIIIDKNEIRR
YKTSLYFIKIQKDISNIFLFWHNTDKKLLLPEDLGYLIKNDKGFILPSPK
KNELINIRFQLEGKILILGREKRRKIKKIWQEHNIPPWLRNKIPLLFYNN
RFISAIGLFVIKEKIINKEKEIQKNWKISWINNVHFNRKNFFLFY
>BUsg031 metE, 5-methyltetrahydropteroyltriglutamate-- homocysteine methyltransferase
MTIFNHTLGFPRIGLNRELKKAQEDYWSGNLLYEDFLCVGSQLRRENWKK
QKDAGIDYIPVGDFAWYDHVLSTSMMLGNIPERHLNVNDNKIDLDCLFRI
ARGCSPDVAASEMTKWFNTNYHYIVPEFNKNRILKFSWKQILEETDEALL
LGYKVKPIILGPITYLWLGKIKGEYFDRLDLLKNILPIYKQVLRELSQRN
IDFVQIDEPALVLDLPEKWKKAYSYAYEYLNGTTKILLTTYFDSIEHNIE
YIRDLPIYGIHIDLVFGKYNLFDFNSKLPKEWILSLGVINGRNVWRADLI
KLFKSISTILKFRKKLLIGSSCSLLHSPIDLQKEKNLDKESKKWFSFAVQ
KCTELSLLSKALNKNDTDSIQKWCSSIYERNFSKRVQKIEVQNRLSEILN
VNFKRSDSYNIRSREQKKKFNLPILPTTTIGSFPQTLQIRKLRRDYKQGL
INDVDYEIGIKKHIKEVIKEQEKLGIDVLVHGEPERNDMVEYFGENLDGF
IFTDNGWVQSYGSRCVKPPIIIGDVSRLKPITVKWSKYAQSLTDKPVKAM
LTGPVTILFWSFPREDISLEKIAKQIGLALRDEVLDLEKEKIEIIQIDEP
ALREGLPLRKSLWNEYLSWAVDAFRLSSSGVKNTTQIHTHMCYCEFHDIM
HAISFLDADVITIETARSDMELLKSFKTFKYPNEIGPGVYDIHSSNIPSI
TSIKFLLNKAIAYIPVERIWVNPDCGLKTRNWNETILALKNMVCAAKEMR
DKIKKIT
>BUsg043 metF, 5,10-methylenetetrahydrofolate reductase
MNFLHQYYQDIIKKKLENLNDKIQCSFEFFPPKNLDTEKKLFSSVVKLSL
LKPFLFSVTYGANSGERKKTYSIVQRIHKKTGITTAPHLTCVDASLSELK
EIAKFYWENGIRSIVALRGDVPNKSYQHKIYALDLVVLLKKIADFDISVA
AYPEIHPESKNAQSDILNLKKKADAGANRAITQFFFNVESYLRFRDNCIK
NNINIEIIPGILPIYNFEQLKKFSSMTNVSIPKWMFEMFNGLDEDLETQK
IIGSNIVINIVKTLLYEGVKNFHFYTLNKSDVIYSICHMFGL
>BUsg102 metG, methionyl-tRNA synthetase
MSNKFKKILVTCALPYANGPIHIGHMLEHIQADIWVRYQRMRNNEVWFIS
SDDAHGTAIMLKSEKLGITPIKLIKKIKEEHIIDFSNFNISHDNYHSTHC
VENLFLLRKIFLSLSEQKLINEKKIFQFYDNTKKMFLPDRFIKGTCPFCS
SKNQNGDNCEICGSIYEPTDLVNPISVISNSVPILKNTTHLYFNLPLFTN
MLNKWIHSGILEKSVAKKTEEWLKSGLKEWGISRDAPYFGFKIPKFDKKY
FYVWLDAPVGYISAFKNFCTKNKKVDFNEFWKKESKCELYHFIGKDIIYF
HTLFWPAILEASSYRKPNGIFVHGHLTINGLKLSKSRGFLIKASDWIKCF
DSDSLRYYYASKLSNNINDIEINLEDFIQKINSDIVNKLVNLASRNASFI
HKYFDGYLADSLGDCNLYQDFIDISKKIANFFENRQFSSVIRECMKLLDL
ANQYINQREPWKIKQDNFNKLHTICTVGINLFRLVVIFLKPIIPDLAKKT
EYFLISDLTWKGIDKPLLSHKIKKFKKLYNRINHDKILQLSLLCK
>BUsg393 metK, S-adenosylmethionine synthetase
MTEYLFTSESVSEGHPDKIADQISDALLDEIIKQDLKARVACETYVKTGM
VLIGGEITTTAWVDVEEITRNTINNIGYINSETGFDANSCAVLSTIGKQS
PDITQGVDRCNPLEQGAGDQGIIFGYATNETEVLMPAPITYAHLLVKKQS
ELRKKNILHWLRPDAKSQVTFKYKNGRIIGIDTVVFSTQHKESITQDVLK
EAVMEEIIKPVLPNKWLTKNTKFFINPTGRFVIGGPMGDCGLTGRKIIVD
TYGGMSRHGGGAFSGKDPSKVDRSAAYAARYVAKNIVAAGLADRCEIQLS
YAIGIAEPTSIMIETFRTGKISNKSLINLVRNIFDLRPYGLIEMLDLLRP
IYLNTAVYGHFGREEFPWEKLDKVDELLQ
>BUsg030 metR, transcriptional activator protein MetR
MIEIKHLRTLQALKNNGSLSAAAIQLHQTQSAISHQFNELEKKLGFKLFI
RKSNPIKFTAQGEILLQLSKEILPKIHKAIQNCKKTHQMIIKLAIECHSC
IQWLTPALKIFQKKWPRVEIDFYSDMIFSPQPSLQQGKLDIVLTSEVLPR
SNLFYFPIFDFEVRLVLSPNHPLAQKKHNILPEDLISEILMIYPVKRDKL
DIWKFFLQPAGIIPIFKNVNNTLLLIQMVAAKMGITALPHWVVDTFEKQG
LVVTKKLGDGIWKRLYAAIRDGDQKELIIKNFIYAIRLHVCTHLKFIRDT
QKPHFFKNVKNI
>BUsg318 minC, cell division inhibitor MinC
MQKMPIELKGSNFTFLVLYLNTNNVDLISKSLYKKIQEYPQFFKNVPVIV
NVSNLLNQVNWKKIQEIIIEYGFYIVGVSGCKDNYFKKIIVESGLPVLLE
SNTTNTNKDLRSFYHTSTLKKTKNEQRLRVKKIEKTHIINTPVRSGQKIY
AKYSDLVVINNVSAGAELVADGNIHVYGSVRGRVLAGANGDITSKIFCTT
LFAELISVSGQYWLSDQIPSHFIGKSAQIYLKNKFLTINSLS
>BUsg317 minD, septum site-determining protein MinD
MTRIIVVTSGKGGVGKTTSSAAIATGLAQKGKKTVVIDFDIGLRNLDLIM
GCERRVVYDFINVIQGDARIQQALIKDKKTKNLFILPASQTRDKESLTYS
GVEKVLNQLINMEFDFIICDSPAGIETGAILAIYFADEAIVTTNPEVSSV
RDSDRILGIISSKSKRSEKNITPIKEYLLLTRYNPTRVKKGEMLSMKDVI
EILRIPIIGVIPEDASVLRASNQGESIILDQNSNAGSAYFDTVNRLLGEN
HKFRFIEEEKKSFLRRLFGR
>BUsg316 minE, cell division topological specificity factor MinE
MALLDFFLSRNKNTAHVAKERLQIIVAEQRKFKSEPDYLPQLKREILSVI
CKYVNIDPHMVTIQLEQKNEDISVLELNIILPD
>BUsg442 mltA, membrane-bound lytic murein transglycosylase
MLNSCINKIKKKKNIKKIILMLIFIFSVNFFTKNTNQGKQYEDKLNKDFT
NIKKINIKNKLVNQKEFLLQLEKIKIFSPNLYSKNISIYNAILKWLKKRA
EINELNKFRIKLFQMKGVDQYGNVKITGYYTPIVKASKIKKNNFIYPIYR
TPSNFKKNEKLPQRKDIYNGFLKKEYILAYSDSLINNFIMEIQGSGFIDY
GDNKPLIFFGYAKKNNWPYTSIGQILIKNGDIQKKNISMNTIKNWCTHHT
QKEIQNLLEKNKSFVFFQETKRKEVYGSSAVPLVEKAAIAVDKSVIKIGS
VVLVKIPVLDKNGIFIHKYEMHLLIALDVGGVIKGQHFDVYQGIGEKAGK
LAGFYNHYGYAWVLKI
>BUsg019 mopA, 60 kDa chaperonin
MGAKDVKFGNEARIKMLRGVNVLADAVKVTLGPKGRNVVLDKSFGAPSIT
KDGVSVAREIELEDKFENMGAQMVKEVASKANDAAGDGTTTATLLAQSIV
NEGLKAVAAGMNPMDLKRGIDKAVISAVEELKNLSVPCSDSKAITQVGTI
SANADEKVGALIAEAMEKVGNDGVITVEEGTGLQNELEVVKGMQFDRGYL
SPYFINKPETGIVELENPYILMADKKISNVREMLPILESVAKSGKPLLII
SEDLEGEALATLVVNSMRGIVKVAAVKAPGFGDRRKAMLQDISILTGGSV
ISEELAMDLEKSTLEDLGQAKRVVINKDTTTIIGGSGEKQAIQSRIGQIR
QEIQEATSDYDKEKLNERLAKLSGGVAVLKVGAATEVEMKEKKARVEDAL
HATRAAVEEGVVAGGGVALVRVAGKISNLRGHNEDQNVGIRVALRAMEAP
LRQIVSNSGEEPSVVTNNVKDGKGNYGYNAATDEYGDMIDFGILDPTKVT
RSALQYAASVAGLMITTECMVTDLPREDKSSDVASSPAGGMGGMGGMM
>BUsg552 mtlA, PTS system mannitol-specific IIABC component
MFRLITLKIQNFGQFLSNMIMPNISIFITWGIMNSLFLSLDWQYNKIFAQ
LISPIIFYLLPILIGYTGGSLIAGQRGGLLGSITTIGMITSTDMPMFLGG
MVAGPLGGWIIKGFDQIIKNRIKSGFEMLVNNFSIAIIGIFLTIFSFFFI
GPFIEGVSKFLGCLIKIIIDFNLLPLIAFIIEPAKVFFLNNAINHGIFSP
LGIQEISENKSSLFFLIESNPGPGLGILIACFFFGKEKSYKSSGTAAIVQ
FLGGIHEIYFSYVLIKPILMISLILGSMTSIFMLVFFKGGLIAAVSPGSI
LSILAMTKKGLYFANLISIFSSFLISFLSAMLFFKINLGQKIKNDKSSIQ
LFKNNLFPIKKIGDEKYDFIKKIKNFQKIKNIIIACDAGMGSSAMGASIL
RKKIKSNNLTHIYVSNIAINLLPKNADLVITHEKLTYLAKKRAPDAQHIS
LTNFLDSNFYTSLVKQLDLNKDFFKKNNIQDKKDRITQINIDSHKEIQSK
CFFQISDKNIFLNQYAENKKEAIKIVGKHLVAQGYVKKDYIDAMLDREKI
ASTWLGESVALPHGTIKSKDSILKTGVIFCQFPKGVHFGETIDDIAYLVI
GIAAKNNEHIMVVSNITNALDDKDVISKLSKTKSVKEVLSYLNVNVKKN
>BUsg551 mtlD, mannitol-1-phosphate 5-dehydrogenase
MRALHFGAGNIGRGFIARVLLKSDFNLIFSDVDQNIINAINNYKKYKIKL
IDNSFEKIININNISAINSYDPNVLNVISHVDLITTAAGVNALYKIASIL
IEGIILRINLKCKKPLNIIACENKIKATSFLKKIIFDKIPLKYHDYFDEY
IGFVDCTIDTIVPTFSSFKEENSLFVIAENFKEWIVDVNQFKGMVPKIID
MTLSDNLTSFIDRKILTLNTGHAIAAYLGLMKNYKNICEAMSDFSIQRIV
KDAMYESGLVLIKRYNFNKKDHLSYIDKIFVRFKNPFILDKLERIARNPL
QKLSKDERLIQPFVEAMKYNLPYFNLVKGIAAALHYRNINDIQSIKLSSL
IKEEGLEETLVKVCKLNANSNEIRIIISEYHSIIKDFL
>BUsg373 murA, UDP-N-acetylglucosamine 1-carboxyvinyltransferase
MNKLYIEGDKKLNGNVIISGSKNAALPILFMTILTEKKIKISNVPKLRDI
NIAIQLLKSLGAQIKYKKKNLYIDTSSIKIHSPPYDLTKQIRASIWMLAP
LLIRFGKAKIFLPGGCKIGARPIDLHIKGLIALGAKIILEKNYISASIKK
PLTGKRIYIEKISVGATITVMSAATLAQGTTIIENAAQEPEIIDTAKFLN
TLGANIIGAGSNRIFIKGVLTLIGGKHKIIPDRIETGTFLIAAAISKGYI
ICHDTEPKYLKNVLMKLSESGAEIKTGKDWIQLDMRGKKPKSINISTSPY
PGFPTDMQPQFALLNSISQSKGTITENIFENRFIYTSELIKMGAKIKIKN
NSIVCKGVPNLYSQNVFSNDLRGSATLVLAGCIARGTTTVDNIHHFERGY
EAFSEKLNKLGANIKYI
>BUsg042 murB, UDP-N-acetylenolpyruvoylglucosamine reductase
MYKKKKSYQSLKNLNTFSINVTAKKIIFVKTIQSLMKIWKTCNLSNIPYI
ILGEGSNVLFLENYAGVVIINRIKGIRIEEKKKNWLLHVFSGEKWHDLVK
YTLRMGFFGLENLALIPGSVGSAAIQNIGAYGLELKNICQYVDVISLENG
KTIRLKKKTCNFSYRSSIFKYKYNNGYAVIAVGIKIKKNWKPVIFSSLLK
SKKILEINAYKIFNIVCQIRKKKLPNLKKLGNAGSFFKNPIITSKKTKKI
LSSYMKMPYYIQKNGFIKIPAAWLIEKYNFKNIQIGDAAIYKKQKLILIN
LKKANSKDILKLAQIIQKCILKKFGIYLEPEVDFINSLGKVKLL
>BUsg212 murD, UDP-N-acetylmuramoylalanine--D-glutamate ligase
MSYNYFGKKILILGLGLTGISCINFFLKKGIQPRVIDESNKPIFLNKIPK
NIEYKLGNLKENWILESDLIIISPGISSFKPILMKARSLGIDIISDIELF
SRETKCPIISITGTNGKSTVATMVKKIAEKSGYKVLLGGNIGFPVLEMLN
KKASLYVLELSSFQLETTFNLKSKIAVVLNITEDHLDRYPEGFEQYKKTK
LSIYNKAKICLIKLKKGEKKPFNTKSKKYISFGTCNNNDYYINYEKEKAI
LFHKNKKIVDTSNILLNGHHNYENILTSLAISDQMKFDQKVSINVLKKFL
GLPHRFQTVHINNNISWINDSKSTNVDSTKAALKNLKIKGTIWLLLGGDG
KSSNFNILKKYFEKIKIKIYCFGKDGLNLSKLCKKKSIYTKTLKQAIILI
SKKIQPGDVVLLSPGCSSKDQFSNFEERGNLFIKLSKEIN
>BUsg210 murG, UDP-N-acetylglucosamine--N-acetylmuramyl- (pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
MNSKRIIILAGGSGGHVFPGLTIAKHLIKKGWDINWIGTKNKIESEIIPK
CNIKIHFIKIQGLRNSSLKNLIMTPINVLNSYLQVRKIIKNWIPDIILGM
GGYVSGPGGLAAWSCKIPFILHEQNKIAGITNKLLSKISTKNMQAFSGTL
LNAEIVGNPIRKNIIDIPPPIKRFKNRKGPLRILIIGGSQGASIFNKILP
KISFFLQEKAIIWHQSGNNDLQKTRKKYKKYSTYKHIVSSFIKNIAEAYE
WADIIISRSGALTVSEITVVGLGAIFIPYPHKDKQQYLNAEDLENNGAAK
IIEQSMFTAELIIKILNSLNREKLFIMAKKAYSLGIRNSTSKISKIIHDV
SNKI
>BUsg536 murI, glutamate racemase
MLIIDSGIGGLSILDNIKKKFPHINYIYMLDNEAFPYGKKKEKFLIERSI
KIINAIKKIYPIKMVIIACNTASTISLPTLKKTFSIPIIGVLPVFKPAIK
ITKNKIIGLIATRSTINSLYIKKTIYKYSLENTIKIIATNELAVIAEKKV
RKLSISNIKLKKIFQSWIILSIKPDTIILGCTHFSFLKKEIQQIFHKPIN
FIDPGDTIVNKIEKYFYQKKIKKNILLCSKYNKQIKQLVFFLKKYKFKKI
QEINLN
>BUsg550 mutL, DNA mismatch repair protein MutL
MQPIRMLSSSLSSQISAGEVIERPSSVIKELLENSIDAQAKNIDISVERS
GLNSITVKDDGFGIEKDQLLLAISRHATSKINRLSDLDNINTFGFRGEAL
ASIRAVSRMKLISCSQNSNIAWSIYSEGFSNHTLLQPIAHPIGTSIIVDN
LFYNIPVRLKFIKNERSEFLKIDETIKKIALSNFGINIFFKKDKKLFVSY
KAITKNNNKIHRLKTVFNQIDLNYVLEIKEKMHNITLFGWLIFPSSLSST
FKKIQYCYVNNRFVYNNLIKSAVFNSFYEIIGNKRSTSFILYLTLPSNEI
DINIHPTKNEIKFHKSNIIYFFVYQSILSSLKKCKIKYISNNFFLKTHSN
KCKNNNSDSLNTKLVSQIHSKYEKKDLYKDVISTDLFKINSQRFLKEYFF
SFGKLLIVFQKYYGLMYYSNTFSLISFPLAKKIVEQYKLRSAIKNNMIPE
IFSYNFLYFITFKQNKILSNNLKLLLKFGFNLILKEKYFFLKTIPIFLKN
QNLDVLLSSFFSFIFFKKKIYIKDIIKWFDTTILIEKNSWNYEDGISILL
EIEYFCPSIFKKPPLKLLQKINVDEVLCILKV
>BUsg414 mutS, DNA mismatch repair protein
MTETNFSTKNSNHTPMIKQYLSLKSQYPNMLLFYQMGDFYELFYEDAKRV
SRLLKITLTKKGNSNNNIIPMAGVPCHTAEYYLSKLVKMGESIAVCDQIK
DVYSEKKLLTRQVVRVITPGTITDEAFLEENKDNFIAAVWKENNKFAYAI
LDISLGFFGVSEHFDRNSLLSEIERTNPTELLYPENFEDMLLISHKKCIQ
KRPLLDFDIKISYKLLTLQFKTSNLNGFGIKKNHFVIRPAGCLINYIKLM
HISFLPHIRKIQFNYIENNIFMNSSTRKSLEIIESISGESKNTLSSVLNK
TVTSMGGRLLNRWLNTPSKDLSLIKNRHGMVKLLRPFYKEIQCILRQVSD
LERICSRLALRTALPRDFVRMRSTLNILPDLCLILKKIKSTSINNVLMSI
GKFEKILFLLKKSINLTVPSSIRDGGVIACNYNKKLDELRSLKKNSQKYL
QDFEVKEKSRLNIDSFKIGYNNIVGYYIQVNKRHSHLIPHSYLKIQTLKN
VERYSVPLLKNYEKQVISAKFQAIFLEKTLYMELFDIIEPFLEDLKNSAF
ALSELDVLVNLSERSISLNYVCPKMTKKYGITLVESRHPVVECFLENPFI
SNSVDLSKKNRMLIITGPNMGGKSTYMRQVALIIIMACIGSFVPAKYASI
GLIDKIFTRIGSADDVSNGYSTFMMEMTEISNILHNATCNSLILIDELGR
GTSNKDGLALAWSCSKYLMTKNKSMILLSTHFIELTKLENFFKNIKNFYF
SAFEHDSNIAFLYKIKKGISKKSYGIAVASLSGIPDIVIQDAKKKLIELE
SDNVF
>BUsg196 mutT, mutator MutT
MKYTNIVIGIIIKKNKIYITKARKKKYVLDLWEFPGGKVKENENLTYSLK
RELSEEVGLKILRFRFFRCIKYFYKKIKLYFFLITRWKGRIYSKEGYLYK
WIFLDDLKYFNFPSPNSHIIHDLQKMIFFK
>BUsg534 mutY, A/G-specific adenine glycosylase
MTIYVFSQLILNWYHINGRKNLPWKKDKTLYKVWISEIMLQQTTVKTAIP
YFKNFISRFPNIQSLNQSKLDDILCLWSGLGYYKRAENIYKTVKIIKEEF
QEKFPTGFSDLIKLPGIGRSTAGAILSLSLDYFFPILEGNVKRILMRYYG
IIGYVTEKKIEQKLWYLIELITPIHNTGSFNQGIMDIGALICTPKNPKCN
LCPLIQKCIAYKEKNWIKYPLKKKKKIILEKKSWFVVIKYQNQFWIEKNT
EKKIWKNLFCFPNFDTKIKTIEWLKKNKINIDKKHKKIQSFYHKFSHFTL
HIIPILVNLSFFKNFQNSKKTGIWYDLKNTHDIGLPKPVQKILEIFK
>BUsg321 mviN, virulence factor MviN
MNILKSLISVGIMTLISRIFGFFRDVLIAHIFGASMFTDAFFIAFKIPNL
LRRIFAEGAFYQSFIPILIDYKSRKDKEYIQEFIRSTCGFTILVLTTFVI
LGIIFSDYIIFISAPGFSESSKKLQLASNLLKIMFPYILFISLSSLCSSI
LNSYNYFFIPSLSSSLLNISIIVFSFFFSDYFEPSIISLAWSVMIGGFFQ
LFYQFPHLYKIKMLVFPKINFKNIGLIKVLKKMGPSTLGSCANQISLIFN
TIFSSLLHSGSISWIYYADRLIEFPIGIIGVSLSTILFTSFSCSYSNNTQ
SEYKILLNWGIRFGLILSLPISVILFMFSKPLVIILFQYGKFTDFDVLMT
QKALELYSFGLVSFILVKILVSAFYSCQEVNIPMRISILTLFLTQLMNPF
LIFYFQHSGLALSCSIASWINFFLLYWKLYQKGIINFKLNDFIFIFRLLI
AVLVMTFFLIFMLYFIPSWKIGSFFDKIIRLFTILSISGIVYLIALHFLG
IRLLNYSDKLFQKK
>BUsg168 nadE, NAD(+) synthetase
MTLQKKIIELLGVKPLIIPKKEIENRIQILKRYLIENTHLKTLIVGISGG
QDSTLTGKLCQLSIQELRKEKKEKSYQFIALRLPYGVQIDEKDCRDAINF
INPDQIFTINIKNAVLNSERSLKKQGIQISDYIKGNEKARERMKVQYSFA
AITNGLVVGTGNAAENVTGFFTKYGDNGTDVNLISKLNKRQGKFLLKELN
CPKHLYLKKPTADLEDEKPQKEDEVALGIKYNIIDDYLEGKKVNSLNKQI
IERLYLTTEHKRKIINLG
>BUsg130 nfo, endonuclease IV
MNYIGAHVSSSGGLEKAVFRAFQIKATTFSFFTKNQRQWISLPLQKKNIE
DFKKACIKYNFSPEKILPHSSYLINLGHPIDFFLEKSRVAFIDEIVRCDQ
LGLRFLNFHPGSHLNKISEVTCLSRISESINIALEKTKNVVAVIENTAGQ
GTNIGYRFEHLYEIIKKIDDKSRIGVCIDTCHLFASGYDLRTKIDYESTF
NKFFDLIEMKYLKGFHLNDSKKQFNSRVDRHENLGLGEIGKSVFKWIIKN
KNFHNIPMILETINPKLWEKEIDWLRSLQ
>BUsg577 nifS, putative cysteine desulfurase
MKNPIYLDYAATTPVEFKVAKKMMNYLTIDGIFGNPASRSHKFGWEAEEV
IDIARNEISELIGSDSREIVFTSGATEANNLAIKGIAFFHRKKGNHIITS
KTEHKSVLDACRYLESVGFSVTYLTPKNNGIIDLNDLKKNINKNTILVSI
MHVNNETGIIQDITNISKICRSHDIFFHVDATQSVGKIAINLKNLFVDLM
SFSAHKIYGPKGIGGLYVRRKPRVRLSALSHGGGHERGMRAGTLPVHQIV
GMGESFKLARKKINDDFIHLTNLRNDLWNGIKNIEEVYLNSDLKQGAPHI
LNVSFNYIEGESLIMALKDLAISSGSACTSSSLEPSYVLRALGIKDELAH
SSIRFSIGRFTTKEEIQHTVKSVHKSIHRLRALSPLWEMFKSGVDLNSIE
WDHT
>BUsg578 nifU, NifU protein
MAYSKKVMDHYENPRNVGSFSNSDSNVGSGLVGAPACGDVMKLQIKVNEQ
GIIEDACFKTYGCGSAIASSSLVTEWIKGKSITEAEAIKNTSIVEELELP
PVKIHCSILAEDAIKAAISDYKSKKNKN
>BUsg173 nrdA, ribonucleotide-diphosphate reductase alpha subunit
MKNSLFVTKRNGKKEKINLDKIHKVLNWAAKGLENISVSQVELRSRIQFY
NNISTVNIHETIIKAAADLISENTPDYQYMAARLAIFHLRKKAYGQFEPP
NLYYHVKKMVQLGKYDEKLLQNYSFEEYVEMNSFVDHRRDMNFSYAAVKQ
LEAKYLLQNRVTGQIYESAQFLYILISACLFSKYEKKVRMNYIQRFYNAI
STFKISLPTPIMSGVRTPTRQFSSCVLIECADNLNSINATTSAIVKYVSQ
RAGIGINAGQIRALGSPIRNGEAFHTGCIPFYKHFQSAVKSCSQGGVRGG
AATVFYPIWHLEIESLLVLKNNRGIEENRVRHLDYAVQINKLMYQRMLLG
QKITLFSPSDVPKLYEFFFSDQKKFKEIYIKYEKNRNIRKKSINAIDLFC
LIMRERASTGRIYIQHVDHCNSHSAFNSKLATIRQSNLCLEITLPTKPLN
NIDDKNGEIALCTLSALNLGLINDLHDLKELSTLSVRALDEILEYQNYPV
VCAKKSAISRRSLGIGVINFAYYLAKNKVRYSDGSAKNLTHKTFEAIQYY
LLKASCELAKEKGSCSLFNQTNYYLGKFPIDTYKKDIDSICNEPLHLNWN
LLRKKIKKYGLRNSTLSALMPSETSSQISNATNGIEPPRGFISIKSSKDG
MLRQVVPEYKKLKSEYELLWEIPNNIGYLELVAIMQKFVDQSISANTNYD
PKRFLNEKIPMKQLIYDLLVAYKLGIKTLYYQNTRDGAEDNQNLNKSIEN
IKEDNCTSGSCTI
>BUsg172 nrdB, ribonucleotide-diphosphate reductase beta subunit
MSYTTFSKKKNNQLKEPMFFGQSVNIARYDQQKYNIFEKLIEKQLSFFWR
PEEIDLSKDRIDFDNLPSNEKHIFISNLKYQTLLDSIQGRSPNIAFLPIV
SIPELETWIETWSFSETIHSRSYTHIIRNIINNPSIVFDDIISNKNINDR
AQDISIYYDELIRITAYWHLLGEGNHKINEKKVEINLKLLKRRLYLCLIS
VNVLEAIRFYVSFACSFAFAEREIMEGNAKIIRLIARDEALHLTGTQHIL
NILNNEKNNENMKNTVLECREEAIKIFISASEQEKKWAKYLFQDGSMLGL
NKDILCQYIEYITNIRMHAIGFKMPFEKTSNPIPWINSWLNSDYIQAAPQ
ETEISSYLVGQIESEISNQEFKNFKL
>BUsg111 nth, endonuclease III
MNKKKRFEILSLFYKKNSNPKIELVFSSDFELLLSVILSAKSTDVMVNKI
TGTLFQIANTPQSILKLGFNKLRHYIKSIGLYNTKSLNIINSAYLIKTKY
NNKVPSNRTELESLPGVGRKTANIILNVLFNKNTIAVDTHVFRVANRTGF
AKGKNVIEVEKKMIKIVPSIFKKYVHFWFVLHGRYVCTARQLKCKTCFIE
KLCEFDKKK
>BUsg147 nuoA, NADH dehydrogenase I chain A
MLKNTLDMTEYLSFLYFIFFSLFFCCFMLFTSWFLGGRSLSRYKNTPFES
GVVSVGNTHLHFSVKFYLIAIFFVIFDVEALYLYAWSVSIVESGWIGFVE
ATIFILFLLLSLFYLVRIKALNWVTS
>BUsg148 nuoB, NADH dehydrogenase beta subunit
MNYTLTRAERKSQRHYPNETTQSTIDPIEGYLKKNILMGKVTKLLHKIVN
WGRKNSLWPYNFGLSCCYVEMVTAFTSVHDVARFGSEVLRASPRQADVMV
IAGTPFIKMAPVIQRLYDQMLEPKWVISMGACANSGGMYDIYSVVQGVDK
FLPVDIYIPGCPPRPEAYIHALTLLQKTINEERRPLSWVVGEQGIYRKKM
LSEKIQNRKKRISVVNLPTSEKI
>BUsg149 nuoCD, NADH dehydrogenase I chain C/D
MIDENKKKNTNLNKNEYEEKSILKDLFHFFGKDFCVVQDTCIDFPVIWIN
KSLLLKVGKFLSSSPKPYNMLFDLHGVDERFRLNRLNLPEADFSIFYHLI
SIERNSDILIKVPLLKDDLNVSTFISLFPNANWYERETWEMFGIIFDQHP
NLTHIIMPNEWKGFPLRKDYPARATEHESFFLDEQKEDLEMENLRFKPEL
WGMKRKNDNVDFMFLNLGPNHPSAHGAFRIVLQLDGENIVDCVPDIGYHH
RGAEKMAERQSWHSYIPYTDRIEYLGGCVNEMPYVLAVEKLANISVPEKV
EVIRVMLSELFRINSHLLYISTFIQDVGCMTPVFLAFTDRQKIYDLIEAI
TGARMHPAWFRIGGVAHDLPKGWNVLLKEFLEWMPKRLKYYVQLALENPI
LIRRSKGIAQYNQKEALQWGVTGSGLRSTGLDLDVRKWRPYSGYQNYTFE
IPIGQGISDCYSRVIIKVEEIYQSLSILKQCLKNMPEGPFKSDHPLTTPP
PKERVLKDIDTMITHFLQVSWGPVIPANESFQMIEATKGINSYYLISDGG
TMSYRTRIRTPSFPHLQQIPSVIRGSLISDLIVYLGSIDFVMSDVDR
>BUsg150 nuoE, ATP synthase subunit E
MDKKKKIKEISTTFTLTTFEINEIEKQKKYYENSRSVSIEALKIVQKKRG
WVCDQAIIEIANILNLNPSEVESVATFYSQIYRQPVGRNVIRYCDSVVCY
LTGYEKIKKFLEDYLFIKIGNTTVDGRFTLLPVCCLGNCDKAPTIMINED
LYSHLNPDLIPNLLELYK
>BUsg151 nuoF, NADH dehydrogenase I chain F
MNNIIPTEETHPLTWRLRNDRETVWIEEYCKKNGYFSLKKALKTMCPEDV
VHLIKESGLKGRGGAGFSTGLKWSLMSKDNSSKIRYLLCNADEMEPGTYK
DRFLMENIPHQLIEGMLLSAFALNVSRGYIFLRGEYIKAEYILKKSIQEA
INFGFIGSNILNSGFNFELFLHTGAGRYICGEETALINSLEGRRANPRAK
PPFPAVFGLWGKPTCVNNVETLSNVPSIVLHGVNWYKKLSKSTDTTGTKL
MGFSGKVNNPGVWELPFGTTAREILEDYARGMKSGLFLKSWQPGGAGTDF
LIEKHLDLPMDFTSIAKAGSRLGTAIAMAVDNKTNMISLVCNIEKFFSRE
SCGLCTPCREGLPWIVKILESLEKKEGHKNDVKNLERLCLDLSPGKTFCA
HAPGAVEPLQSAIKYFRLEFEAGISIKKLKKCSNILGIQSNEFTSKV
>BUsg152 nuoG, NADH dehydrogenase gamma subunit
MAKIYVDGKAYCMSESDNLLQACLSSGLNIPYFCWHPILGSLGACRQCAV
TQYNSSLDNQGKLIMSCMTPVIDGTIISINDDTSKKFRSNIVELLLTNHP
HDCPVCEEGGNCHLQDMTVMTTHNFRNYRFSKRTHKNQYLGSFIKHEMNR
CIGCYRCVRYYRDYADGTDLDVYGANNNIYFGRIEHGVLENEHSGNLIEI
CPTGVFTDKTHSKKYNRKWDMQYAPGICQNCSIGCNISIGERYGEIRRIE
NRYHESINHYLICDLGRFGYSHTNLKNRPKKPILSTKENDVNILNFNKAI
EYATNFFQRYKNVIGVGSIRSSIENNFALQELVGKENFCNGMSDKENSCI
KLILDTLKNNQLYIPSLKEIESYDTILILGEDLTQTAPRIALAVRQAMKN
KAKDLAELYGIPKWNAAPISQISEIYKNYLYIFNTHETKLDNIADWSYFS
SIDNQVRFARAIAYELDKNLPDISFLDSNLRKKASLIAKKIISSKKVLII
SGSHVYSKSIIQASINIAISINQKNINHVGLTFVTSSSNTLGLGILGGFS
IENALKKLKNREAEAIIFMEYDLYRYISKHDCDVLFKKNDNIMSIDHQYT
QTYKNSGFALPSVNFTESSGTIVNFEGRAQRFFQVYDPMFYDKKNCLYVS
WKWLSFIKSKIEKKEISWINLDNIISEYSDKYPIFKKIKTAGPNASFRVH
GQKIARSPHRSSGRTALRANINIHEPSQPKDADTMFSFSMEGYSQPNKSI
SHIPFAWFPGWNSPQAWNKFQKEIGRQLISGDSGVHLFKSNKKILDIYFH
FSPKKFIKEKYWYVIPYYHIFGNEELTQYSSIIKQNIPLEYVLISELDGL
ELGLKKNSIVEFNCLNQDFRLPIRLSKHLTSKHIGLPIGRKGFPISLIGE
KVKSLWEVMS
>BUsg153 nuoH, NADH dehydrogenase subunit H
MNSLGINIYEILFQILHITLIIIFIIFFAATLSILERKFLAFFQNRHGPN
RVGWFGSLQLCADMIKILFKEDWVPQFSKKSIFILSPIIAFVSLLLVIPT
IPFTPNFLIINLNIGILFFLMMASLSVYAVLFAGWSSNNKYSLLGAIRAS
AQTLSYEVFLGLSLMGVIARSGSFNIVDIVNSQKEVWNVIPQFFGFLCFF
IAGIALCHRHPFDQPESEQELADGYHIEYSGMKFGLFFIGEYISIITVSA
LISTVFFGGYFGFWGSSFFWLFLKTVFFILIFILIRASLPRPKYDQIMSF
GWKICLPLTLLNLIITAFFILI
>BUsg154 nuoI, NADH dehydrogenase subunit I
MTVKEIIIGFLLQIRSILMVFKNIFSKSETKMYPEEKLYLSPRYRGRVIL
TRNIDGGERCVACNLCAVVCPVDCISLQKSEKKNGRWYPKFFRINFSRCI
FCGLCEEACPTAAIQLMPDFELSDFNRQNLVYEKEDLLISGPGKYPDYDF
YRFSGVVIKDKKVDKLEGQLKPVNVKDLLP
>BUsg155 nuoJ, NADH dehydrogenase I chain J
MEFVFYACSLIAVISTLLVIIQKNAVYSLLYLIISLLSISGIFFIFGAFF
AGALEVVIYAGAIIVLFVFVIMMLNLGKKNDLQEKKYLNPIFWIGPSFLS
LILFLLMTYAIFFVKDKQIYFSLIDVKEVGINLFGPYLLLVELSSLLLLS
ALVVVFHIGKEKK
>BUsg156 nuoK, NADH dehydrogenase I chain K
MISLFHGLFLSLILFILGLTSLIVRRNILFMLISLEIMMNAAALALVVSG
SYWKQSDGQIMYILAITLAASEASIALALLLQLYRRQRTLNINALSEMSG
>BUsg157 nuoL, NADH dehydrogenase I chain L
MNIIFLIILFPLIGFLFLSLIQGTISERNTNIIGISSIFVSLIITFFYIT
GFINYSSQIFTQKLFSWISINELDIDCSLILDGLSLSMLAMILGIGLLIH
IFSTWYMKDKEGYSRFFAYTNLFIASMSLLVLADNFLFMYLGWEIVSICS
YLLIGFYYKTTNNTSCALKAFVFTRISDVFLIISMFLIYNKYGTFNFQEI
KFLSNFLNVEDCFDLNVLTLCLLLGVMGKSAQLPLHTWLSDAMVGPTPVS
ALIHAATMVTAGVYLIARTHFLFLLTPKILYLISLIGIITIFISSFSALV
QQDIKRILAYSTMSQIGYMFLALGVKAWTAAIVHLIVHAIFKALLFLSSG
SLILSCNNEKNIFNLSKVSSKCPLLYVSFLVGGASLVSFPLITSGFYSKG
NILFSVLKDGYFNLFLIGLFCSFLTSIYTFRMIFVIFHRSSVSFVFSNKR
LAHNLPLLILLFFSTMFGYFIIRLPLFYVFPMVKSLENGKFLYEIISSFI
SFLGIFIAYHIWIKQPFWFFRFLKFKIIKLIHKFLLNGWYFDFFYKILFI
HPYLFISKILSYEPFDFFPTFFVAFIKKTNSIVLKSVNGNVKCYISTMFV
GINLFFILVLCSFLS
>BUsg158 nuoM, NADH dehydrogenase I chain M
MLLSLLVIIPFLSGIFSFFSFRFQKNIPRWIALTGMGLTLLTVIRIWFFE
DYYTYQIQSYTHLSYQLILPWISSFGIQFHIAVDGFSIVMLFLTLFLGII
AILCSWNEIKKNEGFFYLNIMLVLMGTIGVFIAFDLFLFFFFWEIILIPM
YFLISLWNQKKEDKKKCINIANKFFIYTQISGLIMLASILLLVLNYYINN
KILTFNYDLLLIQPVDKSIEYIIMLGFFLAFIIKMPIVPFHGWLADFHER
SPYCGAVDIIGALLKTAPYGLLRYNKMLFPNATEQFAPIAIFLGFLSMFY
GAWVAFSQVNIKRLIAYSSISHMGLMLIAIYGGNEISFQGLIIQILSNSI
STSALFILSGQIYKYLKTQDISEMGGLWTNIYWIPGFSLFFALSNLGIPG
TGNFIGEFLILFGIFKEHPLVSIISTIGIIFSSIYSLNMIQKIYYGLSKH
DFPKFFLNIKEFWISIVLIFALIFLGLIPQKILNISFESIHFIYNFSKRI
Q
>BUsg159 nuoN, NADH dehydrogenase I chain N
MIINLQELIALLPFLILLLTVVIVILSISYNRNHFFIAFLTIISLIVSLC
SLYFLIAIVPIDITSLFHITKRSILYISMIIISSIATCVFAYPWLLKYAF
NKEEFYLLTLISTLGAIFLTISNHMASLFISVELMSLPIFGLIAYSNSQK
YSLEASFKYLVLSGVSSSFLLLGISWIYAISGNLSLLCLNQIFSDLSNSE
KMMVLFGIIMVLMSFFFKLSMVPFHLWTADIYQGTPASVLSFFSVSGKIA
IFSILLYFFSYFSVFDNKVIFLILSLISFFSILFGNLMAIFQTNIKRFFG
YSSISQIGYLLIILLVSKDEYFFSVQTGGIFLLNYLCTNIVYFGVINLFS
NSCDYDIDSIHLYKGLFWVQPLLASIVTIVLLSLGGIPITLGFFGKFCIF
SIIIKNHLWTIGASFLIGTILGLYGYLRLIVNMYLNPSEQSFINDIKKSN
FWLCSPSGILIFISGIMLLILGIYPNPLINLINSVQ
>BUsg366 nusA, transcription elongation factor NusA
MNKEILAVVEAVSNEKSLPREKIFEALEIALATATKKKYEQEIDVRVSIN
RKTGNFSTFRRWMVVDIVVHPTKEITLEAACFEGEQVKINDYVEDKIESV
NFDRITTQTAKQVIVQKVREAERAMLVDQFRKHIGQIITGIVKKISRDNL
TLDLGNNAEALILREGMLPRENFRPGDRIRGILYGVYPEARGAQLFLSRS
KTEMLIELFRIEVPEIGEEVIEIKAAARDPGSRAKIAVKTNDKRIDPIGA
CVGMRGARVQAVSSELCGERIDIILWDDNPAQFVINAMAPADVVSIIVDE
DHHTMDIAVDSSNLAQAIGRNGQNVRLASQISGWELNVMTTEDLRSKHKE
EAYAAFNIFKKNLNVSEKVIKTLVKEGFSSLEELAYIPLNELLEINNLTE
REVQLVREGAKNGLLLLELDQKNQIKNKKIEQALLNVNGMNELLALKLAE
KNIFTVEELANQGIDDLIDIENLNSEQAGLLIMAARNICWFSSKV
>BUsg447 nusB, transcription antitermination protein NusB
MRKQMIIKPNFRRKARACALQMLYSWEISQNNIKDSAIEFLKEKNKKNID
IIYFYELIIGITYNCRSIDDLMKPYLSRSLKELGQIEKAILRISFYELYK
RKDIPYKVSINEGIELAKLFGSEDSHKFINGVLDKAALKIKR
>BUsg040 nusG, transcription antitermination protein NusG
MHESLKKKWYVLQAFSGFESRVAQSIKEHVKLNKMNDFFGEVMVPSEEVI
EIRGGQRRKSEYKFFPGYVLIHMIMTDSTWHLIRNVPRVLGFIGGKSDKP
SPISDKEVDIIINRLRQIGDKPRPKTLFEPGEMIRVNDGPFADFNGVVEE
VDYEKSRLKVSVSIFGRATPVELDFRQVEKN
>BUsg320 ompA, outer membrane protein A precursor
MKKQALTIIFLLVSLVTGIQAKENDHWYLGTKMGWSDFNILEYRSKDITP
FDTKIDTKNPLGAPVFGLFLGYEFNPYFSFEIENDTTGFSPHLIFQKNEQ
NIQINSLQLATKLSYPITDDFHIYTQLGGMMFWDNLSFKKDLQNIFTEKS
RLIPNVSLGAEYIFNKKFITRLDYTWKSNIAKIMNLSMKPVLGDVALSFG
WKFGKSNINEIFSSYIPQSSDKQYVALNENINFPFNSTELKPISHDKLQK
LQKEIKNIKSKNIFIMLSGHADRIGNKEYNQKLSENRAYSIKNYFTSHGI
SQDKISIQGMGNEFSLTNQICKDVSDRPLLISCLAPDRRVEIEVLSD
>BUsg347 ompF, outer membrane protein F precursor
MKNHKSLAILIPMLFAGSTAVNAIEIFNKNGNKLELYGSINPNHNFSNEF
LSTKISSKEDNTNAILGLSGKIKITDKLSSYAQIEYKNNFFMPEDLMNKQ
QPNTVRLGYAGLKYGNLGSIDYGRNYGVIHDAQSLTDHVPYINKKSIFAY
NDNYMVGRNHSLLTYRNNNVFGLVDGISFALQYQDEIKNRDLNKGKSSSG
WGASLKYESDSGLTAVGSCFTSERMISSNKKDLKNTSVDSYGLGFKYDAN
NVYVAAFYGSARNLMPYNMHISDSFINETQNIEAIAEYSFDSGFHPSLSY
LDSKGQNSNSPKKELDLAKQINISTRYEFNKNVSTYMNYKINLLKENDFI
SQNQIPTDNTIGAGVVYQF
>BUsg554 orn, oligoribonuclease
MTINNENLIWIDLEMTGLNSEIHRIIEIATVITDTKLNIISEGPVIAIHQ
KEEHIVIMDEWNTKIHKKNGLIKRVQKSIYNESKAESKTIFFLKKWVPIQ
SSPICGNSVYQDRKFLARYMPNLENYFHYRCIDVSTIKELVNRWCPSFKK
IKKQNHTALEDIHESIIELNFYKKIFFDTIKYSK
>BUsg191 panB, 3-methyl-2-oxobutanoate hydroxymethyltransferase
MESITISKIQNWKKNQIKFAAITAYDFSFSRLFEKEGIPIMLVGDSLGMT
IQGHNSTLPVKIQDIKYHTKAVRRGAPNSFLLSDLPFMSYYSIEETLKNT
AKIIQSGANMIKIEGGKWLVETVKELSKRSILVCGHIGLTPQSINFLSGY
KIQGKEKNDAQRIIDEAFILEEAGIKMLVLECIPSLLAKKITENLSIPVI
GIGSGHHTDGQILVMQDLLGITDGKKLKFVKNFLCHNGSIQNAIKQYINE
VKNGNFPSEKYSF
>BUsg190 panC, pantoate--beta-alanine ligase
MNIIKNINLLEKKIKELKKKNKIIGLVPTMGNLHDGHIKLILLAKKNVDI
VIVSIFINPMQFEDLLDLKKYPKTFEQDCCILKQEKVEILFCPDVNEMYP
LGLKNHTYIDVPKLSKIIEGKVRPGHFIGVTTIVCKLFNLIQPNFSFFGE
KDYQQLLIIKKLVKELNYPIKIISLPIIRLKNGLAFSSRNKHLSDLAQQK
ASYLYQAIKQTCNFIKNNNGKNIKKNIHTSRKYLIKKGFYIDIFNAYDSK
TLDPISKDSKNIIIIASVWLGKIRLIDNKKIILRD
>BUsg355 pepA, aminopeptidase A/I
MKFFIKNVLLEEEKSDCIVIGVFEFCEFKYSNNYLNKSICSYINNFIKKG
DMQGKVGETLLLYDVPNVVSKRILLVGCGKKNRLNRYYLDKIINKSMKIL
NKFSIKNIIFSLTEINIENYDIYWSIRTIVNSINKYLYKNFKINAFLKKE
VYLNSISFHIIEKKDFHIANNSLKHALAINSGITAAKNLADLPPNICNPL
YLSLQAQKLSEKYKDKIHVTSIDIKEMNNLGMNAYVAVGKGSKNKPYMSV
IKYSGINNTEQEKIIVLIGKGLTFDSGGISIKPSNNMNEMKYDMCGAAAV
YGTLIAAAKLNLPLTIIGILAGCENMPGGNAFRPGDIITTMSGKTVEILN
TDAEGRLVLCDVLTYVQRFSPNIVIDIATLTGACVVALGNHFSGLFSNDD
QLAYALEKSSRQTNDKIWRLPLSLEYEKELHSNFADLSNVGRGKAGAITA
SCFLAQFSKKYTWAHLDIAGTAWKSGKNHGATGRPVELLSQFLLNESNFL
KF
>BUsg295 pfkA, 6-phosphofructokinase
MIKKIGVLTSGGDAPGMNAAIRGVVRTALSEKLEVFGIYDGYLGLYENRM
TLLDRYSVSDMINRGGTFLGSARFPGFYKNEIRTIAVNNLNKRNIDALVV
IGGDGSYIGAQKLTKMGIPCISIPGTIDNDVAGTDYTIGYFTALETVVEA
IDRLRDTSSSHQRISIVEVMGRYCGDLTLAAAIAGGCEFIVLPEIHYKKE
ELVSEIQAGIEKGKKHAIVAITEYICDVEKLAKYIEKKTNRETRATILGH
IQRGGAPVVYDRILASRMGAYAVELLIEGYKGKCVGIQNEKMVFNDITDA
LKNMKRVFKKDWLITAKKLY
>BUsg204 pfs, 5'-methylthioadenosine nucleosidase
MKIGIIGAIEQEIRKIKEIINNLKIKKIGNIKIYTGTFKKIEIFLILSGI
GKVSASMSTTISINLFQPDFIINSGSAGSLNACLKIGDIIIPKKTCYYDV
DLTNFGYSKGQIPEYPQTFKTNKNLREILKEIAVEFKFKFLTGLLVTGDS
FIRKSNCIKKIKNQFSSAIGVDMESTAIGQVCHNFKIPFIIIKSISDLSD
NNATSHFEKNIPIASLKSSKLVKLLLKKISSQNSI
>BUsg553 pgi, glucose-6-phosphate isomerase
MKNINLIETKSWKDLKNHFKEVKNIHLKDLFLSDFNRFKKFSIFFENEIL
IDFSKNRITEKTLILLLNLAKEMNVKSAIKLMFSGSKINQTENRSVLHIA
LRNRSNFPILLNNSDIMSEVNDVLKKMKNFSELVIDGTWKGYSGKSISDV
VNIGIGGSDLGPYMVTEALRPYKNHLNIHYVSNIDGTHLSEILKKINPET
TIFLIASKTFTTDETITNANSAKFWFLKHSKTKETLDKHFFALSANINNA
VNFGINIKNIFQFWDWVGGRFSLWSSAGLSIVLSIGFNNFEKFLQGAHVM
DNHFYHTEYDKNIPILLALISIWYTNFFNSETEAIFPYDQYMHRFSAYFQ
QSNMESNGKSIDKNGNKVCYQTGPIIWGEPGTNGQHAFFQLIHQGTKLIP
SDFIVPTVSHNNLNDHHLKLISNFLAQTQVLAFGKSKNSFLKESTSFKKE
EDEFNRILPFKICEGNKPTNSILLRKITPYTLGMLIALYEHKIFVQGHIL
NIFSFDQWGVEIGKEVAQSIYKNINEKTKNSKSYDSSTQGLIDFYNFFKN
KQNYL
>BUsg435 pgk, phosphoglycerate kinase
MNLRKMTELNITGKKILIRTDLNVPIKNGVIQSDARILAALPTIEIAIEK
KAKIIILSHLGRPKEGCYTKKYSLFPIFEYLKKKLKKTKIYFSDNHLKKV
EINSGEILILENVRFNVGELKNDENLSKEYANLCDIFVMDAFGSAHRMQS
STYGIGKFVKIACAGPLLISEINNLKKALKNPKRPMVAIVGGAKVSTKFN
VLNKLAAISDTIIVGGGIANTFLAIDNKIGKSLHEPKFILKAKKLRDKYN
NIVIPIDSRVGKNFSHKEKCTIKLSSNIEKNEEIMDLGDKTIKKIIKILK
KSKTILWNGPVGVFEFPNFRKGTEMIAKAIAENNGFSIAGGGDTLSVIDM
FQIKDKISYISTGGGAFLEFIEGKKLPAMKMLEENFHK
>BUsg379 pheA, P-protein
MPSKNDLLSFRSEINNIDKNIVQLLAKRKKLVLNIAESKIKNNQPIRDIE
REKILLEKLTNLGKKNNLNTNYITRLFQLIIEESVLTQKKLLNKFCNDNN
LDLASFSFLGPKGSYSHIAASQYAEQNFKTCIENACLSFNEVIQSVENNQ
TDYAVLPIENSCSGFINEIFDILKKTNLFIIGEINISINHCLLAIKKIEL
NKIKAVYSHPQPFQQCSYFIKKFPNWKIQYTNSTADAMKKIVKYNITTNA
ALGSELGSKIYGLKVLYKNLANKKKNITRFILLSRKPVSISSKIPTKTTL
IFNTGQESGALAEVLLILKKNKLIMKKLTSQNIYKNPWEEMFYIDVQANL
SSSLMQETLEKIGKITKFIKILGCYPSENITPIIP
>BUsg121 pheS, phenylalanyl-tRNA synthetase alpha chain
MLILQKLFDSVKIEIKNSHTIDKLDHIRIKYLGKKGIFSNLIKDLKNFSL
EERKKYFIIFNEIKKKTINQINKKKIELNKIILDKQIEKEKIDVSLPGRR
IKNGVIHPINHTITYIKNFFSKLGFESISGFEIEDEYHNFDALNIPKDHP
ARNIHDTFWFDENRLLRTQTSSMQIRIMKKEKPPIRLIFPGKVYRNDYDS
THTPMFHQVEGLIVEKNINFSNLKWIIYNFLRNFFHKDIAIRFRPSYFPF
TTPSAEVDVVTNNGKLLEVLGCGMVHPSVLKNVNIDSNFYSACAFGIGIE
RITMLRYGISDLRSFFENDIRFIKQFKHI
>BUsg122 pheT, phenylalanyl-tRNA synthetase beta chain
MKFNENWLREWINPKITSVSLRNQIVESGIEIESIHEFNPIFDGFLVGKI
VECINPCKGNNLKILKVDVGYKKLLNIVCGASNCRNNIKVVVATIDSILP
NGSKIKIKKIKEKLSEGMICSFFELGLFNFCKDIIELPEDIPIGKKINDL
FLLKKDTFIKVAVTPNRPDGLSILGIARNIAAINNLKKIRLKKRILPTTI
EDQFPITINTEKQSVNYFGRIIQNVNLNVDTPFWMKKKLFFCDLLSDNII
ENILNYILIEIGQPLNILNADKIDDVIEIRMAIKKEFLILKNDTRIVLDK
DILVFSDKTKILFIPGNINNSDLEPNKNTKNIFLTSYLVDKKSILNILKK
IDSNNILDYYSHGVDASLQKYAIEYATYLIVKICGGKIGPINTKKSNFNS
LSCSNKIKLYHQNFNKCIDSFVDSSIISNILLCLEYKVNFHKKYWYVFPP
SWRFDILIEEDVIGDILRIYNYNNIPLTPLKQNYYFNSKNKDLKSPLLDE
AAVLLINRGYYEIITYSFINPSLQDDIIPNNNQILISNPISKDFSSMRLS
LWPGLLKTVSYNKNRQQESMRFFERGLCFSIDESQILGIRQEMFLGGVIS
GFYSKENWFSVRRKVDFYDLKGDLESLLEVICGLNKFEIRHQNILGLHPE
QSAKIYLDNKYIGSLGKIHPKIEKKLNLYNSTFLFELSLNYISKLKFYNT
EEISKYPTSRRDIAILVSKDIPFLDIITVCKDFFVNKKVEINLFDVYSCK
EFDNRKKSLGISFVFQNFKKNLKENEVNLMLHDCIKILKKKFQVVLRK
>BUsg566 pitA, low-affinity inorganic phosphate transporter 1
MLYLFSYSDLNHSLFILLALFFVLCYEAINGFHDTANAVSTLIYTRATSA
HFAVIMSGLFNFLGVLLGGLTVAYAIVHLLPNDLLLNSNSKNALAMVFSM
LLAAILWNLSTWYFCLPASSSHSLIGAIIGIGLTNAIITDSSLLHALNVP
KMTNVFLSLIFSPIVGLIISGSLIFLLRFFLKKKKNHYRIHMTPLEREQK
EGKKKPPFLIKIALILSSIGVSYAHGANDGQKGIGLLMLVLIGIAPCGFL
VNLNASKKEIIYTKNTIDHLYEYYSKNKVKIIKNTKNQKKIDFSIKNYNY
FEIIKNIKKTKFLLQNIYDFNQLNIKQRFKLRHFLLFLSENIDQTIHFSN
IVKKEKDFLKKSKKDILKTIEYAPMWIILIIALSLSVGTMIGWKRIVVTI
GEKIGKKRMTYAQAMSAQITASLSIGIASYTGIPVSTTHILSSSVAGAML
SDGDGIQISTIKNIALAWILTLPVSILLSGFFYWITLLFIKNF
>BUsg082 pmbA, PmbA
MQLLNQIEKEENLLIEKVKNTLFLAQEKVNCSIEVCVKKTIGISVNIRNS
IVENVEFNNDSILFVTVYNKFSKGVSSSKDFSTNGIKKMLEIAIDISKHT
SSDFFSGLPDAKFLCFKAQDLDLFYPSEFNIKNAINFASESEREAFKFDK
RIINSEGSFFSNHITIKVFANSLGMLEQYKSTRYSNYNCMIAKDNSTMQR
DFSYSTSRKLDDLEKPDVLGQKTATNAISRLGSKKINTIKCPVIFSKETS
SIFFSHLIPAISGDNIYRKSTFLLYDLKKRIFPEWLNIEENPHIKKGLGS
KPFDSEGVSTTIRSIIKNGILETWLLNTYNARKLGLTTTGHSGGISNWLV
SNKNISFKELLKMMKTGLLITELMGQGVDIVSGNYSRGAVGFWIENGKIK
YPVNEITISGNLKKMWNSILSISNDVNMYSNIQCGSTLLSEIQISGN
>BUsg349 pncB, nicotinate phosphoribosyltransferase
MKQYNYPIVKTLLDTDAYKFYMQQAVFYHYKNVDVVAEFICRGPNILGCY
SHILLDQINMMSSLSLSHEEYLYMTTFPFFKKEYLHWLKKFRYNITQVKV
DNYHGQLHIRISGLWKEVILWEVPILSLISEIFHRHCYPEITSNIAVQHL
NKKLKEFFKKNRDVDLSRLKIVDFGTRRRFSYDVQYSIIKRLKDTFPFLI
GSSNYHISRILKLLPVGTQAHEWFQAHQQISSNLRNSQTLALKTWLSQYN
QHLSIALTDCITMDSFLRDFNLFFSKSYQGIRHDSGDPVKWGEKAIEHYE
RLGIDPTTKTLLFSDNLNFRKMISLYKKFNNRVNIIFGIGTKLTCDIPNV
KPLNIVIKLVKCNGKPVAKLSDSPGKTFCLDRNFIKSLCKAFDLSLTV
>BUsg361 pnp, polyribonucleotide nucleotidyltransferase
MLNPIVRKFQYGQHTITLETGIMARQATAAVMASMDDTAVFVTVVGEKTT
NSSQKFFPLTVNYQERTYAVGRIPGGFFRREGRPSENEILTARLIDRPIR
PLFPKGFCNEIQIIATVVSVNPQINPDIISIIGASAALSLSGIPFYGPIG
AARVGFVNNQYVLNPTIDDMKSSFLDLVVSGTQNAVLMVEAESKVLSEDK
ILGAIMFGHQQQQVVINNIRSLSNEASKLPWIISYPEINTELELKITKLA
EKDISNAYLIFNKQERYEKLNFLKEEIIKLFFSENSNIDISEIEDIFEKI
EKNIVRKRILNNENRIDGREKDMIRALDIRTGVLPRTHGSSLFTRGETQS
LVSVTLGTSRDAQNLDELLGDKTDNFLFHYNFPPYSVGEIGIVGSPKRRE
IGHGRLAKRSLLAVMPKLDDFPYTIRIVSEITESNGSSSMASVCGASLAL
MDAGVPIKSAVAGISMGLVKEGDKYVLLSDILGDEDHLGDMDFKVSGTEE
GITALQMDIKIEGITNEIMRIALNKAKSARLHILNVMKQALSKPRNEISE
FAPRIHKIKINPEKIKDVIGKGGSVIRMLTEETGTIIEIEDDGTIKISAT
IGEKAKNAIRRIEEITAEIEVGRIYSGKVTRIVDFGAFISIGIGKEGLVH
ISQISNKRVEKVSDHLTVDQIISVKVLEIDRQGRLRLSIKEVENSIISNK
SINNIYI
>BUsg416 pol, DNA polymerase I 3'-5' exo domain
MPYTKKKPIIIVDGSLYLYRSYFTFQNFNSNEENPSGAIYGMLKTIQNIL
NKNYNSKKIIIIFDSSKKNFRNTIFKEYKSNRSAMPNKLYVQIQPLFKIL
EEIGIKTLSILGIEADDIIGSLAYKLEQKGEQVLIVSHDKDMIQLITDNI
NVLNISKNSILTPEKIQEKYGIYPKEFIDLLALMGDSSDNIPGVPKIGIK
TALFLLKKFSNIKNIYNNIEKIQSLPFRNAKNAAIQLKNYKKTAFLSYQL
AKIKLDVPINITSEEITLKKTCFKKLSNLIRWYSFNE
>BUsg081 ppa, inorganic pyrophosphatase
MNLNLIKAGNNIPSDIYVIIEISSNSSPIKYEVDKQSGVLFVDRFIPTPM
FYPCNYGYINETLSLDGDPLDVLVPSPYPIQSNVVINCKPVGILKMHDES
GNDAKIIAVPNDKVSKEYENINDISDISELLKKQISHFFQYYKTLEKEKW
VEIIGWGDHHEAKLEIKNSYDRAKKNTSLK
>BUsg462 ppiD, peptidyl-prolyl cis-trans isomerase D
MIKYLKSRLNIIIVKCILGIIILSLVFGTINNYFNRDTTRYIAKVNGEEI
SFITLQKMYIDERKKQEKILGQDFEKIKKNKKFKEETYNYILSQLINNIL
LEQYTKRMNFNIQDNEIKKIIFNIPIFQENNEFNKKKYLNYLSSKNLTHY
EYVSLIRKKLNTTYLINAISETDFILDNEQKKIIKLLSEKRIIKKAIIKI
NPIINNQKVTEKEINNYFDQHKNEFYTPEKFKISYIQLKPNKFKIQCSNE
EIKNWYKKNIDKYSNQERRQYSIIQTKTKNEALSILSELKKGEDFSKIAK
EKSIDPFSSEQGGNIGWITKNFVPNEIKIANLEKIDQISNIIKFNNNFLI
IKLNKILPKKYKKISEVSDLIENEIKYQKSLNTYKKLKDKIAIIAKKNIN
RFDLILKKTNILPKETNWFDKDSVPKELQNPILKKIIFKKGLLDRQKKLK
SHSGLIVLNDHQSFLLSIKNFQKKRIKKLKDIKRNIVNKLKYIKAVEKTK
NKLKKILFQLKIGNEHILKKENIIFEEYETVSRYDKNPNISVIFAMPHPK
EEKNVYTMYQNKNKNFVIALLDKVYNEKFSNEEEKIIIKYLEKNNIDVTF
QCFLQNLHRKATILYNKTDNF
>BUsg165 prfA, peptide chain release factor 1
MNSSIFNKLKSLRNRYEEIEIMLSQKDTISNQEKFKNLSKEYLQISEIVK
NFIKWEKLETDIKNINLLFNDVEMHDIAQEELFIVKKQKKKLEEKIKILL
LPVDPNDQHSCFIEIRAATGGDESSIFAGELFRMYTRYAENYMWKTEIMS
SSENERGGFKEIIAKVTGKGACGRLKFESGGHRVQRVPETESQGRIHTST
CTVAIMPVRPKTKKEEIKVSDLKIDTFRSSGAGGQHVNTTDSAIRITHIP
SGNVVECQDERSQHKNKAKALSILSARVYADKLAKSQKENSSMRRILLGT
GERSDRNRTYNFAQNRITDHRINLTIYKLNEVLQGKLDLLIDPIMQEYQA
DMLSSLSEFKL
>BUsg523 prfC, peptide chain release factor 3
MFNINHQLELSKRRTFAIISHPDAGKTTVTEKMLLLGKVIRTSGTIKARG
NGKYAKSDWMNIEKKRGISITTSVMQFTYKNTLMNLLDTPGHEDFSEDTY
RILTAVDCCLLIIDAAKGIEDRTKKLINVSRLHNTPVITFINKLDRDSRE
AIEILDEIEKELSLDCIPITWPISCGKNFKGICHIHDKIVNLYQKNIVKK
INFNSFSSFLNEHSLKEYLGADLYTQLHEELKLAAYVYPKFSKKKFLKGD
ITPVLFGSALNNFGIDHILESLIKWAPSPIYRVTKTRKVEPEEKKFTGFV
FKIQANMDLKHRDRIAFMRIVSGKYKKGIKLRHVRMKKDIIVSDAFSFLA
GDRFSIEHAYPGDVIGIHNHGTIKIGDTFTEGEEIKFVGIPSFAPEVFRR
IFLKNPLQQKKLKKGLSQLSEEGAIQVFRPMINNSLILGAIGILQFDVVI
ERLKIEYKIDAIYERVNISLARWIRSKNKKIISDFINKNKSYLALDISNQ
LIYLAPNKANLAVIKNIYNNIFFEKTREQ
>BUsg112 priA, primosomal protein N'
MIIVKVVLPLPIRKYFKYFMPDSMCPIIGGRIVVPFRSKDIVGIVISFCN
KKNISNLNLAFVKSCIDTESIYSDVVFSILIWLSRYYYFPIGSIFFSILP
KYLKKICLIDNKNYKFAILRKTKYKDFKTFNLLFFCKKKSFIDKDLEKYT
FFDFFLKKNFLQKSCKNYFYHENIPHIYQNYLIKKKFFLNKKIIFIINKI
LMKNCFTSWLITKNNFYLKVKFYLGLIKECLSKNLQILILVPFVKDIYQI
LFFLKKYFNVYIDIIHSQLNNEDYLKKWIRTKSGKNSIIIGTKNSVFFPF
LKLGLIIVNQEHHLNYRNLDQCRYNVRDIAILRAYKQNIPIILDSDTPSL
RTLYNILHKKCFYIKFIKNKKTFFLKNNVIDLRKERIKIGLSSTLINEIF
NNIQKNYPVLLVLNKFSFVFFGLICRRCGKIEKCHICNDYFETKKYDNFL
FCRNCLIKIKKPLFCYNCKNFSLIVFDFGIKKIKNSFKKIFPNINLFFLL
SLKKNKTKKLKIQFFKFPISNACIIITTEKISQHYYFPYVRFIALTNVDH
YFFSFHFCSIEHFLQFYFNLINLTGENKKLLKIFIQTSYPNNKFLLNLCS
SDYFLFCRKILSLRKKYFLPPWNFQVIFYSSSKFFEKSFIFLECIQIILK
KQSKRDNVSLWFVGPHPVFSLKDRKKCFYQLLIHSPSRTYLKKILKESIN
IVQCFSISQNVQWFLDIDIY
>BUsg234 proS, prolyl-tRNA synthetase
MRASKYLFSTLKETPHHAKIISHQLMLKSGMIRKLSSGIYIWLPTGIRVL
NKIKDIIKNEMRKINALEVLMPVVQPKKLWENSGRLSIYGEELFQFYDRR
NQKFILGPTNEEVVTNFIRNEINSFKELPLIIYQIQTKFRDEIRPRFGIV
RSREFIMKDAYSFHINKHCLEKTYNDFYQSYINIFNKIKIQFRAVNADSG
SMGGSISHEFQALSENGEDEIVFSKNTAYASNINTAKSMQSINFLKEKNR
IIPNQIKSKKCTKNFNEFKKPIKNFIKTILVRTKINNQPSLAALLIRQEH
ELNLFKIEEIDIIEKPLSFVNEEEIITLMGVKSKFLGPLGLKIPIFADVS
VYYMKDFTIGSNINEKFFINVNWNVDLPIPIIKDIRNITKKDISSDGSKS
LEIKKSIEIGHIFQLGKEYSKKMNVLVQEQHNNYKHIHMGCYGIGITRIV
ASVIEQNYDDNGIIWPDSIAPFQVVILPLNTKNCIKIKEITENLYKILKK
EKIDVILYDRNERPGIMFNQIDLIGIPHQIIISPRHINENKVEYRERKNN
KSTLIKVKEITYFLKKKLNLI
>BUsg163 prsA, ribose-phosphate pyrophosphokinase
MPDMKLFAGNSIPKLAKFIAHRLYINLGNAAVGRFSDGEISVQINENVRG
SDVFIIQSTCSPTNDNIMELVVMVDALRRASAGRITAVIPYFGYSRQDRR
VRSARVPITAKVVADFLSSIGVDRVLTVDLHAEQIQGFFDVPVDNVFGSL
ILLEDMLQRELKNPIVVSPDIGGVVRARAIAKLLYDTDMAIIDKRRPRPN
ISQIMHIIGDVANRDCILVDDMIDTGGTLCKAAEALKERGAKRVFAYATH
PIFSGKASENLKKSVIDEVVVCDTIPLEEKIRLLPNVRTLTLAGMLAEAI
RRISNEESISAMFEH
>BUsg170 pta, phosphate acetyltransferase
MSRIIMLIPLNKKVSLTTISLSILYFFNKKEQKNCFKSFSYLPLIKSDNI
NFIRAYFSKKINVLDDINFFKKNFNSDEYSYLLDKIIKECFNKKKINEFI
LIKGISRKEHDDADQINFDIAQNIDAEVIFIDNLKDFSLGCFKRKERKIN
VFLQQKKYKNFLGLIFSDINSPFIFNKMKYNFFDKLIILKNTKKNTCIHA
IKKNIFFNSFFRVIAFIPWNKKLVKSSVINIFKFLNATLVNTISIKDAFI
KNITIFDEDSSVILKKSYANTLVLISSSRMETFFKTLYLVCKSKKIGAIL
LTGVLKLSENSIKLLKFLTNQGVPVFFIKENTVETLSQLQKFNFNINVQN
KYFINKLLEYTSSFFNKNHLISLKKKTTNFYKKTYSPKEFCYRLKILSKS
KHKRIILPESYEPRILKAASICHRLGIAECILLGDPKKIYNIANENKIDL
NKNIEIKDPILIRDQYVPRLLEIRKNKKIDEIFARKQLKDNVILATLILE
SGKVDGLVSGTINTTANTIRPALQIIKTDPIYSLVSSIFFILLPNEVLIY
GDCAINIEPNSKELAEIAIQSANSAKMFGIEPRIAMLSYSTGFSGTGWQV
EKIRDATSIVKSKRPDLLIDGPIQYDAAISKEVAKLKIPYSSILGSANIF
IFPDLNSGNITYKAVQRSADLICIGPMLQGLKKPVNDLSRGASVEDIVYT
IALTSIQSL
>BUsg184 pth, peptidyl-tRNA hydrolase
MNKIKMIVGLSNPKKKYHKTRHNVGSWYIYSLAKNYLSILKEEKKFFGFT
GCLNIKSNFIRLLIPDIFMNINGFSVHRMASFYNISLNQILIVHDDLDLA
PGIIKYKYSYGHSGHNGLRHIIKEFNTKVNFYRLRIGIGRPKNKNEISSF
VLSIPDFKEMKLIKKSISYAIKENFTLLNLIQ
>BUsg344 ptsG, PTS system glucose-specific IIBC component
MFKNVFSSLQKVGKSLMLPVSVLPIAGILLGIGSAHFTLIPEIISQIMAQ
TGGSIFSNMPLIFAIGVALGFSNNDGVAALAAVVAYSILIQTLSAVELNI
LNTDANTIKNKNFSDIGILGGIIAGAISAYMFNKFYKIQLPEYLGFFAGK
RFVPIISGLFAIFVGLILSLIWPSIGNKIQIFSEWAAYQNPIIAFSLYGL
VERALVPFGLHHIWNVPFQMQIGEYKNSIGQIFHGDIARYMAGDTTAGNL
SGGFIFKMYGLPGAALAIWHTAKKENRKKIGSIMISAALTAFLTGITEPI
EFSFILVAPILYIIHAILAGLSFPLCIFLNMRAGTSFSHGFIDFIVLSGH
SHKIFLFPIVGICYGLLYYSIFYFLITTFNLKTPGREENKNTVFFRNNIE
IAPYIVEALGGKNNIKNLDACITRLRITVSEISKVNEENLKNLGAAGVVI
SGSGVQAVFGTRSENIKTAIDEYINNI
>BUsg062 ptsH, phosphocarrier protein Hpr
MFQKEIKINALHGLHTRPAAEFVKEAKNFISDIHIIYHGKSVNAKSLFKI
QTLGLVKDSVIILSAEGEDEKKAVEHLSKIMTELE
>BUsg061 ptsI, phosphoenolpyruvate-protein phosphotransferase
MISGILASPGIAFGNVLLLKKEEIVINRQNISTENIKTEINKFFNGRKKS
VKQLTEIKIATGEKFGKKKEGIFEGHIMLLEDEELEKEIINLITEKKISA
AEATKFIIEGQAKALEKIKDEYLKNRAIDVRDIGSRLLKNILNISIVDLN
NIKNQVILISKDLTPSETAQINLKYILGFITDLGGPTSHTSIMARSLEIP
AIVGTVNITKKVKNNDFIILDSLNNEIIINPSDQIINEKKQVERKYFFKK
ENLKKLRNLYATTTDGHNIKIGSNIGNIQDIYSAKKNGAECIGLYRTEFL
FMGRNALPTENEQFQAYKEIAESMENKPVIIRTMDIGGDKDLPYMNLPKE
ENPFLGWRAIRISMDRKEILHAQLRAILRASAFGKIYILFPMIISVEEIR
TLKIEVHKLQIQLKKEHLVFDENIKIGIMIETPASAIIADHLIKEVDFFS
IGTNDLTQYTLAVDRGNDLISHLYNPISPSVIQLIKQVIDISHLHGKWTG
MCGELAGDERVTTLLLGMGLDEFSMSSTSIPKIKEIIRKTSFSKSQELAK
KVLKAATTKEILDLLNKFII
>BUsg546 purA, adenylosuccinate synthetase
MNTNIVILGTQWGDEGKGKIVDFLSSNSSYVVRYHGGHNAGHTLVVNGKK
IILHLIPSGLLYPNVIGIISNGVVISPFELVKEIRMLEKNNHFINERLFI
SESAPLILPYHIAIDLAREKQLGINAIGTTGRGIGPAYEDKVARRALRVG
DLKNTQKLSTKLKVIVDYYNHQLVSFYKQNPISYKEILKDLLKVKDLIYN
MIKDTSAILHKAIEDKKRIIFEGAQGTLLDIDHGTYPYVTSSNSTTGGII
TGTGVGPKNLGYILGITKAYTTRVGKGPFPTELFDDIDSYLSKKGQEFGS
TTGRKRRTGWLDGVALRYSVKINSLSALCITKLDVLDDLKEIKICTSYKD
VNTKKIYKDFPIFNLEDVTPVYEVHPGWMKKTSGIKKIEDLPKAACNYIN
RIEEIAQVPIDIISTGPDRSDTILLKSLFF
>BUsg253 purB, adenylosuccinate lyase
MELNSLTAISPIDGRYSNSTKLLRNIFSEFGFLKYRLYVEIQWLKKLINM
HQILEIKKVEKTDILFLDNIFETFNEEDAISVKNIEKETNHDVKALEYFL
RKKLSQSKKLSPFLEFVHFLCTSEDINNIAYALMIKNARDEIILPLWKKI
INFLKNASFQYRNNSLLSLTHGQPATPSTMGKEMVNFYYRMQRQYHKLKK
IEILGKINGTTGNYNAHLVAYPKVNWHAVSKEFITSLGIFWNPYTTQIEP
HDYIAELFGCVSLFNNILIDSNRDIWGYISLNYFKQKLIDQEIGSSIMPH
KINPIDFENSEGNLGLSNALMNHMINKLPISRWQRDLSDSTVLRNIGVVF
AYSIIAYNSVLLGTNKLTINTSQLLKNLDNNWSVLSEAIQTVMRRYTIEN
AYEKLKKLTRGKKIEKVDIHKFIDKLNIPKIEKERLKKISPSNYIGAASQ
IIDEIK
>BUsg032 purH, bifunctional purine biosynthesis protein
MSLNNIIKNALVSLSDKTDLLKISKILAEKKINLFCTGGTADVLKKNKIP
VLEISDYTNFPEIMNGRLKTLHPKIIGGILGRREKDQKIMKLHNLIPIDI
VIVNFYPFEKIQNRKEFTIEEIIDNIDIGGPTLVRAAAKNYKDVIVIVDL
SDFTSCIQLINTNTVSLETRFDLATKAFKYTALYEEIISKYFLKKNPYRK
KHQKNIFPNEFQLNFIKKQDLRYGENQHQKSSFYIEKEILKSGTISSSNQ
IQGKNLSYNNICDADIALECVKEFSKPTCVIVKHGNPCGVSESNSLIKAY
FSAYNADPISAFGGIIAFNCLLDLDTAQEIVKKQFVEVIIAPEIDEMAVK
ILKRKKNIRLLICGKIEKNKKGLDFKRITNGLLIQEYDCDEINAKNFDFV
TNRLPTEKELEDAIFSWKVAKFVKSNAIVYSLNKTTIGIGAGQTSRIDAT
KLANLKVKDRNHNNTTGATMASDAFFPFRDGIDNAALIGISCIIQPGGSI
RDKEVIESANEHNISMIFTKKRHFKH
>BUsg311 pykA, pyruvate kinase
MLNRVRRTKIVATLGPSTDKANNLEKIILSGANVLRLNFSHGSSEEHKKR
AKKAKEIMFKLNCHIALLGDLQGPKIRISKFKKNSIFLKVNDVFILDANL
NEKNGNNERVGIDYKKLPNDLNVNDILLLDDGRIQLKVIKIEKCAIFTKV
IIGGILSNNKGINKLGGGLSADALTEKDKKDIILASEIDVDYLAVSFPRC
ADDLIKARELLKKSGSNAQIIAKIERAEAVFDQNAIENIILSSDAIMIAR
GDLGVEIGDAELVGIQKKLIRTARKLNKVAITATQMMESMILNPLPTRAE
VMDVANAVLDGSDAVMLSAETASGKYPSETVISMAKVCKGAEKVPSINVS
RHRLNVEFQSIEEAIAMSSMYAANHLKGITAIITMTESGKTALMTSRITS
GLPIFALSKHKKTLNLTALYRGVIPIYFDSDKDGVEAANEAIILLCKKKF
LFNNDLVIVTQGDIMGKIGKTNTSRILRVTY
>BUsg357 pyrB, aspartate carbamoyltransferase catalytic chain
MRNSLYKKNIISISDLNQNELELVLKKSAFLKVKAQPNLLKNKIIASCFF
EASTRTRLSFETAVHRLGASIIGFSDGSNISLGKKGETLSDTISVISSYV
DAIIIRHPQEGSARLAAQFSNGVPIFNAGDGANQHPTQTLLDLFTIKETQ
NKLNNLNIAMVGDLKYGRTVHSLTQALAKYKNNQFFFVSPDSLTMPNYIN
DMLYKKEIHWKRYKNIEEIISEIDILYMTRVQKERLDSTEYASAKSKFVL
QTSTLKNARNNLKILHPLPRIDEIDNNVDFTPYAWYFKQAANGIYARQAI
LSLVLIEKHFE
>BUsg322 pyrC, dihydroorotase
MSKFLKKIKIIKPDDWHVHLRDNEILKKVSQYTGTFYKRAIIMPNLEEPI
TNCFRSISYRRRILNSMTPNTAFQPLMICYLTEKTSPEELQQGFFKKIFV
GAKLYPHCSTTNSKYGIKNINNIYHLFNIMEKIKMPLLIHGEENNLNIDI
YDREAKFIENTLKPLRKKFPELKIILEHITTEEAISYIEECNSSYLAGTI
TPHHLMLNRNNMFIDGIQPHLYCLPLLKRKKHQIALRNVISSGSKNFFLG
SDTAPHFHKNKINTFGCAGIFNAPSSLLCYVSVFEEMNALQHFQSFCSEN
GPNFYNMPINKETITLVKKPHKILEKINIGKNIIVPFLAGKRLDWSIEK
>BUsg350 pyrD, dihydroorotate dehydrogenase
MFYYLIRKLLFLIDPEKAHTLVLMYLNSKKIQILRKIFIKPIPLKQIKCM
GLTFNNKIGLAAGMDKNGDYIDSLSKIGFGFIEVGTVTPLPQYGNPKPRI
FRVPSIEGIINRMGFNNLGIDYLVNNVKKSKFKGIIGINIGKNKDTKIED
AIKDYLICIEKIYFYASYIAINISSPNTINLRKLQYGILFENLLRDIKKK
QSEMHSKYSKYVPIVIKISPDLSKKELIHISNKLIHYKIDGVIATNTTLD
HSSIPKIKNNKEEGGLSGLPLQKKSNDVISILYKNLKRKIPIIGVGGINS
INSAREKIMCGANLIQVYSGLIYHGPNFIREIIRNL
>BUsg260 pyrF, orotidine 5'-phosphate decarboxylase
MLYTNNYNIPKIIIALDFYNKKEAMTLVDLLDPSVFYLKIGKEMFTILGF
KFVKELHKLGFNVFLDLKFHDIPNTVFNATKAAADLGIWMLSVHASGGKN
MLLSAKKALKSFKKPPLLIAVTMLTSLKEKDLKEIGIKISLKDYILILSK
LSNDCGLDGIVCPGNQAKKIKSLYGDKYKIITPGIRLSSDSSFDQKHIIT
PKEAKEFQIDYIVIGRSITTSKNPIKKLNLIIESMR
>BUsg399 pyrG, CTP synthetase
MTKNYIFITGGVVSSLGKGIAAASLGAVLEARNLKITIMKLDPYINVDPG
TMSPIQHGEVFVTEDGAETDLDLGHYERFIRTKMTCLNNFTTGSIYSEVL
KKERRGDYLGSTIQVIPHITNAIKDRIILCSKNSDIILVEIGGTVGDIES
LPFLEAIRQLAVDIGRKNVIYIHLTLVPYIKTAGEIKTKPTQHSVKELLS
IGIQPDILICRSQKTVPINERKKIALFCNVPVNAVISLKDVDSIYTIPKL
LKDQKLDNYICEYFKLNVPQADLKEWEKVIYEEKNASKEIIIGIIGKYIK
LPDAYKSVIEALKHAGLKNKIKVKIELINSQEIENKNFKLLQNLNGILIP
GGFGDRGIIGKLLSVQYARENNIPYFGICLGMQIAIIEFAQNVIGIKEAN
STEFDPQCKFPVIDLIKTKKNDIKDTRQGKKNNKSNFGGTMRLGSQPCKL
IFNSLSRKLYKKDTIIERHRHRYEVNNFLLKKIEKNGLKIAGRSKKNNIV
EIIEIFDHPWFIGCQFHPEFTSTPRDGHPLFIDFIKSAKKNKKNNFKIKV
KNV
>BUsg227 pyrH, uridylate kinase
MSTNTKFIYHRILLKISGEVLQGVNKFGIDINSLKRIVKEIKLVLQFGIQ
VGLVIGSGNLFRGATLSQLGVNRIVSDHIGILSTIINSLAMKDIMNSYSI
PSYVMSSIPVDGICETYNYERAIDLLSNNFVVIFAAGTGNPLFTTDSAAC
LRGIEIKSDIILKGTKVDGVYSKDPKKYSQAVFYKRLTYKDVIQKELKVM
DLSAFSLARDHNLPIRVFNINKPKSLYRIVKGYDEGTLIK
>BUsg358 pyrI, aspartate carbamoyltransferase regulatory chain
MQINKLQVEAIKSGSVIDHIPAHIGFKLLSLFRFTETEKRITIGLNLPSQ
KLDKKDIIKIENTFLSDDQINQLAIYAPCATVNYIEKYNLVGKIFPSLPK
KIDRILICPNSNCASHNHFITSSFIFTKDINNEINLKCQYCEKEFAKNIV
L
>BUsg124 queA, S-adenosylmethionine:tRNA ribosyltransferase
MHLSNFYFKIPKSLIAFYPCFIRSQSRLLIINGHTGKIAHKFFFNILNEI
NSGDLIIFNDTKVIPARLFGYKKSGGRVEVLLERILNKNSILASIKSSNE
IKMNSYLFFGKKNKIKSFIIGYKNPFYIIKFLHNKKSVIDIFNNIGHIPL
PPYIKRFNEKIDSSLYQTVYKKNLGSVAAPTAGLHFDLPLLEALSKKGVD
IDFLTLHIGSGTFQPIRTAKIEKHIMHSELVEVSSNLIQKIKLCKKKGGR
IIAVGTTTLRALESAYHSNSWNNKKNYVKDTNIFIYPGYKHNVVDALITN
FHFPESTLIMLVCSFLGYKNTMNAYHEAIKNNYRFFSYGDAMYITYNTHA
PYEKILT
>BUsg364 rbfA, ribosome-binding factor A
MDKLFNRSFRIAQELQKNIAFIIQHSLKDPRIKTIITVSEVRLSKDLSYA
QVFVSFLETNSNLTVKKVLILLNRASGYIRKLLCKKMNLRIIPIIVFFHD
DSFFKGNKISKLLNILTEKNNITL
>BUsg439 recB, exodeoxyribonuclease V 135 kDa polypeptide
MVYSDTKTSKKIKKYKINIMKKKLNIFQIPLKGIHLIEASAGTGKTSTIA
FLYLRLLLGLEKNKENIRKLSVKEILVVTFTNAAKEELYIRIKKSIKELH
LSCIKKKSKDPIFQSFLTKIKNFDEAIHILEDAKININNAAIYTIHGFCQ
DVLENNTLISNREIIENESFLYLQATQDFWRYFFYNLPKKIIKIIYEEYR
SPEDLLREIKPILKVNSSINFKKKFDKKETLITFHEKIINKINIFKQKWL
NYNLIILKIINQLKVNKKIYSNFNILKWKKKITEWAESETKNYKMPICLK
YFSETSIEKNIKNYNFKKHIFFEEIDKILKKNFSLKNIILFYAIKNIPKF
VKREKEKKLLLGFNDLLKILLKNIKKEESLREIIIKQYPVALIDEFQDTN
IQQYQIFNTLYKNKKTALFLVGDPKQSIYSFRGADIFSYLHAKFKIKNYY
YLDTNWRSSKNICKAINYLFSKNKNPFYFKNIPFEPILSSSKNLNMKFKI
KEKNQTAISFFFQKKEEVNIEEYRDWIAKQCANEISYWLTCSKKGEAIIS
DGSQERILTEKDIVILVRNRTEAQIIKESLKKVNILSKYSSPYESVFKTF
DALELLSILKSILDPTDINLLKKSILTHILNKIAFQKIKENSKTKISHFL
IQKLYEYNDKWKTIGIFYTIKTMILEYQKYANNFEMYKNQQRNINFLHIA
ELLQEKSQNCYKENSLMRWFEKKILEKNNISENEYIKNFAESKIIRIITI
HKSKGLEYPIVWIPFIVDFNVSKSYFYHEKKTLKIFFDNNKSSETLKKSD
EERLAEDLRFLYVALTRSIYHCSIGISYLVKKRKKNKKSSDIHKSSLGYI
IQNGKCMNYKELLYELKILNKKLYIEVKYQAMNCKSLTIKKDDLYILSQP
QFLLKEIKLYSQITSFTKIKQENKHFNNIQYNNIESYFFKEKDKKKTIHN
FPHGNKAGIFIHYILKTIKFNNTFNIDWFYTILKKYEFSEKWAKTLMFWI
NNILNFKINNLNITLSSLKKTQYIKELEFFLPIKNTLYCEDLNQIIQSID
LISSISQKIFFNPVIGILKGFIDLVFIFNKKYYILDYKCNYLGNNDNCYS
SKNIKKEIIKNRYDIQYQLYTLALHQYLKKKVKQYHYKTHFGGVFYLFLR
GINVKDSIFYILPDYLLIKKLTKLILQKK
>BUsg438 recC, exodeoxyribonuclease V 125 kDa polypeptide
MFFVYRSNQIDILFTKICKIIKKKPLLNIFEREIIIHDNEILFQNLNTFI
ANHTGIAADFKLIYPNVFIWKLFKQVFSDIQLNNIFSRSTITWKIMKIIE
ENDFCKFVQKKDKIMKKFEFSFLMSHLYQQYILYRPNWINMWEKNKKNTL
KIEKKDEWQAKLWIKIILYTEKLQQSKWHFSNLFKKFKTLKKIEHIKFPK
RIFIIYSISLNPKYMEIFKKISTYTDIYFLSINACEKKIFHISFAKNYVV
QKNNLLMNLSEKYEKFYFLFFKKFKKIKYNNFFQKNNSNNLLNIVKNDFL
NFKEKENLLKKNSFLLKDNSISINICCDKKHEIEVLYNKLLSFFNEDSKL
KPSDIVITSFSLNTYIIYINSIFKSKNKKEKIPFYISKKHSDKIEKILFI
FNKILNLPNIRCNNEEILDLIEIQDIRDKFDISEEEINILYEWIEKANIR
WGLHENEKQKNNLIFIKKNQNTWFYGIKKLLISHAINEEEEVWNNVLSCT
SINTSRTELIGKLINFIKVLDQWRDKLFFSKKIKSWRPLFLCFIKDFFYK
NEKIRDSIDIINKTWTKMIDDATLSNYEKKIPISILKKKFSHIMNNFSEK
KFLPGVINFCHPSLVCYIPFKIKCIIGAEYQEIPKKKLSSFNLIDKYPLT
SDLHICKENYIFLQNFISTQETLYISYVGHSLKNNNKVRSSILIDQLLNH
ITSNFYVSEHHDYKNNKKEIFEHICKKHKKENLYEKKQVNKINLNTLQKT
KKINQEIYNKIFSIKNRIISTSTQISLKSLISFWKNPIRYFFNYTLNIKL
KIAKRNIITEPFSINLFDDFKISNIIFKKILNNESIKDEFKKIILSGILP
YGHFGSILLKEKKKEIENIVKAIYKYRISSPKKENFDIKIEKYNINGCLD
EIQNTGLLRWKLGTINYRDRISLWLEHLIYCILGGTGESKIIGYKKNFFS
FYPLSSHLAYNYLFTYIEGYMKGMKNPLLLIKSGSNWFDKVYDKKNDCIK
KNDDIKRKAYKILYHTWMGNEYITGEKEDLYIQQIISELNVKKICKISQK
WFTPILKHQKK
>BUsg440 recD, exodeoxyribonuclease V 67 kDa polypeptide
MNMSHLLQNFANKKIITLVDFYFSQFISKKNSIIMLISACVSFESKNGHI
FLPIEYFEKNCFFSISNKQFINKILKCLNKKKINWSLELSEHISCGDGSI
ITPLVFYKDKIYLYKIWKAEKKILERLYEKNQFDTIDTQQCLNILNNLFS
KKKHDLQKIAVILTLINNIIFITGGPGTGKTTIILKIIIALIKNAKKKIK
IQLSAPTGKATENLIEILNDKWLNRYLLKEEKKQFSFNPIMTIHQLLGIS
KKSEKIFFNKNNLLMIDILIIDEASMIDILMMSNILSALSKKTKIIFIGD
HNQLKPVKSSSILKYICSYAEDGYSLKTQSILQEITQNSIINYKINKKNT
SYISDKICVLKKSYRFEKKTGIYILSNAVYNKETKIFEKLFKNSIENVFF
YEINSEIEYKKMINIIINNNKIFWRKIYEKKNIKEIIKTFKNHQILCIVK
NGFFGVNFINKILEEEMYKRNIFNKRFYINNKLWYIGKPIIITENNQCLG
IFNGEIGITNLSQKNTLQVSFLKKDNFIENIPIEILKNYKTSWSITVHKA
QGSEFNNISLILPNKNLKILKKDILYTGITRTRKQLNIFSTKEIFIKTVL
KN
>BUsg574 rep, ATP-dependent DNA helicase Rep
MSLNFNQKNAIELINGPCLILAGAGSGKTKVIINKIIYLINNCQYKPGNI
IAVTFTNKAAHEIKVRLAKHLNLLQIKKMIISTFHSLGLEIIKKEINTLK
FNSNFSLFDERDQMMLLKKICSKSIKNDTKLLKKLVFMISFWKNKFLTPL
QVQLSAQSNLEKDFAFFYKQYTFHLRKSNILDFDDLICIPTSLLKNNQII
QNRWQKKISYLLVDEYQDTNNSQYELIKMLTNVNSNFTLVGDDDQSIYSW
RGAKPQNLFLIKKDFPNLKIIKMEQNYRSYGRILKAANKLISNNLHYFKK
KLFSNLEYGNKIKVIIGKNEKNEAEKIADKIIHECSNDIMQYKDYAILYR
GNYQSQILEKTFLKKNIPYDISTNSSFFSRPEIKDLLSYLRLIVNPDDNH
AFIRILNIPHRQIGLTTLNKLEELASKKNKSLFQISNDIEIKKILRERTV
KKIKDFIYWIKKIIKLSLLKEDIILDKIINDIKYELWLTKILKEPKKIKT
SINNIYTLSNWLKEMLRGNEFEKPMNLLQIVKKMTLRDILEKKIQINEIP
KNRVQLMTLHSSKGLEFSSVFIIGMNEGILPNIKSINNDNIEEERRLTYV
GMTRARKELFFTYCQTRIQYGQKLYTAPSRFLFELPQEDLQWEKDDYLDA
FHTKEKKI
>BUsg057 rfaE, ADP-heptose synthase
MKKKLINFKNALVLVVGDLILDCYWYSKNYYVVLEESLPIASINKIKKQP
GGAANVAKNIAEIGGNSKIIGFIGMDYEGLTLKKLLNHTRIYPDLISIKK
NKTITKIRILSEKKQLIRLDFQEKYISKKFNLLYEKIISSLTYYKVLVLS
DYAKGTLVNVKKIITLAKKMSIPILIDPKGLDFKKYSGATLLTPNLSEFE
QIVGKCHQEKQILQRGIKLVSELNLSALLVTRSKNGMTLFQPEKQPIHFP
ALSKTASDVTGAGDTVISIIASSLATGYSLEEACFYANVGASIVIQKIGT
ETLTINQLNTVLNI
>BUsg572 rho, transcription termination factor Rho
MNLTALKNMPVSELITLGEKMGLENLARMRKQDIIFAILKQHAKSGEDIF
GDGVLEILQDGFGFLRSADSSYLAGPDDIYVSPSQIRRFNLRTGDTISGK
IRPPKEGERYFALLKVNAVNYDKPENARSKILFENLTPLHANSRLRMERG
NGSTEDLTARVLDLASPIGRGQRGLIVAPPKAGKTILLQNIAQSIAYNHP
DCVLMVLLIDERPEEVTEMQRLVKGEVVASTFDEPASRHVQVAEMVIEKA
KRLVEHKKDVIILLDSITRLARAYNTVVPASGKVLTGGVDANALHRPKRF
FGAARNVEEGGSLTIIATALVDTGSKMDEVIYEEFKGTGNMELPLSRKIA
EKRVFPAIDYNRSGTRKEELLTLPDELQKMWILRKIIHPMSEIDAMEFLL
NKLSMTKTNDEFFDMMKRS
>BUsg261 ribA, GTP cyclohydrolase II protein
MQLIQIEKAILPTPWGDFLIFGFEEKKNGKNHIALVYGKIKKNIPILARI
HSECLTGDAFFSLRCDCGIQLEMAMSRIASEGNGILIYHRQEGRNIGLLN
KIKAYSLQDKGLDTVEANQKLGFSADERDFSLCADIFNILNIKKIRLLTN
NPFKVDMLIASGIEIVERIPIIVEKNDKNAHYLKTKAEKMGHLLFK
>BUsg056 ribB, 3,4-dihydroxy-2-butanone 4-phosphate synthase
MNQTLLSEFGNPIERVKKAISALQLGEGIIILDDEKRENEGDLVFSSETM
TVEQMALTIRYGSGIVCLCITESKRKKLNLPMMVKHNTSTYRTGFTVTIE
ASKGVSTGVSAKDRLTTIKTATADDAQPSDLNRPGHVFPLRANGGGILAR
AGHTEAAIEIVSLAGFKPYGVICELTNKDGSMSRTPEIIKFSKSKKMKIL
TIKDLILYVQNKK
>BUsg445 ribD1, riboflavin biosynthesis protein RibD
MKDRFYMTRAIKLSKLGEFTTSPNPNVGCVIVQNKKIVGEGWHKKYGENH
AEINALNMAGEKAKGSTAYITLEPCNHFGKTPPCCDAIIQSGIKNVIISS
LDPNPKVSGKGVLYLRKKGISVKIGLMSKESQKYNKGFFKRMRTGLP
>BUsg446 ribD2, riboflavin biosynthesis protein RibD
MSIDGRIAMKNGESRWITSKESREDVQKFRAKSSAILTSSATILNDDPLL
NVRYKKFDKNTLSTFPKKIFQQPIRIIIDSKNRVKKSHKIIQTKEKILLM
RLKLDKEIWPENTKQIIIKPYKENIDLLCVLKFLGNLEINNLWIEAGSTL
SGCFLKLELIDEIIIYIAPKILGHEAKPLFIFNNQLKLFDCLKFDFKDIR
QIGPDIRIKLEPKNKKF
>BUsg104 ribE, riboflavin synthase subunit alpha
MFTGIVNGIARVVSINKKKNFHTYTVNFSSILLKNLKIGDSVAHNGCCLT
VKYINCPHVVFDIMKITIANTNLGVLNIGDYVNIERSLKYGDEMGGHIIS
GHIMNTGEISKISKLDKNYILWCKVKDLSLMKYIFYKGFIAIDGISLTIN
NIIKNEFCVSIIPETLSSTTIGFKKIGQLVNIEIDFYTQIIVDTTKRLIK
KDISTLFK
>BUsg143 ribF, riboflavin biosynthesis protein RibF
MKLIRGIHNLKKINSNSAVSIGNFDGVHLGHQKLLSNLYKIGKKNNILTV
LILFEPQPLEFLNNKNSPKRLTTIQNKIKYIQSWKIDIILCIKFNESFSS
LSAEKFIKNILITKLNIKFIIIGDDFRFGSKRNGNISLLKEIGYQYNFKV
IEISSLLYKNKIKISSTNIRKCLLENKIELARKLLGRPFSISGRVIHGNK
IGRKLGYPTANISLRKNIPLNNGVYAVKISCFFNKKFVGICNIGIKPSYF
SSKKHRLLEVHLFNFNLNLYEEKIEVFLYKKIRNECFFSSKNKLKEQISK
DIEIVKKYFNLI
>BUsg443 ribH, 6,7-dimethyl-8-ribityllumazine synthase
MNIIQSGINVKNASITIIIARFNEFINKNLLSGAIDTLTRIGQIDKEKIL
TIYVPGTYEIPIVASYIANTNKYDAIIAIGTIIKGSTDHFKHIANDAYSN
LSRISTKYFIPITMGILTTENIQQSIERSGTKMGNKGSEAALAALEMINI
MKKLKKINN
>BUsg382 rimM, 16S rRNA processing protein RimM
MNIFLKKPLHPILIGKIGKAYGILGWVKFFSFTENKEKIFSYFPWFILKK
KWEIIHVDKWKKHNNNFIIHIENILDRSTVSKFTNLEIFIDKSILPILKE
DEYYWNDVIDCKVFNSRKEYLGKVINLIRNQNNDVLIIRNNLKKNNFKKI
MIPFIHKKIVKYINVKHKIITVIWN
>BUsg336 rluC, ribosomal large subunit pseudouridine synthase
MKYKTTSVSIIYINEDMINQRIDNFLQKKLKNVPRSMIYRIIRTGKIRIN
KKRIKPDYKLKIGDKLRIPPIKILCEKKSSLLTTEYKKNLLNNILYEDNY
LLIINKPSGIAVHGGSGINLGVIEYFRKIRPLEKFLELVHRIDRDTSGVL
MLAKKRRSLLSLHKQIREKKVQKKYIALVHGLWPLSLRKVSEPLLKTHLK
NKQRKILINKEGKPAETYFKIKKQYLFTTLVSITPKTGRTHQIRVHTLHA
GHPILFDKRYGKRDLDCNIKNKTKINRLLLHATSINFIHPETGKKMHIVA
PLDVYFKNYLNTLI
>BUsg388 rluD, ribosomal large subunit pseudouridine synthase D
MEKKELSACVPFMGFSGKRLDQILSKLFMQYSRSCLKKWIIMNNVYINGK
IENQPDKKILGGEKITIYSTDEKLPINLPQNIALNTIYEDSNILIINKPP
GLVVHPGAGNQDGTILNALLYRYTNISSIPRCGIIHRLDKDTSGLMVIAK
TIFSYNKLVTLLKKRKIIRKYQGIIKGNMISGGIVNYPIMRHPFKRICMT
TDSLGKKSITHYKIINRFKFHTHVSFRLETGRTHQIRVHMLHIGYPLLGD
PLYGGIDYGCNYFQENRNIYRKFNLFRQALHADYIEFIHPFTQKVMSWSA
SLPQDMKDILLYLKK
>BUsg256 rnb, exoribonuclease II
MFQNNPLLAQLKKNLHAKTPRVEGIVKSTERGFGFLEVDAQKSYFIPPKN
MKNVMHGDKISAVLKIEKDREIAEPEKLIEPFLNRFVGKIEKKDNKLFIF
PDYPFLKDFIACRPKKSCVHVFQTGDWAVAKLIQHKLNGNHIFYAELIEE
IVKANNPLIPWWVTLSRHNLERKEPKIEKDDLILKNNSHREDLTHLNFIT
IDNFNTKDIDDALFIEEIHNGNLRLIVAIADPTSYIKSGSKLDITAAKRG
FTNYLPGFNVPMLPRSLSEDICSLNPHERRPVLACCITILKDGNICSKIN
FFLAWIKSKSKLSYDNVSDWIEKKSSWKPETKSIENQILLLHRLCLLRIK
WRTSNAVLFQDSLEYRFQFSETGIVEDVVIEKRRIAHKIIEESMIIANIS
AANFLSKNLGFGIYNTHAGFDPINAENVVSFLNNYNLKFTVKEITTLKGF
CNLRRVLNILSDNYINSRIRRYQSFGDFSITPSPHFALGLVEYATWTSPI
RKYSDMINHRLLKSIINQDTNITKPSEDIKLKISEQKRRNRIAERDISDW
LYTLLLQKKEFKNKKFNAEIIDVSRSGIRAKLLENGANVFIPALFLHPIR
EELVFNQETGKVFIKGVLYYKISDLITVVLSEIRLQTRSIIARIDH
>BUsg249 rnc, ribonuclease III
MNHIVANKIQQILGYTFTHQELLKQALTHRSASSKHNERLEFLGDSILSF
VIANALYQHFPYIDEGDMSRMRATLVRGNTLAEIAYEFDLGEYLQLGQGE
LKSGGFRRESILANTVEALIGSIYLDSNIKTVEELILKWYEKRLEKISPG
DTQKDPKTRLQEYLQSKHLSLPSYFIVEVYGEAHNQLFTIHCEVSTLSTS
FIGKGTSRRKAEQDAARKALIKLGVE
>BUsg335 rne, ribonuclease E
MKRMLINATQQEELRVALVDGQRLYDLDIESSRSEQKKSNIYKGKITRIE
PSLEAVFIDYGMEKHGFLPLKEISKNYFPENYNCDVRLNIKDILREGQEL
IVQINKEERGTKGAALTTFITLAGSYLVLMPNNPKIAGISRRVEGSDRIE
LKELLSSLKIPEKMGLIIRTAGVGKSIKSLQWDLSLRLKHWNAIKKASKK
KSAPFLIYQESNVIVRAFRDYLRQDIGEILIDNPKILDIAREHITALGRP
DFINKIKLYTGEIPLFSYYQIESQIDSAFQRKVRLPSGGSIMVDTTEALT
AIDINSSRSTRGADIETTAFNTNLEAVEEISRQLRLRDLGGLIVIDFIDM
TTISHQKIIENKLREIVREDRARIQIGHISKFGLLEMSRQRLSSSLGESS
HHICPRCTGTGTIRDNESLSLSILRLIEEEALKENTYEVHAIVPIEIACY
LLNEKREAVYAIEKRQAGGKTIIVPNKNMKTPHYLVSRIRKGEQIRSMSY
CLSNVRKNKIFNNIKKEIVDKKHKLNSTLTNISLSDDSFDKQKEEKEKFL
RKKNYNNSIINALFNNKNLFFKFIVWIKNSFLKKHIFVKNESFKRNIFQN
KKNILFAKKEEFNSIEEIHKKDNQVSSIDNNKKKQLLNKVKKNNNHQYSH
VFDNNTKYTSLKKIDFQKNTIDFELNSLNFLKKNNFYIFSKYNFLYTKKY
AKNKFKDFENIKSQNDMICYESFQKDLENNTSFKKKLLYNIIFNNCYPNN
ILVNINSTIFQIYKNSEFFKFFPIKISILMTPLNIFSLELILEPSSKKCS
SFKENQVKKRLRINNYKKLNSSFIHKKNNFVKNSVLWPKKFTTEEIKINH
LYKKNKKNTKSYFFETSFKYKTVTKNISKLKVKLTSKKNDYLISNQKKLF
LNKTLKKENTKNKSSAPITKIFSDVFLSKNQKIMNSSIFLKKSNKKIKNS
AGAHSATNFSTSPVKKSE
>BUsg105 rnfA, hypothetical protein
MKSYFFFILSNILIDNFILVKFLGLCPFIGASNQIKQAFGISFATSFVVV
VSTVLLWFVNFFILLPFDLVYLRIIVYMLIISFGVQLIEIILRGTSPILY
RILGIFLPLITTNCAVLAIPLFSLYLNHTFLESILYAVSASFGFTLVMVI
FSSIRERILLSDVPLAFQGSPIVLITVSLISIVFMGFKGLVRI
>BUsg239 rnhA, ribonuclease H
MLKLVKMFSDGSCLGNPGSGGYGTILRYKLHEKILTSGFFLTTNNRMELM
GVICGLESLKESCIVEITIDSQYVKQGITNWIATWEKKKWKTTKKKLIKN
LDLWLRINAVIKNHHITWFWVKAHMGHLENERCDKIARQSAQSPSVKDFF
YENNFYQNKNL
>BUsg014 rnpA, ribonuclease P protein component
MLNYFFKKKSKLLKSTNFQYVFSNPCNKNTFHINILGRSNLLGHPRLGLS
ISRKNIKHAYRRNKIKRLIRETFRLLQHRLISMDFVVIAKKNIVYLNNKK
IVNILEYIWSNYQR
>BUsg545 rnr, ribonuclease R
MVVDSYQKKETKKYRNFIPRREQILFLLKTDKDLISQKKLEKKFSINSQE
QKKALRRRLRAMERDGQIIYTRNRCYITPENLKIVTGKVIGHRDGYGFLR
TETFKDDLWLSIEQMKLCIHGDVILAHIVKSDRKGRNSAKVLKILRPNDV
LIVGRYCVDNKKKFVIPNDTRFNFKIFILDSLISNENISIGTIVVVKLRE
NATKKSKIQGTIVEVLGKEMGTNLAIKIALRTHCIPYLWSKEVEYQLCGI
KSKINEKDFKNRIDLRHLPFFTIDEEDARDFDDAIFCKKKTNGEKGWKLW
VAISDVSYYIQPDTALDKAASKRGTSIYFPSLVIPMLPEKISIDVCSLNP
NAERLSLICEMNLSNKGELITYKHYEAVICSHGRFTYNEIFKIWNGDIEL
CFKYKKLLKYIQNLSSLQKILKKYNVSKRGIYFENIEAKFILDSNYRIKN
ISQNIRNDAHKFIESCMILANIASAEFVKKHKSPVLFRNHDRPDKDSIIN
FRSVLKKLGLSLLGGEIPESTDYSELLKKISTRPDYEMIQTILLRSMKQA
VYSPDNRGHFGLSLSSYVHFTSPIRRYPDLLVHRVIKNLLLKEKNLSKYH
LYNLNEVTKIGLHCSMTERRADEATRDVLDWLKCDFMQKKIGDVLTGVIS
NVTSFGFFVRLNQFFIDGLVHIATLIDDYYYFDSIGLKLIGKSSKNTYCL
GDTLKVKVISVNLNERKIELSLYMSR
>BUsg182 rnt, ribonuclease T
MSITQEFNLLSNRFRTFYPVVIDIETAGFNPKTDAVLEIALITLKMDKLG
WLHKEDILHFHIKPFKGSIINSDAIAFNKIDPFNPLRGAISETLAIESIL
EKVNYGIKIQGCTRGIVVAHNAHFDHNFLMAAIQRVKIKNNPFHPFVTFD
TAALSGLAVGQTVLAKACKAIGLSFDNNQAHSALYDSLQTANLFCKIVNR
WKGLGGWPINVKKSKQNSY
>BUsg518 rpe, ribulose-phosphate 3-epimerase
MKKFFLASSILSADFARLGEDTKKAIDAGSDWIHFDVMDNHYVPNLTMGP
MILKALRNYNITVPIDVHLMVKPVDNLIPQFAEAGADFITFHPESTDHID
RTLNLIKECGCKAGLALNPATSLNFLDYVMEKLDLILLMSVNPGFGNQSF
LPTSFNKLREVRKKIELNSSNILLEVDGGVKLENISEVAFSGANVFVIGS
GIFGYTDYNVIIKKIRKKLKNVYSTSIH
>BUsg397 rpiA, ribose-5-phosphate isomerase A
MNLNELKKKAAWAALDYIYPGTVIGVGTGSTVFYFIQALSTVKHLISGAV
SSSNSSTVLLKKNGIRVLDLNTFDFLEIYVDSADEINNDMQMIKGGGAAL
TKEKIIAAMSKKFVCIIDESKKVNILGTFPLPIEIIPIAFSYISKEILKI
GGQPKLRENIITDNGNVIIDVYNLFINDPISVEKKINSLPGVVSVGLFAS
RVADVVLIGTQKGVEIIKN
>BUsg038 rplA, 50S ribosomal protein L1
MKKINKRMKKIKNDINFEKLYYIDELIQLLKKSSNVNFNESIDVAINLGI
NPKKSDQNIRGSTILPHGTGRCVKVAVFTQGENIKIAKKAGAEFIGMEDL
AEQIKKEGIKFHTAIASPDAMKIVTQLGQILGPRGLMPNPKLGTVTTNIE
EAIKNAKTGQVCYRNDKNGIIHATIGRINFERNQIKENFNVFLESIKKAK
PPQSKGIYIKKVVLSSTMGIGLTLDQSSLSI
>BUsg502 rplB, 50S ribosomal protein L2
MAIVKCKPTSPGRRHVIKVVNKELYKGKPYSLLLSKKSKTGGRNNNGRIT
TRHIGGGHKRIYRIIDFKRNKDNITASIERFEYDPNRSSNIALILYKDGK
RNYILAPKNLKVGDTVISGENVPIKIGNSLPIKNIPVGSFIHNVEMRPGK
GGQIARSAGSYVQLVACDKEYATLRLRSGEMRKTESNCRATIGEVGNSEH
MLKVLGKAGASRWIGIRPTVRGTAMNPVDHPHGGGEGRNFGKHPVTPWGL
QTKGKKTRKNKRTEKFILRHRHK
>BUsg505 rplC, 50S ribosomal protein L3
MIGLVGKKLGMSRIFTKEGSSIPITVIQIQENRITQIRNIKTDKYYAIQV
TTGLKKLNRLKKPESGHFLKSGVIPGRGLWEFRINNNEKFQIGQSIKINI
FNDIKKVDVTGISKGKGFSGTVKRWNFRTQDATHGNSLSHRVPGSIGQNQ
TPGRVFKGKKMAGHLGNNRVTVQNLNIVKIDQNRNLLLVKGAVPGPTGSD
LIVKPAIKI
>BUsg504 rplD, 50S ribosomal protein L4
MELVIKDVPSLLSVSEIIFGRDFNEALIHQVVVAYSASTRQGTRAQKSRA
DVSGSGRKPWRQKGTGRARAGSFRSPIWRSGGVTFASKPQSHSQKINKKM
YRGALKSIFSELIRQKRLIIFEKFSLDLPKTNLLVKKLKEIKLNNVLILT
KEIENNLFLASRNLYSVDVKDVCSMDPVSLIAFEHIIITVAALKKVEEML
S
>BUsg493 rplE, 50S ribosomal protein L5
MTTFYDYYKSKIVKKLMMELNYSSIMQVPKIDKITLNMGVGAASSDKKVL
DNAVLDLTAISGQKPLITKARKSVAGFKIRQGYPIGCKVTLRGKRKWDFF
ERLIVIAIPRIRDFRGLSTNSFDGKGNYSLGIREQIIFPEIDYDKIDRVR
GLDITITTTANSDHEARLLLSSFNFPFRK
>BUsg490 rplF, 50S ribosomal protein L6
MAKLYVMWLNGGKMSRVAKRPILIPEGIKIELNLQSISIKGKYGYLSRII
HDAVKVECLNNKITFSIRSGFSDAWAQAGTSRALVNSMIIGVSKKFSKKL
QFSGVGYRVSLTKGNIVNMSLGYSHPIVYSLPPYIEAENPSPTEIVIKGV
DKQLVGQIAANLRSYRRPEPYKGKGIRYSNEVVHMKEAKKK
>BUsg542 rplI, 50S ribosomal protein L9
MEVILLSKIKKLGDSGAIVHVKSGYARNFLIPKGKAILASKKNIESFEAQ
RVELEKENISKLLIAQSRAEKIKTIKSITIPSKVGKEGKIFGSIGIRNII
KEMNLLGIKVNKKEIKLPNGVLRQVGEHKVIFQPHNEVCEYFIVNIISKK
>BUsg037 rplJ, 50S ribosomal protein L10
MALNLSKKKTIVSKINQISNLALSAIIANSQGISVNKINELRKSGREIGV
KMSIVRNTLLSLAIENTAFKCLKKKLKGSTFIAYSTKHPGSGARLFKEFE
KKNKKFKITGAVFEGKLLSELEINQLADMPTYEEAIRKLLLTLKISIAGK
LIYTLSAIKEKKETS
>BUsg039 rplK, 50S ribosomal protein L11
MAKKIQSYIKLQVAAGMANPSPPIGPALGQKGVNIMEFCKLFNKTTENVE
KGLPIPVIVTVYSDRSFTFITKTPPASVLLKKAAGIKSGSSKPKIETTGK
ITKLQIEEIAKTKKNDMTGLNIESMMRSIEGTAKSMGLIVED
>BUsg036 rplL, 50S ribosomal protein L7/L12
MSLGMITMSITKEQILEAVSEMSVMNVVELISAMEKKFGVSANMSVNTNN
NSEKSTIEEKTEFDIFLKSIGPNKVSVIKSVRSATGLGLKEAKDLVESAP
TVLKENMSKNDAESLKKTLEDAGAEIEIK
>BUsg378 rplM, 50S ribosomal protein L13
MNYEMKTFSLKLNDIKRNWFYVDATNKILGRFASAISIRLRGKHKIEYTP
HLDTGDYIIVLNASKILVTGQKKINKVYYHHTGYIGGIKQLRFEEIMLKN
PAKVIEIAVKGMLPKGSLGRSMFKKLKVFSNENHDHIAQCPQFLNI
>BUsg495 rplN, 50S ribosomal protein L14
MIQEQTILNVADNSGARSAMCIKVLGGSRRRYARIGDIIKITIKEAIPRG
KVKKGEVLKAVVVRTKKGVRRSDGSIIRFDNNACVVLNNNEQPVGTRIFG
PVTRELRIEKFMKIISLAPEVL
>BUsg486 rplO, 50S ribosomal protein L15
MRLNTLSPSLGSRKNHKRLGRGIGSGFGKTAGRGHKGQKSRSGGHVNRGF
EGGQMPIYRRIPKFGFNSRKKNITAEVRLSDISKLSTDIIDLKVLKKENI
INKNIKYVKIILSGKLEVALTLHGLRVTRGARLAIENYGGKIEG
>BUsg498 rplP, 50S ribosomal protein L16
MLQPKRTKFRKMHKGRNRGLAFGANVSFGLFGLKAIDRGRLTARQIESAR
RAITRYIKRQGKIWIRVFPDKPITQKPLEVRMGKGKGNVEYWVALIQPGK
ILYEMDGVSEEESREAFKLAAAKLPIKTTFVTKMVM
>BUsg479 rplQ, 50S ribosomal protein L17
MRHRKIGRKLNCKSDHRNAIFKNMACSLILNEIIKTTLAKAKELRRIVEP
MITLSKIDTVAHRRLLFSRIRNNEVIAKLFKKIGPIFYNRSGGYTRILKC
GFRFGDKAPMAYIELVDRVRKSKEKKKLSSNNNLIKNK
>BUsg489 rplR, 50S ribosomal protein L18
MMFYRNKKIISRTRRLLKARCKIKSLGAIRLVVHRTSRHMYAQIISSESK
VLAFASTLESKIKSDLKYTGNKEAAEIVGKIIAKRALLKGISNVSFDRSG
FKYHGRIKKLADSARNFGLKF
>BUsg384 rplS, 50S ribosomal protein L19
MTNIIQEIEQEQLKENIPHFRPGDTVEVKVWVIEGSKKRLQSFEGIVISI
KNRSLNSSFTVRKVSNGEGIERVFQTHSYSIDSIFVKRKGKVRKAKLYYL
RTRTGKSARIKERIE
>BUsg120 rplT, 50S ribosomal protein L20
MARVKRGVTAHARHKKVLKQAKGYYGARSRIYRVACQAVIKAGQYAYRDR
RQRKRQFRQLWITRINAAVRQSQMSYSSFMYGLKKASINIDRKILSDIAI
FDGFSFNILIKKAKEALL
>BUsg374 rplU, 50S ribosomal protein L21
MYAVFMSGGKQYRVKKNQIIQLEKLNNSPGSIIEFDKILMISAKKEVKIG
EPFLKGTKIKAHVENHGRLKKIKIIKFNRRKHYKKKQGHRQYFTNVKILD
INNFNGK
>BUsg500 rplV, 50S ribosomal protein L22
METLAQHRQARCSAQKIRLIADLIRGKKVPKALNILNFNNKKAAILVKKV
LESALANAEHNDGLDVDQLRIKNIFVDEGSTMKRMMPRAKGRADRILKRT
SHITVIVSDR
>BUsg503 rplW, 50S ribosomal protein L23
MISQERFLKVLLSPHISEKSSISMEKFNTVVLKVSRNTTKNEIKFAVQNL
FNIQVESVKTVYVKGKKKRQSNRIIYRSDWKKAYIKVKKGQNLDFMSNIE
>BUsg494 rplX, 50S ribosomal protein L24
MALKLRRNDEIIILTGKDKGKKGIIKNILSSNKAIVNGLNLVKKHQKPLP
SQNKNGGILEKEAPIQISNIAIFNPELKKADRIGFRFEEGKKVRFFKSNK
KTIK
>BUsg131 rplY, 50S ribosomal protein L25
MFIVKAEIRDKKGKSFSRKLRIEDKFPGVLYGFNNTPISITMDHNLVFNL
QKKEDFYKETLCLLIKEKKYTVKVHAIQRHAFKMKILHIDFIYAKI
>BUsg375 rpmA, 50S ribosomal protein L27
MAHKKAGGSTRNGRDSNAQRLGIKCFGGELIPAGSIIVRQRGTKFHPGKN
VGCGKDHTIFATVKGKVEFKKKGIKKRTYINIVR
>BUsg079 rpmB, 50S ribosomal protein L28
MSRICQVTRKKRMIGNNRSHAMNAKKRQFLPNIQYHRFWIPEEKRFIKLR
ISAHGMRCIDKKGIELIIQEIGITKNKG
>BUsg497 rpmC, 50S ribosomal protein L29
MKEIIKFRKKNRQDLNIELLQLLREQFNLRMQSASGKLKQPHLLRKVRKN
IAQVKMLLKEKECVK
>BUsg487 rpmD, 50S ribosomal protein L30
MKTIKITQIKSSIGRIPDHKKTLLGLGLRHIGHSVIRQDTPSIRGMIKKI
SYILKIQEE
>BUsg556 rpmE, 50S ribosomal protein L31
MKKKIHPAYSQIIATCSCGNIIEIFSTVNVNLNLDICAKCHPFYTGKQRI
IDTGGRVERFKKRFKLIKKDTV
>BUsg337 rpmF, ribosomal protein L32
MAVQKSKPTRSKRGMRRSHDSLKEITLSKDKFSGEMHIRHHITAKGYYRG
KKVI
>BUsg078 rpmG, 50S ribosomal protein L33
MAKKNREKIKMISSAGTGHYYTTTKNKRNTPDKLKLKKYDPIIRKHILYN
EGKIK
>BUsg013 rpmH, 50S ribosomal protein L34
MKRTFQPSILKRNRSHGFRTRMATKNGRYILSRRRAKLRTRLTVSSK
>BUsg119 rpmI, 50S ribosomal protein L35
MPKIKTLRSAAKRFKKTASGKFKRKQANLRHILTKKTTTKKRHLRPKILV
SKGDISKVKSFLPYF
>BUsg484 rpmJ, 50S ribosomal protein L36
MKVKASVKVLCRNCKIVRRKNVVRVICTNDPKHKQRQG
>BUsg480 rpoA, DNA-directed RNA polymerase alpha subunit
MQNSIIGFLKPRLVEIEQITATHTKVTLEPLERGFGHTLGNALRRILLSS
MPGYAVTEVEIDGVLHEYSTKEGVQEDILEILLNLKELAVKVHGKDEVFM
SLNKSGIGSVTASDIIHDGDVEIIKPDHLICHLTDENASIQMRIKVQRGR
GYIPASSRIHMEDDLRPIGCLLVDACYSPINRISYNVEAARVEQRTDLDK
LIIEMKTNGTIDPEEAIRRAATILSEQLEAFVDLRDVKEPEIKEEKPEFE
PILLRPVDDLELTVRSANCLKAESIHYIGDLVQRTEVELLKTPNLGKKSL
TEIKDILAARNLSLGMKLEKWPPSSILEE
>BUsg035 rpoB, DNA-directed RNA polymerase beta chain
MVYSYTEKKRIRKDFGKRPQVLDIPYLLSIQLDSFKKFIKIDPEGLHGLE
AAFRSVFPICGYNGNSELQYVSYRLGDAIFDVKECQIRGATYSAPLRVRL
RLVIYERDVLEPTVKDIKEQEVYMGEIPLMTNNGTFIINGTERVVVSQLH
RSPGVFFDSDKGKTHSSGKVLYNARIIPYRGSWLDFEFDPKDNLFVRIDR
RRKLPVTIILRALNYNTEEILNLFFEKNIFNINNNKIQLELVSERLRGET
ASFDIKKNGKIYVKKGRRITAKHIQELKKDKINSITVPVEYILGRIVSKN
YLDPKTGETIILANTELSLEILTKLKNSSFFSIETLFTNDLDHGPYISET
LRIDSSHDRISALMEIYRVMRPGEPLTKEATENLFENLFFSEDRYDLSSV
GRMKFNRSLLRKKIEGVSTLNKEDIIDVIKKLIDIRNGKGEVDDIDHLGN
RRIRSVGEMAENQFRIGLVRVERAVKERLSVGDLDTLMPQDMINAKPISA
AIKEFFGSSQLSQFMDQNNPLSEITHKRRISALGLGGLTRERAGFEVRDV
HPTHYGRVCPIETPEGPNIGLINSLSVYARTNSYGFLETPYRKVHNRLVT
DEIHYLSAIEEGNYVIAQANTNIDKNNYFIDDLVTCRHKGESSLFNCNQV
DYMDVSTQQIVSVGASLIPFLEHDDANRALMGANMQRQAVPTLKTDKPLV
GTGMERAVAVDSGVTVVAKRGGIIQYIDASRIIIKVNEEETYTGEAGIDI
YNLTKYTRSNQNTCINQKPCVKLREKINKNDVLADGPSTDLGELALGQNM
RVAFMPWNGYNFEDSILVSEKVVQEDRFTTIHIQELSCISRDTKLGPEEI
SSDIPNVGEAALSKLDESGIVYIGAEVTGGDILVGKVTPKGETQLTPEEK
LLRAIFGEKASDVKDSSLRVPNGVSGTVIDVQIFTRDGVKKDKRALEIEN
MQLKKAKKDLTEEFKIFELSLFSRIKKTLVSFNIKEDFLNKLPYEKWFKI
DIQDRNKKKEIEKLLQQHNQLKKEFEKKIEVKRRKITQGDDLAPGVLKIV
KVYLAVKRQIQPGDKMAGRHGNKGVISKINPVEDMPYDENGIPVDIVLNP
LGVPSRMNIGQILETHLGMAAKGIGNKINNMLKKQEKISNLKKFIQKAFD
LGENLRQKVNLDDFSNEEILDLAKNLKKGMPISTPVFDGAQENEIKQMLK
FSNLPTSGQISLFDGRTGEKFERPVTVGYMYMLKLNHLVDDKMHARSTGS
YSLVTQQPLGGKAQFGGQRFGEMEVWALEAYGASYTLQEMLTVKSDDVNG
RTKMYKNIVDGNHQMEPGMPESFNVLLKEIRSLGINIELENE
>BUsg034 rpoC, DNA-directed RNA polymerase beta' subunit
MKDLLKFLKAQTKNEDFDAIKISLASPDMIRSWSFGEVKKPETINYRTFK
PERDGLFCARIFGPVKDYECLCGKYKRLKHRGVICEKCGVEVTQSKVRRE
RMGHIELSSPTAHIWFLKSLPSRIGLLLDMPLRDIERVLYFESYVVIETG
MTNLEKRQILTEEQYLDALEEFGDEFYATMGAEAIQSLLKDINLVKECEN
LRIELNETNSETKRKKLTKRIKLLESFIQSNNKPEWMILTVLPVLPPDLR
PLVPLDGGRFATSDLNDLYRRVINRNNRLKRLLDLAAPDIIVRNEKRMLQ
EAIDALLDNGRRGRAITGSNKRPLKSLADMIKGKQGRFRQNLLGKRVDYS
GRSVITVGPYLRLHQCGLPKKMALELFKPFIYGKLEVRGLATTIKAAKKM
VEREEAIVWDILDEVIREHPVLLNRAPTLHRLGIQAFEPVLIEGKAIQLH
PLVCAAYNADFDGDQMAVHVPLTLEAQLEARALMMSTNNILSPANGEPII
VPSQDVVLGLYYMTREKINGKGEGMILNGSNEAEKVYRLEIAELHSLVKV
RITEYKKNKDQSFIPKTKIINTTIGRAILWMIVPKGLPFSIVNQTLGKKD
ISKMLNTCYRILGLKPTVAFADQIMYTGFAYAARSGASVGIDDMVIPVKK
LNIIHEAEIEVAEIQEQFQSGLVTAGERYNKVIDIWAAANERVAKAMMEN
LSTESVFNKKGEKQKQISFNSIFMMADSGARGSAAQIRQLAGMRGLMAKP
DGSIIETPITANFREGLNVLQYFISTHGARKGLADTALKTANSGYLTRRL
VDVAQDLVVTQNDCGTHEGILMTPLIEGGDVKEPLRERVLGRVTAEKILI
PNTENILIERNTLLNEQWCDLLEKNSIDNVKVRSVVNCETDFGVCAYCYG
RDLARGNLVNKGEAIGVIAAQSIGEPGTQLTMRTFHIGGAASRAATESSI
QIKNKGIINLNNAKSVTNSSGKIVITSRNVELNIIDNFRRTKETYKVPYG
AIMAKGHGEQVNSGETVAKWDPHTIPVITEVSGFVRFVDMIDGQSITRQA
DELTGLSSIVVLDTAERMTIGKDLRPSLKIVDRDGNDVLISGTEMPAQYF
LPGKAIVQLDDRVQISSGDTLARVPQESGGTKDITGGLPRVADLFEARRP
KELAILAEISGIISFGKETKGKRRLIITPVDGSDAYEEMIPKWRQLNVFE
GERVERGDVISDGPESPHDILRLRGVQAVTKYIVNEVQEVYRLQGVKIND
KHIEVIIRQMLRKATVIKSGNSEFLDGEQVEFSRIKISNRILNKQSKIPA
TFSRDLLGITKASLATESFISAASFQETTRVLTESAVAGKKDELRGLKEN
VIVGRLIPAGTGYAYHKERLNRRHTVNTNQIKPNNSSSQISAEEASASLS
ELLNSTLIQHDHT
>BUsg052 rpoD, RNA polymerase sigma factor
MEHNPKSQLKLLVTHGKEQGYLTYAEVNDHLPEEIIDSEQIDDIIQMIND
MGIQVVEEAPDADDLILNEINTDTDEDAVEAATQVLSSVESELGRTTDPV
RMYMREMGTVELLTREGEIDIAKRIEEGINQVQSSVSEYPEAITYLLEQY
DRIKTGQIRLSDIITGFVDPNAEEIFSHSTSAIHIGSEILDNITNDSNEN
EDENEDENEDEDENSIDPELANEKFRELRKQYTNTSNTIKNKNRNHQDSL
LEIYNLSEIFKQFRLVPKQFDHLVNNMRNMMNRVRKQERKIMKLCIEECK
IPKKIFLKIFSGKETDQNWFKKEQSSNQSWSKKLEEIKEKVFSSMKKLKQ
IEKETGLTIEQVKDINKRMSIGEAKAKRAKKEMVEANLRLVISIAKKYTN
RGLQFLDLIQEGNIGLMKAVDKFEYRRGYKFSTYATWWIRQAITRSIADQ
ARTIRIPVHMIETINKLNRISRQMLQEIGREPTPEELSEKMLIPEDKIRK
VLKIAKEPISMETPIGDDDDSHLGDFIEDTTLELPLDSATSESLRSATHD
VLSGLTAREAKVLRMRFGIDMNTDHTLEEVGKQFDVTRERIRQIEAKALR
KLRHPSRSEVLRSFLDD
>BUsg026 rpoH, RNA polymerase sigma factor
MTNKVQILSVTALGNLDAYIRIANLWPMLSIKEEKLLTKRLRYHDDLDAA
KTLILSHLRFVIHISRNYSGYGLLQADLIQEGNIGLMKAVRRFNPDIGVR
LVSFAVHWIKSEIHEYVLRNWRIVKVATTKSQRKLFFNLRKNKKRLGWFN
QEEIEIVARELGVSSEDVREMESRMSAQDITFNPFPEEDLKDGKINGNMF
YLQDKTSNFANGLEQDNWNKHTTSKLSNALLRLDERSRNIIRARWLDKKE
KNTLQKIANNYGISAERVRQLEKNAMKKLKIAIEN
>BUsg299 rpsA, 30S ribosomal protein S1
MNESFAQLFEESLKEIKTRPGSIIRGTIVSIEKDIVLVDAGLKSESAIPV
EQFKNAQGLLDVKVGDQIDVALDAIEDGFGETLLSREKAKRHEAWLILEQ
AHEKSETVIGIINGKVKGGFTVELNEIRAFLPGSLVDVRPVRDTIHLEGK
ELEFKVIKLDQKRNNVVVSRRAVIESENSAERDQLLESLQEGIEIKGIVK
NLTDYGAFVDLGGVDGLLHITDMAWKRVKHPSEIVNVGDEINVKILKFDK
ERTRVSLGLKQLGEDPWIAISNRYPEGIKLSGRVTNLTDYGCFVEIEEGV
EGLVHVSEMDWTNKNIHPSKVVAVNNIVDVIVLDIDEERRRISLGLKQCK
INPWQEFSETHKKGIHVSGKIKSITDFGIFIGLKGGIDGLVHLSDISWKI
SGEEAVKNYKKGDEISAVVLQVDAERERISLGIKQLEEDPFNVYVSNHKK
GAIITGIIKDFDKKTVTVKLSDGVEGNIKFSDSSRVNSEEIIKKLKIDDT
ILVKISNFDRKNRIINLTFHILDENNNKKDLKNKINVKSNDESFSNVMAE
AFKAAQNTE
>BUsg225 rpsB, 30S ribosomal protein S2
MEIVSMRDMLKAGVHFGHQTRYWNPKMKPFIFGSRNKVHIINLEKTLPMF
NFALSELKKISLKKGKILFVGTKRAASKKIKETALNCNQFYVNHRWLGGM
LTNWKTVRQSIKRLKDLETESQDGTFSKITKKEALIRTRELSKLENSLGG
IKNMGGLPDCLFVIDAAHENIAIKEANNLGIPVFAIVDTNSNPDGVDYVI
PGNDDAIRSVTLYLQAVSLSICKNQNGNSFSEMLLDSDKKMNIE
>BUsg499 rpsC, 30S ribosomal protein S3
MGQKVHPNGMRLGIIKKWNSVWFANTKDFADHLDSDYKVRQFLMKKLVKA
SVSRIIIERPAKSIRVTIYTARPGIVIGKKGEDVEKLRINIAKITGVPAQ
INISEVRKPELDAKLVSESITSQLERRVMFRRAMKRSVQNAMRQGAKGIK
VEVSGRLGGAEIARREWYREGRVPLHTLRANIDYSISEAHTTYGVIGVKV
WIFKGEILGGMSTIEKLEKSSIQIKKQHRKNRK
>BUsg481 rpsD, 30S ribosomal protein S4
MARYLGPKLKLSRREGTDLFLKSGFRSIDSKCKLEHPPGQHGVRKPRLSD
YAIQLREKQKVRRLYGVLERQFRIYYKKASRSKGNTGENLLQLLERRLDN
VVYRMGFGCTRSESRQLISHKSIKVNNNIVNIASYQISPNDRISVRDKSK
NQSRIKAALELTEQREKLMWIEVNVTKMEGIFKRFPERSDLSAEINEHLI
VELYSK
>BUsg488 rpsE, 30S ribosomal protein S5
MANIEKKNNSELQEKLITVNRVSKTVKGGRIFSFTALTVVGNGEGRVGFG
YGKAREVPAAIQKAMEKARRNMVTIPLVNKTLQHSLKGSHTGSNIFMKPA
SDGTGIIAGGAMRAVLEVAGIHNVLAKTYGSTNPINVVRATMNGLTNMKS
PEMIAAKRNKLIEDILG
>BUsg544 rpsF, 30S ribosomal protein S6
MRHYEIIFMIHPDYSEKVSVIIEKYKKIIHHNSGIIHRLEDWGRRQLAYP
INKLHKAHYILLNIETFPKTISLLETDFRFNNAVIRNIIISVKKAINEPS
PVIKLKEEKKDKK
>BUsg509 rpsG, 30S ribosomal protein S7
MPRRRIISTRKILPDPKFSSELLAKFINILMVDGKKSIAEVIVYTALKNL
SERTEKKELEAFEIALENVRPTVEVKSRRVGGSTYQVPVEVRPVRRNALA
MRWIVDSARKRGDKSMALRLSNELYDAVENKGTSVKKKEEVHKMAEANKA
FAHYRW
>BUsg491 rpsH, 30S ribosomal protein S8
MSMQDPVADMLTRIRNGQSANKYSVKMPCSKLKYSIIELLKKEGYIKNFN
IQGNNKLKIEVILKYFKGKSVIETIQRVSRPSLRIYKKKNNLPTVMAGLG
IAIISTSQGIMTDRKARRLGLGGEVICYVA
>BUsg377 rpsI, 30S ribosomal protein S9
MVKIQNYGTGRRKSSSARVFLRSGDGEITVNKRSLKDYFGRETSCMVVRQ
PLELVDMMNNFNIYITVKGGGVSGQAGAIRQGITRALIKYNHLLRSELRK
SGFVTRDSRQVERKKVGFRKSRKRTQFSKR
>BUsg506 rpsJ, 30S ribosomal protein S10
MQNQRIRIRLKAFDHRLIDQSTAEIVETAKRTGAQVRGPIPLPTRKERFT
ILISPHVNKDARDQYEIRTHKRLIDIVEPTEKTVDALMRLDLAAGVDVQI
SLG
>BUsg482 rpsK, 30S ribosomal protein S11
MVKNSSVRTRKRVKKQITDGIAHIHASFNNTIVTITDRQGNALGWATSGG
SGFRGSRKSTPFAAQIAAERCAEIVKDYGIKNLEVMVKGPGPGRESTIRA
LNAAGFRITNITDVTPIPHNGCRPPKKRRV
>BUsg510 rpsL, 30S ribosomal protein S12
MATVNQLVRKPRLRKIVKTNVPALEGSPQKRGVCTRVYTTTPKKPNSALR
KVCRVRLTNGFEVTAYIGGEGHNLQEHSVILIRGGRVKDLPGVRYHIVRG
SLDCAGVKERKKGRSKYGVKKAKV
>BUsg483 rpsM, 30S ribosomal protein S13
MARIAGINIPEHKHALIALTSIYGIGKKRSKIICFNANIAENSKISDLKE
EEIELLRENVAKYVTEGDLRREKTLNIKRLIDLNCYRGLRHRRSLPVRGQ
RTKTNARTCKGPRKAIKK
>BUsg492 rpsN, 30S ribosomal protein S14
MAKQSMKAREVKRVKLANKFYAQRIALKNTITNLKLSEEERWDAVLKLQI
FPRDSSPSRQRNRCRQTGRPHAFLRKFGLSRIKVREAAMKGEIPGLKKAS
W
>BUsg362 rpsO, ribosomal protein S15
MSLGIMTIKETILKYGKNEKNTGKTDVQIALLTNQINHLQLHFSQHKKDH
CSRRGLLKMVSKRRKLLNYLKKKNISCYTKLIESLNLRR
>BUsg381 rpsP, ribosomal protein S16
MVRIRLALYGTKKRPFYKMVVADSRFSRDGRFIEKLGHFNPVSKCQNSTL
KLNLNRIEYWQGKGAQISKRSQKLIKLFNKKEDTV
>BUsg496 rpsQ, 30S ribosomal protein S17
MKEKIRTLQGRVTSNKMNKSAVVAIERFVKHPIYGKFVKKTTKLHIHDEK
NECSIGDLIEIRESRPISKTKSWILVKILEKNIF
>BUsg543 rpsR, 30S ribosomal protein S18
MARYFRRRKFCRFTAEGIQEIDYKDIAMLKNYITENGKIVPSRITGTRAK
FQRQLSRAIKKARYLALLPYTDQHH
>BUsg501 rpsS, 30S ribosomal protein S19
MPRSLKKGPFIDVSLLKKVEKAVKINDKKPLKTWSRRSTVFPNMVGLTIS
VHNGRHHIPIFITEEMVGHKLGEFSLTRTYRGHTADKKVKKR
>BUsg144 rpsT, 30S ribosomal protein S20
MANIKSAKKDSIISEERRKKNASQRSKMRTFIKKVRLAISSGDKEKSYDA
FKKMQPIIDKYATKGLIHKNKAARYKSILSFKIAKLHKN
>BUsg054 rpsU, 30S ribosomal protein S21
MPIIKVRENEPFDVALRRFKRSCEKAGILAEIRRREFYEKPTTERKRAKA
SAIKRLAKKLTRENARRIRMY
>BUsg537 sbcB, exodeoxyribonuclease I
MKNNMKNILKKNEVNFLFYDYETFGIHTSLDKPAQFSSIRTDKNFNIMEE
PKCFYCFPSDDYLPDPSSILITGITPEYTEKHGFNEYKFSKKIHDVLLKP
NTCIIGYNNINFDDEITRNIFYRNFLDPYEWSWKNNNSRWDLLNVVRACY
ALRPSGIQWPKNEFGLPVFKLSDLTQKNNISHYNAHDATSDVYATIELAK
LIKRKQPKLFDFFFKYRKKNELCRLIDIEKFTPIIYVSSYFGALRQNMSC
ILPLSWDLHNKNILISIDLFKDIDKLIVFCKTVSISNISIKDLFDLGIVL
VYLNRCPILAPIKVIRKEDTNRLNFKKYFYYKKINLVKKNYFLIDLVKNV
LLKKNENKNSLNVDLQIYDSFFNFHDKNLIKKISLTKSSDLKKMKLDFKD
PRLKELFFRYKARNFFNILKNDEKKEWINYCLKTLNSFFLTGYIDKIESL
LKIYSYDVKKNNLLSDLLKYVFKKYKKVFYKNINLS
>BUsg195 secA, translocase
MFIKFLHKIFSNRNDRILKKFKKIVSSINQLEEKFKKLSDKKLQENTGIF
RLRLKKGECLDDLLPESFATVREASRRVFNMRHFDVQILGGIVLNKQCIA
EMRTGEGKTLTSTLPAYLNALTGRGVHIVTMNDYLAERDAKNNTPLFEFL
GLTVGLNLPEMSFIDKKKAYLCDITYGTNNEYGFDYLRDNMIFSAEERVQ
RELNYALIDEVDSILIDEARTPLIISGPSEDSSFLYKEINKLVPSLICQK
KEDSDKFHGNGHFSIDEKSKQIYLTERGLVEVEKILLDRKLMKKEESLYS
SNNIILMHHVISALRAHNLFTRNIDYLVKDNNIIIVDEHTGRTMPGRRWS
DGLHQAIEAKENVTVRNENQTLASITFQNYFRLYKKIAGMTGTAATESFE
FSSIYNLDTVIIPPNKPMIRKDLSDLVYMTEEEKINAILKDIKNCIKKNQ
PVLVGTISIEKSEMISKKLKILNIKHNVLNAKFHAREAEIIAQAGKPKSV
TIATNMAGRGTDIVLGGSLESQLEKNMYLDKIETIKRNWKKQHDLVVLSG
GLHIIGTERHESRRIDNQLRGRSGRQGDSGSSRFYLSMEDSLMRIFASDK
IISMMRKLGLSLNEAIEHPWVTKAIENAQKKVENRNFDIRKQLLEYDDVC
NEQRRVIYAQRNKLIDSENIQQNIYDILKDVLHSIIKTHLNFDFPKNTRN
ILDLENKLSIEFNLNISIKDWLKKDHDIKKENIIKKIIDIAKKNYLNKEI
QIGFHNIRMIEKSIMLKTLDSLWKEHLSAMDYLRQGIHLRGYAQKDPKQE
YKRESFNMFSNMLELLKYEVISFLSKLDISYIKSNLHLNMNNNSSIVNND
IKMGRNTPCFCKSGKKYKYCHGSL
>BUsg050 secB, protein-export protein SecB
MSEEKLKKKSFEIQRIYIRDASFEAPNTPNIFHKKWDPEIKFNLSTVSKK
LKPNIFETNLQVRVIVKSEENLVFLCDVHQVGIFFISCLDEQELKHCLGS
YCPNILFPYARTCISSLVSYGSFPQLNLSPIDFDDIFCKNLKSKRNNFYQ
KENI
>BUsg041 secE, preprotein translocase SecE subunit
MKIRIPDQKKAKNLEKIKWFFITAIFITSFFINNFFDKIGYFTRISIITL
LVVFAISIALYTKKVKNVFVYINASKNEMKKITWPQYKETLYTTFIIISV
TILISLLLWGLDSIIFRLIAFIISVRF
>BUsg367 secG, protein-export membrane protein SecG
MYLFFLIFLIFISFSLIFLILLQSGKGFNNTIHLNTSNNFNFFNSVGSGG
FIKNIIGFFAGFFLIFSIILCNINDKKVNSDVFLEKNTQKKTINEKKEQK
ILNSELPL
>BUsg485 secY, preprotein translocase SecY
MIKKLGLNFKNTKKVTNELKQRIASVVIALIIFRIGSFIPIPGIDTTILS
RILNDQKGTIIEMFNMFSGGALSRASIFALGIMPYISSSIIIQLLTLVIP
SLSEIKKEGEVGRTKINQYTRYTTLVLALFQSIGIVTSLPKISGMNQIII
HPDFYFYFTAIIILVTGTMFLMWLGELITECGIGNGISIIIFIGIIAGLP
SAIVHTIEQTRQGDLHILLFLCVLILIFSVVFLVVFIERSQRKIIIHYAQ
RQKGRRIYSTQSTHLPLKINMAGVIPAIFASSVVLFPVTIISWFGIDRKC
YLLKTIFFYFQPNQPLYLILYVFSIIFFCFFYTGLVFNPRETADNLKKSG
GFISGIRPGEQTAKYINKIMIRLTLFGSLYIAFICLIPEFMRSAMNVPFY
FGGTSLLIVVVVIMDFIAQIQTLIMSSQYESVLKKANLN
>BUsg302 serC, phosphoserine aminotransferase
MNLIYNFSAGPAMIPKDVLYQAKKELQNWNQIGCSIMEISHRSKEFIQVA
LEAEQDLRDLLNISNSYEILFCQGGARGQFAAVPMNLLGNFKETDYINSG
YWSNCALIEAKKYCIPKNISVRQKKNGKSFLLKPSQWNISDNSAYIHYCP
NETIDGMSIYEEPNFKNKIIVGDFSSFILSRRINIENYGLIYAGAQKNIG
PSGITIILIRKDLIGYASKISPSIFNYYIISKYNSMFNTPPTFSWYLSGL
VFKWLKKQGGIKKIEQLNQKKSNLLYQIIDNSNFYINDIDKRNRSQMNVV
FHLYNSKLDNLFLKEAKNAGLNALKGHNVIGGMRASIYNAMPLEGVQSLA
KFMLYFEKKYG
>BUsg303 serS, seryl-tRNA synthetase
MLNPYLLRNQIDAISKKLLKKKFKLDISLISSLEKKRKKLQIKTDNLQYK
HNTLSALFKKEKKIQELDENLKRTLTKSSKNLSELKIELNLLQEKIHNFS
LSIPNIPSDDVPEGNSSENNKIVKYWGKKREYSFAVRDHVEIGNKLNQLD
WKSSAKISGARFIVMKGNIALLHRALSQFMLDLHTIKHGYTETYVPYLVN
HDSLYGTGQLPKFTDDLFHINSIDKKKYVLIPTAEVPLTNLFSNQILNET
ELPIMLTAHTPCFRSEASSYGRDSKGLIRLHQFDKVELVQIIQPELSMNA
LELLTHHAEKVLQLLELPYRKVLLCGGEMGFSATKTYDLEVWFPSQKKYR
EISSCSNMSDFQARRMKTRYKKKKEKSNSFVHTLNGSGLAIGRTLAAILE
NYQDSDGRVTIPKILQKKYMQGIEYIN
>BUsg476 smg, Smg protein
MFEVLIYLFETYVHSGSEISIDYKNLTSDLSDIGFRSKDIYKALHWLKNL
SCCKKNIFSSINLSLNHTTNRIYTKKEEFKLNSDCRGFILFLEELEILTL
NTREIIIERIMALDISHVNIEDLKWIVLIILFNIPGCEVVYRKLENLLFN
FKKEIVH
>BUsg180 smpA, small protein A
MSNQIVLGMLMIFLFSSCSVLENKHYVLNNNLNESYFNLNKFKKNYKGMT
KEQIIYIFGNPIISDSFNDVFHYIICAEENGFGCHQKILNIFFKKNKVSK
LDIR
>BUsg245 smpB, SsrA-binding protein
MSYKKKRCLKSSIICKNKKAYYNYFIEEVFQSGLVLMGWEVKSIRLGQVN
IIESYINNDNLNEMYLYNSIVQPLHTSSNYVSCDSSRKRKLLLHKNEIQY
LCNKKNKIGSTLVALSLFWEKSWCKLNFGLAKGKTKIDKRASEKQNEWKK
EKLKILKKVKFQN
>BUsg183 sodA, superoxide dismutase [Mn]
MSYSLPDLSYAYNALEPFFDEETMRIHHTKHHQNYINNTNSILERTNFSS
LSIEELMSIFNEISLENKNVLRNNAGGHINHSLFWKGLKIGTILQGDLKS
EINKQFGSVEYFKSKFEDIALNHFGSGWIWLVNQNGILSIVSTINQDNPL
MGKSISGTHGNPIFGLDLWEHAYYLKYQNRRLDYIKSFWNVVNWDEASRR
LSK
>BUsg272 sohB, putative protease SohB
MNLLLNYELFLAKAITFLFIIFITPFIFNIIKRKRTDQKKFKIILLEEKY
KNIKKDILLSKMNKLEKKKWIKEEKKKDKEFEKKNKNNIVTLKKKTLFVL
DFKGGIHAHEVIGLREEISAILLAANKDDEVLLRLESSGGVIHGYGLAAA
QLERLRQNKIRLIISIDKIAASGGYMMACVADYIISAPFAIIGSIGVVGQ
LPNFNKLLKKCNIDVELHTAGDYKRTLTMFGQNTELTRKKFCQELNLTHE
IFKKFIKKMRPCLDIENISNGEHWFGTIAFKKNLVDEINTSDNILMSKMK
EKYTLLNIQYIYKNKKLENFTSFIIENIKIIIIKIFSYKKIL
>BUsg202 speD, S-adenosylmethionine decarboxylase proenzyme
MQKLKLYGFNNLTKSLSFCIYDICYANTNDSRNSYISYIDEQYNAIRLTK
ILKKTCSIIGANVLNVFHQDYEPQGASVTILVCEEPINLEKVNIVNKSNK
IISSSVLAHLDKSHICVHTYPESHPQSGICTFRADIEVSTCGIISPLNAL
NYLIHQLESDIVTIEYRVRGFTRDIHGIKHFIDHKINSIQNFMSHDIKSM
YEMFDVNIYQENIFHTRMLLKEFNLKNYLFNINVKDLSKKEHSYIIDLLW
KEMREIYHGKNISMIKKI
>BUsg203 speE, spermidine synthase
MINEKIWHEKLHRHVGQYFSIDKILYQKKNKYHDIIIFQNSIMGRIMAID
GVVQTTEKDEFIYHEMLTHVPIFYHGLIKNVLIVGGGDGGILREICRHKS
IENITMVEIDLNIIDLCKQFFPKHNNNAYKDPRLKIVIDNGLNFVQKTKE
KFDLIISDSTDPIGCGKDLFLSDFYFHCKNCLVKNGIFVGQNGVFFLQKN
DINQSYKNLKKNFHDVSFYQATIPSYYGGTMMFSWGTDNIDFRQINIKNL
EKRIKDKKLTFNYYNSNIHISSFYLPQYIINTLDKS
>BUsg527 ssb, single-strand binding protein
MYLIFLKLENGVLIMASRGVNKVILIGHLGQDPEVRYMPNGNAVVNMTLA
TSENWKDKNTGENKEKTEWHRIVLFGKLAEIAGEYLRKGSQVYIEGSLQT
RKWQDQNGLERYTTEVIVNIGGTMQMLGNRNSNSHNVTLNENNNIVKTKK
IEINNSPKKIEKIDSSEIDFDDEIPF
>BUsg292 sucA, 2-oxoglutarate dehydrogenase E1 component
MKKNTLEKWFNSSWLSGNNQNYIEKIYESYLINPKSVDITWQDKFSDLSK
KRKNILKEEKFVYKNNSFKEIKIDKQEILEKKINYIINTFRKKGYKKSLI
DPLKLNEQKKYKYLEPTFYHFSEDELKKTVKIDFKNSSQYEIKIRDLYEQ
LNNKYCGSIGFEYMYIENSFEKKWITKHIELFFKENLFIKKEKIRFLKEI
LYGETFEKYLGKKFSGTKRFSLEGGETLISILHEIIRYSKKNDVSEIILG
MAHRGRLNVLVNVLNKNPQVLFNEFSGINIPKEYSGDVKYHMGGITKIKN
DKKKIYLKLAYNPSHLEIVNPVVLGIARASINQLKISENKFLSINIHGDA
SIIGQGVIQETLNMSQTEAYKIGGTIHIVINNQIGFTTSNPKNLRSSKYC
TDVAKMIQAPVFHVNADDIEASIFAIQLALKFKKKFKKDVFIDLVCYRRH
GHNEVDDPFVTQPIMYKKIHNHPTIGQIYSNLLISEKLITSNDIEKIIEK
YTTKLVQGKNVLSQERNITFQNGNKNFFIKKQKENTQLNFLNIKDLLYSI
NTIPNSIEVHNRVKKIYQERIGMADGQILLDWGTAELLAYATILKEGISC
RLSGEDISRGTFFHRHAFIHDQNNGSIYVPLQNIEKNQGKFEIWDSVLSE
EAVLAFEYGYSLFPSNNLTIWEAQFGDFANGAQVVIDQFISSSEQKWNQK
SNLVLFLPHGYEGQGPEHSSARLERFLQLCAENNIQVCIPTVSSQIFHLL
RRQIFSNVYKPLIVLTPKSLLRNNVARSSLEVLVNENFKNVINEIDKNQK
EVKRIIFCSGKIYYDLLEYRNKCDINNVLLIRIEQLYPFPKDEILTILKS
YSYVQDFIWCQEEPHNQGAWFYIKDLLSTLLPLNSHLNYVSRPSAASPAA
GHILIHRKEQEKLINNAFNFKIA
>BUsg293 sucB, 2-oxoglutarate dehydrogenase E2 component
MNRINILVPDLPESVNDAVVVKWYKKIGEQISSEDNIVDIETDKVMLEVS
APCNGILNEILEKEGSIVKSNQILGNIVESKNIESKTKSKLEKSNKYFIK
DKNFNISFKEKIYNFPPSIRRIIRIKKNKEIFNELNYIKNQENIIEEKLN
DQSFSNEKEKKIYENRIKMTRLRQKIAERLLETKNNTAMLTTFNEVNMQP
IISLRKKYGEFFEKKHGVRIGFMPFFVKAVVESLKKFPEINASIDKNDIV
YYKNIDVSIAVSTPRGVITPVLRNADNMSMADIEKKIKEFSIKGIENKIK
IEELIGGNFTITNGGIFGSLMSTPIINPPQSAILGMHLIKERPMAINGKV
KILPMMYLALSYDHRLIDGKESVSFLVTIKNILEDFNRIIINV
>BUsg274 suhB, extragenic suppressor protein SuhB
MHPMLNIAIRAIRKGGNIIVQNYDTQKFIKEDLDKKKIFIKNIMYKTYRI
ISEVIYKSYPNHIILNKNTDLIKNEKNTLWIINELDGKNNFIKNFPHFCI
SIAVIMKNNTEISVIYDPIRNDLFTAVKGQGSQLNGYRIRCNNINSLNYS
TIAINLPLKHYAKSLFYLKIYKKLILSGISLRCTGSTLLDLAYVASGRID
CLFDFNPQSINLIAGKLQAREAGCLTSKFTENSEKKSEKGNFCTSNLTSS
SKFMRLITEKISQCYSFNN
>BUsg133 surA, survival protein SurA precursor
MKVYFFLILYVFLSFFSITYSKELEIDKIIAIVNNQIILNSDVNQVLFSL
KEEDQRVKIPLKINFLRNKIIKKLITETLILEEAKKFNIVVTDDQVNNVL
SKYALKKNITIEELKRNILMNNTNTSFSYNDYFNKIKNSLKVKIIQDYVL
HNRVHISEKEVDLFLNKLINTQNELKKIDINCIFLPFIKEKNKIFIKNTK
ILADHFAKKIKKDASFNYYYEYFKKNNNIFLSKEIRSKSLKYLKKIFLNK
LKIIKKNQILGPILGLKGFYILKINKIENENKENLTTEFHIQHCLIRPSV
ILDDKQAKNSIYYIYNNIKNKKYSFDYAVQKLSHDVYSSHKKGDLGWIST
DFFSNDFRNFLTDLRKNEISKPIKSNFGWHIIKLLDIRQVDKSNRIDKNL
VYRFLLEKKIKKERYNWIRQLKKSSYIKIFKN
>BUsg085 tal, transaldolase
MNQLNALKQFTTIVADTSDIESICKYKPQDATTNPSLILKAVSSSVNKRF
IDQAIEYARKKGGSYNYKIVNASDKILVDLGVEILKHIPGYISSEVDARL
SFNKEKCILKAKKIIDMYEEKGISRNRVLIKLAATWECIKAAEELKKNNI
ACNLTLLFSFAQARACAESNVFLISPFVGRIYDWYLSQNLILKNPADQDP
GVLSVCKIYDFYKKYNYKTIIMGASFRNVQQILSLSGCDRLTISPVLLKE
LESSNKELNRKLCPPTSFLNPPVPLTEAEFRWEHNQDEMAVQKLSEGIRN
FGKDQLSLEKIFSKLI
>BUsg125 tgt, queuine tRNA-ribosyltransferase
MKFQVISQDKEARHGMFNFNGNIIETPVFMPVGTYGTVKSLNIEEIKNTG
SKIILSNALHLYLRPGQDIIKLHGSLHNFMNWNGPILTDSGGFQIFSLSN
FCRIKEEGVIFKNHINGKKFFLTPELSMEIQIDLGSNIIMIFDECIAYNK
DWEKTKFAMERSLNWSRRSRIHFDLKKKNKKNLLFGIIHGGSYKSLRDIS
LKELIKMDFDGYALGGLAVGESKLEMHDLLDHITPQIPKKKPRYLMGVGK
PEDLIESVYRGIDMFDCVLPTRNARNGHLFVTNGIIKIRNAKYKKDLSVL
DKKCTCYTCQNYSRSYLHHLDSCNEILGARLNTIHNLHYYQTLMFNIRNA
IKQKKFDEFVSNFYNQKK
>BUsg017 thdF, tRNA modification GTPase
MIRNDTIIAQVTCPGKSAVGILRVSGIHANQVAFAVLGKIPKPRFATYSK
FFDESKKVLDEGISLWFPAPFSLTGEDVLELQGHGNPFIMDLLIKRILCL
KNIKIRIAQPGEFCQRAFLNGKIDLIQAEAIDDLINSETESVVRASLNSL
HGNFSFYIQKIIKKLIEFRTNIEASIDFSEENIDFDFNIFIMSNFEKLND
KFLKIKNIVSEGSLIREAKRIVIVGPPNAGKSSLLNVLSCRDRAIVTDLP
GTTRDVLYENINIHGISCEIIDTAGLRETEDKIEKIGIQRSWEMIKNSDH
VLYVMDKTISLEDQKKTSIQFMKQISSYNIQEVTFVLNKNDLVEDFCGIT
KIENLLFISISALTGQGIDILKKHLSNRQKDKSQEGLFIARRRHIHQIDL
SYCELLKAQKNWLKYKNIELLAESLNIINKLLGEITGEFTSSDLLKRIFS
TFCIGK
>BUsg444 thiL, thiamine-monophosphate kinase
MEYNEFEIISKFFKNHQKKDKNQIKGIGDDSALIKIPKNNLLAISTDTLV
EGKHFLKNITPKDLAYKSVAVNLSDLAAMGAKPTWITLSITMPKSDSVWL
KSFSKSFFKILNKYKLNLIGGDTNSGPLSITLSIYGLIEGKNALLRGNAK
NGDLIYITGNLGESAAGLSLLQKKTFLKNVKICNYLIKKHLKPIPRISEG
IALRNIANAAIDISDGLISDLGHILKNSKCGADINLNTIPISKILTDNFK
IDEYLNWALNSGEDYELCFTISKKNIKKLNVAIKKKIIKCTCIGYITSAE
KGLNLIQNQKKIIFKKSGFNHFI
>BUsg188 thrA, bifunctional aspartokinase I/homeserine dehydrogenase I
MKLLKFGGTSLANAKKFLCVADIIEKKNKKEQIAVVLSAPAKITNYLATI
IENKIDDEVLKKINLAKNIFIELIQDIKRIQPLFPYENTKSTIEIEFNKL
KKIINGILLIKQCPEGIKPIIISRGEILSVDIMKNILQSRNHEVTILNPV
TNLLSIGNYLDSTIDIKESKKRIKKINIDQKNIILMAGFIAGNKEGELVV
LGRNGSDYSAAILASCLNAKCCEIWTDVDGVLTADPRIVSNTYLLDYISY
QEAMELSYFGAKVLHPRTIEPISQFQIPCVIKNTNNTESKGTWIGKENNP
SDNSLKGVTYLDNIIMFNISGSCLKDSGNTIARIFTILSRESMKIILIIQ
SSSENQINFCTFEKDIDYILLILKKEFTLEIKEGLLNDFNIVKNLTILSV
IGSNISEKNNIASKIFSSLGSSKINVLAIAHGSSKHSISIVIKKENLLQG
IQNIHNTLFFKKTIINVFLIGIGGVGKALLKQILKQEKFLDQKNIKIQFR
MIANSKKLLFLKNSINLNNWEENFKKSKEKFNLTILNELLKNTCDSNSVI
IDCTSDYILSKQYISFIKKGFHIITSNKKANTDSLKYYSEIRTTALKENK
KFLYETNVGAGLPVINTLQSLFSTGDCLISFKGILSGSLSFIFGKLEEGV
LLSEATKEAKKLGFTEPNPFDDLSGIDVARKLLVLAREIGYSIELKDISI
EPILPERFKKYQNSEEFLFKLKELDSFFSERVNKARDIGNVLRFIGSIEK
NGKCSVKIEEINSNNPLYKVKNGENALTFYTNYYQPIPLVLRGYGAGNDV
TASGVFSDLLRIIL
>BUsg187 thrB, homoserine kinase
MIKIYAPASVANVGVGFDILGAAIIPINGTLLGDCVTVKLSKKFELINKG
IFSNKLPINKEQNIVWKCWFKFCKVIKKNIPVSIILEKNMPIGSGLGSSA
CSVVATLVAINQICNNPLNSKELLLLMGEIEGEISGSIHYDNVAPSYLGG
LQLILEDSDIISQKIPNFKHWFWIIAWPGIKVSTAEARKILPKEYKKDIC
IKNSRYLAGFIHASYTKQSHLAARCMQDFIAEPYRSKLLPNFLNAKEKIK
KIGAISCGISGSGPTIFAISDKIKTAEKISLWLKNNYLQNKTGFVHICAV
DVKGVRKIG
>BUsg186 thrC, threonine synthase
MKLYNLKNHNEQVNFETAVKLGLGQKQGLFFPVKLPIMTPVELSKILKMD
FITRSTEILSKFISSEISKEVLHEHVKKAFSFSKPLKICINKNISCFELF
HGPTLAFKDFGARFMAQMILCLNKKNESFTILTATSGDTGAAVAHAFYGM
KNIRVIILYPKGKITLLQEQLFCTLGKNIKTISINGSFDDCQKLVKKAFD
DKKLKESIGLNSANSINISRLLAQICYYFEAFSLISEEKRKNLVIAVPCG
NFGNLTAGLLAKSLGLPIQSFIACTNSNDTVPRFLNSGKWNPKKTVSTIS
NAMDISCPNNWPRIEELFRRKKWDLKELRFGSVSDNVTKETLKELFRMGY
VSEPHAAIAYRLLHDQLKKEEFGLFLGTAHPSKFKDTVEKILENSISLPK
ELKNRNNLPLLSHNINPDFNKLKEFLLEK
>BUsg117 thrS, threonyl-tRNA synthetase
MPVIRFCDGSQQVYKHSVSLREIIENKKPNIIRSLIAISVNNSFSNFNTL
ITEDSSISFISKKDCEALNIIRYSCIQLLNYAAKKTWPSCKIGESEITKS
GFYCDIDFENSITEEDFFILENNMKTLIKREYFISHQNISFDHAYEMFKK
KSEIYKIHLIKKYINKKNKISLYYHENYFDIDMGMQVFNIKFCKYFKLQK
IGGIYWKGDHKNKMLQRIYGTAWSTKKELDKHLSYINELKKRDHRKIGKL
LNLYHMQKESPGMIFWHNNGWIIFNELEIFVREKLKEYKYKEVKTPLLID
KSIWQKSGHWDNYQDAIFTTSSENREYCIKPMNCPGHVQIFNCGLKSYRD
LPIRMAEFGSCHRNESSGSLHGLMRIRNFTQDDAHIFCTQEQLRYEINNC
IKMIYDLYSTFNFKKILVKFSTRPKKRIGDESVWDQAEKDLSDVLIENNL
KFEHQEGEGAFYGPKIEFVLQDSLDRNWQCGTIQLDFYLPIRLRSFYIDE
HNHQKIPIIIHRAILGSIERFIGILIEEFSGKLPTWLSPIQVVILSITDS
HINYVKKIVQHFSDINIRVESDLRNEKIGFKIREHTLRQIPYILICGEKE
IKSKKISVRTRNGYNLGIIDIDCFIKKLQKEIFTRSFYQMEE
>BUsg425 thyA, thymidylate synthase
MKQYLDLIKKIIKNGNSKKDRTGTGTLSIFGHHMKFDLKKGFPLITTKKC
HIPSIIHELLWFLRGETNIKYLNENKISIWDNWADKFGDLGPIYGKQWRS
WDTSNGKKIDQIKNVLKQIKEDPDSRRILVSSWNVGEIDKMSLAPCHILF
QFYVLKKKLSCQLYQRSCDVFLGLPFNIASYAILIHMIAQQCNLQVGEFL
WTGGDVHLYKNHVELAKKQILRIPKKLPELIILKKPQSLFQYSFEDFKIV
GYKPYSLIKGKISV
>BUsg458 tig, trigger factor
MKFFIEKNKKNTDRVTINIPKKIVSNELIREFIEINKKTKINGFRKGKTP
IKIIQEKYGNRVYYDVFNQLMQKFFYEFIKKEKIKIIGLPKYVMHENEDQ
KEYFKYSVNYEVYPKFEIKDVNLIKVEKIIVNIKDEDVKKNIEKTASYEK
DIWNKVNRAIKTNDLVTINYCIYENNKKLDKFNVEKFKFIVSQNNFIPEL
NNKLINHFTNDVIFFKINFCKFHPEEELQGKDITFKIKILNVEEKQENIE
IEKNIKTIKINKLSKLNYQTIKNNIIEKIKSLTQNHLQNQIIKQLIIKNP
INIPPTLLREETNFLRNKFIKEYKEKQENILKKKYHTNLESKAKTRLHIK
LIIEKIIRDNKISVNEEKVDLLIKKISLKYKKPLEIINIYKKNTMLRKTI
KNIELEMQVMQFLIKKVKIIEKNWTLDEIMNYNWKNNEELFA
>BUsg086 tkt, transketolase
MCVRRELANAIRMLSIDAVQNAKSGHPGMPMGMADIAEVLWRKFFKHSPT
NPNWNNRDRFILSNGHGSMLLYSLLHLTGYDLSIDELKKFRQLHSKTPGH
PETGETPGVETTTGPLGQGLANAVGMAIAERTLSAYFNRPDYDIVDHYTW
VFVGDGCLMEGISHEVCSLAGTLKLGKLIVFYDKNGISIDGKISNWFTDD
TVMRFKSYNWHVVDKVDGHDANSIKNSIEEAKSVKDQPSIIICNTIIGFG
SPNKSGTADSHGAPLGEEEIFLTRKNLNWKYSPFEIPNKIYDKWNFVKQG
LKLEENWNKQFHLYKSEYPALAEEYSRRIKKKLPTQWYKKTKDYIFNLQK
NPQNIATRKASQNAIEEFAALLPELIGGSADLSPSNLTMWSKSSSITENL
CGNYIHYGVREFGMTAIANGISHHGGFIPYTSTFLMFVEYARNAVRMAAL
MNTKHIFVYTHDSIGLGEDGPTHQPIEQLANLRMTPNIDVWRPSDQVETA
VAWKYAIEEKNGPTALILSRQNLFQFSRNNEQIKNISYGAYILYDSKKPI
DIIFISTGSELQITLTSAKKIAALGYSVRVVSMPSNNVFDRQNIDYKESI
LPSYITKRIVIEASIKDFWYKYAGSEGLIIGMETFGESASEEVLFKKFGF
TVENIVNKSKILLKH
>BUsg385 tldD, TldD protein
MTLELVTESLLTKNQINHQDVFSCLEDFCTHNIDYGDFYFQSRICESWSL
ENGIIKEGDYHLDQGVGVRAVSGETTGFSYADQISIDAVRKSAHMAKSIF
DKKEKIKIKPLLNQEKKFFYDPINPLKTFTSSEKTNLLYKVDHIARKTDN
RVVQVNANLSGSYEEILVVSTEGNLATDIRPLVEFSVSVLVEERGRREKG
RSGGGSRTNYSFFITQDDCFGENRIDYWTKEAVRIALLNLSSHEAPSGTF
PVVLGSGWPGVLLHEAVGHGLEGDFNRRGTSIFTNMIEKKVASELCTIID
DGTMKNQRGSLNIDDEGVPGQCNVLIENGILKKYMQDKLNARLMNTKSTG
NGRRESYSHLPMPRMTNTYMIPGKSKLEDIINSVDYGIYAINFSGGQVDI
TSGQFVFSTSEAYLVKKGKIFSPIRNTTLIGSGLEVMQQISMVGNDLKMD
QGMGMCGKDGQNIPVGIGQPSIKLEKLTVGGTV
>BUsg341 tmk, thymidylate kinase
MMIKSKFIVIEGLEGAGKTHACICVQRILKENNIKNVILVRQPGSTPVAE
KIRKLIKNNTYIEDFEKETELLLMYAARIQLVKKIIQPALKKGTWVISDR
HDLSSLAYQGGGLGIKRKLINKLKYLFLQDFIPDLTIYLDVYPEIGLKRA
SKRNHLDRIEHRSLTFFKKTRASYLKNIKLDKKIIKINANLNIKIVTQNI
KNQILKWLQQKVV
>BUsg273 topA, DNA topoisomerase I
MCKSLVIVESPVKAKTISKYLGKQYIVKSSVGHVRDLINNKSKNKKNIKK
SNIKHNEKTALIQQMGINPYKNWKAEYHILPGKEKIISELKNIANKVHYI
YLATDLDREGEAIAWHLKEVIGGNSLKFRRVVFNEITKKSIEKAFQNIGK
INMNRVYSQQARRFMDRIVGYMISPLLWKKISRGLSAGRVQSAAVRLITD
REYEIKNFIEREHWKISLSLLSKENKKVTMDITHYRNKTFLLNNKKEVNS
TIEKIKNLSFIITDRKDKIFKKKPPAPLITSTLQQASNIDLGFSVKKTMF
LAQKLYEQGYITYIRTDSYFLSNYAIEKVRSYIENFYGSDFLPKKSNIYS
NQKYSQEAHEAIRPSDVQVVNIDNCDPDAKKLYKLIWNYFIASQMKSERY
KSIKTTVMADVFKLQSNTKIVLFSGWTKILKKSNNVNFKFPVLDIGTTLI
LDKILPHQIFTKPPPRFSESSLVRELEKKGIGRPSTYATIITKIKEKGYL
KIKKNKFYAAKIGEILITRLKKNFSDLVDYDFTARMEKNLDQVSDKLINW
KHLLNSFFDNFSQQLEQAKKPPEEGGMELNTTVPTEIDCSLCNKKMGIKT
AVTGVFLSCLGYNSEPNEKRCKNTINLISLNDLSTTKKEEKNFHLKNRCK
KCNLVMDVYLINENLKIFICINNPSCNGYNLKKGIFKKSLNCSLKKIKCE
KCKNDMLFKTGRFGNFFMCINDTCKNTRKILPNGEISEPKFEPIPFPDIL
CEKSNTWFVLREGISGIFFAANTFPKSRETRSPFVEELARFEYLLPKKLH
YLASAPQRDNKGNKTIVCFNKLNKQQYIASKKEGKFTGWAAFFIDRKWCI
VNK
>BUsg297 tpiA, triosephosphate isomerase
MKKKIIAANWKLNGSIKTISYFLTFLKSQISSFLKNNIIIIAPPTVFLER
VYKDINSINIHLAAQNIDVNLTGAFTGENSALMMKDIGVKYIIIGHSERR
LLHNENNEIIAKKFCLVKNLNLVPILCIGETEAEKKSNKTEKILKEQLNS
IFNSFGEKAFRNAVIAYEPIWSIGTGVSADPKNVQLIHKFIKNYIKKYDI
VSAENLIVQYGGSVTSLNAGNFLKQPDIDGLLIGSASLKHEEFLKIIKIS
DSFL
>BUsg383 trmD, tRNA (guanine-N1)-methyltransferase
MELNKHDQTKTKYDNTLIWFCIITIFPEMFYAITNYGVTGKAIRKNIINI
KFFNPRDFTDNKYKSVDDRPYGGGPGMLMSAKPLYLAIKNAKNLLKSAIV
IYLSPQGKRLNQKKILEIIKNKKIIFVCGRYEGIDQRIIDCQVDEEWSIG
DYILTGGELAAMVAIDSISRFIPGVIKKKQSVQEDSFFNGLLDYPHYTRP
KIIEKMKVPEILLSGNHDKIRLWRLKKSLEKTWTKRPDLLKNKILKKEEK
ILLNELKKINKR
>BUsg252 trmU, tRNA (5-methylaminomethyl-2-thiouridylate)-methyltransferase
MIKKNKKVIIAMSGGVDSSVSAWFLKNENYQVEGLFMKNWEEDDEKEYCN
AAKDLSDAEEVCKKLNIHLHKVNFSKEYWEKVFENFLNEHKKGKTPNPDI
LCNKEIKFKIFFNYAIQELQSDYIATGHYAQIKKKNGKYFLLKAVDLNKD
QSYFLYTLKGIQLKNILFPIGGLKKSQVRIIAKKIGLKVAEKKDSTGICF
IGPKKINNFLNRYIKAEKGDIITTEGTIVGKHNGLFCYTLGQRKGLGIGG
IKGNYNIPWYVIEKNIINNTLIIAQGSCNKRLMSIGLIAEKINWINDDKI
IFPFSCQAKIRYRQIDIFCNIKYINDFLIKVLFDSPVSSVTPGQSIVFYS
SKICLGGGVIQSRLPLL
>BUsg266 trpA, tryptophan synthase alpha chain
MSRYKKMFQKLSFLKEGCFVPFVVIGDPSLEMSLKIIETLIENGADALEL
GIPFSDPLADGPIIQKASLRALYKKNTFLQCFELIENIRNKYLHLPIGIL
LYANLVYNYGIKNFYYQCFRSGLDSVLIADIPIEEYEPFYKIANQYNINS
IFICPPDADDSLLSKISLYAKGYIYLLSRPGVTGIEKKTISLSNIFIEKI
KKYNSLPLLQGFGIENPTQIQKSILSGTNGVICGSAIIDIIEKNLNKEKK
MINEIKNFTSKLKKATKFVQS
>BUsg267 trpB, tryptophan synthase subunit beta
MTLLNPYFGKFGGMYVPQILMPALYQLEKNFVDAKKDSNFQKSFFNYLKN
YAGRPTPLTLCNNLTNGTKTRIYLKREDLLHGGAHKTNQVLGQAMLAVKM
KKKEIIAETGAGQHGVAAAIASALFNLKCKIYMGYKDIKRQSPNVFRMKL
MGAEVVSVESGSGTLKDACNEALRDWSRNYQKSHYMIGTAAGPHPYPTIV
KEFQKMIGEEAKKQILEQENRLPDAIIACVGGGSNAIGIFSDFIDEDVNL
IGVEPAGQGIETGKHGAPLNHGRTGIYFGMKSHLMQSQEGQIEKSWSISA
GLDFPSVGPEHSWLNSIHRAKYVSITDIEALEAFQILSKKEGIIPALESS
HALAYALKLMYLDPKKEQVFIVNLSGRGDKDIFTVREILKKTEKKHESL
>BUsg268 trpC, bifunctional indole-3-glycerol phosphate synthase/phosphoribosylanthranilate isomerase
MQETILNKIIKDKIDWIKYRKKIQPLIKFKNKINKETRNFYNSLKEKRPF
FILECKKSSPSLGIIRKKFNLIEIANIYKNYASAISVLTDEKYFHGNIEY
INVVRRCVSQPILCKDFFIDSYQVYLARYYSADAILLMLSVLNDSQYLEL
SRIAKELNMGVLTEINNIKELKRAIKLNASVIGINNRNLHDLSIDLNRTR
TLSPLIKNKIIVSESGIKKNHQIKELSNIVHGFLIGSSLMYRTNLETNIK
SLIIGDNKVCGLTRIIDAKIVESCGAVYGGLIFADNSLRKTNEKIAEKMI
FENNLRFIGVFQNQDIEKIVNIAQRLSLYAVQLHGSENQKYINILRKKLC
KKIKIWKAFSIQSTLPLLNWDHIDKYIFDSGSGGTNKTFNWSILKGSILE
NVILAGGINTDNVLIASQLNCSGLDFNSGVEKSPGIKDHKKISLIFKKLT
F
>BUsg269 trpD, anthranilate phosphoribosyltransferase
MQNIFNKIYESKSLNQEESYQLFKSIALGKINEIQLSSILTAMQMHGESE
KEILGAIYAFSERMKFFPRPNYIFSDIVGTGGDSKNTINVSTSSAFVAAS
CGFKIIKHCNKGVSSKSGSSDLLNKFKINLNTSLENSKKILDKLNICFLF
APKYHSVFKYASKTRSILKIKTIFNLLGPFLNPSRPPLTLIGVYKKDLVN
PMSRILKKLKYQRGIILHGDDTDEVTLHGTTYISELLNNKIYSYELEPED
FGIKRHSKSIFVEYSPEENYHIIKKTMQGKGEKLHEELIAVNVALLLKIF
GHENLKENTKIALKKIRSGDVYKHIMQVSNMLKED
>BUsg517 trpS, tryptophanyl-tRNA synthetase
MINSKPILFSAIQPSGNLTIGNYIGTMRYWSSFQDDYECLYCIADLHSLT
TLNKNFSLKKSILDTLALYLACGVNPKKSIIFIQSHVYQHSQLNWILSCF
SSFGELSRMTQFKNKRKKEKNDIKNINIGLLNYPVLMSSDILLYQTNLVP
VGQDQKQHLELTRNIANRFNFLYGDIFTLPNPLISKNGSKIMSLLDPTKK
MSKSDTNKNNVIFLLENISSVFFKIKNAVTDSETPPKIYYDVKRKLGISN
LLEILSAITNKEIFILEKEFDGIMYSEFKNIVFDNISKFLHKLQKSYLIY
RKDESYLKNIAKEGAIKARLKSEKILKRVFSAVEID
>BUsg193 truA, tRNA pseudouridine synthase A
MKEKKNKKFALGVEYDGSYYHGWQSQKGLSTIQSEIEKALSKIANHQVNV
ICAGRTDSGVHSIGQVIHFTSISFRSDFSWIVGVNSYLSKNISVKWIKEV
SENFNARYSAISRSYRYIIYNHKCRSAIFRNRSNHVYKELNVDKMYFEAQ
SLLGEHDFSSFRSSGCQSRSPFRTITDLNIRRLKNLVIIDITANSFLYHM
VRNIVGSLIQINDNTKKNYIKKILDKKDRNYAGPTVSARGLYLFFVKYPM
CFNLPIFKDDFII
>BUsg363 truB, tRNA pseudouridine synthase B
MFFHKKRNVNGFLLLDKPKGMTSNNVLQKVKIIFKAKKAGYIGTLDPLAT
GILPICFGEATKFSNYLNASDKHYNVIARLGEKTSTSDSDGIIVRKRPIL
FTPIQLSLALKALTGSVNQIPSMYSAVKYKGIPLYKYARQGINVKRNIRC
VFIYKIDLVDQKDNWIELNVHCSKGTYIRTLIEDLGEKLFCGAHVIRLRR
LKIGLLSYSKLVKLSFLENLLNEKNVVKINFFKKIDDLLMPVDTPVYFLP
KIYISIEKLSVFRLGQKVNFSSSITNGLVRVFEKDNNTFIGLGKINSEKT
LIPYRLVSMLTN
>BUsg573 trxA, thioredoxin
MNKIIELTDQNFEKEVLEHKSFVLVDFWAEWCNPCKILAPILEEIAQEYF
NKIKVGKLNIEKNPNTAPIYSIRGIPALLLFHGREVLATKVGAISKLQLK
DFLDENIK
>BUsg304 trxB, thioredoxin reductase
MELKNHKKIIILGSGPAGYTAAIYSSRANLNPLLITGINKGGQLMNTNEI
ENWPGDFKKITGPELMNRMHEHSLKFKTEIVYDNIISVEFKKKPFFLLGE
YNKYTCDAVIIATGANPRYLGLSSENKFKGKGISTCAVCDGFFYKNKEIA
VVGGGNTAIEETLYLSNFVKKIYLIHRRNNFKAEKILIDRLLKIVKTKKV
ILHLNSTIEDILGNNKGVTHLLIKNKNLKEKKKLKIAVSGLFVAIGYIPN
TDIFTDQLKMKDGYIKIKKGTHGNYTQTNIPGVFAAGDVIDHVYRQAITS
SASGCMAALDSERYLNSLS
>BUsg226 tsf, elongation factor Ts
MSHITALLIKELRLRTGAGFMECKRALIEEKGDIELSIDNLRKSGQARAE
KKIHNITNQGLIFAKIKNKIGAMVELNCQTDFVAKDTLFYSLGKEIILTA
LSKKIKNIDDIRNVFEIKKTELIVKTGENIKINRFSFIEGDNIISYIHSG
RIGVLVSASNLNQETLKNIAMHIAASKPEYLSPNDISDSVFKREYEIQLE
LAKKQNKSSEILKKIVQGRMNKFVNDISLVGQKFIMDNTKTVGALLNEYN
ARIISFIRFEIGDKIFN
>BUsg507 tufB, elongation factor Tu
MSKEKFQRVKPHINVGTIGHVDHGKTTLTAAITTVLSKKYGGSARAFDQI
DNAPEEKARGITINTSHVEYDTELRHYAHVDCPGHADYIKNMITGAAQMD
GAILVVAATDGPMPQTREHILLGRQVGVPYIIVFLNKCDMVDDEELLELV
EMEVRDLLTQYDFPGDDTPIIRGSALKALEGDADWESKILDLSKFLDTYI
PEPKRAIDQPFLLPIEDVFSISGRGTVVTGRVERGIVKVGEEVEIVGIKK
TTKTTCTGVEMFRKLLDEGRAGENVGVLLRGTKRDEIERGQVLAKPGSIH
PHTTFESEVYVLSKEEGGRHTPFFKGYRPQFYFRTTDVTGSIELPEGVEM
VMPGDNIKMTVTLIHPIAMADGLRFAIREGGRTVGAGVVSKVLV
>BUsg418 typA, GTP-binding protein BipA
MHQNIRNIAIIAHVDHGKTTLLDQLLQQSGTFQKHEEKKERIMDSNDLEK
ERGITILSKNTSIKWKEYKINIVDTPGHADFGGEVERVMSMVDSVLLIVD
ALDGPMPQTRFVTKKAFKYGLNPIVVINKIDRKNSRPDWVINEIFDLFVN
LNANDKQLDFPIIYTSAILGTSGINYLDMKENMIPLYEAIIKYAPAPNVD
PNQKFQMQISQLDYNNYLGVIGVGRIKQGHIKPNDSVVIIDSLGNTRNGK
INKVLNYFGLKRLEIQKGDAGDIIAITGLNKLNISDTICHPDNLCPLPPL
IIDEPTVNMFFSVNTSPFSGKEGKYITSRQILERLKKETIHNVALQVKET
KDANIFSVSGRGELHLSILIENMRREGFELEVSRPKIIFREINDIKQEPF
ENIILDIEEKHQGNIMKFIGERKGELKNITVDPNKRIRLEYLLSSRALIG
FRTEFMSITSGTGLFYSSFSHYQKYQKNDIGQRKNGVLISNSTGMAVAFA
LFNLQERGKLFLGHGTQVYEGQIIGLHNRSNDLTVNCLTGKKLTNMRASG
TDEAIILTTFTKFTLEEALSFINDDELVEITPKSIRLRKRYLKENERKKA
NRDRTTIVD
>BUsg113 tyrS, tyrosyl-tRNA synthetase
MDLINELHQRNLIFHITNENKLKELIKNKYISLYCGFDPTEDSLHVGHLL
PLITLKRFQVLGHKPIVLIGGATSLIGDPSFKTKERLLKSDSFVEKCTLK
ISQQISFFLDFNSNFNSAIILNNNLWFKKINILQFLRDVGKYFSVNALIN
REAVKKRIKRSDQGISFTEFSYNLLQAYDFFILNQKNQVSLQIGGSDQWG
NISSGMHLIHRISKKEAYGLTLPLLMQSNGIKFGKTESGTVWLDPQKTTP
YRFYQFWMNIEDSNVYRFLKLFTFIDIHEINEREKNSYKKNQIVSDKVLL
AKHMTRLVHGDEKLSAAERITNILFFKNINDIQISDLEQLRKDGVPVVET
YKIKDLQEALVLSSLAQSRTQAKNMIISNSISINTKKIVNKNYIIDDNDK
LFNQFTLLSRGKKNHCLIYWNK
>BUsg230 uppS, undecaprenyl pyrophosphate synthetase
MLYKSSLKNKKRIQKENLRHIAIIMDGNGRWAEKRGKIRTLGHKEGFKTA
RKIIKYAVENNIKILTLYVFSRENWRRPKLEITALMKLFFFALKSEIKNL
NKYNIRLKIIGDTSPFNENLKNYIHKVEKQTFNNTGLILNIAANYSGRWD
IIRGIKKIIKDVQKDVLDIDQIQERNFSQYLSTSELLPVDLVIRTGGEKR
ISNFLLWQIAYSELYFTDILWPDFNWRDFQHAIDYFFTRERRFGGISIS
>BUsg352 uup, ABC transporter ATP-binding protein Uup
MPLISIQNAFLAFSDLEILKNAVLYINKKERISLIGKNGAGKSTLLKVIN
KNQELDHGSIIYQKNIKISYLKQDNPKNLDISIYDFIKNQLKKENNKEIN
INTIVEIKKIIKTFQIDKHSLLSELSGGSLRKVVLGSALLSQPDVLLLDE
PTNHLDINTIAWLEKFLKKFSGTTLFISHDRSFIQNLCTRIIDLDRGKLT
SFPGDYKEFIKLKKENNRIEKTKKKLFDQHLEKEEIWIRKGIKARTTRNE
GRVRNLKVLRKEYKNYKKIENFNNVIINEIKNYSGKIIFKLKNISFFIEK
KTIIQSFSSIIQYGDKIGLIGNNGSGKSTMIKILMGEKKIQKGSIHFGTK
LNIAYFDQDRSTLDSNKSILENVNNGREKIVLNGKEQHLIGYLKKFLFKP
NQMKCLVKNLSGGECNRLLLAKLFLKPSNVLILDEPTNDLDLDTLELLEN
IIIKYSGTVLIVSHDRNFIENTVNKYWIFKGDGLINTHFSSHNNIIKEKN
KKIQKKYVLNPIKSNISFLKTKQNQVKKELKKVLNEIEKIENSIKTLKIQ
MNEPDFFKQHIKNQLPIVKQFNIEEKKLEKILIYWENLEKKL
>BUsg354 valS, valyl-tRNA synthetase
MKKNYNPKDIEEHLYNFWEKNGFFKPNNNLNKPAFCIMMPPPNITGNLHM
GHAFQQTIMDILIRYNRMQGKNTLWQVGTDHAGIATQILIERQIFSEERK
TKKDYSRNDFIKKIWKWKKKSNFSVKKQMKRLGNSVDWDREKFTLDPDIS
NSVKEAFIILYKNNLIYQKKRLVHWDSKLETVISDLEVEHRLIKSKKWFI
RYPIIKNIKNINIEYLLVATTRPETLLGDTALAINPKDDKYNHLIGQSVI
CPIVNRIIPIIADHYADMNKDTGCVKITPGHDFNDYEVGQRHKLPMINIF
TFNGKIKSNFSIYDYQGSKSNFYDSSIPTEFQNLDILSARKKIIYEIEKL
GLLEKIEECNFFTPYSERSGVIIQPMLTNQWYLKTSHLSQSAIDVVREKK
IKFIPNQYKSMYLSWMNNIEDWCISRQLWWGHQIPVWYDDKKNIYVGHSE
KKIREEYNISDDMILNQDNDVLDTWFSSGLWTFSTLGWPEKTEFLKIFHS
TDVLVSGFDIIFFWIARMIMLTMYLVKDSYGNPQIPFKDVYITGLIRDEE
GKKMSKSKGNVIDPIDMIDGISLNELIEKRTSNLLQPHLSQKIRYHTIKQ
FPNGISATGTDALRFTFSALASNTRDIQWDMNRLKGYRNFCNKLWNASRF
VLKNTKDHDYFNFSVNDNMLLINKWILIKFNNTVKSYRNSLDSYRFDIAA
NILYDFIWNVFCDWYLEFVKSVIKSGSYQDIYFTKNVLIHVLELLLRLSH
PIMPFITEAIWQRVKIIKHIKDRTIMLQSFPEYNDQLFDKSTLSNINWIK
KIIIFIRNTRSKMNISSTKLLSLFLKNINSEKKKVIQENKFILKNIASLE
KISILSKQDDEPCLSLKEIIDGVDILVPVLKAIDKEIELKRLNKEIEKIK
SKMLISEKKMSNQDFLSYAPKNIIDKEIKKLKSLNEIYLTLSQQLESLHD
AFCKKNKIFN
>BUsg218 yabC, hypothetical 36.0 kDa protein
MNQTIKHISVMKKELIESLKIKKNGIYIDGTFGMGGHALSILKTIGREGR
LYAIDRDPNSVFIGNQIKDKRFHIIHSNFSKILNYAKYNNIIGKVNGILF
DLGTSSLQIENEKRGFSFKKNGPLDMRMNPHAGISASEWLFKSDINKIYF
VLKNFGEERFSKRIAYAIKDYCKKKKINNTFELVDIIKKATPIKNKFKHP
AKRTFQAIRIYINQELEEIKKGLENSLKILKPGGRLSIISFHSLEDRIVK
NFMMKYSKKATVPYGLPITENKLETLRICKLKIINRIFPTQKEIEKNPRA
RSSVLRTAELKE
>BUsg132 yabI, hypothetical 26.3 kDa protein
MESWLTSLITQSLTFSILIVGIVSFLESLALVGLLLPGIVFMATLGTFIG
NGKLPFYPSWIAGIIGCLLGDWCSYFIGLYFKNWLYSLKFLKKNCHLLDK
TKSLLHKHSMITILVGRFIGPTRPLIPMVSGMLKLPLKKFILPSLLGCIL
WPPIYFFPGIITGITINIPPNPKNDYFKWLLLIIAILIWFGIWLTSKWWK
IKKIKNKNNIHFIKRNIGWIALIILSSGIIGLILIQFHPTMIIVRKVFST
IL
>BUsg197 yacE, hypothetical 22.6 kDa protein
MIYIVALTGGICSGKTTVSDRFKKIGINVIDTDVIGRKIIEKNKKISDSI
KKKFGKKILNKDNSINRFLLRNCIFNEKKSRLWLENILHPEILKKSKKKI
KLIQSTWCLWVVPLLFEKKIQKKANRILLIDTPIRIQIRRMIKRDKININ
EAKKIISYQVRRKKRISLSDDIILNKNKNIEKLSLYIHYLNNFYIYLSKQ
NNPKNMKKII
>BUsg205 yadR, hypothetical 12.1 kDa protein
MEKNPIKYIEFTNSAAKKIKSIIKEKKNKNVKLRIYIIGGGCSGFQYQFI
FDEKINEDDILVKKLNICLVIDPISLQYLHGGTIDYLENLEGSKFIVSNP
NAKNTCGCGLSFSI
>BUsg231 yaeT, hypothetical protein
MLIKTIFIIFLMFFSVNVFSKNVWIIENIQFKGLKYFSKDEVLKNIFFNI
GSNISENDIKHSIKSLFQTGKFETIKIVHSGKTIIFEIKERPIISNITFS
GNKIIKDSILKKYLTELGIKEGNFFNPFLNTVFVKNLKEFYSNVGRYNSD
IKIFKKISSNNKIDLQIFIHESNLVEINHIKIIGNNHFPRDKILSLFKLK
DCKSWWNFLEKRFYYSQQLEEDLKNLSNFYLNQGYYYFNIHRKKVRFLKD
KNKVNITVYISEGKKYKISNFFLNGNLLQYYQSIKNFINIHNNEFYNKEK
ITLIVKKIQRFLSEKGYIDPKIIIYPQINFKEKKIILNFNIDIQKRYFVN
KINFRGNELTQDIVLRREMKQIEGEWFNLKLIELGIKSLEKLKFLSDITV
QKEILFNKENGVDITYTLKEQPTGTLNFGLGYGRDSGLSFNASISQDNLF
GSGNSLKASIIKNDNQKYADISIMHPYFIDDGTNLDTRIFYNDFKYNINS
FYNIVKTTSGFESDLSFLINAFNRVNIGFGYTHNGLLNKEEKFFSKNGNK
SSDKFLKTSLVDDFTLNYSLTHDTLKYFYFPISGNQTYISGKNTIPGSDN
KFYKFLFDSEQYIPLEEEKKFIFLTHIRAGIGNSLNKEKLPFYENFHAID
SNNIRGFRANTIGPKKIYINSNLEECLGYNKKSIFCESVDSIGGNAMIIS
NLELITPIPLIKTEYSKFLRSSFFLDAGNIWDTRWDKEQNIHFSQFPDYT
ILNNIQASIGISLQWFSPIGPLVFSYAYPIYKNKNNQLEAFQFNFGKNW
>BUsg126 yajC, hypothetical 11.9 kDa protein
MSFFIKDANAAVNQALEGNSYSLIFMLVTFILIFYFMLFRPQQKKDKEHK
NLMNSIAPGDEVMTTSGFLGRVKKVTENGYVLLQLNNTTEIFIKKDFIVS
SLPKGTLESL
>BUsg450 yajR, hypothetical 49.0 kDa protein
MNFIELQVTLSFCVVFLLRMLGIFSVLPILSKYGLYLNGGNKFLIGLAVG
IYGATQIVFQIPFGILSDRFGRKQIIIFGLFIFFIGSLIVVSTNSIFGLI
IGRAIQGSGAISGVSMALLSDLIRKENRIKSISIIGVSFAVSFLISVVSA
PIIAENFGFFSIFWISAVFSIFSILIVFFLIPSSQNEILKNYKKNIYQKK
IKFIFNKIFFRFYLGVFLLHFLLTMNFLIIPYEFELSGLALHYHWIVYFA
TIVFSFFFLFLIVFYFKFHFFLKNIIEICIFFIFLSLLLFLLSQHNLICL
TFALQIFFIAFNILEIFFPSHLSQEISINYYKGSIMSIYSTSQFLGIACG
GVLNGLLCTFFNTNHIFLFEIFITLIWFIFSFFCKK
>BUsg175 yba2, hypothetical protein
MKDEEKNLIENLFHRLKKIELNCSERDDTADVLIQNLVKKQPYSSYYMVQ
TILIQETAIKKMNLKIEELKNQISILNSDQVNKKPSFLSNFLKKDPGSKT
ISYDNTIWKKNQNNLESCNTNIPSSSAATTRNSGFLKNALQTATGVAGGM
ILGNMLMNLFNHTTPEEEIFDNINQSSASDIDNEYDSIQNNHSDLVNYDN
QNEPLENYSDDNNFSNFDETEHVDDSEMNDDNFI
>BUsg564 yba4, hypothetical protein
MSSNVTLVDKLNPIRHKELKVKIDEICHKSLKNLKNTSKILIEEKKHPIS
STKVSINYIENENENKNNLINLENFYKKYLLKFNDFIMKKKLFLNPLLSP
LLKVLPTIHSIY
>BUsg467 ybaB, hypothetical 12.0 kDa protein
MFTKGGLGNLMKQAQQMQEKMAKVQEEIAKMEVTGEAGAGLVKVTINGAH
NCRRVEVDPSLLKDDKDMLEDLAAAAFNDATRRISEVQKKKMSAISTGMQ
LPTGFNIPI
>BUsg463 ybaX, hypothetical 25.5 kDa protein
MKKILIIFSGGQDSTTCLIHYTNIYKEIYCITFDYNQLHKSEIDSARFIS
NYFNVKKHIFVDLKCLKNLSISSLTDEKISILDNHPLNFSLPSTFVPGRN
ILFLTLSSIYAFNHQINSIVLGVNEIDFSGYPDCRNAFLKKMNDVVQIGM
NCKINFQSPLINLSKAEIWALSDYWNSTQFILNNTVTCYQGIQGKGCGQC
QSCILRNDGFNKWKSNPSYYMKKLKEKFNFDN
>BUsg472 ybeD, hypothetical protein
MKTKLREMLKFPCFFTYKIIGLAQPELVDQIIKVIQIQIPGDYTPQVKSS
NRGNYLSVSITICAKNFEQIETLYHDISKINMVRMVL
>BUsg431 ybeN, hypothetical 24.5 kDa protein
MKEIYAIFGGNFDPIHYGHITSAEKLSREISIKKIILLPNYGPPHRSKTK
TSIIDRLKMIKFAIKDNKLFTISYLETKKNTTFYTIETLKKIRKKIGYLQ
PLCFIIGEDNLNNLNIWKDWKKILSLSHLLICPRIHIKKSNPKLKKWISD
HTTKNSNLLHKKPFGFIFFSKMSMLNISSTAIRKSYYEGKSACGLLPSKI
DKYILSKNLYKIYNQN
>BUsg428 ybeX, hypothetical 33.3 kDa protein
MSNKDTQGTDKINRKGFFSILLNQIFHDEPKNREELLVLIRDSEQNELID
QDTCDMLEGVMHIAKKRIKDIMIPRTQMITLKLNYNLNKCLDIIIESAHS
RFPVMSRDQNYVEGFLIAKDLLPFMKHPEDAFCIKNILRSAVVVPESKSV
DTMLKEFRLKRSHMAIVIDEFGAVSGLVTIEDILELIVGEIQDEYDDEEK
VNIRKLKKCIFSIKALTEIKEFNDTFETNFSDEEVDTIGGLVMKAFGHLP
SRGDHININGYNFKVSIADSRKVIQIHVTVPENKIPKKLEK
>BUsg427 ybeY, hypothetical 17.5 kDa protein
MKNINLKYRGKNKSTNILSFKFDLFINKNQTLLGDLVLCKKIIEKESLKY
QKTLESRWAHMIIHGTLHLLGYDHKNKKEKKIMEKIENKIMLFLNYEKPY
FMKSS
>BUsg291 ybgI, hypothetical 26.9 kDa protein
MENFLLEKIINKKLSSDQYSDVVPNGLQIEGEKIIKKIITGVTACQELLD
KALSYGANAIIVHHGYFWKNESQCIHNMTRKRLTTILSNNINLYSWHIPL
DIHPKLGNNAQIAKKLNIRIKGYILPYLFWGTLEENINAFDFSKKIEKKY
EKKPIHIYANAPIYISRIAWCSGRGQNFIKQAYNFGIDAFLTGEISEETM
HIAKELGIHFFSIGHHATEKDGIKSLGKWLNNKYDLDVTFIDIHNPA
>BUsg282 ybhE, hypothetical 36.3 kDa protein
MQQIIYIANAESENIEVWILYNNGDMKLIQTVQTDGQVQPISIIKNTKLL
YAGIRPKNRVITYQIDKNGLLKKKKESIVPGTPNYISFDSSEKFLFCSSY
HADCISVSPLDKNGIPKDPIQIIHNIEGCHAAKFNSKYNVLFITSLKNDC
IYLYYLTHFGILKSTEQKLVFSQKNSGPRHVIFHPNQNFSYTVNELNGSV
DVWKISKENKVLEVKNIQNIKLLNDLISKKYWSSDIHLTSCGNFLYVSDR
YLNSISLFHVNKNDNTIIFFKQYLTEEQPRAFCIDRNNNYLIVIGQKSNK
LSVYKICQKTGELKKINQYQTGNGPLWITSFLI
>BUsg351 ycbY, hypothetical 78.9 kDa protein
MNYLFASTNFGCEELLEKELRALGAKNLKVVKGGIYYEGEDSILYNSLMW
SRIASRIFLCIKKFTIKNSNDLYKNTYNINWTQILYLEKTFLVKFRGTNN
IIRNSLFGALKIKDAIVDTFYQKYSARPNINLLTPDVRIISYLCQNLVHI
MLDLSGEALNKRGYRKFFNISPIKENLSAAIILSSGWKKNTPLIDPMCGS
GTLLIEAAMISSDRAPGLKRTEWGFKSWKGHKEKVWKETLKKAKERFKIG
IKKCLKNYFIGYDCNPDVIKKAQKNVINANLENIISFFACNLSHLKNPYQ
KEEIGTLISNPPYGERCKTENNLIALYIELGIMSKKYFEKWNLSVFSSSE
FLLNFLQMKSYKNFCLKNGPLYCTLKNYEIFLNKFNNTNKEYENRLEKNF
KKLKKWNDLKEIECFRVYDSDLPNYKLIVDVYKKWLVIQEYQAPKSINYE
KAHKRLCSAIYHSKEILSIPTNNVVIKFRKKQKRKEQYQKLFNSNSFFII
REYHVKLLVNLIDYLDTGLFSEHRLVRKLIGSMSKGKDFLNLFSYTGAAS
VYAGLGKSKSITTVDISNTYIQWSMRNMSINNLINSKNIFIQKDCLEWII
STKNKFDLIFINPPTFSNSKRMKKSFELKRDYIKLMINLKQILRKDGNII
FSSSTHNFEIDLNNIKKINLYAKKITNLVKTKDFLKKNYHSWLIKHI
>BUsg451 yccK, hypothetical 12.4 kDa protein
MLKNNHTKKLYEKIEKDTEGYLKKAADWSIELAKEIAKKEKIVLTNDHWT
VINFIRKFYFKFNITPSMRMLIKSIEKKIGLKKSNSIYLFRLFPEGPAKQ
ASKIAGIPKPSRCL
>BUsg353 yceA, hypothetical protein
MMSNLCNRISKKELKKKILMNEESRIVVSFYKYFLIKNTKEYRDRIYQNF
YKYNVLGRVYVSDEGINAQISIPVKFYFFVKNFLYNSDLELNNLFINKSL
SNHKKAFWVLSVKIKKKIVNDGITNPLFNFKKVGIYIKSRQVNMMLSDRN
VIFIDMRNSYEYEIGHFPNAIEIKSQTFREQLKKVIQIMHYAKNKKIVMY
CTGGIRCEKASAWMHFNGFKYVYHLKNGILGYVHDANKNGLPILFQGSNF
VFDNRMSEKISDKIISFCKQCDKPSDRYVNCNFNLCHLLFIQCKDCTIKF
KKCCSKYCMQHL
>BUsg345 ycfF, hypothetical 13.2 kDa protein
MNNKDLIFQKIIKRETSTHIIYQDKIVTAFEDIAPKAPIHIIVIPNIFIK
TLNDINQKNKNIFAHMLYIAVKIAKNKKISEDGYKIVMNCNKNGGQEINY
LHMHLLGGEKLKALY
>BUsg343 ycfH, hypothetical 29.8 kDa protein
MFLIDSHCHIDQMNIDQKNDDLLHQEIEKILNKAYENHVKKFLTVSTSIQ
NFYKTKKLLSTYDSIFYSCGIHPLYCQKEIECLNELKKLSYDKCVIALGE
TGLDYYYSFETKNLQEKFFREHIRIAITLNKPIIIHSRNAIKDTIKILKE
ENAEKCGGILHSFTESEKSAFELLDMGFYISFSGIITFKKSIELCNTLKK
IPLEKLLIETDSPYLAPIPYRGKKNQPAYLLDIAKKIALIKEISLKELAK
ITTNNFFTLFNLNF
>BUsg284 ycfU, hypothetical 43.3 kDa protein
MYKPIYIFIGLRYLWNPYLPNFKKIIIILSILGIGIGISSTIITISIMNG
FQNKFKNDILSFIPHIIITNKNRNINKLNFPKETLKLKNVEEITDFISKK
VIIENKNEINIGEIIGINIKNEKNLENYNIKKFLHTLHSRKYNAIIGSEL
AKKMHVNINDQIKLIVLPISKKKFLQNDLNIKLFKITGIFSTNSEIDEYQ
ILINKKNALNFLNYNKNYITGWKIKLKDPFILNIQKIKKLNKNFIILDWK
TKKGELFKAMKIEKYIMLFFFILILLVSSFNIVISLTMNVLDKKNNISIF
QSQGLSRYKIMLIFIILGSTISIVGNSFGTIISIILIFQKDFLNFLIKIF
FIDIEIPIEISLIQILTINITFIFLTILSTLYPIWYAIKSTPSRILSDE
>BUsg285 ycfV, hypothetical ABC transporter ATP-binding protein
MNNNIILQCINLTKSFYRKKEEIRTLNKISLKIRKGDITFITGKSGSGKS
TLLHLLGGLDKPTSGSILFDGVSLHSMSSNEIAKLRNLKLGFIFQFHHLL
LDFNVLENIAIPSLISKKSIQESKEKSYEILKKVHLEKKINKYPSELSGG
ERQRVAIARALVNQPSLVIADEPTSHLDKNNAKIIFDLIFELNSNLNTSF
LIVSHDLRFIKKAPILLEMKNGQLFNNKN
>BUsg286 ycfW, hypothetical 45.3 kDa protein
MNFLPFLIAKRLYHRNNKNHAVLLVSILSKIGISISIFTLILSFSALNGF
QILIKKNILSSLPHGIIELTNTSAFTWKDITKKLESLPEVIYSEPYVLMN
SVLLKNDKMRFINIKSFKNIKYIKKYFSFQKKLYNFSKLKKIYNNEIIIS
SDLAKYFSLKEGDCINLIILNKKISFDKTQIQSFSFKVKSIFHSNGISNS
NIGLIPFIFFQKFFNIKNNINKIELYMSDPFQADKIILKIAKKIKTPLFF
YNWMYSYKYIYHDIKIIKTIIYVTLFLIIIISCFSVISICLTSISKKTKD
IAILRSIGANNILIQLIFFYYGMRFIIIGNLIGLLTGIITVLNFKKIMFF
LEKHFEENWFLKNVYYKNFLLLQINFFDLIIIFISTLTIGIVANWYPIYY
ASKINPNKILKEY
>BUsg167 ychA, transcriptional regulator
MKSFSNIDFSKLSLIDSIIATSQIIREDFPTKFVISDLYNKVKEAKFYIS
SEIEPNLKLKKLLKLFYKTWNFGAASGIYKLSDVLWIDNVLKTRQGTAVS
LGILFLHIAQELKLPLNPVVFPTQLILRADWINKKKWLINPFNGEMLDQH
TLEVWLKGNISPTAELYEHDLYKAESITVIRKMLDILKSALMEEKKMELA
LNVSNLLLQINPNDPYEIRDRGLIYANLECNHVALTDLIYFVEHCPEDPI
SEIIKVQIHAIEQKKMILH
>BUsg257 ychE, hypothetical 23.5 kDa protein
MHISMFDFSIYIKFFVSLCALVNPIGMIPIFTTMTNHQSHLERKKTNLVA
NFSAFIILLISLFAGNSILNAFGISINSFRIAGGILIISIAFSMISGKFT
KNNKTSKEKNQENISVVPLAMPLIAGPGAISSTIVWSTYYSTWSDFLGCS
IAIFLFAFVCWLCFRAAPCVVEILGKTGINIITRIMGLLLMSLGIEFLSI
GIKSIFSALLH
>BUsg185 ychF, probable GTP-binding protein
MGFKCGIIGLPNVGKSTLFNVLTKGNSAVANFPFCTIKPNIGIVSVPDNR
INNLSKIILPKKITNAFIEFVDIAGLVKGASKGEGLGNQFLSNIRDTHAI
AHVVRCFKDDNVSHIYNQLQPKIDVDIINSELILADFETCEKSILKLQKK
LNFNKKEIEEKLVVLSKCLDHLKKFLMLKTLELDENEKKIISYLRFLTLK
PTMYIANINEQKESCFFLNELEKMAKKEGSSVIPINSNLELDLIKMNEDE
QKYFMKSFNITNLGLNNIIKSGYKILNLITFFTAGIKEVRAWAIPNGSTS
LQAADKIHSDFRRGFIRAQIINYLDFIKYKSETKVKEAGKYRSEGKFYQI
QDGDIINFLFNV
>BUsg263 yciA, hypothetical protein
MPKKNKLPQGTIVLKTLTMRSDTNANGDIFGGWIMSQMDMGGAILAKEIA
GGRVVTVQVNGITFFKPVSVGDIVSCYAHCIKTGNSSITINLEVWIKKIY
SKPLGQFYCAAEAIFIYVAIDETGKPRELLPMSII
>BUsg265 yciC, hypothetical protein
MSITIRELCNDTYHFVSKEIKIIIFISVLAAFISILINVLIKPNIHIISI
IENKKFLSSHSIFDLINSMSIYEKKELLKYSIFKIFEFLISKTFLLGSII
TLITHLSNHKKESIQFSLNSLCKFLPSLFILNFITTFFIQIGFMFFIFPG
IFLSVLLALSPIILSFKKNNLIDCIRLSISISCKHLNIVGTSVLFWMCVK
FILTTVFSNTYIISKNFIFLILNINMNIFFSILIVYLFRFYMLFLRS
>BUsg271 yciL, hypothetical 30.2 kDa protein
MTAKIQKILSDLGYGSRRFIECMIKCGKISINGEKAIIGQYLNKKNPGEI
LIDKKKIIVKRNKNLPKVLIYNKPIGEVCTRDDFQKRLTVFDKLPKLNLN
RWVSVGRLDINTKGLLLFTNDGTLANKLMHPRSQIEREYNIRIFGEMNKN
KINILRKGVKIIHGYVSFKEIVPLYDKKEGKNKWFKGILCEGKNREIRLM
FKSIQCQVNQLIRVRYGNIILPKNLKEGQWMMLNSIFLKKLYNLINFDKE
IINKKKN
>BUsg106 ydgM, putative ferredoxin-like protein
MSITIILIFSILSFLLGIILSYVKYIFPIKKNSIIAEVDDLLPQSQCAQC
GYSGCYPYAKAIVKNNENIDKCIPGGNNLKFKIAKVLNIKNIKYSLDNLN
AKNEKNIHTTVLIDEKNCVGCSKCASFCPVDAIIGTPNFMHTVLQKFCTG
CNICLLHCPTNCIKIIKE
>BUsg108 ydgO, hypothetical 38.1 kDa protein
MKLKKMNLPYISNTYDVRKIMFLVVLSCIPGLCTEIYFFGCGVLIQTLLF
VIISLLFEIIILKMRRKNIKNSLFDYSSFLTAVLLGLSTPCALPWWMIIF
SCFFAIVISKYLYGGLGQNIFNPAMIGYVVLLISFPVHMTAWNEKNSSLS
FYNDIKKSINLILFYNKLNNSKKKICPDNFTEATPLDDFKTKSHFDYDFF
PEESAVKKKTKIVSIAWKYINISFLIGGCFLLYKKVICWRIPLSFLSSLI
FFSSITYFYSQKFFCSPLFHLFSGGTMMCAFFIATDPVTTSCTKIGKIFF
GLIIGFLVWIIRNYSDYPDGIAFSVLFANMIVPLMDAYLKTSGYGHKNL
>BUsg109 ydgP, hypothetical 21.9 kDa protein
MKSFKETIINACLMGFFSFFSLSSVIFVKNITNNQIKNIKEKQKNTLIQQ
VIPRVMYHSFEKKYFLIKDKLLGDQKKHNLWLLFKNKQAKVAVVESIAPD
GYSGSISILVAAYLNGKIIGVRVLSHKETPGIGDKIEISISNWITKFQDM
NVIDLKDKKFLLKKYGGKIEQFTGATITPQSVSNAVKRTVVFIKKIPLIF
SL
>BUsg110 ydgQ, NADH-ubiquinone oxidoreductase
MEFKKFFKKRLWNNNSSLVQLLGLCPILAMTTNTINAIGLGITTTFVLTI
TNSIISILKNFIPKDIRIPIYMIIVSSTVTCIEMLLHAYQFNLYQSLGVF
IPLIVTNCIVVGRADCIAYKSSFVISFLDGMSIGLGSTFAMFVIGSIREI
LGNGTFLFGANKIFNVLDHSFFFTFIDKNSTIILAMLPSGGFLVLGFVIA
FKNYLDLGKKNCLKCFHSCKLKK
>BUsg181 ydhD, hypothetical 12.9 kDa protein
MNVIEKIERQIKDNIILIYMKGTPQSPSCGFSAQAVQALSICGEKFAYVD
ILENLDIRKELPRYANWPTFPQLWIKGELIGGCSIILEMLENGELKKIIS
NAVLNSK
>BUsg114 ydiC, hypothetical 13.3 kDa protein
MKIEKMNFYSPKKYKWKGIKITEQAIEQILFLINKNPKNKGIRIGTKKSG
CAGFRYTMELVKNNTIEKENKNDIVFYYNNILVYISLKEAPFLNGIKIDF
VKDSINEVFKYCNPRIKTFCGCGESFSID
>BUsg115 ydiK, hypothetical 39.8 kDa protein
MQNPKEKMDLSQFILSLIFIIAISATSFLIIQPFILGFSWASMIVIATWP
LMLKMQKFLGGKRLVAVIGMIIILLLLFIIPIVFLVNSLIKTSIPLIHWF
SSNNLEFPELIWLQDIPIIGKKIFISYQELLDSDGGELIREIRPYMGRTT
EFFIIQAKNCGLFIMHLTLMLLFSLLLYWNGEKISNSIRQFASRLSSRNG
EAIVLLSVQAVRAVALGVVVTALIQAVLSGIGLLISGVPYWTLLMILIVF
SCLIQLGPLPILIPSVIWLYWNSNTTWGTLLLIWSCFVFILDNILRPFFI
RIGSDLPTFLILLGVIGGLLAFGMIGLFIGPVVLVILYRLIVSWIYGISI
ASFLENTTLKSKSN
>BUsg315 yeaZ, hypothetical 25.2 kDa protein
MSDIILAIDTSIDHCSVAVYKKKVIYSLSENCKKEHTIKILPMIKKVLMN
AKITLKDLNYVAFSKGPGKFTGIRISIGIAQSLSLSLKIPIFGISTLSIL
AQKAWRKYKKKQILVAVNAKIGQVYWGEYLRNNTLLWTGEKTESLIKINK
IEDKMKKLKKKWILVGDGWKKIKRENSLKFEQKKILYPNAKDIIPFLFSE
NSKPRILSFF
>BUsg310 yebA, hypothetical 46.7 kDa protein
MQQIYKIIFLSFNQDFFYKTIKILINIILIVIFILLSSCNFLTDKKAFFL
NKEFSQKEKEFKRLKEKKEYLKKHTIHKHIFSYGNTISIFLKKSGVKIND
ILKLIKIDKNLNNITIGQKIVCKVDNLGNLIKLKWYISKFQKKIYKRYKN
TFKFIKYTYDSFLEKKSIYIKKNSNFFKSAYQSGLNKSEINSVIKAIEWQ
INFNKLHIGSKFNVIFLNQKTKNKKILLGVKLDNLDRKYFSIRAFNGKFY
DSDGFNKSEELINFSFLKKYRISSPFNLRRVNPVTHRISRHLGIDLAMPQ
GTPVIATSSGKIIKAQFNKIAGFYISLKNKNYYTTRYMHLKKILVKVGQK
IKKGEKIALSGNTGRTTGPHLHYEIWINHRAINPIKAEYILSTQLTKSER
IKYLKESKNILSKLK
>BUsg538 yeeX, hypothetical protein
MNTKKTFKSALEFVHKFRRKNKIKREISDIEKKIRDNQKRILLLDNLNQY
ITPDMNYEEIKKIIFMMKNDYEDRIDDYIVKNAELSKEKRSLSKELKLIV
D
>BUsg275 yfgB, hypothetical 43.1 kDa protein
MHKSINIKNISDDKINLLDLNRKEIEIFLLSLGAKKFVTDQLMKWIYNRH
CNNFNLMSNLKKDIRKKLNERSYIFASNFIEEKISYDGTVKWITSIDKQK
IETIYIPEKKRATLCVSSQIGCSLKCKFCATGQQGFNRNLKVSEIISQIW
QANKILKEKKNNSTITNIVFMGMGEPLLNLNNVISAIKIILDKNGFGLSK
RRITLSTSGIVPALNKLIKKIDVSLAISLHAPNDFIRNSIMPINMKYNIK
SFLNSVSKYLKHSHANRGGVTVEYVMLRGINDLNEHAEELGNILKKIPSK
INLIPWNFFKNANFICSSKNRINIFANILRKKGFNTTIRKNRGQDIGAAC
GQLTGDIVNRIKN
>BUsg583 yfgM, hypothetical 22.2 kDa protein
MHLNKMKKVSLKTYLVLFFLIFFIFCSFWFIKPKEKKLKLEKLRYEEVIK
KINAKNNQNLKSVENFITENKNIYGTLSSLFLAKKYILDKNLDKALIQLN
NSLKYTKEENLQNILKIRIAKIKIQQNKNQDAIKILEEIKDNSWKNIVEN
MKGDIFMKNKEIKKAILAWKKSKYLEKSNASKEIINMKINEIKR
>BUsg246 yfhC, hypothetical 20.0 kDa protein
MKSNRDSYWMKIALKYAYYAEENGEVPIGAILVFQEKIIGTGWNSVISQN
DSTAHAEIIALREAGRNIKNYRLVNTTLYVTLQPCMMCCGAIINSRIKRL
VFGASYKDLKKNPFLKKIFINLEKNKLKIKKHIMRNECAKILSNFFKNKR
F
>BUsg389 yfiO, hypothetical 27.8 kDa lipoprotein
MKKKNTVFIFMILFLSFAIYSKNLKNYNLILNNYLYQKCRKELKEKNFYK
AIFDLKKIENNHAINFNNDKIKMNLIYAYYKVSDFNTAEKNIEEFIKKYP
KHLNIDYIFYIQSLINISLDKKIFHNVFPIQIYKSNPIYAIKAFFQLKKF
VYNYPNSIYVINAKKDLFYLKKRLSEHDLTILKYYFYHKKYIAVINRGEE
ILQKYPETSAAIDTLKYMEKSFLALKIFDTAKKISKIILLNKV
>BUsg179 yfjB, hypothetical 32.6 kDa protein
MKQYFNCIGIVGRPRHSTALITHEILYKWLIKKGYQVFIEYNISKKLNLK
NPKTATLIEIGRLCDLAIVIGGDGNLLFTARILSYFNIKIIGINCGNLGF
LTDLNPDNKFKKLSEVLSGKYFVENRFLLDVMIYKKEQVSKSSIAINEVV
LHPKNVAHMIEFEVYINDNFAFSQRSDGLIISTPTGSTGYSLSAGGPIIE
TSLESILLVPMFPHTLSARPLLIRSDSVIRLRFSDIETDLKISCDSQIVL
PVKKKEYVFIRRSNYYLNLIHPKSYNYFETLTSKLNWSKKFF
>BUsg244 yfjF, hypothetical protein
MNIIKVKVVYALPDIQYIKEVHIDSNSTVKDAILASNLLNTVKNIQFYKN
NVGIYNKLVHLNENVKNGDRIEIYRNLIIDPKERRRKRSNICLKK
>BUsg404 ygbB, hypothetical 16.9 kDa protein
MRIGYGFDIHAFGSIKPLIIGGVQIPYNKGLIAHSNGDLLIHSLIDALLG
ATAMGDIGTFFPSEDKKYKNINSRILLKYIWKRIYLKNYRISNIDITIIT
ETPKILSYIFLMRSNIASDLNIKIEKISVKSTSSKMIGCIGRKEGIACQS
LVMLVKSKNTDRKNNII
>BUsg405 ygbP, hypothetical 25.7 kDa protein
MKLINSPKLKIIAIVPAAGIGRRMKLDFPKQYIKIKDCTILEYTLKTLLS
HPNIVRIVVSLHQEDNFFQKLSISSDLRVFSVLGGNERIHSVLSGLIITT
DAKWVIIHDAVRPCLSYQDLENLIAITKNTKVGGILARPVCDTIKYSNRK
NKTILHTIPRNQLWHALTPQLFPINLLRFCLKKIVEDKINITDEASALEY
CGYHPLIVLGSYKNIKITYPEDLIFAEFYLKELLKN
>BUsg406 ygbQ, hypothetical protein
MKMLKIFLLFLLFWLQCSLWIGKNGILDYIKIYKKIIVQKKKNEDFQIRN
NQLILEIERLNNAIKN
>BUsg401 ygcF, hypothetical 25.0 kDa protein
MYYPINEIFQTIQGEGYYTGTPSIFIRLQGCPVHCKWCDTKYTWKCNNED
QISYEKIIMKKKSNRKWSYMNVKEIILIIKIKKWTAKHIVITGGEPCLYN
LLEITKELEKEDYKCQIETSGTELIKCSLNTWITLSPKINKKTLKTSILR
SNEIKYPVLKKEDLFYLNSILKKIKNKKHNLIFLQPISQNEEALNICIKT
CIIKNWRLSVQIHKYLKIR
>BUsg402 ygcM, putative 6-pyruvoyl tetrahydrobiopterin synthase
MKTIIFKDFQFEAAHYLPYVPKMHKCRRLHGHSFFVRLELKDKINEKNGW
IIDYAEIKLAFQPIYDQLDHHFLNDIPGLENPTSEILAKWIWHRLKPKLS
ILNTIIIKETCTSGCIYQGF
>BUsg396 ygfA, hypothetical 21.1 kDa protein
MSTKRSQNRKEIRSYIRIVRNSVTLTKKYDESNKIVRTAFNCNIIYNAKN
IACFLSFDGEINTYPLILKLWLNNKNVFLPIVSSSYSRKLFFVPFTCKSI
LYYNQYNILQPFYNMKDIILESDLDLIIVPLVAFDCRGVRLGMGGGFYDQ
FLKNWERKKFIPIGMAYDFQFVNYIPRQPWDISLPIVLTPNKIHFFHQN
>BUsg420 ygfZ, hypothetical protein
MSLSKCFKNSIYPSINLPLTLSLLEEWCLIYICGIDSKKHLQNQFTIDIN
CLKKEEYKLCAHCNFNGKVWATMFIFHYKKGFAYIIRKSIAKIQIKELKK
YAIFSKVEIRELDDIYLFGLSGFNAKFFLSKNFVDIPNKNCSLISNQDRT
ILWFSEPCERFLLVLSLKDLLLLKRKENEITLLNNSKQWLLFDIEAGFPI
IDKQTSQKFLPQSINLILLQAVSFDKGCYYGQETIARVFYKNLNKYSLYL
LSSKGNINPKIGSIIEMKKEEKWYRIGFLLAIVHVEFNRTVIQAVLNKSI
NIQNIFRIYEFKNIFLIKN
>BUsg437 yggB, hypothetical 30.9 kDa protein
MNELNVVNDINHAGNWLIRNQELLFGYVINLTSAIIILISGMFIAKIISN
GVNQILITRHIDATIAGFLSALMRYIIITFTLIASLGRIGVQTTSVIAIL
GAAGMAIGLALQGSLSNFAAGVLLVTLRPLKTGEYVNLGNVAGTVLNIHI
FYTTLRTLDGKIVVVPNNKIISGNIINYSREPARRNEFSISVSYNTDIDL
VIKVLKRVIENEDRVMKDRDIVIGLSELAPSSLNFIIRCWSSTDELNAVY
WDLMVKFKKELDKNNINIPYPQIDVHLYKKNKN
>BUsg533 yggH, hypothetical 27.3 kDa protein
MKNNIITPQYNCNGTFLRKNRSFVCRKGRITKSQLQAIEKYWLSIGIDFK
LEPLDFTSVFKNSAPVILEIGFGSGESLVKTAANFPNKNFLGIEVYKSGI
GSCLRLAHYSGINNLKIIYHDAIEVIDQMILDHTLSKVQIFFPDPWNKKR
HHKRRMIQDFFLIKILKKLNNDGILHIVTDSKEYNFFILNLIQNIDNYIN
LSKKRMCFEHFKYRLVTNFEKKAKLSGNKIFDLIFKLKK
>BUsg395 yggJ, hypothetical 26.9 kDa protein
MKKRIPRIYIKYFLQINQVISLSKSYTHYIKKVLRMKKKDKLEIFNNTNY
IFFSEILEINNHTIEIIILKKQIKNLESPLLIHLGQVISKNEKMNFSIQK
SVELGVNTITPLFSEYCNFQNKLICFPKKKIHWENIVISSCEQCHRNNIP
EIKNPEYILPWCKRTYENETKIVFSPSATFTINELPEKINCVRLLIGSEG
GFSFLEIEKIIQYGFIPIKLGPRILRTETAVIAAITALQIKFGDLS
>BUsg531 yggS, hypothetical 25.8 kDa protein
MNNININIKIIKKKIQYFLKKNNYPLKKIKIIAVSKNQGIDKIKLAISSG
IHEFGENYVQEGIDKIQKLKKYQNIIWHFIGKVQSNKTKIIAENFDWCQT
IDREKIAILLNKYREKKSFPMNVLMQINISNEVTKNGICIKNYKKLAKTI
SLMPNLNFRGIMMMPEVEKKMIKQNDNYKNGNFIFNELKKEYQSIDTLSL
GTSFDIENALLFHSNMIRIGRFIFKNQVR
>BUsg532 yggW, hypothetical 42.6 kDa protein
MFKLPPISLYIHIPWCIKKCGYCDFYSYVNKSFIPEKEYIDHLLKDLEKD
LSLIKEREINSIFIGGGTPSLLKSSSIKKMMREIKKRINISNTAEITIEA
NPTTLEYKRFFNYKKSGINRFSIGVQTFNSDLLKKIERTYNKREAILAVE
EIKKINKNFNLDIMYGLPNQSLKDVLLDLQYAVKYNPTHISWYQLTLEPN
TPFYVKKLNLPNENNIFKMLVEGEKFLKQSGYKKYEISSYAKLNYECQHN
LNYWNFGDYIGIGCSAHGKITQINGDIIRTIKNKNINDFMNGKYLKHKNF
VLKKDKPFEYFMNIFRLYKPVLKRQFEERTNINQNYIKEKIKKAIEKGYL
KNKIDFWDTTKKGKMFLNSLLKIFLD
>BUsg535 yggX, hypothetical protein
MNRIIFCTFLQKKSEGQDYPPYPGKLGEKIYNQISKIAWKEWKLQQTKLI
NEEKLNMFNQNDRKKIEKYMKLFLFNNE
>BUsg160 ygjT, hypothetical 35.8 kDa protein
MIYFFISSLFFLILITLMFSKNIFKNIKKIKLFSKNNFFFYFLLFVLFIF
IFWLVVYTDQGIKVANQKIIYFLTSYFLEILLSIDNVFAWFFIFKSLKIP
LIYQKKVLLYGLWGALILRSIFSFSGSFLFSKWHWILYLFGGFFILTSLK
FIFFSNLECDNKEENIKKLWIYKFFRVTENINNENFFVKIEKKIFITPLF
VSLILIELSDIVFSVDSIPAALSVNNDLFIIFSSNFFAVLGLRSMYLFTA
YFLKNFPIMKYALSLILMFIGFKILIEKFFTFSIFLTLAVILIILITTFL
INLIFNLKKC
>BUsg359 yhaR, hypothetical protein
MNVIVNTENAPKPIGPYSQAIKNENFLIISGQIPIDVKSGKIPNNISEQT
YIVLKNIKSIIIASKYTIQDIIKITVFTTNLEKIHIINEIYEKFFIDNKS
SFPTRSCIEVQKLPKNVKIEMEAMAFKK
>BUsg376 yhbZ, putative 43.3 kDa GTP-binding protein
MKFIDQTIIQVIAGNGGNGCVNFRREKYIPKGGPDGGDGGDGGNVWLQSD
NNLNTLIDLRFKKTFQAPHGENGSGKNCSGKKGSDIKIYVPVGTKIINYQ
TREIIGDLIKHKQKILIAKGGWHGLGNTRFKSSINRTPRQRTLGSVGEKR
DIQLELILIADVGTLGMPNAGKSTLVKSISGAKTKIANYPFTTLNPVLGS
VNTEGKKFIIADIPGIMQNASQGFGLGVRFLKHLERCKILLHIVDLCPTD
HSNPVENIRIILNELKKYNTSLYNKPRWLILNKIDLIKSSEIKKIIDKIK
NFLKVEERFYLISSIKKIGVKKLCSDIAFYLQK
>BUsg511 yheL, hypothetical protein
MLHTLMKSPFETNISFFSGMLKKTDDFLALQDGVLIALIDNIFLKKITFS
SENLYVIKEDVYARGIHKNISSSFILISYIDFVNLTLKNKKQIIW
>BUsg512 yheM, hypothetical 13.0 kDa protein
MFISMEKIAFVFSHAPHGTSFGKEGLDVILGVSSIIKKISLFFIGDGVLQ
ILKHSKSENILARNYTSSFRILSIYDIKNFYCCKSSLIDRGLYSHNQFIL
KVNILNSYFFRIKLDDHDAIINF
>BUsg513 yheN, hypothetical 13.6 kDa protein
MNYTVLVTGSAYGTQNASTAFLFCQSLIKMSHILNSVFFYCDGVLNANNF
NKPSVDEFDLLSAWKQLNEKNKVKLYVCVSAASRRGVIEDEKISNTKIKN
GNFASFFQSSGLLELAYSIKISDRIIQF
>BUsg516 yhfC, hypothetical protein
MQNINQIKLTWISFFSYAFTGALIVITGMIMGDIADYFNLSVSEMSNIFT
FLNAGILISIFLNSWLIDLISIKKQLIFGFLFSIIAILGIVFSTSILLFS
INIFILGLVSGITMSIGTFIITCLYSGEKRGSQLLLTDSFFSMSGMIFPI
ISAYLLDRKILWYWIYVFLGIIYFLIFILTVKSHFPVSEEKTKNNNEIKN
LNINIILLSISALLYILGQLSFISWVPQYTTEIININIKKTGVLVSNFWM
AYMIGMWCFSFIIKFFNLQRMFIFLTGSSSVLMYCFIYSKSYLALKYTII
SLGFFSSAIYTIIITLASLETKKPSAKLINLILFFGTIGTLLTFIITSPI
VAKKGLYTTLIFSNVLYVIVFFLSCIIFKNSKKKDHC
>BUsg525 yhgI, hypothetical 21.0 kDa protein
MINISDKAQNHFISLLSKEPIGTQIRVFIINPGTQNAECGVAYCTEDDVE
NHDIKLNYNHFFVYVDRSIISFLKNSEIDLIVDNVGSQLTFKAPYAKQNY
SKNTASSLKERIENFLNNNINPQLSMHGGKVHLIQISQNNTALIKFTGGC
NGCSMIGTTLKEIVEKKILSFFPEIKKVIDQTDHLHGNHSFY
>BUsg434 yhgN, hypothetical 21.5 kDa protein
MNEIISTTILLILIMDPLGNLPIFMTILKKLDAKRRRIVVIREMIIALIV
MLIFLFVGEKILTILNLKTETVSISGGIILFLIAIKMIFPSDEGNNGTSS
EEEPFLVPLAIPLVAGPSLLATLMLLSHQYLHHMPYLVGSLLIAWFFTII
ILLLSGLFLKLFGDKGVNALERLMGLILIMLSTQMFLDGIKAWFKN
>BUsg432 yhhP, hypothetical protein
MISISLKKTKYEKKNIILNLIGLRCPEPIMVIRKTLRKMKKNEKILVLAD
DPSTKRDIPYFCYFMEHQLLDRFIHVKPYRYLLKKG
>BUsg565 yhiQ, hypothetical 26.9 kDa protein
MNIYLIINHENQRIQNLIDKYHLKHDENSSMALIMNSNSLELYDRSKPRN
KSIKVNFSSKKNNYRCLNFKKKNEILYKAIGIKKNYFPSVLDATAGLGQD
SFLISFLGCYVIMMEYHPVIAALLTDGLERGYKDEKIGFWLKKRLHLIYD
NSLNILNIPISQPDVIYLDPMYPINKKKSLPKKNMQFLRKLANKDDQSKN
LLKVARKFAKKRVVVKRPSYANPISDEKVDFIISNKYHRFDIYLPFKKK
>BUsg049 yibN, hypothetical 15.6 kDa protein
MQDALFFISNNLVLSLIWLFFLILIFFLSTKNMFLKSKIINNFHAINLIN
QKKAIIVDTRSVELYDSGHIINAINIPFNNICRKTIKKLSLSRSVPIILI
IDSLEYNKYIKKFTKYGLDKVYFLKNGMNSWNSENLPTTFKKNIFLK
>BUsg016 yidC, inner membrane protein
MMELQRNFFIFAFLFVSFLLWQAWQSQSLKKNKKNEETNSFFHLNHKKED
KNQIIIKNDVLRLVINMYGGDIEEASLLDYKTQLNSPENLKLLETKSDFV
YQAQSGLIGKDGLDNSINKIRPLYSAKKNFFELGHNEKELRVPITFIAKN
GITYIKNFILKPGKYNVEVEYDINNLSNKKLELNIFGQLKQTVKLPKNRD
IYSGNFALQTFRGAAYSSSDAKYEKYKFDNIANHEHLHIITHHGWIAMLQ
QYFVVAWVPDTNISSSNIIYTSYLDNDGIAIIGYKSSLINIPSNSRYIIK
SKLWIGPEKQQEMALVAPNLDLTVDYGFLWFLSQPLFKLLSTIHNFIGNW
GFSIILITFMMKAITYPLTKAQYTSMSKMRELQPKINELKKNFGHDKQRM
SKEIMALYKKEKINPLGGCLPVFIQMPIFLSLYYMLIGSVELRHAPFLFW
IKDLSDQDPYYVLPIFMGLTMFFIQRTSSNNISDPFQQKIMHFMPFIFTV
FFLWFPSGLVLYYIVSNLVTIIQQKYILSNFKKNQKR
>BUsg015 yidD, hypothetical protein
MVKLSTIVVFCLTFFVSIYQNYISFFMPSNCRFYPTCSTYMILSLRKFGV
IKGIILTILRLFKCHPLHQGGEDLVPLKIKDKSEY
>BUsg029 yigL, hypothetical 29.8 kDa protein
MYRIIAADLDGTLLSPENKITKYTEKIIKFLIEKGFYFVFASGRHYIDIM
KIRDTLNIKVFMITSNGAQVYDLNNVLIFENHLDEEIALKLCKMKYLDAD
IITQVYRNNQWYINNNKIDNNFCPTLSSLRYKYFCPDVFNFKKVSKVFFT
SHNLKKLHTLQKDIISFLGNRVNVHFSVPGCLEVVSGEVSKGYGLKLISN
ILGISLKECITFGDGMNDQDMLSISGKACIMENADSSLKKNLPYAEVIGS
NKNDGVAVFLNKNFIKNNKFIKCF
>BUsg417 yihA, hypothetical GTP-binding protein
MIILNYNKTFFLKSISNISDIQIEHGIEIAFIGYSNSGKSSAINALTNQK
KLARFSKTPGRTQLINLFQVTSDFRIVDLPGYGYAKAPLLIKIKWQNMIY
SYLKNSRSLKGLVLLMDIRYPLKILDQDIISMALNCKIPILLLLTKCDKF
TINNQKIQFQKVYEKLDKFLNELHIQLFSSLKKIGIEKLKSKLNFWYEKY
R
>BUsg020 yjeK, hypothetical 38.7 kDa protein
MKHYNTKKLNREKDSWLYEISNSIVEPKKLLKFLHLEKYPKYYDSKPKKV
FPFRVPYSFASRMKKNDPKDPLLLQVITKNQEFLNNLQFNEDPVKEKKDI
VLPGLLHKYKDRVLWILKTNCAINCRYCFRKHFPYEKNKGNKKNWIQILH
YISQNIELNEVILSGGDPLMAKDHELLWLITSLSKIKHIKRLRIHTRLPI
VIPNRITSDLCQIFSNSVLKIIIVTHINHPQEINEQLSDSLLKLKKSNVI
LLNQSVLLKNINDNAIILAELSSRLCENNIIPYYLHILDKVKGTSHFLVS
NKKAKSIISDLMKMISGFLVPRLVFDNGSKDNKLIII
>BUsg319 yjjT, hypothetical 37.6 kDa protein
MIFSKNSQLILRHQKIFKNKIVFFSGNIEDELPINLLTIKTKIHLQKSQN
FLKINNNKNITFYRKLLVSQDTVQDCNILIYYWPKNKSEARFQLFNILSF
LPIKSEIFIVGSNSSGVKSAKLILEESIKLKKIDNANHSILMSGILINKT
KFKLEKFFKIHIWKNLIIKSLPGVFGHKKIDEGSKFIASTFSEKINGKIL
DVGCGSGFLSVSILRKSPKCVVTMIDRKLSALESSKATLDANFFKGEVLS
SNIYSNIFKKFNMIVSNPPLHDDLKINFDITKKIIFNSKKHLKKNGELRF
VTNHCFSYDFYLKKVFSEFHIMKKDNKYKVYQAFLK
>BUsg426 yleA, hypothetical 53.7 kDa protein
MKYIYIKTWGCQMNEYDSSMITVFLEKTGRYLITKEVEKADILILNTCSI
REKAQEKVFHQLGRWKKLKNKKPDVIIAVGGCVATQEGKEIFKRANYVDI
VFGTQTLHKLAQMIDKVEKNRRFMIDISFPQLEKFNYSLEPKKTGYTASI
SIMEGCNKYCSFCVVPYTRGHEISRPSDDILLEISILAENGVREINLLGQ
NVNAYRGRTFNGKICFFSELLRLVSEIDGIDRIRFTTSNPLEFTDDIIEV
YQDTPKLVSFLHLPVQSGSNRILQLMKRSYTTEEYEKIIEKLILARSNIQ
ISSDFIVGFPSESEEDFQKTINFIKKINFDMSFSFIYSSRPGTPASEMKD
NIDLQEKKKRLYTLQNCINKQTMSWSRKMLKSTQSVLVEGVSKKNIMELY
GKTENNRIVTFKGSHKMIGKFIKLKIKKVHTHSLQGELI
>BUsg567 ynfM, hypothetical 45.3 kDa protein
MDIYTYKKHILFKKCFLYFWKIKNVIKKKNTKKFNQIVLSLFLGGFSSFS
ILYCVQSILPVFSKQFCLTATESSLSLSAATATMSIGTLFIGPLSDRIGR
KSIMSSSLLIAAVLTIICSISNNWTVIVFLRALTGLALSGVVAVAMTYIV
EEVHPNSVSFCMGLYISGNTIGGCSGRILSSILAEYFSWHIAFIVIGFFS
LMSSCLFLYFLPSSKNFYPISIDFNKFLKNFYLHLKNPTLLILFAIGFML
MGSFITIFNYISYRLMLSPFFLSSSNIGFLSIIYLTGVYSSPKAGILINQ
YNRSSILRIALLLMILGLLMTQYNEIFIIILGLVIFSSGFFASHSIASSW
IGFHAKIAKVQATSLYLFFYYLGSSIFGTFGGFFWFYLKWIGISSFIIII
LIFAILLSLKLKK
>BUsg314 yoaE, hypothetical 56.5 kDa protein
MEFFLDPSIWAGLLTLVVLEVVLGIDNLIFVAILSEKLPPNQRDKARLIG
LGLALIMRLALLSLISWVVTLTSPIISNNFFSLSIRDLILLIGGLFLLFK
ATIELHERLENEDHENTENKNYASFWAVVIQIVVLDAVFSLDAIITAVGM
VNQLLIMMIAVVLATILMLLASKALTNFINIHQTVVVLCLSFLLMIGFSL
VAEALKFYIPKGYLYAAIGFSILIEIFNQIARHNFMKNQSRKPMRQRAAE
AILRLMIREKNNNKNRIKTDNKAEIVLSSSLETETFKDEEKYMINGVLTL
AGRSIKSIMTPRSNISWVNTEKTINEIRLQLLDTPHNLFPVCKGELDEII
GIVRAKELLVAIEKNIDVYTFASQIPPIIIPDTLDPINLLGVLRRAQGSF
VIVSNEFGVVQGLITPLDVLEAIAGEFPDADETPDIIKEQNSWLVKGETD
LHSLQQLLNTKELIKQDDCASLGGLLISQKGQLPLPGETIKINSFSFHIV
NATEYRIDLVRITKN
>BUsg288 yqcD, hypothetical 29.0 kDa protein
MSLKINNFNFLRPISRKKHRKKIKLNCLNLPFKGKDIWTLYELSWLNKNG
LPQIAIAKIEIDVNSANIIESKSFKIYINSFNQMKFNNNIDFINILTNDL
TKCICGQISIKLFSLDAIKNETITDFHGICIDNQNIKIESYKYTPSFLMI
NSERKIIKEDLYTHLFKSNCPVTQQPDWASIYIAYTGLSINHASLLRYLI
SFRSHNEFHEECIERIFNDINNICKPEELSVYARYTRRGGIDINPWRSNT
NFSPFLTRLARQ
>BUsg530 yqgF, hypothetical 15.2 kDa protein
MKIKYINRDQKMIVIAFDFGLKNIGVAVGENILKKGRALNKLSAKNGSPD
WNNIKNLLKIWQPKFLVVGLPLNIDGTRQDITKKAEKFAFLLKYKFNIFV
YLHDERLSTKEAKSLIFKKNGFKVLKKEKIHSVAAVIILESWFNQNLY
>BUsg083 yraL, hypothetical 31.3 kDa protein
MNSLNKTGLLYIVPTPIGNLSDITYRAVETLKNVNLIAAENIHHTNILLQ
HYNVKNILISLNKNNEKKQSDYVINELKKGKKIALVSDAGTPVINDPGYF
LVKKCCFLNIKIIPLPGPCAAITALSASGISTNRFCYEGFLPSKKKIRRD
LLKSLKKEIRTIIFYESKHRILESIKDIIETIDENRYLVIAREITKKWEY
IYGAKANIILSWLKEDQSRYKKGEIVIIIDGFKELKNKDISAKAINTLTI
LRNFLSLKQSVFITSKIHKIKKNDLYQHAIKEKDK
>BUsg372 yrbA, hypothetical protein
MNKKKIISILKEKLNLKDIYVTEDNNHYEITAIGNVFKGLTQVKRQKKIY
NPLIDLITENKIHAISIKSYSLEEWDKNQK
>BUsg475 yrdC, hypothetical 20.8 kDa protein
MSKDYFLSSLIKCIRKLYDKKIIAYPTEAMFGLGCDPTSEKAVKRLLDLK
KRSIKKGLILVASNYNQIKMYINESKLSAQQKKTMFFHWPGPYTFLVPAN
SLVPCWLTGQFDTIAVRISAHFSIIKLCNVFGKALVSTSANISNMSPCLT
REDVLKDFGKDFPVLYGHIGNESHPSKIINIVNGKLIRYV
>BUsg080 ytfN, hypothetical 136.8 kDa protein
MSLYQRYLSKSLIFIFSLFFLILFFLESSIGFKYFFNFTNYFFIGLKTEE
ISGNWRDFKLKKINFNIFGTSIKAESVHIITDPISLFKVSTILKKIKTKN
LVISFNKKIKKVALKNNFLKEKKIKNTIFFKHSLILRKIYSDKILLKTQK
KNIFLFGVFSGLQLSNDTCTFLPTKINSIYIDSSMRNVKNIDNKKSNFFI
KKDIFYRNKIDNALSFFSIFKNFFIPININLINLKCNQLKFFNRTFLDIY
KIKMSAQLKKNILKIKKIQIYSKYFKTKSKGKIFFRSDFSIFFIVKNEMS
INIINNKAMNLLFKDTIDHKLNFKSNNLIKFNIHGEISLDDLNYPIHINL
HLNRLFLPISKNLILSSKNFNFSLKGKINNYFLSLKNIINISGMPSFFIS
ISAIGNIQNVVIKKIHFFPFFKEIKTKKFIKIKKEIDYNKYITQLAGKMR
ILSDFNKQSSNIFLPYFHVYGDFMRKKISVLGSLYYRKLNGITIPRINFL
LGKNKGHISGSISKKVNLRSSIYANNLNYFSPNLKGIIKATLNIYSFCSL
PSFSSVILGQKINWKNILYFNNIKITTNGNLKKSFPNKFFADFKNIRFSK
FHINSLHIKSDWNNINQKFSLSLKDKKLSITFILNGHLNRKVGIWKGVLK
KIDVKTSWGQWISRNNPLIFYHIKNSINFKNIKKIKNKNAFYSAINNIQT
SLFKLIRQSPVKFQTDLFFNTQFQWKLRENITNLKLFLKGSNINLEKKIK
EKIMFEKISAVNLYINFKKNNFITKWIIKKSKNSLKVNKISGFLNIYDFF
HEKKIEGKVFLSDFSCSFLNFFENFFTKIQGKFSGNINFLGTIYQPQISA
DINFQDFYIKSDKIFKYMLLFFCSFPNKIENIKINQEIIMKKGNALFKLN
SVVKNNISHIKWNILFHSNKLAIVLFPKIKLNFSSQLNLYYFLSKYDLIG
YLKFSFFSFKINEKNFLF
>BUsg309 znuA, high-affinity zinc uptake system protein ZnuA
MNINIMLKNKKKKFFSILAILFILMPNNSYASILTVFKPLGFIAAAIAHN
VTNVEVIPPNGTTVENYYLLPFDLIKIKHSDFIILIGDQIEPFFFKKAVK
YFKKKTIVLTKIKNIKFLLKHKSNFKKGKKKQKNTLQNKKEINNISYDMY
LWLSPQIALESAIVIHDMLLKSMPQKKITIDKNLKYFKLCLSKTNKDIKK
NVLSIKEKKYFTFHNTYKYFEKFYGLHPSGQFKTYPGIKTGVQYLYKIKN
ELLKKQAICVFIEPQFHANIIDFIIQGTNIQKENLDLFGTAIPLVQDSYV
NFLVKLSNQYISCLKKI
>BUsg307 znuB, high-affinity zinc uptake system membrane protein
MFELIYPGWLAGILLSFATGPLGSFIIWRRISSFGDTLSHSSILGLAISI
LFQIDSFYTELFFMSFLAIILVWMEQLLSVSLETILSIISHSSLSLGIIC
ISLMSTSHHIDLSNYLFGDLLLVTVFDLCIIALGSLIVLTILFFRWNSIL
LLTVNEELAQIDGVNIFYARLTLMLTTAICISIAIKFVGVLLITSLLIIP
PATAQIFSNSPEKTIGFSILISIISVTGGIFLSFFYNVPTSPSIVLFSSC
VYLLSNIKKLI
>BUsg308 znuC, high-affinity zinc uptake system ATP-binding protein
MLELITLKNIHVSFSGRSILSNISFSLLSNRIITLIGPNGAGKSTLIRVI
LGLIQPNLGNIIRSPKISVGYVPQKLYFNNLLPITVEKFMKLSKRKKNIN
ILKILKRVKAQSLQYSRLQNLSGGEMQRILLARALLNNPNLLVLDEPTQG
VDVMGQLDLYELINQIRSEMQCSILIVSHDLNFVMAKTNYVICLNKHICC
SGTPQTVFKNLEFISIFGLKHIRELAIYQHNHDHVHQY
>BUsg312 zwf, glucose-6-phosphate 1-dehydrogenase
MIIETNQACDLVIFGTKGDLARRKLLPALYKLEKSQKIHPDTRIIGTGRA
DWNTEDYIKIVKKAIKMFLNEKIDEKIWKKLRSRLNFFYIDVFQDLHFLE
LKNILNQKKNIIIYYCAVPSNTFNAIFTGLGKVNLNSFPSRIIIEKPLGV
SLETSKKINNQIAKYFLESQIFRIDHYLGKESILNLLALRFSNSFFFHSW
NNKIIDHIQITVSEEVGIENRWNYFDQMGQTRDMVQNHLLQILTIVSMDK
PKNITPEGIRDEKLKILRSLKKIDLNEIHIKTARGQYASGIINGKKVPSY
IEENGANKHSKTETFVSIKVDINNDRWFGVPFYLRTGKRLAYKYSEIVIV
FKKISKNLFQEFNKNLSPNKLIIRLEPNESIKIYFLNKVPGLSKEYKLKS
DKMEFNFNINNTKNFVDAYERLLFESMRGIQSLFVCREEVEEAWKWIDPI
INGWKKTNINTVQLYKSGTWGPKSSDEIIMRDGRFWETFN